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Abstract 
Background: Although previous studies have reported a J-shaped association between the 
volume of alcohol consumption and incidence of type 2 diabetes (T2DM), a number of 
limitations weaken the validity of such findings. This thesis aims to systematically explore the 
effect of key methodological shortcomings. 
Methods: Analyses were undertaken using Whitehall II data from 1985-2013. To examine the 
degree to which conventional survival analyses might be subject to misclassification error due 
to the use of a single baseline measure of drinking status, mixed effects models were used to 
plot the trajectory of alcohol intake according to baseline categories of consumption. Mixed 
effects models were also stratified by diagnosis status to shed light upon whether increases or 
decreases in risk are likely to accrue gradually over the life course or occur as a consequence of 
differences in intake specific to periods of heightened biological sensitivity. Finally, given 
changes in alcohol consumption across the life course, increasingly complex survival models 
were used to explore the relationship between different dimensions of the longitudinal 
trajectory and T2DM risk. 
Results: Alcohol consumption within categories of baseline drinking converged over the adult 
life course toward moderate volumes, with moderate drinkers increasingly contaminated by 
participants defined at baseline as heavy or infrequent drinkers. Men who developed T2DM 
were found to increase their consumption up to their date of diagnosis, while drinking among 
women remained relatively stable up to diagnosis. Marked decreases in consumption were 
evident among both sexes following diagnosis. Reductions in the risk of T2DM were specific to 
or most pronounced among female current drinkers in middle age, with drinking in later life 
associated with an increased risk regardless of sex, after adjustment for prior consumption.  
Conclusions: Variations in alcohol consumption across the adult life course highlight the 
importance of considering drinking histories when defining alcohol consumption categories, 
with the risk of misclassification error appearing to increase with age. Although reductions in 
the risk of T2DM were most pronounced among middle-aged women, evidence concerning the 
determinants of such a sex-specific disparity is lacking. That risks are heightened in older age 
suggest that any benefits from drinking earlier in the life course may be countered by age-
related deteriorations to the alcohol metabolism.  
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1 Introduction 
Diabetes mellitus (DM) is a condition implicated in the development of vascular dysfunction and 
thereby a heightened risk of numerous vascular conditions, including coronary heart disease 
(CHD) and ischaemic stoke,1,2 as well as blindness, kidney failure and limb loss.3 Beyond its 
human costs, the financial burden of the condition is sizeable, at up to £13.8bn of National 
Health Service (NHS) expenditure in 2010/11 and an estimated annual loss to the United 
Kingdom (UK) economy of £15.4bn through absenteeism and early mortality.4 
Such factors are made all the more alarming by trend data indicating a rise in the prevalence of 
DM over recent decades, particularly within older age groups.5 By 2014, DM was estimated to 
affect 6.4% of adults living in the United Kingdom, or around 2,913,538 people – an increase of 
67% relative to 1994.6 Thus, although the rate of newly diagnosed cases appears to have 
plateaued in recent years,7 DM continues to pose considerable human and economic costs that 
represent a substantial public health challenge.  
Fortunately, around 85% of known cases are of a type caused largely by exposure to deleterious 
yet modifiable lifestyle factors,8 indicating that many future cases may be preventable. With this 
in mind, Public Health England published in 2015 a systematic review into the effectiveness of 
preventative lifestyle intervention programmes, of which the majority appeared to target 
improvements to physical activity and diet, including the regulation of fat and fibre 
consumption.9 
In contrast to these programmes, a growing body of evidence has suggested that alcohol 
consumption may play a role in reducing the risk of type 2 diabetes mellitus (T2DM), with one 
meta-analysis from 2009 reporting that men and women who consumed ~22-24 g/day (154-168 
g/week) of ethanol may be subject to a one-third reduction in the risk of T2DM, relative to never 
drinkers,10 or a volume of intake equivalent to around 1.2 pints of 4% alcohol by volume (ABV) 
lager per day.11  
With alcohol consumption appearing to represent a modifiable risk factor to which the majority 
of UK adults are exposed, Chapter 2 provides a more detailed overview of the evidence 
concerning alcohol consumption and T2DM, as well as a number of biological mechanisms by 
which alcohol consumption has been hypothesised to modify a person’s risk of T2DM. The 
chapter also includes a summary of recent trends in alcohol consumption behaviour, and 
outlines a number of methodological limitations that may have led to an overestimation of 
reductions in T2DM risk at moderate volumes of alcohol intake. Acknowledging these 
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shortcomings, Chapter 3 reports results from an updated and revised meta-analysis that set out 
to explore the effect of such factors upon the observed dose-response relationship, with 
Chapter 4 providing a summary of the current literature, including gaps in the evidence base, 
such as a failure within conventional literature to consider the effect of longitudinal changes to 
drinking behaviour. Chapter 5 sets out a number of aims by which the longitudinal relationship 
between alcohol consumption and T2DM risk can be better understood, with Chapter 6 
describing the selection and structure of a dataset for such an exploration and Chapter 7 
establishing the suitability of the chosen cohort for quantifying the association between alcohol 
consumption and T2DM. Chapter 8 reports changes in alcohol consumption over the adult life 
course and investigates whether these trajectories differ according to T2DM diagnosis, while 
Chapter 9 utilises increasingly complex survival analyses to formally explore the relationship 
between different dimensions of the longitudinal trajectory and T2DM risk. Chapter 10 
summarises findings from the analyses undertaken and documents a series of policy implications 
and areas for future research. 
  
Chapter 1: Introduction  
23 
 
 
  
24 
 
Chapter 2 
Background 
Chapter 2: Background  
25 
 
2 Background 
2.1 Diabetes mellitus 
DM is a chronic metabolic disorder characterised by the body’s inability to effectively regulate 
the metabolism of carbohydrates and fats, leading to chronically elevated levels in the 
bloodstream. Such a homeostatic impairment is currently understood to take two primary 
forms:  
 Type I diabetes (T1DM): an auto-immune disease in which an abnormal immune 
response leads to the destruction of insulin-producing pancreatic β-cells. Given the joint 
role of insulin in promoting the absorption of glucose from the blood into muscle and 
fat tissues, and the inhibition of glucose release from the liver, absolute insulin 
deficiency as associated with T1DM results in a build-up of carbohydrates and fats in the 
bloodstream.12 T1DM has been identified as most common among younger individuals 
and estimated to represent around 5-10% of known cases worldwide, or around 15% of 
known cases in England.8 
 Type 2 diabetes (T2DM): T2DM is characterised by relative insulin deficiency (reduced 
production) and/or the presence of insulin resistance (impaired response), which 
develop progressively over time and commonly following prolonged exposure to 
detrimental lifestyle factors, such as obesity.8 Accounting for around 85-90% of known 
cases, T2DM represents both the most common and preventable component of DM.  
Regardless of type, these metabolic abnormalities have been linked to an increased risk of 
numerous vascular complications and corollary costs to health services and the economy.  
2.1.1 Costs 
2.1.1.1 Morbidity and mortality 
Although the precise nature of the relationship between DM and vascular pathogenesis appears 
complex and multifactorial, with biological mechanisms currently posited rather than 
conclusively established,13,14,15 DM has been associated with the onset of numerous deleterious 
vascular conditions.3 
Chief among these, macrovascular conditions appear to represent the leading cause of 
morbidity and mortality among diabetic patients worldwide, with cardiovascular disease (CVD) 
accounting for around half of all documented deaths.16 This elevated cardiovascular risk profile 
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among people with DM was first identified in 1979, when data from the Framingham study 
indicated that participants with the condition were twice as likely to develop CVD as those 
without, even after adjustment for age, sex and common cardiovascular risk factors such as 
smoking.17 Subsequent studies have consistently identified an elevated risk of macrovascular 
health complications among people with DM.1 The latest macrovascular risk estimates are 
provided by an analysis of data obtained via the CALIBER programme, which links data from four 
English electronic health databases.2 Based on a cohort of over 1.9 million participants, T2DM 
was positively associated with more than a 50% increase in the risk of heart failure (HR 1.56, 
95% CI 1.45-1.69) and myocardial infarction (HR 1.54, 95% CI 1.42-1.67), as well as a 72% 
increase in the risk of ischaemic stroke (HR 1.72, 95% CI 1.52-1.95). Elsewhere, studies indicate 
that recovery from such conditions may also be impaired among persons with T2DM, with such 
individuals having exhibiting a heightened risk of stroke recurrence and post-stroke 
mortality,18,19,20,21 physical disability22 and dementia.23,24  
Aside from macrovascular conditions and their negative consequences for health, diabetes-
induced damage to the microvasculature represents a further serious concern, increasing the 
risk of conditions ranging from kidney failure and incontinence to limb loss and blindness.3  
2.1.1.2 Primary care expenditure 
Through its direct impact upon population health, DM necessitates investment in a wide range 
of health services. Applying estimates of disease prevalence and population size to inpatient and 
outpatient data available from Hospital Episode Statistics and other sources, two recent studies 
have attempted to calculate expenditures for healthcare resources including diagnostic tests, 
primary care consultations, prescription drugs and treatment for diabetes-attributable vascular 
conditions. Depending on the methods and data utilised, these direct costs have been estimated 
at between £9.8bn25 and £13.8bn4 in 2010/11, or around one-tenth of total NHS expenditure 
over the period.26 These figures represent the latest published estimates of DM-related primary 
care expenditure. 
2.1.1.3 Indirect costs 
Costs associated with DM are not limited to health services. As a chronic and sometimes 
debilitating condition, DM can also introduce indirect costs to the economy through premature 
mortality, early retirement, absenteeism and an increased dependence on social welfare and 
care services. 
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Few sources of UK-specific data are available for determining indirect costs attributable to 
diabetes.4,25 One approximation was undertaken by The Economist Intelligence Unit in 2007 
using data from the United States (US),27 which estimated foregone earnings attributable to 
absenteeism and mortality at £1.7bn/annum in the UK. Elsewhere, attempting to include 
indirect costs due to presenteeism, informal care and welfare, estimates of between £13.9bn25 
and £15.4bn4 were estimated for 2010/11.  
Whatever the precise figures, direct and indirect costs look to be sizeable – an observation 
notable given stagnated or reduced NHS, public health and social care budgets,28,29,30 plus 
ongoing increases in the number of cases requiring treatment. 
2.1.2 Prevalence and incidence 
According to data published at the end of 2015,5 the prevalence of self-reported DM cases 
among non-institutionalised adults in the England rose from 2.4% to 6.2% between 1994 and 
2014 (Figures 2.1 and 2.2), reaching 2,707,850 cases by the end of the period.31 Taking a more 
inclusive measurement, capturing both institutionalised and non-institutionalised residents 
from across the UK as a whole, objective data collected as part of the Quality and Outcomes 
Framework (QOF) indicated a prevalence of 6.4%, or 2,913,538 cases in 2014/15.6 Temporal 
increases in the prevalence of T2DM appear most pronounced among older age groups, with 
prevalence consistently greatest among men.  
 
Figure 2.1 Age-specific prevalence of male self-reported doctor-diagnosed DM. Health Survey for 
England 1994-2014. 
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Figure 2.2 Age-specific prevalence of female self-reported doctor-diagnosed DM. Health Survey for 
England 1994-2014. 
However, a marked rise in the prevalence of T2DM does not necessarily translate to a DM 
epidemic; an increase in prevalence may occur instead as a result of successful public health 
initiatives, such as improved disease management and consequent decreases in premature 
mortality.32 Looking instead to the number of new cases diagnosed each year, trend data from 
The Health Improvement Network (THIN)33,34 indicate that, while the incidence of T1DM has 
been low and constant over time, the age and sex standardised rate of T2DM rose by 63% 
between 1996 and 2005, to 4.31 cases per 1,000 person-years at risk.35 Although alarming, more 
recent figures indicate that these earlier increases may now have stabilised, falling to 3.99 and 
3.73 cases per 1,000 person-years at risk among men and women in 2013 (Figure 2.3).7  
These figures indicate that increases in the prevalence of DM are most likely a consequence of 
improvements to the treatment and management of the condition, and resultant reductions in 
premature mortality. However, although an average 15,665 new T2DM cases were diagnosed 
annually between 2000 and 2013,7 the human and economic costs of DM are not inexorable. 
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Figure 2.3 Crude annual incidence of T2DM per 1,000 person-years at risk. THIN 2000-2013. 
2.1.3 Risk factors 
A number of risk factors have been identified for the development of T2DM, ranging from 
adiposity and smoking, to alcohol consumption and physical activity.36,37 While not all factors 
are modifiable, current epidemiologic evidence indicates that the risk of T2DM may be 
attenuated in large part through simple lifestyle changes. Several risk factors are discussed 
below, beginning with adiposity and ending with alcohol consumption. 
2.1.3.1 Adiposity 
Some of the rise in the incidence of T2DM observed between 1996 and 2005 was posited by 
researchers as attributable to rising obesity over the period, with the proportion of newly 
diagnosed patients presenting as obese having risen by 22% over the period, reaching 56% by 
2005.35 This was better substantiated by results from the British Regional Heart Study, which 
indicated that 25.9% (95% CI 16.5-38.3%) of the rise in T2DM incidence among men between 
1984-1992 and 1999-2007 was attributable to an age-adjusted increase in average body mass 
index (BMI) of 1.42kg/m2 (95% CI 1.10-1.74kg/m2).38  
An aetiological association between obesity and T2DM has been supported by multiple 
longitudinal studies, including a meta-analysis of 15 cohorts, which identified a standard 
deviation increase in BMI raised the relative risk (RR) of T2DM of by 55% (RR 1.55, 95% CI 1.43-
1.69), with similar increases identified across alternative measures of adiposity, including waist 
circumference (RR 1.63, 95% CI 1.49-1.79) and waist-hip ratio (RR 1.52, 95% CI 1.40-1.66).39 
Although waist circumference was found to be a stronger predictor of T2DM risk than BMI and 
waist-hip ratio in primarily white study populations, this relationship differed according to a 
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diverse range of participant characteristics. Regardless of the measure adopted, the importance 
of adiposity as a predictor of T2DM risk is supported by studies that indicate decreased insulin-
mediated glucose transport and metabolism within adipose tissues relative to skeletal muscle, 
contributing to the development of insulin resistance and hyperinsulinaemia.40 
2.1.3.2 Diet 
Given links between adiposity and T2DM risk, a number of dietary exposures are likely to be 
important modifiable risk factors for T2DM risk, including fat, carbohydrate and fibre 
consumption.  
Fibre has been hypothesised to reduce T2DM risk by hastening intestinal transit, decreasing the 
amount of carbohydrates and fats digested and dispersed into the bloodstream.41,42 Data pooled 
from 17 studies indicated a 9% reduction in risk per 10 g/day increase in total fibre consumption 
(RR 0.91, 95% CI 0.87-0.96). 
Through their effect on blood sugar and obesity, carbohydrate-rich foods have been found to be 
linearly associated with the risk of T2DM. With foods ranked according to their glycaemic load 
(GL), with one unit equal to the effect on blood sugar of consuming 1 g of glucose, figures 
collated from 18 cohort studies indicated a 3% increase in T2DM risk for every 20 unit increase 
in GL per day (RR 1.03, 95% CI 1.00-1.05).43 
By contrast, results reported by a recent meta-analysis of eight longitudinal studies indicated no 
dose-response association between saturated fat consumption and the risk of T2DM, with 
elevated risks observed only among crudely adjusted models.44 Similarly, despite 
polyunsaturated fats commonly found in fish having properties thought advantageous toward a 
lowering of T2DM risk, including reductions in serum lipids, platelet aggregation and blood 
pressure,45 data pooled from 18 cohorts identified no association between T2DM and fish 
consumption (RR per 100 g/day 1.12, 95% CI 0.94-1.34) or polyunsaturated fatty acids (RR per 
250 mg/day 1.04, 95% CI 0.97-1.10).46  
Reporting an array of positive, inverse and null associations, studies sampled as part of the 
saturated and polyunsaturated fat meta-analyses were notable in their considerable degree of 
heterogeneity, drawing into question the validity of reporting single summary measures. It was 
possible that real dose-response effects were lost due to noise resulting from marked 
differences in methods, populations and quality. While the proportion of variation in risk 
explained by between-study variance was low to moderate among fibre (I2=29%) and GL studies 
(I2=54%),43 heterogeneity was considerable among those that investigated saturated fats 
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(I2=91%)44 and polyunsaturated fats (fish consumption, I2=81%; polyunsaturated fat 
consumption, I2=78%).45 Additionally, the majority of sampled studies had adjusted for some 
measure of adiposity. With obesity likely positioned on the causal pathway between fat 
consumption and T2DM risk, it was possible that risks associated with dietary exposures had 
been biased toward the null by having controlled for an important intermediate factor.47,48  
Taken collectively, fibre and carbohydrate appear to have an important influence upon T2DM 
risk beyond any effects they might have upon adiposity, while the effects of saturated and 
polyunsaturated fats remain inconclusive owing to substantial heterogeneity between studies. 
2.1.3.3 Heritability 
Although not modifiable, a predisposition to T2DM appears to be transferred vertically between 
generations via genetic inheritance. Compared with age-specific rates of T2DM as found in the 
US general population, individuals with a parental history of T2DM were found to have 2.3 times 
the risk of T2DM, while those with both a parent and a grandparent exhibited 3.5 times the risk 
of having developed the condition.49 
Looking to the incidence of T2DM as documented by the largest twin study to have explored the 
heritability of T2DM, the degree of concordance was reported to be 34% (95% CI 27-41%) among 
monozygotic and 16% (95% CI 12-20%) among dizygotic twin pairs, with levels of concordance 
higher among female twins pairs50 Indeed, the proportion of total variance calculated as 
attributable to genetic factors was highest among women, at 69% of male and 79% of female 
variance, suggesting that women may be more likely to inherit a genetic predisposition to the 
disease.50 Other studies have reported higher levels of concordance, though sample sizes were 
substantially smaller and therefore subject to greater variance.51,52 
Beyond twin studies, new data are becoming available from genome-wide association studies 
(GWASs), which sequence or impute the entire human genome and quantify the degree of 
association between SNPs and disease. To date, the number of SNPs associated with T2DM risk 
has risen in just a few years from 3853 and 3954 to more than 70,55,56 with almost two dozen 
variants implicated in dysfunctional metabolic processes, including abnormalities in insulin 
secretion and insulin response.53  
Despite such findings, SNPs that reach genome-wide statistical significance currently account for 
only around 6%57 to 10%53 of total variance in T2DM risk attributed to heritability, suggesting 
that more genes have yet to be discovered, have too small an effect on their own to be selected 
at the GWAS significance threshold,58 or that heritability estimates derived from twin studies 
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may have been overestimated or unreliable, such as through their small sample sizes.59 Until 
these issues are overcome, adjustment for family history of T2DM may present a pragmatic 
approach by which heritability may be accounted for in observational studies. 
2.1.3.4 Physical activity 
Physical activity is also a significant risk factor for T2DM, with longitudinal studies from a range 
of populations indicating an inverse relationship.60,61 Specifically, results from the latest available 
meta-analysis indicates a 35% reduction in T2DM risk among study participants in the highest 
exposure category relative to those in the lowest category (RR 0.65, 0.59-0.71), with 
heterogeneity low across the 14 applicable studies (I2=18%).61 Reductions in risk were also 
evident among individuals who switched from low to moderate or higher categories (RR 0.64, 
95% CI 0.50-0.70, n=7, I2=0%), suggesting that any negative effects conferred by low physical 
activity may be reversible. 
Although reductions in T2DM risk associated with physical activity may be mediated via an effect 
upon adiposity,62 both factors has been identified as independent. This is supported by the 
results from physical activity meta-analyses, which identified large measures of effect despite 
adjustment for BMI across the majority of constituent studies. However, obesity appears to be 
the stronger determinant of risk.63  
Accordingly, various additional mechanisms have been proposed beyond the direct effect of 
physical activity upon adiposity. These include exercise-induced increases to (a) the 
capillarisation of muscle tissue,64,65 (b) the production of glucose transporter proteins,66,67,68,69 
and (c) muscle glycogen synthase activity, an enzyme involved in the conversion of glucose into 
glycogen for energy storage.70,71 Together, these three processes have been posited to increase 
the rate at which glucose can be metabolised and transferred out of the bloodstream and into 
skeletal muscle tissue, resulting in improved insulin sensitivity as evident in the form of lower 
post-load blood glucose measurements among individuals who exercise for longer durations and 
with greater intensity.72 
2.1.3.5 Smoking 
The latest available meta-analysis of 84 longitudinal cohort studies and indicated that current 
smokers exhibit a 37% greater risk of T2DM relative to non-smokers (RR 1.37, 95% CI 1.33-
1.42).73 This relationship was also found to be dose-dependent, with risks largest among those 
classified as heavy smokers (RR 1.57, 95% CI 1.47-1.66). A stratification of non-smokers revealed 
an elevated risk among former smokers relative to those that reported never smoking (RR 1.14, 
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95% CI 1.10-1.18), suggesting that complete life-ling abstention may be optimal for reducing 
T2DM risk, but that elevated risks conferred by current smoking may still be attenuated by 
cessation. This latter inference is supported by the inverse relationship between the duration of 
cessation and T2DM risk.74 Were a causal relationship present between smoking and the 
development of T2DM, the authors estimated that around 12% of male and 24% of female T2DM 
cases worldwide were attributable to active smoking.  
Paradoxically, however, smoking has repeatedly been associated with advantageous changes in 
adiposity,75 with BMI lowest among current smokers and smoking cessation linked to increases 
in BMI even after adjustment for baseline adiposity.76 Putative mechanisms for such an inverse 
relationship range from smoking being a behavioural alternative to eating75 to a direct genetic 
link between the two factors.77 Whatever the underlying process, smoking appears associated 
with marked reductions in one of the leading risk factors for T2DM. Additionally, although 
smokers tend to exhibit a clustering of obesogenic health behaviours,78 the dose-response 
nature of the association between smoking and T2DM risk and the magnitude of observed effect 
sizes were such that the relationship appeared unlikely to be attributable to residual 
confounding alone.  
Any causal mechanism between smoke exposure and T2DM remains unclear, though there is 
some suggestion from experimental studies that smoking may increase insulin resistance,79,80,81 
with improvements to insulin sensitivity observed following cessation.82 Such a relationship may 
be mediated by nicotine through its apparent effect upon insulin signalling proteins.83 
2.1.3.6 Alcohol consumption 
2.1.3.6.1 Average volume of alcohol consumed 
An increasing body of evidence has highlighted the role that the average volume of alcohol 
consumed may play in modifying the risk of T2DM. According to a recent meta-analysis, which 
comprised 20 longitudinal studies, a J-shaped dose-response relationship exists between the 
volume of alcohol consumption and T2DM risk.10 Relative to never drinkers, reductions in risk 
were reported to be greatest at 22 g/day (RR 0.87, 0.76-1.00) among men and 24 g/day (RR 0.60, 
0.52-0.69) among women, with risks rising incrementally thereafter. A newer meta-analysis 
published after the analyses undertaken in Chapter 3 also reported a non-linear dose-response 
relationship, with risks lowest among adults that consumed 91-168 g/week (men: RR 0.80, 95% 
CI 0.72-0.89; women: RR 0.57, 95% CI 0.48-0.67), relative to the lowest consumption category 
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reported among constituent studies. Peak reductions in risk were evident at around 22 g/day 
(RR 0.57, 95% CI 0.51-0.62) among men and 30 g/day (RR 0.70, 0.64-0.76) among women.84 
These findings have been countered by a Mendelian randomisation meta-analysis of 48 
international cohorts.85 Rather using a self-reported measure of alcohol intake, adults were 
instead categorised according to a genetic proxy for alcohol consumption. Because genotypes 
tend to be assigned at random during meiosis (assuming that the choice of partner was not 
associated with the genotype (panmixia)), groups of drinkers defined according to a genetic 
variant should benefit from a more even distribution of confounding factors akin to a 
randomised controlled trial, strengthening any inferences drawn.86 However, despite being less 
prone to reverse causality and confounding, it should be noted that results derived using genetic 
data are subject to a unique set of assumptions. Aside from the requirement that a genetic 
polymorphism be associated with the exposure of interest, explaining a substantial proportion 
of variance in the volume of alcohol consumption consumed, it is assumed that a selected 
marker be associated with the outcome of interest solely through its effect on alcohol 
consumption, e.g. is unrelated to other genetic traits that may influence the outcome 
differentially (antagonistic pleiotropy).86  
In this particular analysis, rs1229984 was selected as a single-nucleotide polymorphism (SNP) in 
the alcohol dehydrogenase 1B gene (ADH1B), responsible for encoding an enzyme implicated in 
the metabolism of alcohol.87 Compared to the more common G-allele variant of the SNP 
(rs1229984(G)), carriers of an A-allele (rs1229984(A)) exhibit an impaired clearance rate of 
alcohol metabolites, leading to increased flushing, palpitations and drowsiness through a 
resultant accumulation of acetaldehyde, a metabolic by-product of alcohol.88 Due to the adverse 
biological response it elicits following alcohol consumption, rs1229984(A) has been associated 
with lower volumes of daily alcohol consumption and a higher prevalence of non-drinking,88 as 
well as a lower odds of alcohol dependence.89 
Results from this Mendelian randomisation meta-analysis were in concordance with these 
negative effects. Although mean intake was not reported, carriers of the rs1229984(A) 
polymorphism had a 17% (95% CI 15.6-18.9%, I2=64%) lower weekly volume of alcohol 
consumption and a 27% higher odds of being a non-drinker (OR 1.27, 95% 1.21-1.34, I2=73%), 
relative to non-carriers (rs1229984(G)).85 Notably, an analysis of all available individual 
participant data showed no difference in the odds of T2DM by genetic variant (p=0.627, 
n=145,063). Similarly, when data were restricted solely to those who defined themselves as 
current drinkers, no decrease in odds was detected among rs1229984(A) carriers (OR 0.97, 95% 
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CI 0.86-1.09, n=111,140) despite a lower volume of alcohol consumption. Such findings suggest 
that poor adjustment for confounding factors may have explained at least some of the apparent 
reduction in risk observed at moderate volumes of alcohol consumption present in 
observational studies, with around one-third of such studies having provided crude or age-
adjusted estimates only.10 Weak confounder adjustment among current observations studies is 
an issue discussed in more detail in Section 2.3. 
A number of alternative explanations for a null result were possible. With consideration to the 
biological effect of the A-allele polymorphism, the absence of any reduction in risk among lighter 
drinkers with a genetically impaired alcohol metabolism might be attributable to higher 
concentrations of inflammatory alcohol metabolites, which may have offset any reduction in risk 
otherwise conferred by a more moderate volume of alcohol consumption. This was argued by 
authors of a paper which analysed participants from the Nurses’ Health Study and Health 
Professionals Follow-Up Study.90 While reductions in risk were observed among self-reported 
moderate drinkers in accordance with the 2009 meta-analysis, the presence of an alcohol 
dehydrogenase polymorphism was found to significantly attenuate the reductions in risk 
reported among moderate drinkers (p=0.02). Such a finding led the authors to conclude that, 
were there a causal relationship between the volume of alcohol intake and T2DM, the risk of 
T2DM may be mediated by an impaired clearance of inflammatory metabolites such as 
acetaldehyde91,92,93 (see also Section 2.2.2.3).  
Aside from this, a null result may also be a consequence of numerous statistical limitations.94 
Firstly, the Mendelian randomisation meta-analysis does not rule out a relationship between 
some other dimension of alcohol consumption and the risk of T2DM, such as the effect of 
drinking pattern. As highlighted in the following section, there are indications from some 
observational studies that the frequency of drinking or propensity for binge drinking may 
represent important determinants of T2DM risk beyond a simple measure of average volume 
consumed. Secondly, only a relatively small proportion of the variation in alcohol consumption 
was explained by the ADH1B genotypes. Were the mean volume of alcohol intake equal to a 
value of 50 g/week, for example, then the average difference in consumption between carriers 
and non-carriers would equate to just 8.5 g/week, or barely one unit. In this sense it was possible 
that the disparity in consumption between the two groups was too small to detect any effect. 
Thirdly, the prevalence of rs1229984(A) carriers within the pooled dataset was low, at just 7% 
of the sample, meaning that statistical power may have been insufficient to detect any effect, if 
present. Accordingly, though Mendelian randomisation studies can offer advantages over 
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observational studies, evidence from cohort and case-control studies still have an important role 
to play in developing a better understanding of the relationship between alcohol consumption 
and T2DM risk. 
2.1.3.6.2 Drinking pattern 
Beyond the volume of alcohol consumed on an average day or week, there is some suggestion 
that the pattern of alcohol consumption may represent a second and important component of 
T2DM risk. Of the 20 studies selected as part of the 2009 meta-analysis, just three were 
documented as having investigated some measure of consumption patterning.10 The first, which 
utilised data from a US occupational cohort, found that the frequency of consumption over an 
average week was significantly associated with T2DM risk, even after adjustment for the average 
volume of alcohol consumption (p=<0.001).95 Specifically, each additional drinking day per week 
was associated with an independent and multivariable adjusted reduction in risk of 7% (RR 0.93, 
95% CI 0.90-0.97).  
The second publication, a prospective cohort of monozygotic twins, looked instead at episodic 
heavy drinking. Although they provided no detailed dose-response analysis of the interaction 
between volume and pattern, they did document that female participants who reported 
consuming >179 g on any one occasion at least one a month during the preceding year had 
double the risk of T2DM relative to those that did not report binge drinking (RR 2.1, 95% CI 1.0-
4.4).96 No such association was observed among men, though the average volume of alcohol 
consumption among binge drinkers was not reported.  
Finally, the third publication, based on a male multi-ethnic prospective cohort study, stratified 
volumes of weekly alcohol intake by the number of drinking days during the week.97 Although 
sub-group sample sizes were small and confidence intervals consequently wide, point estimates 
revealed a notable interaction between weekly volume and frequency. At the lowest volume of 
alcohol consumption (<70 g/week), little difference in risk was evident when stratified by 
frequency of drinking over the week, suggesting that such a volume of intake may have been 
too low to detect an interaction effect in such a small sample. However, at higher volumes of 
consumption, risks were lower among those who distributed their consumption over a greater 
number of days. For instance, relative to non-drinkers, those who consumed >210 g/day over 1-
3 days/week were five times more likely to have developed T2DM (RR 5.21, 95% CI 1.79-15.2), 
while those that distributed the same volume over a full seven days exhibited the lowest risk of 
T2DM (RR 0.68, 95% CI 0.39-1.20). Consumption within this group was equivalent to around 30 
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g/day, or a level almost equal to that associated with the peak reduction in risk reported by the 
2009 meta-analysis.10  
Although studies that investigated joint associations between the two dimensions of drinking 
and T2DM risk were few in number and explored the relationship in different ways, both the 
volume and frequency of consumption appeared to represent important risk factors, with T2DM 
risk appearing lowest among regular moderate drinkers, and any benefits potentially offset by 
concentrated periods of episodic heavy consumption.  
2.2 Alcohol consumption 
Representing a potentially modifiable risk factor for T2DM and appearing from observational 
studies to reduce risks at regular moderate volumes of alcohol consumption, trends in the 
volume and pattern of UK alcohol consumption are described below. With a peak reduction in 
risk appearing to be conferred at an volume of around 22-24 g/day, according to estimates from 
longitudinal observational studies,10 trend data gave an indication as to the likely risk profile of 
the UK general population and thereby the degree to which the burden of T2DM could 
potentially be attenuated through population-level changes in alcohol consumption behaviour. 
2.2.1 Trends 
2.2.1.1 Volume of alcohol consumption 
Current national alcohol guidelines advise that the total volume of consumption exceed no more 
than 21 units/week among men and 14 units/week among women.98 A recent review of the 
available evidence recommended that these thresholds be revised to 14 units/week for both 
sexes.99 This newly proposed threshold equates to 16 g/day, or a volume close to the 24 g/day 
nadir in T2DM risk reported by observational studies.10 
In aggregate, data from the Health Survey for England 20145 and the Scottish Health Survey 
2014100 both indicate that consumption among men and women is close to or within current 
national guidelines, measuring an average 19.0 g/day among English men and 9.9 g/day among 
English women,5 with values slightly lower in Scotland. Even within age groups where 
consumption is highest, volumes are not of a level associated with an increased risk of T2DM. 
For instance, among English men aged 65-74 years, consumption measured 23.0 g/day on 
average (Figure 2.4), with 11.9 g/day consumed by English women aged 16-24 years (Figure 2.5). 
However, it was unlikely that the volume of drinking is distributed uniformly across all seven 
days. As discussed in the next section, alcohol intake is marked by instances of episodic heavy 
consumption potentially associated with an increased risk of T2DM.96,97 
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Figure 2.4 Mean volume of alcohol consumption among male current drinkers, stratified by age group 
and country. Health Survey for England and Scottish Health Survey, 2014. 
 
Figure 2.5 Mean volume of alcohol consumption among female current drinkers, stratified by age group 
and country. Health Survey for England and Scottish Health Survey, 2014. 
2.2.1.2 Pattern of alcohol consumption 
To get some idea as to the prevalence of episodic heavy consumption in the general population, 
data were obtained from the annual Opinions and Lifestyle Survey, which reported alcohol 
consumption from a random probability sample of UK residents.101 Based on the data available, 
episodic heavy consumption was defined as any current drinker who reported consuming more 
than twice the recommended daily limit on their heaviest drinking day in the week prior to 
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interview, equating to >63 g among men and >47 g among women. The degree of episodic heavy 
consumption was lowest among women in all age groups (Figures 2.6 and 2.7). Although 
gradually declining over time, episodic heavy consumption is most common within younger age 
groups regardless of sex. By 2013, 20.9% of male and 15.8% of female current drinkers aged 16-
24 years reported consuming more than twice the recommended limit on at least one day in the 
week.  
 
Figure 2.6 Proportion of male current drinkers who reported episodic heavy consumption. Opinions and 
Lifestyle Survey, 2005-2013. 
 
Figure 2.7 Proportion of female current drinkers who reported episodic heavy consumption. Opinions 
and Lifestyle Survey, 2005-2013. 
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If regular moderate alcohol consumption is causally associated with marked reductions in T2DM 
risk, relative to never drinkers, then the presence of episodic heavy drinking among around one-
fifth of younger drinkers suggests that UK drinking behaviours may not be optimal for the 
attenuation of T2DM risk. Such trend data also suggest that an increase in the burden of T2DM 
may become apparent over coming decades as younger episodic heavy drinkers grow older. 
2.2.2 Putative biological mechanisms 
There are multiple proposed mechanisms by which alcohol consumption might influence the 
risk of T2DM. Three of the most commonly discussed hypothesised pathways are discussed 
below. 
2.2.2.1 Insulin sensitivity 
One pathway concerns the effect of alcohol upon insulin sensitivity, which refers to the rate of 
metabolic response following insulin exposure, including the metabolism, transport and storage 
of carbohydrates and fats.102,103 High insulin sensitivity is marked by the prompt metabolism of 
carbohydrates and fats in the presence of nominal insulin concentrations. Here, elevations in 
blood sugar, such as those following meals, are acute and easily regulated without the need for 
dietary or medicinal control. Conversely, low insulin sensitivity is indicated by an impaired insulin 
response, resulting in chronically elevated levels of blood glucose. Often referred to as insulin 
resistance, these chronic elevations in blood glucose trigger a compensatory feedback loop that 
can result in a state of hyperinsulinaemia. 
To date, analyses exploring the relationship between alcohol and insulin sensitivity have been 
predominantly cross-sectional,104 with just three out of 16 non-interventional studies identified 
as part of a recent review having been longitudinal in design. Of all the observational data 
identified, both U-shaped and inverse linear associations with insulin sensitivity were found, as 
measured variously via fasting insulin, fasting glucose or homeostasis model assessment 
(HOMA). 
Among studies that identified a U-shaped relationship, insulin sensitivity was greatest at 
volumes of alcohol consumption at which reductions in risk were reported by Baliunas et al,10 
ranging from 9 g/day105 and 20 g/day106 to anything below 40 g/day.107 By contrast, upper limits 
in studies that identified a linear relationship ranged from >23 g/day108 to >100 g/day.109 
Interestingly, although a cross-sectional analysis of data obtained from the French DESIR cohort 
identified a strong and sizeable linear relationship with average volume of alcohol consumption 
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among both sexes (p=<0.001),110 no such association was identified in a three-year longitudinal 
analysis later undertaken on the same cohort bar a linear increase in glucose among men.111 
A separate review and meta-analysis looked specifically at results from interventional studies 
that spanned at least a two-week period.112 A total 14 studies were selected, with participant 
samples ranging in size from 17 to 51. Although no difference in fasting glucose concentration 
was identified among either male (p=0.48, study n=5) or female (p=0.94, n=6) drinkers, relative 
to controls, a significant sex interaction was reported between alcohol consumption and insulin 
sensitivity (p=0.018), which tended to be higher among female (SMD 0.16, 95% CI -0.04-0.37, 
p=0.12, study n=5) but not male drinkers (SMD −0.30, 95% CI −1.23-0.64, p=0.54, study n=5). 
However, heterogeneity among the studies was particularly high (I2=95%). When a study largely 
responsible for such heterogeneity was removed, no significant difference in insulin sensitivity 
between men and women remained (p=0.180). With regard to the effect of alcohol upon fasting 
insulin, significant reductions in concentration were observed among women (p=0.02, study 
n=6). While no such effect was reported among men, analyses were based on estimates 
extracted from just two small interventional studies of low precision (men: p=0.59, study n=2). 
Data from the two studies indicated a similarly advantageous direction of effect. 
Although a meta-analysis of alcohol consumption and T2DM risk found greater reductions in risk 
among moderate female drinkers than their male equivalents,10 observational and 
interventional research were insufficient to conclude that this difference in dose-response may 
have occurred due to a sex-specific disparity in alcohol-induced insulin response. In addition to 
the majority of observational research thus far being cross-sectional, negating any conclusions 
concerning the direction of effect, results from interventional studies should also be viewed with 
caution. Such studies were small in size, few in number and reported heterogeneous levels of 
alcohol intake. Collectively, such limitations constrain any attempt to generalise interventional 
results to the general population. 
2.2.2.2 High-density lipoprotein 
Besides its putative effect upon markers of insulin sensitivity, alcohol may confer some 
reduction in the risk of T2DM through a causal relationship with the production of high-density 
lipoprotein (HDL). HDL has been linked to a number of positive metabolic processes, including 
the reverse cholesterol transport process, which transports lipids out of the bloodstream for 
storage in the liver.113,114 Elsewhere, HDL has appeared to play a role in the transfer of glucose 
away from the bloodstream and into adipose tissue for storage, as well as the promotion of 
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glucose metabolism by skeletal muscle tissue.115,116 Finally, there has been some suggestion that 
HDL may help promote insulin secretion by β-cells and protect them against apoptosis.116  
Investigating alcohol-related changes to HDL concentration, data were abstracted from 25 
interventional studies.117 The researchers identified a linear dose-response relationship, 
whereby HDL concentrations increased by 0.133mg/dl per gram of daily alcohol consumption, 
relative to controls. At the average volume of alcohol consumption (30 g/day), which was close 
to the nadir in risk reported by the 2009 T2DM meta-analysis,10 HDL concentration increased by 
8.3% over a period of four weeks compared with controls (3.99 mg/dl, 95% CI 3.25-4.73).117 This 
linear relationship was supported by a more recent meta-analysis of 33 studies (p=0.013),118 
with similarly positive findings reported by a recent trial of 224 participants followed over two 
years (2.0 mg/dL, 95% CI 1.6-2.2 mg/dL).119 The earlier of the two meta-analyses reported the 
dose-response relationship by sex, and found a stronger association among men than women 
(men: β=0.134 mg/dl per 1 g/day alcohol; women β=0.095 mg/dl per 1 g/day alcohol), though 
differences between sexes were not significant (p=0.930).117 However, the absence of a 
statistically significant interaction may have been due to low statistical power as opposed to the 
absence of a sex-specific dose-response, with only three small studies reporting female data.  
Taking a different approach, a recent Mendelian randomisation meta-analysis found no overall 
difference in the concentration HDL (p=0.259) when data from 46 studies were stratified 
according to a genetic polymorphism predictive of variance in alcohol consumption,85 though 
this null finding may have been a result of limitations outlined elsewhere (see Section 2.1.3.6.1). 
That observed relationships in prospective cohort studies were linear as opposed to J-shaped 
suggested that any beneficial increase in HDL concentration following increased alcohol 
consumption may be offset by metabolic harms at higher intakes, such as a triggering of 
pancreatic β-cell apoptosis and signalling dysfunction.120 Moreover, even if alcohol consumption 
is causally associated with increases in HDL concentration, there is an indication that HDL may 
not itself be associated with the onset of T2DM despite its apparent role in effective glucose 
transport and storage. For instance, in a recent Mendelian randomisation study based on 47,627 
participants sampled by the Copenhagen City Heart Study and the Copenhagen General 
Population Study, no association was found between SNPs linked to HDL concentration and 
T2DM risk (p=0.550); significant dose-response relationships were specific to models that 
utilised observational data as opposed to a genetic indicator of HDL variance.121 
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2.2.2.3 Inflammation 
A further hypothesis concerns the effect that alcohol may have upon inflammatory 
response,122,123 a mechanism triggered following damage to human tissue or cellular function. 
Specifically, inflammation and a consequent production of pro-inflammatory proteins has been 
associated with the disruption of endothelial and pancreatic β-cell functioning, impairing the 
breakdown and transport of glucose, increasing blood glucose concentrations and thereby 
implicated in the pathogenesis of T2DM.93,124,125 
As with studies investigating alcohol-related changes in HDL concentration, observational data 
concerning inflammatory markers is scarce and almost exclusively cross-sectional.122,126 
Focussing on results from interventional studies, a recent meta-analysis identified publications 
that reported dose-response relationships between alcohol consumption and a range of 
inflammatory biomarkers.118 These included C-reactive protein (CRP), understood to increase in 
concentration during periods of inflammatory response but with an unknown function beyond 
its prognostic value,127 and tumour necrosis factor alpha (TNF-α), a pro-inflammatory protein 
hypothesised to play a role in the development of insulin resistance through its suppression of 
insulin signalling.128,129,130 The concentrations of such markers were not found to be influenced 
by the volume of alcohol consumption, though the number of constituent studies was small (e.g. 
CRP, n=5; TNF-α, n=3).118 By contrast, a Mendelian randomisation meta-analysis of 42 
longitudinal studies found CRP concentrations to be 3.4% (95% CI 1.1-5.7%) lower among A-
allele carriers whose average volume of alcohol consumption was 17% lower than among non-
carriers (p=<0.001).85 Moreover, when a non-linear dose-response relationship was estimated 
based on data reported by 22 Mendelian randomisation studies, CRP concentrations were 
predicted to be elevated only at volumes of alcohol intake greater than around 166 g/week, 
relative to zero alcohol consumption.131  
Data from these Mendelian randomisation studies therefore indicate an advantageous 
reduction in the concentration of CRP at relatively moderate volumes of weekly consumption, 
consistent with the J-shaped association observed between alcohol intake and T2DM risk.10 
However, in the absence of supporting evidence from interventional or longitudinal studies, the 
plausibility of such a pathway remains in question. This was especially so given a lack of robust 
evidence linking inflammatory intermediates to T2DM. For instance, while a study of the 
Whitehall II and Northwick Park Heart Study II datasets reported significant associations 
between baseline concentrations of CRP and the risk of insulin resistance (HOMA), 
hyperglycaemia and T2DM, null associations were present when data were stratified according 
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to SNPs significantly associated with variance in CRP concentration but independent of 
confounding factors such as obesity, blood pressure and socioeconomic position.132 Elsewhere, 
consideration alternative inflammatory markers, a recent Mendelian randomisation meta-
analysis reported null associations between genetic variants linked to concentrations of 
interleukin 1 receptor antagonist, a regulator of inflammatory response mechanisms, and T2DM 
risk (OR 0.99, 95% CI 0.97-1.01).133 Although meta-analyses of Mendelian randomisation studies 
have linked SNPs associated with variance in the concentration of interleukin 6 (a cell signalling 
molecule implicated in the suppression of inflammatory response) to a slightly lower but 
statistically significant risk of CHD of between three134 and five per cent,135 no studies appear to 
have thus far explored associations between SNPs of interleukin 6 and T2DM risk.  
2.2.2.4 Summary 
Longitudinal observational studies that investigated putative mechanisms by which alcohol 
consumption might attenuate the risk of T2DM have tended to be lacking, with the majority of 
studies being cross-sectional in design and thus inappropriate for developing an understanding 
of cause and effect. Interventional studies have provided a better source of data, but their 
generalisability has been limited by heterogeneous designs, short durations and singular 
volumes of consumption, obfuscating any understanding of dose-response effects following 
chronic alcohol intake at the population level. Finally, with large-scale Mendelian randomisation 
studies having identified no association between either HDL or inflammatory markers and 
T2DM, the likelihood of such pathways being the route by which alcohol may confer differences 
in T2DM risk is low.  
2.3 Reference groups and confounding 
Although observational and experimental data have hinted at potential biological mechanisms 
by which alcohol may induce a reduction in T2DM risk, the validity of such studies was 
questionable. As an alternative to a direct biological effect, it is possible that observed 
reductions in T2DM risk among moderate drinkers may instead have been a statistical artefact 
attributable factors such as the selection of a reference group potentially predisposed to the 
condition under study, and a failure to account for any such predisposition. 
For instance, of the 20 studies selected as part of the 2009 alcohol-diabetes meta-analysis, 18 
calculated risks associated with current drinking relative to pooled non-drinkers.10 Criticism has 
been levelled at this choice of abstention group on the grounds that is may capture former 
drinkers whose lifestyle behaviours and health status may place them at increased risk of 
negative health events, including T2DM.136,137,138 Such criticism is supported by studies that 
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report a higher prevalence of T2DM risk factors among non-drinkers than moderate consumers 
of alcohol following adjustment for differences in age and sex,139,140 including being of Asian 
ethnicity, having a high BMI and low physical activity. Elsewhere, studies also report a higher 
prevalence of poor self-reported health and limiting longstanding illness among non-drinkers 
than any other drinking category,141,142,143 with the onset of ill-health associated with a 
subsequent cessation of alcohol consumption.144,145,146 In at least one instance, the prevalence 
of limiting longstanding illness has been found to exhibit a J-shaped relationship, with the 
proportion of illness highest among non-drinkers and lowest among moderate consumers of 
alcohol.141 Such data suggest that pooled non-drinking categories may indeed comprise a group 
of former drinking ‘sick quitters’ who cease alcohol consumption due to ill-health. Such 
individuals were likely to have health profiles that placed them at greater risk of T2DM than 
moderate drinkers, potentially confounding the dose-response relationship between drinking 
and T2DM risk in poorly adjusted studies.  
Of the studies selected as part of the 2009 meta-analysis, risk estimates abstracted from 13 of 
the 20 selected studies had been adjusted for just three or fewer confounding factors, with one-
third of studies providing only crude or age-adjusted estimates. There was therefore a possibility 
that estimated reductions in the risk of T2DM among healthier moderate drinkers may be 
overestimated. Unfortunately, the meta-analysis provides no sensitivity analysis examining the 
effect of confounder adjustment or abstention reference category upon the shape and 
magnitude of the dose-response relationship. Similarly, a new meta-analysis published after the 
analyses undertaken for Chapter 3 provided no adjustment or stratification according to the 
choice of reference category by consistent studies, opting only to use the lowest category of 
consumption in each case, however so defined.84 As such, the impact of former drinkers and 
poor confounder adjustment upon reported dose-response relationships is currently unknown. 
In the absence of such an analysis, the possibility that reductions in T2DM risk may have been 
overestimated is instead supported by a recent analysis of studies that explored the relationship 
between average volume of alcohol consumption and all-cause mortality.136 Of the 21 all-cause 
mortality studies to have included former drinkers within a pooled non-drinking reference 
group, all reported a J-shaped association consistent with the 2009 T2DM meta-analysis. 
However, of a further seven studies that had explicitly excluded former drinkers, no difference 
in risk was reported between non-drinkers and moderate drinkers. Similarly, in a meta-analysis 
of 34 longitudinal studies,147 reductions in the risk of all-cause mortality were lower and present 
across a narrower range of alcohol intake among studies that utilised a robust never drinking 
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reference category (n=27) rather than a group of pooled non-drinkers (n=21). These analyses 
and others148 all support the assertion that former drinkers represent a less healthy drinking 
category predisposed to or already suffering from chronic health conditions. 
Although these findings suggest that former drinkers should be excluded from among pooled 
non-drinkers so as to leave a category of never drinkers, it should be noted that even the use of 
a never drinking reference category has drawn criticism. This has included the impact of such a 
reference group upon statistical power given their relatively small sample size in populations 
where alcohol consumption is otherwise normative,149,150 and evidence suggesting that 
morbidities in early adulthood may predict never drinking, potentially subjecting never drinkers 
to the same limitations as former drinkers.151 These limitations have led some to recommend 
the use of an occasional drinking category as a reference group.138,152 However, without knowing 
their average volume of consumption at each drinking occasion, such a category could capture 
either episodic heavy drinkers who appear to be at the greatest risk of T2DM, or episodic 
moderate drinkers that may drink infrequently due to the same morbidities as former drinkers. 
It is unclear why such a heterogeneous group would prove a better choice of reference category 
than robustly defined never drinkers, especially in a well-adjusted study of sufficient size. 
Looking back to the 2009 meta-analysis, the authors attempted to work around the bias that 
may have arisen from selected studies having utilised a pooled non-drinking reference category 
confounded by less healthy former drinkers. Specifically, Baliunas et al10 weighted risk estimates 
reported by such studies according to the sex-specific proportion of former drinkers 
documented by studies where non-drinkers had been explicitly bifurcated into groups of never 
and former drinkers.  
The validity of such an approach is questionable. In addition to having calculated weights from 
just five studies, closer inspection revealed that two of the five studies had not utilised a robust 
never drinking category. One defined never drinkers as those that had never consumed more 
than 11 alcoholic drinks in any year,97 while the second defined never drinkers as those that 
reported no alcohol consumption during the five years preceding baseline and consumption no 
greater than four drinks per day prior to those five years.153 In the latter instance, never drinkers 
may actually have been former drinkers who had once routinely consumed 72.7 g/day, assuming 
that each drink was equal to one average (1750 ml) glass of 13% ABV wine.11  
As well as estimating sex-specific proportions of former drinkers based on studies that had not 
defined abstention categories in a robust manner, it was unclear how reliably the baseline 
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prevalence of former drinkers averaged from five studies could be applied to 15 studies of 
disparate populations and demographics, with alcohol consumption differing according to 
factors beyond sex alone, including age, economic wealth, smoking and education,154,155 plus 
both per capita consumption and the prevalence of non-drinking differing markedly between 
countries.154  
In summary, an updated and revised meta-analysis was required to explore the impact of 
confounder adjustment and reference category selection upon the dose-response relationship 
between the volume of alcohol consumption and T2DM risk. Such analyses would help highlight 
the degree to which previous research may have overestimated any reductions in risk through 
a failure to properly account for a potential predisposition of former drinkers toward the 
development of T2DM.  
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3 An updated and revised meta-analysis 
3.1 Introduction 
Observational studies that utilised a self-reported measure of alcohol consumption appear to 
indicate a peak reduction in the risk of T2DM at levels of consumption below the equivalent of 
8.5 pints of 4% ABV lager per week (22 g/day).10 However, such studies predominantly calculated 
risks relative to pooled non-drinkers, a group likely to comprise former drinkers whose poor 
health and clustered negative lifestyle behaviours potentially predispose them to the 
development of T2DM.136 In addition, two-thirds of selected studies adjusted for three or fewer 
confounding factors, with one-third providing only crude or age-adjusted estimates. As a 
consequence, an unequal distribution of risk factors for T2DM may have been largely 
unaccounted for, leaving observed reductions in risk less a consequence of a direct biological 
effect and more a statistical artefact. This possibility is hinted at by studies of all-cause mortality, 
which report an attenuation or nullification of reductions in risk following the removal of less 
healthy former drinkers from the abstention reference category,136,147 as well as a Mendelian 
randomisation meta-analysis which found no relationship between drinking intensity and 
T2DM.85 
To gauge the degree to which observed reductions in risk may have been overestimated, this 
chapter details an updated and revised meta-analysis of longitudinal observational studies, 
including sensitivity analyses chosen explicitly to explore the effect of confounder adjustment 
and choice of abstention reference category upon the dose-response relationship. The revised 
analyses also discuss new studies that report joint associations between the volume of alcohol 
consumption and drinking pattern. It was hypothesised that any reductions in risk would be 
shallower among studies that used a more robust abstention category or adjusted for a broader 
range of confounding factors. Results from the meta-analysis were later published.156 A copy of 
the publication is included in Appendix 3.1.  
3.2 Methods 
3.2.1 Selection criteria 
3.2.1.1 Types of study 
Studies were limited to those of cohort and case-control design, and both community and 
occupational datasets were considered. Although occupational datasets may have captured a 
narrower spectrum of drinking and lifestyle behaviours,157,158 data would still have captured 
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moderate levels of consumption – a range of particular interest given apparent reductions in 
T2DM risk at lower levels of intake.10 
3.2.1.2 Types of participant 
All adults aged ≥16 years were considered eligible regardless of sex, ethnicity or setting.  
3.2.1.3 Types of exposure 
Given apparent differences in dose-response between men and women,10 sex-specific self-
reported alcohol consumption was selected as the exposure of interest. With a non-linear dose-
response relationship having previously been identified between alcohol consumption and 
T2DM risk,10 studies were only considered if risks were reported across ≥3 categories denoting 
the average volume of alcohol consumption, inclusive of reference category. Studies were also 
excluded if the volume of alcohol consumption could not be converted into g/day, and if any 
abstention category was contaminated with participants other than non-drinkers (i.e. included 
light or occasional drinkers of some definition). 
3.2.1.4 Types of outcome 
T2DM was selected as the outcome of interest. Diagnostic tests and their respective thresholds 
have varied over time, with initial World Health Organisation (WHO) recommendations from 
1965159 having been revised in 1980,160 1985161 and 1998,162 with glycated haemoglobin A1C 
(HbA1c) added as a new diagnostic indicator in 2011.163  
Restricting selection to publications that defined T2DM according to current recommendations 
would have unnecessarily excluded publications prior to 2011, which were likely to have 
adopted the gold standard diagnostic criteria at the time they were published. Such an approach 
would also have excluded publications that utilised self-reported measures of T2DM. An 
inclusive range of diagnostic measures were thus considered in order to maximise the number 
of studies selected, including: all objective diagnoses, all self- or physician-reported diagnoses, 
any reported hypoglycaemic drug treatment, or linkage to clinical registry data. Where not 
explicitly defined, cases of DM among adults were assumed to be T2DM given the tendency for 
T1DM to occur early in life.8 
3.2.2 Search methods  
PubMed (MEDLINE), Embase, The Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) and the Alcohol and Alcohol Problems Science (ETOH) databases were each searched 
for relevant studies. 
Chapter 3: An updated and revised meta-analysis of the dose-response relationship between 
alcohol consumption and T2DM  
51 
 
Where possible, searches of each database identified publications with titles or abstracts 
containing the terms ‘alcohol’, ‘ethanol’ or ‘drink*’, plus ‘diabet*’, ‘NIDDM’ or ‘T2D*’, plus 
‘cohort’, ‘inciden*’, ‘prospective’, ‘longitudinal’, ‘case’ or ‘retrospective’. During each electronic 
search, no limits were placed upon the language or date of publication. Searches were 
undertaken on 18/02/2014. 
Of publications selected for inclusion in the final meta-analysis, referenced and referencing 
publications were searched for additional literature not captured by initial electronic searches. 
Grey literature was excluded owing to its lack of peer review. Although technical reports and 
conference papers may reflect the latest research in a given field, results can be preliminary and 
not subject to peer review.164 
3.2.3 Data extraction and analysis 
3.2.3.1 Study selection 
3.2.3.1.1 Screening 
Duplicate publications were omitted by Craig Knott (CK), who then screened the titles, abstracts 
and full texts of remaining publications to exclude any that failed to report a longitudinal 
association between volume of alcohol consumption and T2DM among persons aged ≥16 years. 
3.2.3.1.2 Shortlisting 
Screened publications were then shortlisted by CK, Annie Britton (AB) and Steven Bell (SB) 
according to a priori selection criteria. These criteria were as follows:  
 The full text was available, allowing the identification of population characteristics and 
methods used; 
 Data were reported separately for men and women, enabling the analysis of differences 
in dose-response according to sex; 
 The volume of alcohol consumption was defined across ≥3 categories so as to permit a 
dose-response analysis; 
 The abstention category free of contamination by current drinkers, i.e. the inclusion of 
light current drinkers; 
 Reported data were sufficient for determining both the average volume of alcohol 
intake and the degree of T2DM risk for each consumption category. 
During shortlisting, CK reviewed all screened entries while AB and SB each acted as second 
reviewer for two-thirds of the screened entries. This ensured all studies were reviewed 
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independently by at least two individuals, with one-third reviewed by all three reviewers. In the 
presence of any differences of opinion, a publication was reviewed by all three reviewers and 
the majority decision upheld.  
Agreement between pairs of reviewers was quantified via Cohen’s kappa statistic (κ), while 
agreement between all three reviewers was determined via the calculation of a Fleiss’ kappa 
coefficient. The Fleiss kappa coefficient served as an extension of κ and permitted the calculation 
of agreement across more than two reviewers.165 Inter-rater agreement could take any value 
from −1 to +1, standardised such that a value of +1 was indicative of perfect agreement between 
reviewers and -1 a complete absence of agreement across all shortlisted publications.166 
3.2.3.2 Data requests 
If a publication was agreed not to meet shortlisting criteria, contact was made with authors in 
an effort to obtain revised data, such as risks calculated relative to an uncontaminated reference 
category. Similarly, authors of publications that met shortlisting criteria were contacted if 
published data were found to be insufficient for the extraction or calculation of risk estimates, 
or sex-specific data were not reported. 
In each instance, authors were given one month in which to respond. If no additional data were 
received, the publication was excluded (Figure 3.1). Where revised data were provided, this was 
noted in tables describing the characteristics of selected studies (Tables 3.1 and 3.2). 
3.2.3.3 Duplicate studies 
Publications that analysed the same dataset were identified and duplicates omitted with 
consideration to their respective degree of confounder adjustment, sample size and length of 
follow-up. Decisions were reached qualitatively by consensus, as detailed in Section 3.3.1. 
3.2.3.4 Exposure data 
A variety of methods were used for deriving volumes of alcohol consumption from categories of 
intake. Where the central tendency of each category was explicitly reported, the median or 
mean value was used, with preference given to the former measure owing to the skewness of 
continuous alcohol consumption.  
If studies reported no central tendency for a category of alcohol consumption, intake was 
estimated according to the median of the lower and upper limit. However, in some 
circumstances the upper limit of the heaviest drinking category was not reported. Looking to 
meta-analyses undertaken elsewhere, methods applied for estimating an unknown upper limit 
were found to be arbitrary and inconsistent. While some authors operated on the assumption 
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that the range of a category with an undefined upper limit was equal to that which preceded 
it,167,168 or three-quarters the width of the preceding category,10 others multiplied the category’s 
lower limit by a value of 1.2.169 With no reason to conclude that any method was better than the 
other, unspecified upper limits were defined as 1.2 times the value of the lower limit. Where no 
lower bound was defined for the bottom category of volume of alcohol consumption, a value of 
0.1 g was assumed. 
In circumstances where alcohol consumption was reported only as the total number of drinks 
consumed over a given period of time, intake in g/day was estimated assuming country-specific 
standard drinks170 unless otherwise defined by the study authors.  
Finally, the volume of alcohol consumption as categorised according to periods longer than a 
day were converted into daily estimates assuming an even distribution of consumption over the 
period. For instance, a weekly volume of alcohol consumption was divided by seven. 
3.2.3.5 Risk estimates 
Extracted risk estimates took a number of forms. The pooling of ORs alongside other effect 
estimates risked being inappropriate given indications from simulated cohorts that ORs tend to 
overestimate equivalent RRs the greater the incidence of an event.171 In an effort to bring ORs 
and RRs into greater concordance, ORs and their respective CIs were adjusted according to the 
Zhang and Yu method shown in Formula 3.1.  
RR=OR/(1-p)+(p*OR) 
Formula 3.1 Approximation of relative risks according to reported odds ratios 
Here, p is a value equal to the proportion of T2DM among unexposed participants. Although not 
perfect, such an approach improves the suitability of pooling extracted ORs alongside other risk 
estimates for a high-incidence event such as T2DM. 
Of shortlisted studies, some reported risk estimates according to a reference category other 
than abstention. These risk estimates were recalculated such that all risk estimates were relative 
to an equivalent category of non-drinking. This was undertaken iteratively using the Hamling 
method.172 In short, the method uses the total number of exposed and unexposed participants 
in conjunction with the original risk estimates reported for each consumption category (k) to 
derive an approximated kx2 table of either cases and controls (for case-control studies) or cases 
and at-risk participants (for cohort studies) at each level of alcohol consumption. This table can 
then be used to calculate adjusted risk estimates for any consumption category relative to a 
reference category of choice. The calculation of corresponding CIs incorporated the covariance 
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between the original risk estimates from which the kx2 table was constructed, ensuring that the 
degree of variance for each new estimate was not underestimated.172 
In all cases, estimates were extracted from models that incorporated the maximum number of 
confounding variables without adjustment for putative mediators – i.e. markers of insulin 
sensitivity, HDL concentration or inflammation. Such models would likely have been subject to 
an overadjustment bias, effectively controlling for the very mechanisms under investigation and 
thereby biasing risk estimates toward the null to a degree proportionate to the magnitude of 
dose-response effect explained by the mediating factor.47 
3.2.4 Data synthesis 
3.2.4.1 Model selection 
Although meta-analyses have explored dose-response relationships according to a series of pre-
defined alcohol consumption categories,173 step functions provide a crude operationalisation of 
the relationship under study. Although easily interpretable by lay audiences, categories simplify 
the dose-response association, modelling risk as constant across a category’s entire range and 
changing only at the exact threshold of each category.174 In so doing, dose-response 
relationships become conditional upon both the number and width of exposure categories 
chosen, with the potential to inadvertently conceal nuanced changes in risk when categories are 
broad and few in number. 
Fractional polynomial (FP) regression models provided a more flexible means of analysing non-
linear dose-response relationships, utilising alcohol consumption data in its continuous form.175 
An extension of standard linear regression, FP regression models use transformations of alcohol 
consumption according to a restricted range of fractional powers (x-2, x-1, x-0.5, ln(x), x0.5, x1, x2 
and x3).176 Added as a single term, these transformations are capable of modelling monotonic 
dose-response relationships, while as a pair can also form non-monotonic functions with a single 
turning point, such as the J-shaped dose-response association previously observed between 
volume of alcohol consumption and T2DM risk. For example, a FP regression that comprises two 
polynomial terms is expressed as per Formula 3.2, with xp1 and xp2 equal to any pre-defined 
transformation of alcohol consumption from the restricted range of fractional powers, β1,…,n 
equal to the change in risk for every unit change in xp1,..,n, and β0 equal to the constant. 
 
RR=β0+β1xp1+β2xp2+ε 
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Formula 3.2 Derivation of regression coefficients according to a polynomial exposure 
To identify the best-fitting transformation, all possible FP combinations were compared against 
a null model containing only a constant parameter. Fit was determined according to the 
deviance statistic (D), equivalent to the sum of squared residuals under OLS regression, or the 
degree to which observed data differed from the fitted function. Accordingly, the best-fitting 
model was that which reported a D value closest to zero.  
FP regression models were constructed using the -fp- command in Stata 13.177 As the -fp- 
command calculates dose-response relationships using weighted least squares regression, any 
resulting coefficients are under the assumption that data are independent. Such an assumption 
is invalid in this instance given that groups of risk estimates are nested within selected studies 
and calculated relative to a common reference category. When applied to non-independent 
data, least squares regression produces estimates with too great a degree of precision.178 
Accordingly, using an approach similar to the Hamling method,172 covariance present between 
groups of extracted risk estimates was used to inflate standard errors reported by the best-
fitting FP regression models. This was undertaken using the -glst- command.179  
3.2.4.2 Heterogeneity 
An assumption commonly underlying the pooling of data for meta-analysis is that, for a given 
level of volume alcohol consumption, corresponding effect estimates extracted from each study 
(yi) were approximations of the same underlying effect (θ), with the extracted estimates each 
distributed around θ according to random sampling error.180 Under this assumption, an inverse 
variance weight is typically applied (Formula 3.3), providing less prominence to smaller studies 
on the grounds that more precise information about the same underlying effect would be 
provided by larger selected studies. 
w=1/SEi2 
Formula 3.3 Inverse variance weight 
However, given that no two selected studies were likely to have been methodologically identical, 
some degree of between-study heterogeneity was expected beyond simple random error,181 
with each yi thereby estimating an underlying effect specific to the characteristics of its design 
and population (θi). In such a circumstance, the use of an inverse variance weight would be 
inappropriate, giving prominence to a sub-sample of selected studies that may have estimated 
an underlying effect different to those given lower prominence. Accordingly, random effects 
models were used throughout. These assumed that each effect estimate (yi) for a given level of 
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exposure approximated its own specific underlying effect (θi), and that each underlying effect 
(θi) was itself distributed around a ‘grand’ value for all possible effects (μ) at the given level of 
exposure. The introduction of random effects thereby added an additional variance component 
(τ) equal to the estimated deviation between each θi and μ, thereby attenuating the inverse 
variance weight proportionate to the estimated deviation of each effect estimate’s underlying 
effect from the grand effect of interest (Formula 3.4). Results from the random effects models 
were more conservative, with wider confidence intervals in the presence of between-study 
heterogeneity. Where no between-study heterogeneity was present (τ=0), however, and the 
random effects models would naturally report figures analogous to a fixed effect model.180  
w=1/SEi2+τ 
Formula 3.4 Inverse variance weight plus a random effects variance component 
The degree of between-study heterogeneity was quantified using the I2 index.181 This estimated 
the proportion of total variance in risk as attributable to factors other than random error, and 
was calculated for each fitted polynomial term according to Formula 3.1: 
I2=((Q-df)/Q)*100% 
Formula 3.5 Calculation of the I2 statistic 
Here, df was equal to the number of constituent studies minus one, and the Cochran Q statistic 
equal to the sum of squared differences between each abstracted data point and the fitted 
polynomial function, with the contribution of each data point equal to its weight in the dose-
response meta-analysis. An I2 of 0% would thus indicate complete homogeneity between 
studies, with no variability between risk estimates other than that which would be expected 
through random error. Beyond this, the following guidelines were used for interpreting the I2 
index: 0-40%, low heterogeneity; 30-60%, moderate heterogeneity; 50-90%, substantial 
heterogeneity; 75% to 100%: considerable heterogeneity.182  
3.2.4.3 Publication bias 
There was a possibility that studies that investigated the relationship between volume of alcohol 
consumption and T2DM risk were more likely to have been published if they reported a 
significant and beneficial dose-response association. For instance, in an analysis of publication 
rates among 29,729 biomedical abstracts presented at scientific conferences, half were 
eventually published in full and the probability of publication associated with positive directions 
of effect (RR 1.30, 95% CI 1.14-1.47) and statistically significant results (RR 1.17, 95% CI 1.02-
1.35).183 Similar findings have been identified elsewhere.184 If such publication bias were present 
Chapter 3: An updated and revised meta-analysis of the dose-response relationship between 
alcohol consumption and T2DM  
57 
 
in the field of alcohol research, published studies selected for meta-analysis would have 
underrepresented smaller studies or those that reported contrary results and thereby 
overestimated the apparently advantageous relationship between moderate alcohol 
consumption and T2DM risk. 
Funnel plots have commonly been used as a means of visualising the degree of publication bias 
present across sampled studies, plotting effect estimates along the x-axis and an indicator of 
their precision rising along the y-axis. In the absence of bias, less precise studies would be 
distributed evenly around the base of the plot with more precise studies clustered near the top, 
collectively resembling an inverted and symmetrical funnel. Accordingly, an asymmetrical 
distribution of risk estimates would indicate that studies of a particular statistical significance or 
direction of effect may have been less likely to reach publication.  
Funnel plots are conventionally constructed by including a single risk estimate from each 
selected study, with all risk estimates relating to a consistently defined binary exposure (i.e. the 
risk of exposure versus non-exposure) such that they are assumed to be distributed around the 
same overall effect in a manner akin to a fixed effect meta-analysis.185,186 Given that dose-
response meta-analyses required the abstraction of multiple risk estimates from each selected 
study, with estimates pertaining to differing volumes of alcohol intake, such an assumption 
would have been invalidated were all extracted data included in a single plot. 
Accordingly, new risk estimates were recalculated using the Hamling method so as to represent 
the risk of current drinking relative to non-drinking in each study.172 These new estimates were 
then plotted against their respective standard errors. The contribution of each risk estimate to 
the calculation of an overall risk of current drinking was then estimated according to an inverse 
variance weighted linear regression equivalent to a fixed effects meta-analysis.188 Random 
effects were not used when calculating the summary estimate and doing so risked shifting the 
summary estimate such that the small study effects being investigated may become masked.188 
Risk estimates were plot on a logarithmic scale to ensure that effects in opposite directions but 
of the same magnitude were all equidistant from a risk of 1.0.182 A formal test of funnel plot 
asymmetry was also undertaken using the Egger’s test, which tested the null hypothesis of no 
difference in effect according to sample size by way of an inverse variance weighted linear 
regression of standardised risk estimates against their SEs.187  
Although a customary to view funnel plots as indicators of publication bias, such an 
interpretation should be made with consideration to factors other than publication bias that 
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may have produced an asymmetrical distribution. Alternative explanations include selection bias 
(selection criteria may have inadvertently excluded studies distributed around specific areas of 
the funnel plot, such as if negative associations between an exposure and event were most 
common among occupational cohorts but such populations had been excluded) and 
heterogeneity among selected studies (that, free of selection bias, selected studies still differed 
by characteristics associated with the relationship of interest, such as primarily representing a 
population sub-group in whom a particular direction of effect was more common). Accordingly, 
any funnel plots should only be used as a rough guide and best interpreted as a graphical 
representation of small-study effects – i.e. the tendency for studies of lower power to show 
lower levels of precision.188 
3.2.4.4 Quality assessment 
The quality of selected studies was assessed using the Newcastle-Ottawa quality assessment 
scale (Appendix 3.2).189 It comprised eight questions ranging from the representativeness of the 
sample, the method of case ascertainment and the length of follow-up. A single point could be 
awarded for each question apart from one concerning confounder adjustment for which up to 
two points could be awarded. One point was awarded for adjustment for any confounding 
factors, with an additional point awarded if a study adjusted for ‘the most important factor’. 
This was defined as adiposity, based on a study by Hu et al, which identified excess body fat as 
the strongest predictor of T2DM in a cohort of female nurses.190 Study quality was thus ranked 
on a scale from 0-9 points, with larger scores indicative of higher quality. 
Besides confounder adjustment, a number of other questions had to be subjectively defined. 
For instance, an ‘adequate’ period of aggregate follow-up was defined as at least six years in 
total. This threshold was decided upon with consideration to research by Tabak et al,191 which 
examined 13-year trajectories of fasting and post-load glucose prior to the development of 
T2DM. They identified a gradual increase in glucose concentration over time, followed by a rapid 
elevation in concentration around three (fasting glucose) and six (post-load glucose) years prior 
to T2DM diagnosis. Assuming that study participants were free of T2DM at baseline with 
normative blood glucose readings, it was thus expected that a period of at least six years would 
have been required for blood glucose levels to reach a concentration sufficient for the formal 
diagnosis of T2DM.  
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3.2.4.5 Sub-group analyses 
In addition to a summary dose-response analysis of all extracted data combined, a series of 
secondary analyses were undertaken to explore whether the relationship differed according to 
pre-specified factors. 
3.2.4.5.1 Sex interaction 
Given a higher incidence of T2DM35 and a slower metabolism of alcohol among men,192,193,194 it 
was possible that the relationship between the volume of alcohol consumption and T2DM risk 
may have differed according to sex. Such a hypothesis was supported by data from the last 
available meta-analysis,10 which indicated that female drinkers experienced greater reductions 
in T2DM risk across a wider range of alcohol consumption than men, relative to quasi-never 
drinkers. Accordingly, in addition to the primary analysis of all data combined, consideration was 
given to a possible sex interaction. In addition to formally testing a sex interaction, the dose-
response relationship was reported separately for men and women.  
3.2.4.5.2 Reference group 
To explore the effect of reference group selection upon the dose-response relationship, 
abstracted data were adjusted for any differences in dose-response according to sex and then 
an interaction term tested according to whether risk estimates had been calculated relative to 
never or pooled non-drinkers. Data were then stratified and dose-response relationships 
reported separately according to reference category. It was hypothesised that the magnitude of 
any reductions in T2DM risk at moderate volumes of alcohol consumption would be smaller 
among studies that excluded former drinkers from their reference category.  
3.2.4.5.3 Confounder adjustment 
As noted previously, it was hypothesised that confounder adjustment was likely to have a 
marked impact upon whether reductions in T2DM risk were observed at moderate levels of 
alcohol intake, with the magnitude of any reduction posited to be smaller among studies with 
more comprehensive adjustment for confounding factors.  
To test this, dose-response data were adjusted for sex and reference group, with an interaction 
term then tested according to each study’s degree of confounder adjustment. Confounder 
adjustment was defined according to a binary variable denoting whether extracted risk 
estimates were either crude or age-adjusted only, or multivariable-adjusted. In addition to 
formally testing whether the dose-response relationship differed according to the degree of 
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confounder adjustment, results were reported separately for each category of the binary 
variable. 
3.2.4.5.4 Other sub-group analyses 
Aside from sex, reference category and confounder adjustment, a number of other factors were 
posited to be likely modifiers of the observed dose-response relationship and thereby sources 
of heterogeneity between studies. These included the baseline age of participants, method of 
case ascertainment, population type, population region195 and overall study quality assessment 
score. The reasoning behind the selection of such factors was as follows:  
 Baseline age: It was hypothesised that any reduction in risk would be lower among older 
participants owing to age-related decreases in liver function and body water, increasing 
and prolonging the concentration of blood alcohol and alcohol metabolite beyond those 
seen in younger individuals at equivalent volumes of alcohol consumption.196,197,198,199 
Accordingly, any reductions in risk at moderate intakes might therefore be smaller 
within older populations as a consequence of prolonged accumulations of alcohol 
metabolites and their impact upon oxidative stress and a triggering of inflammatory 
response.200,201  
 Case ascertainment: Subjective diagnoses of T2DM may have been subject to recall or 
self-reporting biases, leading to cases of T2DM being underreported. Depending on how 
any underreporting was distributed according to the volume of alcohol consumption, 
studies that utilised a subjective measure of T2DM diagnosis may have either 
overestimated or underestimated the magnitude of any dose-response relationship. 
Although an analysis investigating the validity of self-reported T2DM in epidemiologic 
studies found subjective measures to be reliable.202  
 Follow-up duration: It was possible that studies with shorter periods of follow-up may 
have captured few new cases of T2DM and thereby have both insufficient power for the 
detection of dose-response effects.  
 Population region: Given a genetic susceptibility among Asian populations to impaired 
alcohol metabolism203 and increased T2DM risk,204 it was hypothesised that any 
reductions in risk among moderate drinkers would be less pronounced among Asian 
studies in much the same way as older drinkers. 
 Population type: Termed the ‘healthy worker effect’, studies have found participants in 
occupational cohorts to be healthier than those sampled in general population 
studies.205 Accordingly, were a reduction in risk observed among moderate drinkers, any 
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such reduction in risk may have been shallower in studies of general populations whose 
participants were less healthy and potentially at greater risk of T2DM beyond any 
adjusted confounding factors.  
 Quality assessment: With studies scoring low on the Newcastle-Ottawa assessment 
scale189 potentially being less well adjusted for confounding factors, utilising self-
reported outcome data, short follow-up periods and unrepresentative samples, it was 
posited that dose-response relationships reported by publications of lower quality 
would differ markedly in some fashion from those of higher quality.  
Unfortunately, in the absence of individual participant data, the effect of differences in baseline 
age and follow-up duration were not explored due to the risk of aggregation bias, which would 
have inappropriately treated all study participants as having shared the same average age or 
length of observation.206 For all remaining factors, interaction terms were formally tested in a 
mutually exclusive manner following adjustment for sex, reference category and confounder 
adjustment, if found to be significant modifiers of the dose-response relationship. Data were 
then stratified according to the value of each factor.  
To explore the role of case ascertainment as a modifier of the dose-response relationship, a 
categorical variable was created denoting whether case ascertainment was subjective, objective 
or some combination of the two. A binary variable was created to investigate population type, 
indicating whether studies sampled occupational groups or the general population. Asian and 
non-Asian studies were identified and coded into a binary variable, studies also coded according 
to whether they fell below the median quality assessment score.  
3.2.4.6 Sensitivity analyses 
Having identified a study that contributed a substantial proportion of sampled data, an a 
posteriori sensitivity analysis was undertaken to explore the effect of including such a study upon 
the pooled analyses. An additional sensitivity analysis was also carried out to compare the dose-
response relationship according to whether selected studies had been sampled by the preceding 
meta-analysis. Such an analysis would highlight whether the results of any newly analysed 
studies differed markedly to those previously examined. 
3.3 Results 
3.3.1 Excluded studies 
As shown in the study flow diagram (Figure 3.1), 2,357 unique publications were identified by 
the initial search procedure, with preliminary screening by CK leading to the exclusion of 2,255 
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publications that reported no temporal association between volume of alcohol consumption 
and T2DM risk. The remaining 102 publications were then shortlisted by three reviewers against 
a priori selection criteria.  
CK assessed all 102 publications, while AB shortlisted the first two-thirds (n=68) and SB 
shortlisted the last two-thirds (n=72), providing an overlap of one-third (n=38) for which 
shortlisting was undertaken by all three reviewers. Agreement between reviewers was high, 
with a κ of 0.86 between CK and SB, 0.91 between CK and AB, and 0.82 between all three 
reviewers. 
Of the 102 publications that reported a temporal association between volume of alcohol 
consumption and T2DM risk, reviewers agreed that the full text of one was unobtainable, 45 
reported <3 levels of alcohol intake, and seven provided data insufficient for estimating drinking 
in g/day. A further seven publications provided no sex-specific risk estimates, one reported 
information insufficient for calculating risk estimates for each consumption category (i.e. a 
figure without numbered axes or estimates), and one reported an abstention category 
contaminated by current drinkers.  
With 40 shortlisted publications agreed to have met all selection criteria, a further six suitable 
publications were identified following an examination of their referenced and referencing 
material. The resulting 46 publications were then checked to ensure that cohorts were each 
sampled only once. Where the same dataset was analysed by multiple publications, risk 
estimates were included from only the most robust analysis. Agreed upon by all three reviewers, 
the qualitative rationale in each instance was as follows: 
 Four of the 46 shortlisted publications analysed the US Nurses' Health Study. Two of 
these were excluded for providing substantially shorter periods of follow-up and smaller 
sample sizes than the chosen publication.207,208 Although the third publication provided 
almost twice the follow-up duration of any other paper, it was excluded due to its much 
smaller sample size and stratification of risk estimates for each consumption category 
according to a genetic polymorphism as opposed to the volume of alcohol 
consumption.90  
 Three studies analysed the US Health Professionals' Follow-up Study. The first was 
excluded for providing data on 46,000 fewer participants than the chosen publication.90 
Although the second paper included adjustment for two additional confounding factors 
Chapter 3: An updated and revised meta-analysis of the dose-response relationship between 
alcohol consumption and T2DM  
63 
 
than the chosen publication,209 it sampled over 5,000 fewer participants and utilised half 
the period of follow-up than the third publication.  
 Three studies also analysed the multi-centre European Prospective Investigation into 
Cancer and Nutrition (EPIC) study, each with roughly equivalent levels of confounder 
adjustment. The first sampled over 10,000 fewer participants than the chosen 
publication and was thus excluded.210 While the second publication sampled 8,800 more 
participants than the chosen study,211 it was excluded in preference of a paper that 
sampled a much wider range of European countries (Netherlands versus Denmark, 
France, Germany, Italy, Netherlands, Spain, Sweden and the United Kingdom).  
 Two papers were published in 2010 by the same primary author, each sampling the 
same Japanese Gifu Prefectural Center for Health Check and Health Promotion cohort. 
Reporting similar levels of confounder adjustment and follow-up duration, the 
publication with the smaller sample size was excluded.212 
 Two other shortlisted publications were also published by an identical primary author, 
with each sampling employees from the same Japanese gas company with equivalent 
levels of confounder adjustment and follow-up. Here, the study with the smaller sample 
size was excluded.213  
The removal of these eight duplicate studies left a final sample of 38 unique studies. 
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Figure 3.1 Study flow diagram 
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3.3.2 Included studies 
As per the study flow diagram in Figure 3.1, 38 unique studies met a priori selection criteria out 
of an initial 2,704 search results. Of these, nine had provided additional, updated or recalculated 
risk estimates via personal correspondence.  
Data extracted from the 38 studies represented 1,082,639 male and 819,966 female 
participants, among whom 79,633 and 46,293 cases of T2DM were reported. Crude or age-
adjusted estimates were provided by 15 (39.5%) studies. Of the 23 remaining studies, measures 
of adiposity were universally accounted for, with smoking controlled by 16 (69.6%) studies, 
physical activity by 15 studies (65.2%), and familial heritability by 10 studies (43.4%). Other 
confounding factors included education (n=9, 39.1%), dietary variables (n=6, 26.1%), blood 
pressure (n=5, 21.7%), ethnicity (n=3, 13.0%) and some marker of social status such as 
occupational grade (n=3, 13.0%). More detailed information concerning the characteristics of 
the selected studies are reported in Table 3.1, while Table 3.2 lists the risk estimates for each 
level of alcohol consumption.  
Despite capturing an additional 18 studies relative to the preceding alcohol-T2DM meta-
analysis, only five studies were identified as having used a never drinking category strictly 
defined as complete abstention across the life course.96,219,225,230,244 These included Kao et al,219 
who defined never drinkers as those who answered in the negative to the two following 
questions: “Do you presently drink alcoholic beverages?” and “Have you ever consumed 
alcoholic beverages?” Similarly, Carlsson et al,96 defined never drinkers as baseline non-drinkers 
who also reported no change in alcohol consumption at any time prior, while Wannamethee et 
al225 defined never drinkers as those who reported no consumption at all periods of follow-up 
(ages 15-17, 18-22, 23-30, and 31-40 years of age). Where a study’s definition of never drinking 
was deemed inadequate, such as through an inclusion of infrequent97 or former drinkers,153,234 
such studies were classified as having use a pooled non-drinking reference category. 
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Table 3.1 Characteristics of selected studies 
First author Year Country Dataset Design Population Age 
(years) 
Duration 
(years) 
Exposure ascertainment Case ascertainment 
Holbrook214 1990 US Rancho 
Bernardo 
Cohort Community 40-79 14 Self-reported average weekly 
consumption of any alcoholic drinks. 
A positive FPG or OGTT result, or a 
self-reported doctor-diagnosed 
diabetes. 
Kawakami215 1997 Japan Large electrical 
company 
Cohort Occupational 18-53 7.9 Self-reported mean consumption of 
alcoholic drinks usually consumed per 
week during the past year. 
A positive FPG result among 
participants identified following a 
urine sample as having glycosuria. 
Tsumura216 1999 Japan Osaka Health 
Survey 
Cohort Occupational 35-61 9.7 Self-reported usual daily volume 
consumption. 
A positive FPG or OGTT result. 
Ajani217 2000 US Physicians' 
Health Study 
Cohort Occupational 40-85 12.1 Self-reported frequency of consumption. 
Responses interpreted as number of 
standard drinks consumed. 
Self-reported doctor diagnosis. 
Wei218 2000 US Cooper Clinic 
Study 
Cohort Community 30-79 6.1 Self-reported average weekly volume 
consumption of beer, wine or hard 
liquor. Alcohol content estimated as 1.1 
g/1 oz beer, 2.7 g/1 oz wine, and 15.1 g 
/1 oz liquor. 
A positive FPG result. Of those 
without a positive result, a self-
reported history of diabetes or use 
of hypoglycaemic medication. 
Conigrave95 2001 US Health 
Professionals' 
Follow-up 
Study 
Cohort Occupational 40-75 10.9 Self-reported average frequency of 
consumption, with average daily volume 
estimated assuming 12.8g/beer, 
11.0g/glass of wine, 14.0g/glass of 
liquor. 
A positive FPG, non-FPG or OGTT 
result, or an elevated plasma glucose 
reading on two different occasions, 
or self-reported hypoglycaemic 
treatment. 
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Hu190 2001 US Nurses' 
Health Study 
Cohort Occupational 30-55 15.3 Self-reported average frequency 
of beer, wine and liquor 
consumption. Daily volume 
estimated according to assumed 
nutrient content by drink type. 
Self-reported cases confirmed 
following a positive FPG result, or 
an elevated randomly measured 
plasma glucose concentration. 
Kao219 2001 US ARIC Cohort Community 45-64 Men: 5.3 
Women: 5.4 
Self-reported average number of 
drinks consumed per week. 
Assumed 12.0 g/drink. 
A positive FPG, or the self-reported 
use of hypoglycaemic medication, 
or a self-report of doctor diagnosis. 
Meisinger220 2002 Germany MONICA Cohort Community 35-74 Men: 7.5 
Women: 7.6 
Self-reported volume of beer, 
wine and spirit consumption on 
the previous workday and the 
previous weekend. 
Self-reported doctor diagnosis or 
self-reported use of hypoglycaemic 
medication. 
Wannamethee221 2002 UK British 
Regional 
Heart Study 
Cohort Community 40-59 16.8 Self-reported frequency, quantity, 
and type of alcohol consumption. 
Self-reported T2DM, confirmed via 
primary care records. 
Carlsson96 2003 Finland Finnish Twin 
Cohort 
Cohort Community ≥18 28 Self-reported volume of alcohol 
consumed during an average 
week (beer, wine) or month 
(spirits). 
Death certificates, the National 
Hospital Discharge Register and the 
Medication Register of the Social 
Insurance Institution. 
Lee222 2003 Korea 
Steel 
company 
Cohort Occupational 25-55 4 
Self-reported data. No further 
detail published. 
A positive FPG result. 
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Nakanishi223 2003 Japan 
Building 
contractor 
Cohort Occupational 35-59 6.1 
Self-reported frequency of alcohol 
consumption per week, and usual 
amount consumed per day in 
units of “go” (23 g ethanol). 
A positive FPG result, or self-
reported use of hypoglycaemic 
medication. 
Sawada224 2003 Japan Gas company  Cohort Occupational 20-40 13.6 
Self-administered questionnaire. 
No further detail published. 
A positive FPG or OGTT result, or 
the self-reported prescription of 
hypoglycaemic medication. 
Wannamethee225 2003 US 
Nurses' 
Health Study 
II 
Cohort Occupational 25-42 8.1 
Self-reported beverage-specific 
frequency of consumption during 
the past year. Volume 
consumption estimated according 
to assumed drink-specific ABVs. 
A positive FPG or OGTT result, or 
elevated plasma glucose levels on 
two different occasions, or self-
reported hypoglycaemic treatment.  
Lee226 2004 US 
Iowa 
Women’s 
Health Study 
Cohort Community 55-69 9.3 
Self-administered questionnaire. 
No further detail published. 
Self-reported doctor diagnosis. 
Waki227 2005 Japan JPHC Study Cohort Community 40-59 10 
Self-reported type and frequency 
of alcohol consumption per week, 
and the usual amount of alcohol 
consumed per day. 
Self-reported doctor diagnosis. 
Hodge97 2006 Australia 
Melbourne 
Collaborative 
Cohort Study 
Cohort Community 40-69 4 
Self-reported beverage-specific 
average frequency and quantity of 
consumption, plus volume via a 
seven-day diary. 
Self-reported doctor diagnosis. 
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Hu228 2006 Finland FINMONICA Cohort Community 35-74 
Men: 13.0 
Women: 13.8 
Self-administered questionnaire. No 
further detail published. 
National Hospital Discharge Register 
or National Social Insurance Drug 
Register, confirmed via a positive FPG 
or OGTT result, or self-reported 
hypoglycaemic drug treatment. 
Strodl229 2006 Australia 
Australian 
Women’s 
Health Survey 
Cohort Community 70-74 3 
Self-administered questionnaire. No 
further detail published. 
Self-reported doctor-diagnosis.  
Burke230 2007 Australia 
Kimberley 
Aborigines 
Cohort Community 15-88 12.9 
A contextualised diary of the last 
two 48-hour drinking periods. 
Linkage to hospital admission and 
mortality records. 
Djoussé153 2007 US 
Cardiovascular 
Health Study 
Cohort Community ≥65 6.3 
Self-reported usual frequency of 
beer, wine and liquor consumption, 
and quantity consumed on an 
average occasion. 
A positive FPG result or self-reported 
hypoglycaemic drug treatment. 
Maty231 2008 US 
Alameda 
County Study 
Cohort Community 17-94 34 
Self-reported frequency of 
consumption, and quantity 
consumed on an average occasion. 
Self-reported doctor-diagnosed 
diabetes. 
Onat232 2009 Turkey 
Turkish Adult 
Risk Factor 
Study 
Cohort Community ≥18 7.4 
Self-administered questionnaire. No 
further detail published. 
A positive FPG result or self-reported 
hypoglycaemic drug treatment. 
Roh233 2009 Korea 
Annual health 
evaluation 
Cohort Community 
Not 
reported 
4 
Self-reported frequency of 
consumption, and quantity 
consumed on an average occasion. 
A positive FPG result. 
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Boggs234 2010 US 
Black 
Women’s 
Health Study 
Cohort Community 21-69 9.4 
Self-reported average frequency of 
beer, wine, and liquor consumption 
during the previous year. Volume 
consumption estimated assuming 12.0 
g/drink.  
Self-reported doctor diagnosis, 
excluding cases among participants 
aged <30 years. 
Jee235 2010 Korea 
Korean Cancer 
Prevention 
Study 
Cohort Community 30-95 14 
Self-administered questionnaire. No 
further detail published. 
Outpatient treatment for diabetes 
(at least three visits for diabetes 
care per 365 days). 
Nagaya236 2010 Japan 
Gifu Center 
for Health 
Promotion 
Cohort Community 30-59 
Men:8.2 
Women: 7.7 
Self-administered questionnaire 
reconfirmed by a personal interview 
with a public health nurse. No further 
detail published. 
A positive FPG result or self-
reported hypoglycaemic drug 
treatment. 
Balkau237 2011 France DESIR Cohort Community 30-65 9 
Self-reported usual daily consumption 
of wine, beer, cider and spirits. The 
following volumes were assumed: 10.0 
g/125 ml wine or 250 ml of beer/cider, 
and 7.0 g/20 ml of spirits. 
A positive FPG or HbA1c result, or 
self-reported treatment for 
diabetes. 
Beulens238 2012 
Denmark, 
France, 
Germany, 
Italy, 
Netherlands, 
Spain, 
Sweden, UK 
EPIC–InterAct 
Nested 
case–
cohort 
Community 35-70 9.9 
Self-reported number and frequency of 
glasses of beer, cider, wine, sweet 
liquor, distilled spirits or fortified wines 
consumed during the previous 12 
months. Volume estimated according 
to assumed glass volume and ethanol 
content for each drink type. 
Self-reported doctor-diagnosed 
diabetes or self-reported 
treatment for diabetes, or linkage 
to primary or secondary care 
registers or diabetes and 
pharmaceutical registers. 
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Cullmann239 2012 Sweden 
Stockholm 
Diabetes 
Prevention 
Program 
Cohort Community 35-56 8-10 
Self-reported frequency and quantity of 
medium and strong beer, wine, dessert 
wine and spirits.  
A positive FPG or OGTT reading. 
Sato240 2012 Japan 
Kansai 
Healthcare 
Study 
Cohort Occupational 40-55 3.5 
Self-reported weekly frequency of alcohol 
consumption and quantity consumed per 
average drinking day. Volume estimated 
according to a Japanese standard drink 
equivalent to 23.0 g/180 ml sake. 
A positive FPG result or self-
reported hypoglycaemic drug 
treatment. 
Stringhini241 2012 UK Whitehall II Cohort Occupational 35-55 14.2 
Self-reported quantity of drinks 
consumed in the previous week, 
converted to UK units. No further detail 
published. 
A positive FPG or OGTT result, or 
self-reported doctor-diagnosed 
diabetes, or self-reported 
hypoglycaemic drug treatment. 
Teratani242 2012 Japan 
Steel 
company 
Cohort Occupational 
Not 
reported 
4.4 
Self-reported quantity of daily alcohol 
consumption. Volume estimated 
assuming 22.0 g/180 ml sake, 500 ml 
beer, 60 ml whiskey, 180 ml wine, or 110 
ml shochu. 
Self-reported doctor diagnosis, 
or a positive HbAlc result, or 
≥6.1% or self-reported 
hypoglycaemic drug treatment.  
Abbasi243 2013 Netherlands PREVEND Cohort Community 28-75 8 
Self-administered questionnaire. No 
further detail published. 
A positive FPG or random 
plasma glucose result, or a self-
reported doctor diagnosis, or 
objective hypoglycaemic drug 
treatment. 
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Heianza244 2013 Japan TOPICS 11 Cohort Community 26-80 10.2 
Self-reported frequency of consumption 
and average quantity of alcohol consumed 
per occasion.  
Positive FPG or HbA1c result, or self-
reported doctor-diagnosed diabetes. 
Rasouli245 2013 Norway 
Nord-Trøndelag 
Health Survey 
Cohort Community ≥20 11 
Self-reported, beverage-specific average 
quantity of beer, wine or spirits consumed 
over a two-week period. Assumed 
16g/beer, 12g/glass of wine or spirits. 
Of those with self-reported diabetes, 
T1DM was tested using a marker of 
pancreatic autoimmune damage. Those 
with a negative result were classified as 
having T2DM. 
Shi246 2013 China 
Shanghai Men’s 
Health Study 
Cohort Community 40-74 5.4 
Self-reported type, frequency, and usual 
quantity of alcohol consumed (wine, beer, 
and liquor). 
Self-reported cases confirmed via a 
positive FPG or OGTT result or use of 
hypoglycaemic medication. 
FPG: Fasting plasma glucose test; OGTT: oral glucose tolerance test; UK: United Kingdom; US: United States. 
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Table 3.2 Measures of alcohol consumption, confounder adjustment and effect estimates reported by selected studies  
     Alcohol consumption   Risk of T2DM     
First author Sex  Exposure categoriesa Estimated g/dayb   
Cases 
(n) 
Non-cases 
(n) 
  Measure Effect estimates Confounder adjustment Quality 
Holbrook214 
Men 
 Non-drinkers Non-drinkers   6 31   
Relative 
risk 
1.00 (reference) 
Age 7 
 0.1-84.3 g/week 6.0   7 53   0.72 (95% CI 0.26-1.98) 
 84.4-176.0 g/week 18.6   6 55   0.61 (95% CI 0.21-1.74) 
 176.1-750 g/week 66.2   16 47   1.57 (95% CI 0.67-3.65) 
                 
Women 
 Non-drinkers Non-drinkers   16 68   1.00 (reference) 
 0.1-41.3 g/week 6.0   7 67   0.50 (95% CI 0.22-1.14) 
 41.4-117.4 g/week 18.6   12 60   0.88 (95% CI 0.44-1.73) 
 117.5-750 g/week 66.2   12 61   0.86 (95% CI 0.44-1.70) 
Kawakami215 Men 
 0 ml/week 0.0   11c 590c   
Hazard 
ratio 
1.00 (reference) Age; BMI; education; family history 
of T2DM; occupation; physical 
activity; smoking; shift pattern 
7  <300 ml/week 16.9   23c 1,595c   1.04 (95% CI 0.47-2.32) 
 ≥300 ml/week 40.6   12c 533c   1.09 (95% CI 0.44-2.67) 
Tsumura216 Men 
 Non-drinkers Non-drinkers   76 1,058   
Relative 
risk 
1.00 (reference) 
Age 6 
 0.1-19.0 ml/day 7.5   95 1,226   0.98 (95% CI 0.73-1.33) 
 19.1-29.0 ml/day 19.0   120 1,386   1.08 (95% CI 0.81-1.44) 
 29.1-50.0 ml/day 31.2   60 1,057   0.80 (95% CI 0.57-1.12) 
 ≥50.1 ml/day 47.4   105 1,179   1.40 (95% CI 1.04-1.88) 
Ajani217 Men 
 Rarely/Never drinkers Rarely/Never drinkers 145 2,900   
Relative 
risk 
1.00 (reference) 
Age; BMI; physical activity; 
smoking; treatment group 
6 
 1-3 drinks/month 0.9   111 2,189   1.03 (95% CI 0.80-1.33) 
 1 drinks/week 2.0   122 2,806   0.89 (95% CI 0.70-1.14) 
 2-4 drinks/week 6.0   157 4,614   0.74 (95% CI 0.59-0.93) 
 5-6 drinks/week 11.0   80 2,613   0.67 (95% CI 0.51-0.88) 
 ≥1 drink/day 16.8   151 5,063   0.57 (95% CI 0.45-0.73) 
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Wei218 
Men 
Non-drinkers Non-drinkers   36 1,811   
Relative riskd,e 
1.00 (reference) 
Age; family history of T2DM; 
years of follow-up 
6 
1-61.8 g/week 4.8   21 1,675   0.78 (95% CI 0.44-1.37) 
61.9-122.7 g/week 13.1   16 1,682   0.56 (95% CI 0.31-1.00) 
122.8-276.6 g/week 26.6   35 1,655   1.22 (95% CI 0.75-1.98) 
≥276.6 g/week 83.5   41 1,661   1.32 (95% CI 0.83-2.11) 
Conigrave95 Men 
0 g/day 0.0   416 10,656   
Relative risk 
1.00 (reference) 
Age; BMI 5 
0.1-4.9 g/day 2.3   450 11,356   1.09 (95% CI 0.95–1.24) 
5.0-9.9 g/day 7.3   214 6,941   0.88 (95% CI 0.74–1.04) 
10.0-14.9 g/day 12.3   163 6,050   0.77 (95% CI 0.64–0.92) 
15.0-29.9 g/day 19.7   174 6,321   0.80 (95% CI 0.67–0.96) 
30.0-49.9 g/day 38.1   116 4,419   0.72 (95% CI 0.58–0.88) 
≥50.0 g/day 70.1   38 1,419   0.64 (95% CI 0.46–0.89) 
Hu190 Women 
0 g/day 0.0   1,715 27,165   
Relative risk 
1.00 (reference) Age; family history of T2DM; 
menopausal status; time; 
use of postmenopausal 
hormone therapy 
6 
0.1-5 g/day 2.6   1,034 26,997   0.78 (95% CI 0.72–0.84) 
5.1-10.0 g/day 7.6   189 9,155   0.56 (95% CI 0.48–0.65) 
>10 g/day 12.0   358 17,480   0.59 (95% CI 0.52–0.66) 
Kao219 
Men 
Lifetime abstainers Lifetime abstainers   69 600   
Relative riskd,e 
1.00 (reference) 
Age; BMI; education; 
ethnicity; family history of 
T2DM; history of 
hypertension; physical 
activity; smoking; total 
energy intake; waist-hip 
ratio 
7 
Former drinkers Former drinkers   118  978    0.93 (95% CI 0.70-1.24) 
≤1 drink/week 0.1   74 741   0.88 (95% CI 0.64-1.23) 
1.1-7 drinks/week 6.1   139 1,227   0.98 (95% CI 0.74-1.30) 
7.1-14 drinks/week 17.7   55 670   0.72 (95% CI 0.50-1.02) 
14.1-21 drinks/week 29.3   32 281   0.94 (95% CI 0.62-1.41) 
>21 drinks/week 57.4   60 379   1.75 (95% CI 1.26-2.44) 
                
Women 
Lifetime abstainers Lifetime abstainers   236 1,987   1.00 (reference) 
Former drinkers Former drinkers   108  872    1.00 (95% CI 0.75-1.34) 
≤1 drink/week 0.1   110 1,626   0.92 (95% CI 0.72-1.17) 
1.1-7 drinks/week 5.7   90 1,226   0.99 (95% CI 0.74-1.33) 
7.1-14 drinks/week 16.7   18 378   0.75 (95% CI 0.45-1.25) 
14.1-21 drinks/week 28.9   5 125   0.60 (95% CI 0.24-1.47) 
>21 drinks/week 49.6   2 56   0.39 (95% CI 0.10-1.55) 
Chapter 3: An updated and revised meta-analysis of the dose-response relationship between alcohol consumption and T2DM  
75 
 
Meisinger220 
Men 
0 g/day 0.0   23 439   
Relative risk 
1.00 (reference) 
None 6 
0.1-39.9 g/day 20.0   46 1,518   0.59 (95% CI 0.36-0.96) 
≥40 g/day 48.0   58 968   1.14 (95% CI 0.71-1.82) 
                
Women 
0 g/day 0.0   48 1,212   1.00 (reference) 
0.1-19.9 g/day 10.0   26 1,199   0.56 (95% CI 0.35-0.89) 
≥20 g/day 24.0   12 618   0.50 (95% CI 0.27-0.93) 
Wannamethee221 Men 
Non-drinkers Non-drinkers   4 285   
Relative riske 
1.00 (reference) 
Age; BMI; history of CHD; 
physical activity; smoking; 
social class 
9 
<1 unit/week 0.6   62 1,150   0.91 (95% CI 0.50-1.65) 
1-15 units/week 7.9   99 1,612   0.74 (95% CI 0.45-1.20) 
15-42 units/week 32.7   64 1,361   0.60 (95% CI 0.36-0.99) 
>42 units/week 63.2   18 566   0.87 (95% CI 0.50-1.51) 
Carlssonf,96 
Men 
Lifetime abstainers Lifetime abstainers   64 1,045   
Hazard ratio 
1.00 (reference) 
Age; BMI; smoking 8 
Former drinkers Former drinkers   11 151   0.91 (95% CI 0.46-1.80) 
<5 g/day 3.1   181 2,525   1.06 (95% CI 0.78-1.42) 
5–30 g/day 10.7   261 4,480   0.86 (95% CI 0.63-1.16) 
>30 g/day 42.8   75 1,023   0.90 (95% CI 0.61-1.32) 
                
Women 
Lifetime abstainers Lifetime abstainers   280 2,977   1.00 (reference) 
Former drinkers Former drinkers   2 75   0.93 (95% CI 0.23-3.73) 
<5 g/day 2.3   273 5,655   0.79 (95% CI 0.66-0.95) 
5–20 g/day 6.9   55 2,173   0.66 (95% CI 0.47-0.91) 
>20 g/day 25.9   10 303   0.79 (95% CI 0.40-1.55) 
Lee222 Men 
Non-drinkers Non-drinkers   23 816   
Relative risk 
1.00 (reference) 
None 3 
≤90 g/week 6.5   33 1,793   0.66 (95% CI 0.39-1.12) 
91-180 g/week 19.4   11 733   0.54 (95% CI 0.26-1.10) 
181-360 g/week 38.6   11 497   0.79 (95% CI 0.39-1.61) 
>360 g/week 61.7   5 133   1.32 (95% CI 0.51-3.42) 
Nakanishi223 Men 
0 g/day 0.0   63 358   
Relative riske 
1.00 (reference) 
Age; BMI; family history of 
T2DM; physical activity; 
smoking 
7 
0.1-22.9 g/day 11.5   67 467   0.87 (95% CI 0.60-1.26) 
23.0-45.9 g/day 34.5   66 632   0.66 (95% CI 0.47-0.93) 
46.0-68.9 g/day 57.5   107 774   0.78 (95% CI 0.56-1.10) 
≥69 g/day 82.8   67 352   0.95 (95% CI 0.65-1.38) 
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Sawada224 Men 
Non-drinkers Non-drinkers   50 1,412   
Relative risk 
1.00 (reference) Age; BMI; family history 
of T2DM; fitness; high 
blood pressure; smoking 
7 1-45 g/day 23.5   206 2,814   1.59 (95% CI 1.16-2.17) 
≥46 g/day 55.2   24 239   1.68 (95% CI 1.03-2.76) 
Wannamethee225 Women 
Lifelong abstainers Lifelong abstainers   181 14,736   
Relative risk 
1.00 (reference) 
Age 4 
Former drinkers Former drinkers   334 23,791   1.18 (95% CI 0.98-1.41) 
0.1-4.9 g/day 2.5   336 44,048   0.67 (95% CI 0.56-0.80) 
5.0-14.9 g/day 10.0   70 18,309   0.34 (95% CI 0.25-0.44) 
15.0-29.9 g/day 22.5   8 2,308   0.29 (95% CI 0.15-0.60) 
≥30 g/day 36.0   6 758   0.63 (95% CI 0.28-1.42) 
Lee226 Women 
Non-drinkers Non-drinkers   1,168 15,829   
Rate ratio 
1.00 (reference) 
None 4 1-14 g/day 8.0   675 15,592   0.60 (95% CI 0.55-0.66) 
≥15 g/day 18.0   78 2,356   0.47 (95% CI 0.37-0.59) 
Waki227 
Men 
Non/infrequent drinkers Non/infrequent drinkers 196 3,834   
Relative riskd 
1.00 (reference) 
Age; BMI; family history 
of T2DM; hypertension; 
physical activity; smoking 
6 
≤23.0 g/day 11.55   169 3,162   1.08 (95% CI 0.88-1.32) 
23.1-46.0 g/day 34.55   174 2,735   1.24 (95% CI 1.02-1.52) 
>46.0 g/day 55.32   164 2,479   1.23 (95% CI 1.00-1.52) 
                
Women 
Non/infrequent drinkers Non/infrequent drinkers 436 13,919   1.00 (reference) 
≤4.9 g/day 2.5   15 465   1.14 (95% CI 0.69-1.90) 
5.0-11.5 g/day 8.25   16 636   0.81 (95% CI 0.49-1.34) 
>11.5 g/day 13.92   13 481   0.79 (95% CI 0.45-1.38) 
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Hodge97 
Men 
Lifetime abstainer Lifetime abstainer   25 1,795   
Relative riskd 
1.00 (reference) 
Age; BMI; country of birth; 
dietary glycaemic index; 
dietary energy intake; waist-
hip ratio 
8 
Former drinkers Former drinkers   17 500   2.44 (95% CI 1.29-4.52) 
<10 g/day 4.3   56 3,031   1.55 (95% CI 0.95-2.50) 
10-19.9 g/day 15.0   30 2,247   1.21 (95% CI 0.69-2.07) 
20-29.9 g/day 24.2   13 1,333   0.80 (95% CI 0.40-1.59) 
≥30 g/day 45.0   38 3,129   0.86 (95% CI 0.50-1.57) 
                
Women 
Lifetime abstainers Lifetime abstainers   114 7,729   1.00 (reference) 
Ex-drinkers Ex-drinkers   9 589   1.12 (95% CI 0.55-2.24) 
<10 g/day 3.5   32 5,659   0.66 (95% CI 0.44-1.00) 
10-19.9 g/day 15.0   18 2,838   0.82 (95% CI 0.49-1.37) 
≥20 g/day 30.2   10 2,210   0.60 (95% CI 0.30-1.17) 
Hu228 
Men 
Non-drinkers Non-drinkers   223 3,608   
Hazard ratio 
1.00 (reference) 
Age; BMI; food consumption 
(bread; coffee, fruit, tea, 
sausage, vegetable); 
education; physical activity; 
smoking; study year; systolic 
blood pressure 
8 
1-100 g/week 7.2   190 3,661   0.91 (95% CI 0.75-1.11) 
>100 g/week 17.1   104 2,402   0.74 (95% CI 0.58-0.95) 
                
Women 
Non-drinkers Non-drinkers   357 6,350   1.00 (reference) 
1-100 g/week 7.2   87 3,877   0.74 (95% CI 0.57-0.94) 
>100 g/week 17.1   3 523   0.23 (95% CI 0.07-0.73) 
Strodl229 Women 
Non-drinkers Non-drinkers   87 2,698   
Relative riskd 
1.00 (reference) 
None 3 
Rarely drinkers Rarely drinkers         1.00 (95% CI 0.74-1.35) 
1-2 drinks/day 15.0   54 2,922   0.58 (95% CI 0.42-0.82) 
≥3 drinks/day 36.0   12 306   1.21 (95% CI 0.67-2.17) 
Burke230 
Men 
Life-long abstainers Life-long abstainers   7 14   
Relative risk 
1.00 (reference) 
None 6 
Ex-drinkers Ex-drinkers   14 40   0.78 (95% CI 0.37-1.65) 
 <150 g/day 88.0   12 86   0.37 (95% CI 0.16-0.82) 
≥150 g/day 209.0   8 48   0.43 (95% CI 0.18-1.04) 
                
Women 
Life-long abstainers Life-long abstainers   25 66   1.00 (reference) 
Ex-drinkers Ex-drinkers   11 38   0.82 (95% CI 0.44-1.52) 
<100 g/day 57.0   10 48   0.63 (95% CI 0.33-1.21) 
≥100 g/day 136.0   9 18   1.21 (95% CI 0.65-2.28) 
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Djoussé153 
Men 
Never drinkers Never drinkers   37 476   
Relative risk 
1.00 (reference) 
Age; BMI; 
education; 
smoking 
8 
Former drinkers Former drinkers   10 183   0.7 (95% CI 0.3-1.4) 
<1 drink/week 0.4   13 326   0.5 (95% CI 0.3-0.9) 
1-6 drinks/week 4.0   24 421   0.6 (95% CI 0.4-1.1) 
≥7drinks/week 30.0   25 384   0.8 (95% CI 0.4-1.3) 
                
Women 
Never drinkers Never drinkers   74 1,221   1.00 (reference) 
Former drinkers Former drinkers   10 143   1.2 (95% CI 0.6-2.3) 
<1 drink/week 0.4   23 582   0.7 (95% CI 0.4-1.1) 
1-6 drinks/week 4.0   13 400   0.6 (95% CI 0.3- 1.1) 
≥7 drinks/week 30.0   5 285   0.4 (95% CI 0.2-1.0) 
Maty231 
Men 
0 drinks/month 0.0   21 373   
Relative risk 
1.00 (reference) 
None 4 
1-45 drinks/month 10.6   85 1,652   0.92 (95% CI 0.58-1.46) 
≥46 drinks/month 25.4   34 591   1.02 (95% CI 0.60-1.73) 
                
Women 
0 drinks/month 0.0   42 771   1.00 (reference) 
1-45 drinks/month 10.6   116 1,969   1.08 (95% CI 0.76-1.52) 
≥46 drinks/month 25.4   9 250   0.67 (95% CI 0.33-1.36) 
Onatf,232 
Men 
Non-drinkers Non-drinkers   102 936   
Relative risk 
1.00 (reference) 
Age; physical 
activity; smoking 
6 
<3 drinks/day 16.0   46 434   1.23 (95% CI 0.88-1.73)  
>3 drinks/day 38.4   14 71   1.91 (95% CI 1.06-3.45) 
                
Women 
Non-drinkers Non-drinkers   157 1,384   1.00 (reference) 
<3 drinks/day 16.0   2 63   0.38 (95% CI 0.11-1.23) 
>3 drinks/day 38.4   0 4   Too few data 
Roh233 Men 
Non-drinkers Non-drinkers   150 276   
Relative risk 
1.00 (reference) 
None 5 
1-14 g/day 8.0   251 412   1.08 (95% CI 0.91-1.26) 
15-29 g/day 22.5   166 200   1.29 (95% CI 1.09-1.53) 
≥30 g/day 36.0   123 139   1.33 (95% CI 1.11-1.60) 
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Boggs234 Women 
Never drinkers Never drinkers   1,669 20,457   
Relative risk 
1.00 (reference) 
Age; questionnaire 
cycle; energy intake 
5 
Former drinkers Former drinkers   1,159 9,966   1.22 (95% CI 1.13-1.31) 
1-3 drinks/week 4.0   552 7,658   0.84 (95% CI 0.76-0.93) 
4-6 drinks/week 10.0   132 2,530   0.60 (95% CI 0.51-0.72) 
7-13 drinks/week 20.0   97 1,484   0.70 (95% CI 0.57-0.86) 
≥14 drinks/week 33.6   43 654   0.71 (95% CI 0.52-0.96) 
Jeef,235 
Men 
0 g/day 0.0   14,407 172,786   
Hazard ratio 
1.00 (reference) 
Age; age2; BMI; physical 
activity 
8 
1-24 g/day 13.0   33,332 418,536   0.95 (95% CI 0.93–0.97) 
25-4 g/day 37.5   7,588 80,680   0.99 (95% CI 0.96–1.02) 
50-99 g/day 75.0   4,188 41,104   1.05 (95% CI 1.01–1.08) 
≥100 g/day 120.0   1,440 13,703   1.04 (95% CI 0.99–1.10) 
                
Women 
0 g/day 0.0   24,860 359,916   1.00 (reference) 
1-24 g/day 13.0   3,596 60,024   0.90 (95% CI 0.87–0.93) 
25-49 g/day 37.5   6 210   1.85 (95% CI 0.77–4.43) 
≥50 g/day 60.0   2 46   1.03 (95% CI 1.00–1.06) 
Nagaya236 
Men 
0 g/day 0.0   212 3,940   
Relative risk 
1.00 (reference) 
None 6 
<25 g/day 12.5   198 4,035   0.92 (95% CI 0.76-1.11) 
25-40 g/day 32.5   223 4,071   1.02 (95% CI 0.85-1.22) 
≥40 g/day 48.0   236 3,913   1.11 (95% CI 0.93-1.33) 
                
Women 
0 g/day 0.0   188 6,434   1.00 (reference) 
<25 g/day 12.5   30 1,413   0.73 (95% CI 0.50-1.07) 
≥25 g/day 30.0   6 297   0.70 (95% CI 0.31-1.56) 
Balkauf,237 
Men 
0 g/day 0.0   18 206   
Relative riskd 
1.00 (reference) 
Education; physical 
activity; smoking 
5 
<20 g/day 2.0   27 411   0.77 (95% CI 0.42-1.40) 
20-39 g/day 23.0   79 844   0.84 (95% CI 0.49-1.40) 
≥40 g/day 67.0   47 244   1.27 (95% CI 0.73-2.16) 
                
Women 
0 g/day 0.0   35 206   1.00 (reference) 
<20 g/day 1.0   35 411   0.95 (95% CI 0.59-1.48) 
≥20 g/day 21.0   22 1088   0.87 (95% CI 0.51-1.43) 
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Beulens238 
Men 
0 g/day 0.0   485 452   
Hazard ratioe 
1.00 (reference) 
Age; BMI; education; food 
consumption (coffee, fruit, 
meat, total energy, 
vegetable); physical 
activity; smoking;  
8 
0.1-6.0 g/day 3.1   1,303 1,262   1.03 (95% CI 0.86-1.24) 
6.1-12.0 g/day 9.1   890 891   0.93 (95% CI 0.79-1.09) 
12.1-24.0 g/day 18.1   1,116 1,166   0.97 (95% CI 0.83-1.13) 
24.1-60.0 g/day 42.1   1,448 1,555   0.89 (95% CI 0.77-1.02) 
60.1-96.0 g/day 78.1   393 363   0.80 (95% CI 0.65-0.99) 
>96.0 g/day 115.2   126 85   1.10 (95% CI 0.79-1.54) 
                
Women 
0 g/day 0.0   1,601 2,013   1.00 (reference) 
0.1-6.0 g/day 3.1   2,429 3,828   0.91 (95% CI 0.86-0.96) 
6.1-12.0 g/day 9.1   743 1,483   0.75 (95% CI 0.66-0.84) 
12.1-24.0 g/day 18.1   623 1,322   0.79 (95% CI 0.70-0.90) 
>24 g/day 28.8   402 838   0.81 (95% CI 0.69-0.95) 
Cullmann239 
Men 
Non-drinkers Non-drinkers   10 62   
Relative riskd,e 
1.00 (reference) 
Age; BMI; education; 
family history of T2DM; 
physical activity; smoking 
8 
0.01-6.79 g/day 3.4   46 501   0.62 (95% CI 0.32-1.19) 
6.80-13.01 g/day 9.9   28 488   0.41 (95% CI 0.23-0.73) 
13.02-22.13 g/day 17.6   41 505   0.56 (95% CI 0.33-0.96) 
≥22.14 g/day 26.6   50 486   0.56 (95% CI 0.33-0.96) 
                
Women 
Non-drinkers Non-drinkers   6 94   1.00 (reference) 
0.01-1.49 g/day 0.8   34 724   0.92 (95% CI 0.37-2.26) 
1.50-4.71 g/day 3.1   14 766   0.39 (95% CI 0.18-0.83) 
4.72-8.75 g/day 6.7   20 739   0.69 (95% CI 0.34-1.41) 
≥8.76 g/day 10.5   24 755   0.87 (95% CI 0.43-1.75) 
Sato240 Men 
Non-drinkers Non-drinkers   142 1,479   
Hazard ratio 
1.00 (reference) 
Age 5 
0.1-2.0 drinks/day 14.7   350 4,055   0.94 (95% CI 0.78-1.15) 
2.1-4.0 drinks/day 42.7   268 3,093   0.94 (95% CI 0.77-1.15) 
≥4.1 drinks/day 68.9   118 1,126   1.16 (95% CI 0.91-1.48) 
Teratanif,242 Men 
Non-drinkers Non-drinkers   131 2,287   
Hazard ratio 
1.00 (reference) 
None 5 
1-76 g/week 6.3   71 1,677   0.81 (95% CI 0.61, 1.08) 
77-153 g/week 15.7   73 1,243   0.94 (95% CI 0.70, 1.26) 
154-307 g/week 22.0   85 1,469   0.95 (95% CI 0.72, 1.25) 
≥308 g/week 44.0   104 1,283   1.14 (95% CI 0.88, 1.49) 
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Stringhinif,241 
Men 
0 units/week 0.0   85 623   
Hazard ratio 
1.00 (reference) 
Age; ethnicity 4 
1-21 units/week 12.4   369 3,037   0.96 (95% CI 0.75-1.22) 
≥21 units/week 25.2   102 825   1.04 (95% CI 0.77-1.39) 
                
Women 
0 units/week 0.0   111 540   1.00 (reference) 
1-14 units/week 8.5   139 1,198   0.73 (95% CI 0.56-0.94) 
≥14 units/week 16.8   13 195   0.51 (95% CI 0.28-0.92) 
Abbasif,243 
Men 
No/Almost never No/Almost never   47 496   
Relative risk 
1.00 (reference) 
None 6 
1-4 drinks/month 0.8   32 379   0.90 (95% CI 0.58-1.38) 
2-7 drinks/week 6.3   76 1,121   0.73 (95% CI 0.52-1.04) 
1-3 drinks/day 19.8   53 768   0.75 (95% CI 0.51-1.09) 
≥4 drinks/day 47.5   18 257   0.76 (95% CI 0.45-1.28) 
                
Women 
No/Almost never No/Almost never   70 1,106   1.00 (reference) 
1-4 drinks/month 0.8   39 655   0.94 (95% CI 0.65-1.38) 
2-7 drinks/week 6.3   34 1,084   0.51 (95% CI 0.34-0.76) 
1-3 drinks/day 19.8   22 491   0.72 (95% CI 0.45-1.15) 
≥4 drinks/day 47.5   3 69   0.70 (95% CI 0.23-2.17) 
Heianzaf,244 Men 
Lifetime abstainers Lifetime abstainers   15 138   
Relative risk 
1.00 (reference) 
Age 7 
Former drinkers Former drinkers   10 30    2.83 (95% CI 1.27-6.31) 
8-54 g/week 2.9   35 199   1.74 (95% CI 0.95-3.19) 
55-98 g/week 10.9   31 214   1.54 (95% CI 0.83-2.86) 
99-160 g/week 17.6   23 221   0.94 (95% CI 0.49-1.80) 
161-229 g/week 24.7   30 230   1.43 (95% CI 0.76-2.66) 
230-287 g/week 32.9   37 236   1.61 (95% CI 0.88-2.93) 
288-748 g/week 66.3   35 166   2.38 (95% CI 1.29-4.38) 
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Rasoulif,244 
Men 
Abstainers 0.0   44 1,513   
Hazard ratio 
1.00 (reference) 
Age; BMI; education; family history of 
T2DM; physical activity; smoking 
7 
0.01-4.9 g/day 1.7   324 11,343   0.94 (95% CI 0.66-1.35) 
5.0-9.9 g/day 6.9   96 3,855   0.81 (95% CI 0.54-1.22) 
10.0-14.9 g/day 11.7   18 1,387   0.46 (95% CI 0.25-0.85) 
≥15 g/day 19.7   16 807   0.79 (95% CI 0.42-1.46) 
                
Women 
Abstainers 0.0   74 3,342   1.00 (reference) 
0.01-4.9 g/day 1.1   330 15,774   1.34 (95% CI 0.99-1.83) 
5.0-9.9 g/day 6.6   33 2,220   1.37 (95% CI 0.86-2.20) 
≥10 g/day 12.0   5 504   1.12 (95% CI 0.44-2.85) 
Shif,246 Men 
Non-drinker Non drinker   894 33,415   
Hazard ratio 
1.00 (reference) Age; BMI; education; energy intake; 
family history of T2DM; hypertension; 
income; occupation; physical activity; 
smoking; wait-hip ratio 
6 
<1 drink/day 9.6   74 3,115   0.88 (95% CI 0.70-1.12) 
1-2.9 drinks/day 26.0   169 8,349   0.80 (95% CI 0.67-0.94) 
≥3 drinks/day 53.6   101 3,973   0.91 (95% CI 0.74-1.13) 
a The upper limit of the highest exposure category was conservatively defined as 1.2 times the value of the lower bound, unless explicitly defined within each publication. 
b Conversions into g/day were undertaken according to the median volume of alcohol consumption in each category. Means were used if medians were unreported. If neither indicator of central 
tendency were reported for each category, the median of the upper and lower bounds was used. 
c Figures were obtained via personal correspondence and reflected the crude number of cases and non-cases in each exposure category. These figures therefore differed slightly from those 
contained within the analytical sample of the original study. Figures reported via personal correspondence were used only for the estimation of covariance between reported coefficients. Total of 
cases and non-cases in the analytical sample were 41 and 2,271 respectively. 
d RRs were estimated based on reported ORs using the Zhang and Yu formula.171 
e The Hamling method was used to recalculate risk estimates according to a reference category other than that originally reported.172 
f Additional, updated or recalculated risk estimates were provided via personal correspondence and may thus have differed from those reported by the original publication. 
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3.3.3 All data 
Data pooled from all 38 selected studies are presented in Figure 3.2. Constituent studies each 
contributed ≥3 point estimates, inclusive of reference group. In the figure, each risk estimate is 
plotted as a bubble of size proportionate to the inverse of its standard error such that larger 
bubbles represent more precise estimates.  
Visual inspection of plotted risk estimates suggested sizable heterogeneity between data points 
at equivalent volumes of alcohol consumption. This was corroborated by the calculation of an I2 
index for each fitted polynomial, which revealed an I2 of 75% (95% CI 67-80%) along the first 
polynomial, and 50% (95% CI 31-63%) along the second.  
The greatest reduction in risk is evident at an alcohol intake of 12 g/day, equating to an 18% 
decrease in risk relative to pooled non-drinkers (RR 0.82, 95% 0.79-0.85). Risks increased 
incrementally above this volume, with significant reductions in risk evident up to 64 g/day. The 
best-fitting FP model provided a substantially better parameterisation of the dose-response 
relationship than a standard linear regression (p=<0.001). 
 
Figure 3.2 Dose-response relationship between the average volume of alcohol consumption and T2DM 
risk, utilising all data combined
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3.3.4 Sex 
A scatter diagram of risk estimates stratified by men and women revealed that the dose-
response association differed by sex, with a reduction in risk at moderate volumes of alcohol 
consumption appearing most pronounced among women (Figure 3.3). 
 
Figure 3.3 Scatter diagram of extracted risk estimates, stratified by sex 
A sex-interaction was thus introduced against each polynomial term and a likelihood ratio test 
run to compare the basic FP model to one inclusive of a sex interaction. The interaction was 
significant overall (Wald test, p=<0.001) and improved the fit of the basic model (p=<0.001).  
Sex-stratified results are reported in Figure 3.4. The dose-response relationships shown in Figure 
3.4 were restricted to levels <140 g/day due to a dearth of risk estimates concerning higher 
volumes of alcohol intake. The results shown in Figure 3.4 appear to indicate that any reduction 
in risk relative to pooled non-drinkers may have been specific to women. While men show no 
reduction in risk at any volume, statistically significant reductions in the risk of T2DM are 
observed among women who reported average volume of alcohol consumption of <71 g/day. 
Reductions in risk were greatest at 35 g/day (RR 0.66, 95% CI 0.55-0.78), or close to two pints of 
4% ABV lager.11  
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Figure 3.4 Dose-response relationship between average volume of alcohol consumption and T2DM risk, 
stratified by sex 
3.3.5 Reference group 
Only five studies were deemed to have utilised a strictly-defined never-drinking category, with 
four studies having reported risk estimates for men, and four for women. Having identified a 
significant interaction by sex, an additional interaction was included according to whether 
constituent studies had calculated risks relative to never or pooled non-drinkers. The dose-
response relationship differed significantly by both sex (p=<0.001) and reference group 
(p=<0.001), with the addition of a reference group interaction improving the fit of the dose-
response relative to one containing an interaction only for sex (p=0.009).  
To visualise differences in dose-response according to abstention category, risk estimates were 
stratified by reference group and adjusted for sex through an inclusion in each model of a sex 
interaction term. Sex-adjusted differences in dose-response are reported in Figure 3.5, with the 
level of consumption restricted to <100 g/day due to the small number of risk estimates 
available above that level of consumption among studies that utilised a never drinking reference 
category. Reductions in risk appear most pronounced among studies that calculated risks 
relative to pooled non-drinkers, evident up to 82 g/day and largest at 12 g/day (RR 0.80, 95% 
0.83-0.86). Although a U-shaped dose-response relationship is also evident among studies that 
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used a strictly-defined never drinking reference category, decreases in risk are smaller in 
magnitude and not statistically significant, peaking at 41 g/day (RR 0.94, 95% CI 0.72-1.20). 
 
Figure 3.5 Sex-adjusted dose-response relationship between average volume of alcohol consumption 
and T2DM risk, stratified by reference group 
The dose-response relationship was then calculated based solely on studies that reported a 
never-drinking abstention category. As shown in Figure 3.6, risk estimates were sparse 
particularly at higher volumes of alcohol consumption. As such, the plotted results shown in 
Figure 3.7 are restricted to values of alcohol consumption <140 g/day due to the wide 
confidence intervals reported by the model. Given the small number of constituent studies, 
Figure 3.7 should be interpreted with caution. Nevertheless, the results indicated that potential 
reductions in risk at moderate volumes of alcohol consumption remained specific to women 
when studies excluded former drinkers from the reference category. 
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Figure 3.6 Scatter diagram of extracted risk estimates calculated relative to never drinkers, stratified by 
sex and inverse weighted by SE 
 
Figure 3.7 Dose-response relationship between average volume of alcohol consumption and T2DM risk, 
relative to never drinkers, stratified by sex 
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3.3.6 Confounder adjustment 
A total 15 studies reported crude or age-adjusted estimates (n=15), with the rest providing more 
comprehensively adjusted data (n=23). Although sex (p=<0.001) and reference category 
(p=<0.001) remained statistically significant modifiers of the dose-response relationship, little 
statistical difference was evident according to whether or not risk estimates had been extracted 
from crude or age adjusted studies or those with more comprehensive confounder adjustment 
(p=0.165). The addition of a confounder adjustment interaction provided no marked 
improvement in model specification of a sex-adjusted model (p=0.168). 
When data were stratified by confounder adjustment and adjusted for differences in dose-
response attributable to sex and reference group, multivariable-adjusted estimates appear to 
show shallower reductions in risk at moderate levels of alcohol consumption (Figure 3.8). This 
relationship was little changed when using an alternative confounding variable that defined 
studies according to whether their degree of adjustment was above or below the mean of four 
confounding factors.  
 
Figure 3.8 Dose-response relationship between average volume of alcohol consumption and T2DM risk, 
adjusted for sex and reference group, stratified by confounder adjustment 
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3.3.7 Sub-group analyses 
Beyond analyses stratified according to factors of primary interest, a number of further sub-
group analyses were undertaken, investigating the effect of putative modifiers of the dose-
response relationship. 
3.3.7.1 Case ascertainment 
Cases of T2DM were defined according to a variety of methods, summarised as participant self-
reports (n=11), objective ascertainment (n=21), or a combination thereof (n=6). Given the small 
number of studies to have employed mixed methods of case ascertainment, attention was 
focussed upon the subset of studies that used either a subjective or objective methods. 
Accordingly, data were restricted to the 32 applicable studies. The addition of an interaction 
according to method of case ascertainment provided little improvement over a dose-response 
model adjusted for differences by sex and reference category. While sex (p=<0.001) and 
reference category (p=<0.001) remained statistically significant modifiers, this was not the case 
for method of case ascertainment overall (p=0.166). 
 
Figure 3.9 Dose-response relationship between average volume of alcohol consumption and T2DM risk, 
adjusted for sex and reference group, stratified by method of case ascertainment 
Looking to the stratified dose-response relationship reported in Figure 3.9, studies that utilised 
an objective measure of case ascertainment reported reductions in risk of smaller magnitude 
and across a narrower range of consumption than studies with cases defined according to 
subjective self-reports. Among the latter, a peak 35% reduction in T2DM risk was observed at 
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20 g/day (RR 0.65, 95% CI 0.55-0.76) versus a 14% reduction in risk at 4 g/day (RR 0.86, 95% CI 
0.82-0.91) among studies that defined cases using an objective measure, relative to pooled non-
drinkers after adjustment for sex and reference group. 
3.3.7.2 Population region 
A total 13 studies sampled participants from Asian regions, with the remaining 25 studies having 
sampled participants from non-Asian countries. Population region represented a statistically 
significant modifier of the dose-response relationship (p=<0.001), even after accounting for the 
effect of sex (p=<0.001) and reference category (p=0.029). Inclusion of an interaction according 
to population region improved specification over a model that comprised interactions only for 
sex and reference category (p=<0.001). 
Looking to the stratified dose-response relationship shown in Figure 3.10, risk estimates 
extracted from Asian studies reported no reduction in T2DM risk at any level of average volume 
of alcohol consumption. By comparison, estimates from non-Asian countries exhibited a J-
shaped association even after adjustment for sex and reference category, with an intake of an 
average 26.5 g/day associated with a 27% reduction in risk relative to adjusted non-drinkers (RR 
0.73, 95% CI 0.67-0.78). 
 
Figure 3.10 Dose-response relationship between average volume of alcohol consumption and T2DM 
risk, adjusted for sex and reference group, stratified by population region 
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3.3.7.3 Population type 
Another factor posited as a modifier of the relationship between volume of alcohol consumption 
and T2DM was population type. Of selected studies, 12 sampled occupational cohorts and 26 
analysed participants from the general population. Alongside the addition of sex (p=<0.001) and 
reference group (p=0.008) interaction terms, the dose-response relationship did not differ 
significantly according to population type (p=0.407). The inclusion of an interaction by 
population type did not improve a model already adjusted for differences according to sex and 
reference category (p=0.410). 
Little difference in dose-response was observed when data were stratified according to 
population type, though reductions in risk among general population studies may have been less 
pronounced than those reported by occupational samples (Figure 3.11). 
 
Figure 3.11 Dose-response relationship between average volume of alcohol consumption and T2DM 
risk, adjusted for sex and reference group, stratified by population type 
3.3.7.4 Quality assessment 
The quality of selected studies ranged from three to nine points out of nine. One study received 
the maximum score of nin e,225 while two studies received a score of just three222,229 for 
limitations including the use of a self-reported measure of T2DM, no information concerning the 
derivation of alcohol consumption volume, short periods of follow-up and no adjustment for 
confounding factors. The median score was six, indicating a moderate level of quality on 
average. 
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There was no significant difference in overall dose-response according to whether studies fell 
below a median quality assessment score of six points (p=0.837) after adjustment for differences 
according to sex (p=<0.001) and reference category (p=0.01). Although reductions in risk 
appeared greater among studies of below median quality, the difference was small and not 
significant (Figure 3.12). 
 
Figure 3.12 Dose-response relationship between average volume of alcohol consumption and T2DM 
risk, adjusted for sex and reference group, stratified by quality assessment score 
3.3.8 Sensitivity analyses 
3.3.8.1 Newly analysed studies 
Of the 20 publications analysed by the preceding meta-analysis of volume of alcohol 
consumption and T2DM, 17 had been selected for analysis as part of the revised meta-analysis. 
Of those not selected, two were superseded by newer analyses of the same studies that also 
benefitted from larger samples and periods of follow-up,207,210 whilst the remaining study did 
not report sex-specific estimates.247 This left 21 publications with analyses that were either 
updated since the last meta-analysis, or else missed by the previous authors. 
A statistically significant difference in dose-response was identified according to whether studies 
had been previously sampled by Baliunas et al10 (p=<0.001) after accounting for any differences 
attributable to sex (p=<0.001) or choice of reference category (p=0.357). Stratifying the data 
revealed that newly analysed studies appeared to report a shallower reduction in risk at 
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moderate volumes of alcohol intake after adjustment for sex and reference category (Figure 
3.13). Of studies sampled in the previous meta-analysis, a peak 29% reduction in risk was 
observed at 20.5 g/day (RR 0.71, 95% CI 0.61-0.82) versus a 13% reduction at 14 g/day (RR 0.87, 
95% CI 0.83-0.91) among newly analysed studies, relative to adjusted non-drinkers. 
Potentially explaining at least some of this discrepancy, sex-specific logistic regression analyses 
comprising putative sources of heterogeneity reported that previously analysed studies of men 
were more likely to have used subjective case ascertainment (p=<0.001) and sampled non-Asian 
populations (p=<0.001), while studies reporting female data adjusted for a greater number of 
confounders (p=0.029), less likely to have analysed occupational samples (p=0.028) and were 
more likely to have utilised subjective measures of case ascertainment (p=0.020) and a strictly-
defined never drinking category (p=0.003). 
 
Figure 3.13 Dose-response relationship between average volume of alcohol consumption and T2DM 
risk, adjusted for sex and reference group, stratified according to selection in the preceding meta-
analysis  
3.3.8.2 Sensitivity of dose-response to a high precision study  
Having extracted data from all selected studies, 63% of constituent participants were found to 
have been sampled by a single, high quality study.235 Questioning the generalisability of any 
results where more than half of participants had been drawn from a single publication, a 
sensitivity analysis was undertaken to compare the impact of the study upon the observed dose-
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response relationship. As shown in Figure 3.14, the inclusion of the large study had little overall 
effect upon the dose-response relationship beyond contributing to a reduction in variance. This 
was posited to be attributable to the calculation of dose-response relationships using random 
effects, which applies a lower weight to larger studies. On this basis, as well as its high quality 
assessment score, the study was considered appropriate for inclusion in all reported analyses. 
As per the sex-specific analyses reported in Figure 3.4, plots were restricted to volumes of 
consumption below 140 g/day due to a dearth of risk estimates at higher levels.  
 
 
Figure 3.14 Dose-response relationship between average daily alcohol consumption and T2DM risk: sex-
specific data, stratified by Jee et al235 
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3.3.9 Small-study effects 
Recalculated estimates denoting the risk of current drinking versus non-drinking were plotted 
against the standard error of their log (Figure 3.15). The resulting funnel plots indicated that, 
while male risk estimates appeared largely symmetrically dispersed around a summary estimate 
denoting the overall level of risk reported for current drinkers (p=0.181), female estimates may 
have been asymmetrical (p=0.063), with selected risk estimates appearing more likely to report 
a reduction in T2DM than might have been expected in the absence of small-study effects.  
 
Figure 3.15 Funnel plot of current drinking versus non-drinking, stratified by sex  
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Given the summary estimates were calculated using a simple inverse variance weight,188 
asymmetry was hypothesised to be a consequence of a high precision study that reported results 
contrary to the majority of other studies. A prime suspect for such an effect was a large, high 
quality Korean study, which represented 65% of sampled participants and reported a smaller 
reduction in risk than many other selected studies.235 The impact of the Korean study upon 
estimated small study effects is reported in Figure 3.16. After its exclusion, observed asymmetry 
among female risk estimates was indeed attenuated, with no significant different in risk 
estimates according to the degree of study precision among either men (p=0.610) or women 
(p=0.508). Small study effects and the risk of any potential publication bias was low. 
 
Figure 3.16 Funnel plot of current drinking versus non-drinking, stratified by sex and excluding Jee et 
al.235 
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3.3.10 Pattern of consumption 
Of the 21 newly analysed studies, only three of their associated publications included a joint 
analysis of both the volume of alcohol consumption and drinking pattern. The first publication 
reported that middle-aged male binge drinkers (>1 bottle of wine on any one occasion 
≥1/month, or around 95.6 g assuming a 750 ml bottle of 13% ABV wine11) had a 67% (OR 1.67, 
95% CI 1.11-1.20) greater odds of T2DM relative to light drinkers (0.01-6.79 g/day).239 This 
finding was in keeping with a previously discussed study, which reported double the risk of 
T2DM among women that consumed >179 g on any one occasion at least once a month during 
the preceding year (RR 2.1, 95% CI 1.0-4.4).96 In both cases, however, reporting of the joint 
association between volume and pattern was limited, providing no indication as to the average 
volume of alcohol consumption among binge drinkers. It was possible their elevated risk of 
T2DM may have been attributable to a high average intake as opposed to infrequent periods of 
episodic heavy consumption. 
A more comprehensive analysis was reported by Sato et al,240 which explicitly set out to explore 
the joint association between the frequency and volume of alcohol consumption in a cohort of 
Japanese men. While no difference in the risk of T2DM was observed among men who 
consumed low volumes of alcohol (≤28 g/day) infrequently throughout the week (1-3 days), 
relative to pooled non-drinkers (RR 0.93, 95% CI 0.72-1.20), reductions in risk were apparent 
when the same low volume was consumed on at least four days in an average week (RR 0.74, 
95% CI 0.58-0.95). Such a result indicated that moderate volumes of alcohol consumption may 
only confer a reduction in risk when drinking is regular.  
The third and final study to have investigated the two dimensions of alcohol consumption was 
authored by Heianza et al.244 Sampling 1,605 Japanese men, risks associated with the average 
volume of alcohol consumption per drinking occasion were stratified according to four weekly 
frequencies. Consistent with the preceding analysis, risks were lowest among participants who 
frequently (≥6 days/week) consumed moderate volumes of alcohol (23 g/day). Relative to this 
group, those who consumed the same moderate volume of alcohol across just 2-3 days/week 
reported a 48% greater risk of T2DM (RR 1.48, 0.65-3.37). Notably, risks were consistently 
greatest at all frequencies within a light drinking category that also included pooled non-
drinkers, providing further indications as to the unsuitability of pooled non-drinkers as a 
reference category.  
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3.4 Strengths 
In revising the 2009 meta-analysis, these most recent results benefitted from the addition of 
new studies published after the last search in 2008, plus the inclusion of two historic papers 
missed or discounted during previous meta-analyses. Thus, while Baliunas et al10 sampled 20 
studies, 477,200 participants and 12,556 cases, revised analyses were based on data obtained 
from 38 studies, 1,902,605 participants and 125,926 cases. Although the majority of these 
additional observations were extracted from a single Korean study,235 a sensitivity analysis that 
compared results calculated with and without the large study showed negligible difference in 
the dose-response relationship beyond an expected change in precision (Figure 3.14). 
Some alcohol researchers have argued that never drinkers may present a more suitable 
abstention category than pooled non-drinkers.136 Although the preceding meta-analysis 
reportedly adopted a never drinking reference category when calculating the risk of T2DM 
among current drinkers, the never drinking category was only approximated. Specifically, effect 
estimates reported by 15 studies that used a non-drinking reference category were weighted 
according to the average sex-specific proportion of former drinkers reported by five studies that 
included a never drinking abstention category. This approach assumed that the average 
prevalence of former drinkers reported by the five studies was equal to that unreported by the 
remaining 15 studies and their varying population characteristics. In addition to the possibility 
that the study-specific proportion of former drinkers was determined by factors other than sex 
alone, two of the five studies from which an average proportion of former drinkers had been 
estimated did not define never and former drinking in a robust manner. For instance, one study 
defined never drinkers as participants who described themselves as non-drinkers at baseline 
and who also reported (a) not having changed consumption during the five years prior to 
baseline, and (b) never having regularly consumed ≥5 drinks/day.153 Here, never drinkers were 
likely to comprise a number of former or infrequent moderate drinkers. Accordingly, it was 
possible that the previous meta-analysis may not have reliably estimated the proportion of 
never drinkers contained among pooled non-drinking categories. Contrary to their method, the 
updated meta-analysis opted instead to test for an interaction in dose-response according to 
type of reference category defined by selected studies. Such an approach avoided the potential 
for having weighted data under inappropriate assumptions. Beyond this, the revised meta-
analysis also tested the effect of hypothesised modifiers of the dose-response relationship, 
providing insight into their effect upon summary dose-response estimates.  
Chapter 3: An updated and revised meta-analysis of the dose-response relationship between 
alcohol consumption and T2DM  
99 
 
3.5 Limitations 
3.5.1 Heterogeneity 
Heterogeneity between sampled studies was high, with the breadth of effect estimates at 
equivalent volumes of consumption complicating interpretation of the overall dose-response 
relationship. In order to better understand the effect of such heterogeneity upon the observed 
dose-response relationship, potential explanatory factors were posited a priori and, where 
appropriate, explored individually through the inclusion of a corresponding interaction term 
along each fitted polynomial, with results then reported separately at each level of the a priori 
factor. The use of meta-regression to jointly test differences in dose-response according to all 
putative sources of heterogeneity was avoided owing to the potential for low statistical power, 
even when effect sizes and the number of studies are large.248,249,250 Though suggested that 
statistical power may have been sufficient in instances where the number of factors did not 
exceed a ratio of one to every 10 studies,251 simulations have suggested that power may remain 
low in circumstances where heterogeneity is high.252 
3.5.2 Quality assessment 
Although the quality of selected studies was assessed using the Newcastle-Ottawa assessment 
scale,189 with studies found to be of moderate quality on average (a score of 6/9), quality 
assessment tools are subject to notable limitations. Although a wide range of instruments have 
thus far been devised for the assessment of quality among non-randomised studies, each 
comprised assessment criteria that were disparate in both number and nature.253 In addition to 
the use of different rating scales or summary scores that risked weighing the importance of 
component items in ways disproportionate to their impact upon the validity of a given study, 
their differing designs were such that the choice of tool was likely to have had a sizeable bearing 
upon the assessment of study quality.254,255 Alongside such general limitations, the Newcastle-
Ottawa tool used to assess the quality of studies selected as part of the revised meta-analysis 
had criticisms ranging from the tool’s focus upon the generalisability of results as opposed to a 
study’s internal validity,256 to weak inter-rater reliability on some questions.257,258 With these 
limitations in mind, results from the Newcastle-Ottawa quality assessment tool should be 
considered only as a rough guide as opposed to a definitive measure of study quality. 
3.5.3 Stability of consumption 
In defining alcohol consumption using only one baseline measure, almost all studies sampled as 
part of the meta-analysis had modelled risk under an assumption that alcohol consumption was 
stable over the course of the study. However, having investigated datasets for which repeated 
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measures of alcohol consumption were available, researchers identified numerous disparate 
trajectories of alcohol consumption behaviour as a function of time.259 As such, the cross-
sectional categorisation of alcohol consumption may have been an inappropriate approach for 
defining drinking, with baseline categories potentially subject to misclassification error.150  
Defined as latent classes, numerous discrete trajectories have been identified across the adult 
life course.260,261,262,263 For example, looking to analyses that captured alcohol consumption data 
between the ages of 16 and 42 years, five distinct classes were observed in a Finnish cohort.264 
Here, in addition to stable categories of light (22%), moderate (35%) and heavy consumption 
(23%), 9% of participants decreased and 11% increased their consumption between the ages of 
16 and 42.264 Elsewhere, in a study of Canadians aged ≥50 years, nine different classes were 
identified over an average six years.265 As well as stable light (7%), moderate (11%), heavy (2%) 
never (6%) and former drinkers (8%), plus those who increased (16%) or decreased (31%) their 
consumption, this older cohort also captured U-shaped (10%) and inverted U-shaped (9%) 
trajectories.265 
 
Figure 3.17 Common latent trajectories of volume of alcohol consumption: the ‘cat’s cradle’ 
As evident from just two examples, exact trajectories identified within cohorts will differ 
according to their baseline age, duration of observation and frequency of repeated measures. 
Despite this, four trajectories appear robust to such factors, having been consistently observed 
across cohorts: stable non-drinking and current drinking, increasing consumption and 
decreasing consumption – a so-called ‘cat’s cradle’ of latent classes (Figure 3.9).259 Of these four 
classes, increasing consumption may be most common during early adulthood, with younger 
participants typified by never drinking and therefore exhibiting little opportunity for alternative 
trajectories of consumption. Conversely, in later life, decreased consumption may become the 
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dominant trajectory following factors including age-related deteriorations to health status. This 
disparity was hinted at by the examples above,264,265 and supported by findings from an analysis 
of mean volume consumption calculated from nine UK-based cohort studies (Figure 3.10).266 
 
Figure 3.18 Predicted mean alcohol consumption trajectories (in units/week) across the life course in 
UK cohort studies. Reproduced from Britton et al266 in BMC Medicine under a Creative Commons 
Attribution License (4.0). 
Despite such evidence highlighting the variability in the volume of alcohol consumption as a 
function of time, the vast majority of alcohol-T2DM studies modelled the dose-response 
relationship according to a single baseline measurement, with just one out of the 38 selected 
publications having utilised repeated measures of alcohol consumption. The authors of the 
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paper modelled the dose-response relationship using an unconditional logistic regression model 
equivalent to an extended Cox survival model with time-varying covariates updated at six-month 
intervals over a period of 10 years.153 Relative to never drinkers, results showed attenuated and 
non-significant reductions in risk across all levels of current drinking after accounting for changes 
to alcohol consumption over time.153  
A second publication, which was excluded from the meta-analysis, reported analyses of male 
participants in the Health Professionals Follow-Up Study.267 Compared with stable none or light 
drinkers (0-4.9 g/day), those who increased their consumption to moderate levels (5.0-29.9 
g/day) in any four-year period exhibited a statistically significant 25% reduction in hazard (HR 
0.75, 95% CI 0.62-0.90), while those who became heavy drinkers (≥30.0 g/day) showed a sizeable 
but not significant 65% reduction in hazard (HR 0.35 95% CI 0.11–1.10). Of moderate drinkers 
that reduced their consumption to none or light drinking, a 9% increase in hazards was observed 
(HR 1.09, 95% CI 0.92-1.30). Such participants may have reduced their intake due to poor health, 
though no such increase in risk was evident among heavy drinkers who switched to none or light 
consumption (HR 0.78, 95% CI 0.44-1.38). Such inconsistent results may have been a 
consequence of particularly small sample size in a number of sub-groups, with estimates subject 
to sampling error.  
The variability of alcohol consumption across the life course suggests that the dose-response 
relationship may be more complex than modelled by conventional analytical methods. With the 
validity of existing research potentially limited by a failure to account for the effect of such 
variability upon T2DM risk, epidemiological research needs to explicitly adopt analytical 
approaches capable of giving consideration to changes in drinking over time. 
3.6 Discussion 
Although few additional studies were found to have reported a strictly-defined never drinking 
abstention category, sex-adjusted analyses confirmed that the choice of reference category had 
a marked and statistically significant impact upon the observed dose-response relationship, with 
reductions in risk at moderate volumes of alcohol intake appearing specific to studies that 
excluded less healthy former drinkers from their abstention category (Figure 3.5). Results from 
Figure 3.5 thus mirror findings from meta-analyses of other health conditions, which reported 
attenuations in risk reduction when former drinkers were explicitly excluded from an abstention 
reference category.136,147 Such a difference in dose-response provides support to arguments 
made by some academics against the use of a pooled non-drinking category,136,137 and suggested 
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that reductions in risk at moderate volumes of alcohol consumption may thus have been 
overestimated by close to 95% of observational studies. 
Beyond the impact of reference category, little independent difference in the overall dose-
response relationship was observed according to whether or not risk estimates were 
multivariable-adjusted. Such a finding suggests either that confounder adjustment had little 
additional impact after the exclusion of former drinkers, or that the type as opposed to number 
of confounding factors may have been a more important determinant of heterogeneity in 
observed dose-response. 
Reductions in risk were previously identified as smallest among men.10 These were rendered 
completely absent in revised analyses following the addition of new data (Figures 3.4 and 3.6). 
These new data were more likely to have been obtained from Asian countries (53% versus 21%) 
and have utilised an objective measure of ascertainment (89% versus 71%) – two factors 
associated with less pronounced reductions in risk even after accounting for differences 
attributable to sex and reference category (Figures 3.10 and 3.9 respectively). Among women, 
peak reductions in risk were broadly comparable between the two meta-analyses: a 40% peak 
reduction was reported at 24 g/day among women (RR 0.60, 95% CI 0.52-0.69) sampled in the 
earlier meta-analysis,10 and a 34% peak reduction at 35 g/day (RR 0.66, 95% CI 0.55-0.78) in the 
revised meta-analysis.  
It was unclear why the dose-response relationship between the volume of alcohol consumption 
and T2DM risk operated differently according to sex, though five conceivable hypotheses were 
proposed: systematic differences in study characteristics; sex-specific differences in drinking 
pattern; sex-specific differences in the effect of alcohol upon putative biological pathways; sex 
hormones; and drink type. These were explored separately and in detail below: 
1. It was possible that sex-specific disparities in dose response may have been in some part 
a consequence of systematic differences in study characteristics. Following a 
stratification of study characteristics by sex, female data was found more likely to have 
been extracted from studies of non-Asian regions (61% versus 87%) or that utilised a 
subjective measure of case ascertainment (35% versus 18%). Both factors were 
associated with more pronounced reductions in risk than in studies of Asian regions 
(Figure 3.10) and that used an objective measure of defining T2DM (Figure 3.9). 
Although studies of women were also more likely to have sampled the general 
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population (87% versus 70%), population type was observed to have very little 
independent effect upon dose-response (Figure 3.11).  
An a posteriori analysis was thus undertaken to explore the significance of case 
ascertainment and population region interactions solely among female data. Both case 
ascertainment (p=0.002) and population region (p=0.010) were found to be statistically 
significant modifiers of the female dose-response relationship, with plotted results 
similar to those reported in Figures 3.9 and 3.10 when both sexes were combined.  
Although no sizeable difference was found in the proportion of studies that reported 
multivariable-adjusted risk estimates (men: 64%; women: 61%), it was possible that the 
degree of confounder adjustment was less important than the type of confounders for 
which dose-response relationships were adjusted. For instance, male studies were more 
often adjusted for a number of key risk factors for T2DM, including adiposity (45% versus 
39%), family history of T2DM (24% versus 17%) and smoking (39% versus 30%).  
Given the association between these risk factors and the risk of T2DM, as well as the 
possibility that they appear most prevalent among non-drinkers than moderate 
drinkers,136,139 it is plausible that discrepancies in the type of confounder adjustment 
alongside other differences in study characteristics may have explained at least some of 
the difference in dose-response between men and women. Such a conclusion is 
supported in part by the absence of any alcohol-T2DM relationship in a recent 
Mendelian randomisation meta-analysis, in which confounding factors should have 
been more randomly distributed between drinking groups.85  
2. With the risk of T2DM modelled exclusively according to the volume of alcohol 
consumption, no account was given to drinking pattern upon T2DM. The importance of 
such a consideration is illustrated by a recent meta-analysis of seven observational 
studies that reported data on both dimensions of alcohol consumption investigating the 
risk of ischaemic heart disease (IHD).268 Here, relative to never drinkers, a 36% (RR 0.64, 
95% CI 0.53, 0.71) reduction in risk was documented among those that reported a 
moderate level of average volume of alcohol consumption (<30 g/day) and no episodic 
heavy drinking. By contrast, no reduction in risk was evident among those who reported 
the same moderate level of average volume consumption but additionally indicated 
episodic heavy drinking (RR 1.12, 95% CI 0.91, 1.37). Of studies selected as part of the 
revised meta-analysis, few had considered the effect of consumption pattern, but 
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largely mirrored findings reported by Roerecke et al when researching IHD:268 that 
regular moderate alcohol consumption was associated with the lowest incidence of 
T2DM,95,97,240,244 with risks most pronounced among infrequent heavy drinkers.96,239,244 
Such results indicate a possibility that any putative health benefit conferred by regular 
exposure to moderate volumes of alcohol may be countered by infrequent episodes of 
heavy consumption. Unfortunately, data for IHD were not stratified by sex, with the 
majority of T2DM studies having only analysed men or women separately. Accordingly, 
it was unclear whether a volume-pattern interaction operated similarly among both 
men and women. Nevertheless, assuming a comparable effect in both sexes, sex-specific 
differences in the relationship between the volume of alcohol consumption and T2DM 
risk may have been attributable to sex-specific disparities in the prevalence of episodic 
heavy drinking. 
The possibility of a difference in consumption pattern between men and women is 
supported by data collated from 7,193 attendees at European 172 general practices.269 
Among participants, the odds of episodic heavy drinking (≥6 drinks on any one occasion 
at least once every month) among non-hazardous male drinkers (an AUDIT score of <8) 
was four times that of women following adjustment for country, age, employment 
status, mental and physical health (OR 4.38, 95% CI 3.27, 5.85). Similarly, of data 
reported by the Opinions and Lifestyle Survey, episodic heavy drinking was found to be 
greatest among men.101 
Although more data are required, current evidence indicates that both the volume and 
pattern of alcohol consumption are likely to be important modifiers of T2DM risk. 
Differences in dose-response between men and women may therefore have been a 
consequence of differences in consumption pattern. Specifically, a greater prevalence 
of episodic heavy drinking among men. 
3. Observed differences in dose-response between men and women may have been 
attributable to sex-specific disparities in the effect of alcohol upon putative biological 
pathways. Evidence in support of such a hypothesis was limited, however.  
Looking to research concerning a possible effect of alcohol upon insulin sensitivity, a 
meta-analysis of 10 interventional studies identified a significant sex interaction 
between average volume of alcohol consumption and insulin sensitivity (p=0.018).112 
Specifically, insulin sensitivity was found to be higher among female but not male 
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drinkers, relative to controls. However, heterogeneity among the studies was high, and 
when a study largely responsible for such heterogeneity was removed, no significant 
difference in insulin sensitivity between men and women remained (p=0.180). Although 
women were also found to exhibit significant reductions in fasting insulin concentration, 
the absence of any detectable effect among men was due to a dearth of data; men were 
represented by just two small interventional studies that, despite low precision, each 
reported similar reductions in fasting insulin following alcohol consumption. 
A second potential pathway concerned alcohol-mediated increases in HDL 
concentration. Although a linear dose-response relationship was identified across 33 
interventional studies,118 a sex interaction was not statistically significant. Such a result 
was mirrored by analyses reported in a Mendelian randomisation meta-analysis, which 
found no alcohol-mediated change to HDL concentration and no significant difference 
in mediation between men and women.85 
Finally, regarding the effect of alcohol consumption upon inflammatory response, a 
meta-analysis of interventional studies to have researched various inflammatory 
biomarkers found no difference in concentration by alcohol consumption,118 and while 
a Mendelian randomisation meta-analysis of 42 longitudinal studies found 
concentrations of CRP to be lower among A-allele carriers whose average volume of 
alcohol consumption was 17% lower than non-carriers, the magnitude of the difference 
was small and not stratified by sex.85 
Aside from the methodological weaknesses that underpinned such studies, evidence 
indicating a difference in alcohol-mediated biological response between men and 
women was lacking. 
4. A fourth possibility was that sex hormones may have played a role in altering the effect 
of alcohol upon T2DM risk. Associated with levels of insulin resistance and glucose 
concentrations independent of adiposity,270,271,272 at least two hormonal biomarkers 
have been implicated as modifiers of T2DM risk, including estradiol, a female sex 
hormone, and sex hormone-binding globulin (SHBG), a protein responsible for the 
transport of sex hormones. Of nine case-control studies to have reported 
concentrations of estradiol according to T2DM status, levels were significantly higher 
among those who developed T2DM (SMD 12.8 nmol/L, 95% CI 3.44, 22.2 nmol/L), 
though with no apparent interaction by sex (p=0.870).273 Of 20 case-control studies to 
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have reported on SHBG, concentrations were significantly lower among female cases 
than controls (SMD -16.23 nmol/L, 95% CI -20.24, -12.22 nmol/L), with little difference 
observed among men (SMD -5.07, 95% CI -11.92, 1.77).273 Effect modification of SHBG 
concentrations by sex were statistically significant (p=<0.001). Lower levels of circulating 
SHBG were also identified in cohort studies, where the risk of T2DM was substantially 
lower in participants with higher concentrations of SHBG, particularly among women.273  
In addition a lack of understanding concerning the precise biological mechanism by 
which factors such as SHBG may modify T2DM risk,273 research investigating the effect 
of alcohol upon circulating concentrations of sex hormones is scarce, particularly how 
moderate volumes of alcohol consumption might specifically elicit advantageous 
changes in female sex hormone concentration. One cross-sectional analysis data from 
Women's Health Study stratified alcohol consumption according to whether or not 
participants consumed in excess of 25 g/day. Estradiol concentrations were elevated 
only within the higher consumption category, relative to pooled infrequent and non-
drinkers (β=0.17, 95% CI 0.05, 0.29).274 While concentrations of SHBG also appeared to 
be higher among regular current drinkers, differences in SHBG were not statistically 
significant (β=0.02, 95% CI -0.11, 0.15). Elsewhere, a cross-sectional study of 202 pre-
menopausal women reported that those who consumed ≥10 g/day had an 18% higher 
mean salivary estradiol concentrations than those who consumed <10 g/day 
(p=0.034).275 Similar findings have been reported by cross-sectional studies 
elsewhere,276 as well as linear increases in estradiol concentrations across categories of 
weekly alcohol consumption,277 and acute elevations in small placebo-controlled studies 
of female participants following dosages of 0.5 g/kg (or around 27.5 g in a 55 kg 
woman)278 and 0.7 g/kg (or around 38.5 g in a 55 kg woman).279 
Such studies were limited by only having sampled a single sex, meaning that side-by-
side comparisons of alcohol-related changes to estradiol concentration were not 
possible. Similarly, with most studies having reported concentrations according to only 
a one or two volumes of alcohol consumption, a more complete understanding of the 
dose-response relationship was unclear. However, based on the few small studies 
available, there was an indication that the association between alcohol consumption 
and estradiol concentration may sit contrary to what is expected, with concentrations 
appearing elevated at volumes of alcohol consumption otherwise associated with a peak 
reduction in T2DM risk among women.10 The validity of beneficial alcohol-induced 
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changes to endogenous sex hormone concentrations having served as a pathway by 
which women might experience the greatest reductions in T2DM risk therefore seemed 
weak. 
5. Finally, there was a possibility that sex-specific differences in dose-response may have 
been a consequence of men and women having consumed different types of alcoholic 
drink; that reductions in risk were less to do with the total volume of ethanol so much 
as some other drink-specific component. Such a possibility was plausible given a 
purported role of flavonoids and stilbenes commonly found in fruit-based drinks as anti-
oxidants capable of impairing inflammatory response, and promoting both good blood 
flow and endothelial function for the effective transport of blood glucose.280,281 
Of the studies selected as part of the revised meta-analysis, seven reported 
multivariable-adjusted risk estimates according to drink type. However, in many cases, 
the stratification of risk estimates by drink type and categories of volume consumption 
led to small sub-group samples and high imprecision, weakening inferences drawn 
concerning any effect modification by drink type. 
In one study, risks stratified by drink type were only reported for men owing to the low 
volume of consumption among women. Among the 5,423 male US participants, 
multivariable-adjusted odds of T2DM showed no independent association for any drink 
type.219 Although point estimates indicate greater reductions in risk among men who 
drank wine at higher frequencies (e.g. OR 0.63 at >25 g/day, 95% CI 0.08-4.95), relative 
to non-drinkers, the estimates were subject to substantial imprecision given the small 
number of male wine drinkers. In a male cohort that benefitted from a much larger 
sample size, reductions in risk were statistically significant among moderate wine 
drinkers (HR 0.80 at 25 g/day, 95% CI 0.65-0.97), relative to pooled non-drinkers, with 
no reduction evident among beer or spirit drinkers.246 By contrast, a final male cohort 
reported independent linear reductions in risk per 15 g/day increase in consumption for 
beer (RR 0.80, 95% 0.70-0.91), white wine (RR 0.77, 95% CI 0.65-0.90), and spirits (RR 
0.85, 95% CI 0.76-0.94), plus some indication of a reduction in risk among red wine 
drinkers (RR 0.91, 95% CI 0.78-1.08).95 However, in this instance confounder adjustment 
was much lower, accounting only for age and BMI. Nevertheless, in another model with 
greater covariate adjustment, but with additional adjustment for potential mediators of 
the alcohol-T2DM relationship, significant associations were unchanged. 
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In a US cohort study, participants were categorised according to their preferred drink 
type.245 Unfortunately, to boost sample size, data were adjusted for sex as opposed to 
stratified. All current drinkers showed reductions in risk relative to non-drinkers, but 
with no difference in risk according to whether participants consumed beer (RR 0.7, 95% 
CI 0.4-1.1), wine (RR 0.6, 95% CI 0.4-0.9) or spirits (RR 0.6, 95% CI 0.4-0.9). Conversely, 
in another cohort where sex-specific data were combined, reductions in risk were 
evident among wine drinkers only (HR 0.93 per g/day wine, 95% CI 0.87-0.99), with point 
estimates no different from the null for all other drink types.153  
Relative to never drinkers, reductions in risk among Australian female drinkers were 
specific to those who reported wine consumption.97 However, none of the relationships 
were statistically significant due to high imprecision owing to a small number of cases 
within sub-groups. Imprecision was also high among men, though with reductions in risk 
indicated across all drink types. In particular, a statistically significant linear association 
trend was observed between increased wine consumption and decreased T2DM risk 
(p=0.037). Benefiting from a much larger number of cases per sub-group, a European 
multicentre prospective case–cohort study also reported significant effect modification 
among male wine drinkers (p=0.003), with hazards lowest at 24.1-60.0 g/day (HR 0.82, 
95% CI 0.71-0.95) relative to very light drinkers (0.1-6.0 g/day).238 Little variation from 
the null was evident across categories of beer (p=0.660) or spirit (p=0.440) consumption 
in men. Among women, significant effect modification was documented for wine 
(p=0.048) and fortified wine (p=0.023) drinkers, with hazards lowest in each case among 
those who reported consuming 24.1-60.0 g/day (wine: HR 0.89, 95% CI 0.72-1.11; 
fortified wine: HR 0.64, 95% CI 0.24-1.70).  
On balance, reductions in risk appeared most consistently reported among male and 
female participants who reported consuming wine, particularly in studies of greater 
precision.238,246 Although in keeping with research indicating that chemical compounds 
in fruit-based drinks such as red wine may have anti-inflammatory effects,280,281 with sex-
specific reductions in T2DM thereby a result of compounds other than ethanol, a recent 
probabilistic study casts doubt on such a conclusion. Using dose-response data from 
animal models, researchers estimated the comparative risks and benefits of alcohol 
consumption according to the putative carcinogenicity of ethanol and the anti-
carcinogenicity of the stilbene resveratrol.282 Based on abstracted data, the authors 
estimated that a person would have to consume at least 111 glasses of wine before 
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reaching a therapeutic dose of resveratrol at which the risk of cancer would begin to 
decrease. Having an effect over 100,000 times more potent than resveratrol, the 
increased risk of cancer from ethanol consumption would far outweigh any anti-
carcinogenicity from resveratrol.  
Although equivalent analyses have yet to be published for T2DM risk, such a finding 
suggests that reductions in risk among wine drinkers may instead be confounded by 
differences in health and lifestyle according to drink preference. Although the few 
papers that did stratify T2DM risk by drink type were generally included a number of 
primary T2DM risk factors such as age, adiposity, physical activity and smoking, residual 
confounding was a possibility, with marked differences in the characteristics wine, beer 
and spirit drinkers according a wide range of socio-economic variables.283,284 In the 
absence of high precision studies able to isolate the independent effect of drink-specific 
compounds, a clear conclusion concerning the clinical effect of different drinks at 
moderate levels of alcohol consumption remains in question.  
Although sex-specific differences were observed in the dose-response relationship between 
volume of alcohol consumption and T2DM risk, it was not possible to say with certainty which 
factor or combination of factors contributed to reductions in risk at moderate levels of 
consumption being specific to women. Based upon the available literature, the most credible 
determinants included a statistical artefact arising from differences in study characteristics, or 
else the result of biological mechanisms modified by sex-specific variations in drinking 
behaviour, such as consumption frequency or drink preference. 
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4 A summary of current evidence 
DM has been linked to the development of multiple vascular morbidities,1,3 the management 
and treatment of which was estimated to have accounted for around one-tenth of the NHS 
budget in 2010/11, or £13.8bn.4 The effects of DM are not restricted to health and healthcare 
systems, however, with deteriorations in health having sizeable impacts on patients’ ability to 
maintain jobs and care for themselves independently.4 Fortunately, of all known cases, T2DM 
represents by far the largest proportion, at around 85-90% of UK diagnoses.8 As such, the burden 
of DM may be largely attributable to modifiable environmental exposures, such as obesity and 
smoking, with the potential to attenuate disease risk in the general population through modest 
lifestyle changes. 
A growing literature has indicated that alcohol consumption may represent one such change. 
Results from an updated and revised meta-analysis indicated a J-shaped dose-response 
relationship relative to pooled non-drinkers (Figure 3.2), with reductions in risk most 
pronounced among women (Figure 3.4). Although few in number, studies have also indicated 
that the frequency of consumption may represent an important modifier of T2DM risk, with 
T2DM lowest among regular moderate drinkers, and any reductions in risk potentially offset by 
concentrated periods of episodic heavy consumption. 
To date, a number of biological mechanisms have been proposed to explain apparent reductions 
in T2DM risk at moderate levels of alcohol consumption, including alcohol-related 
improvements to insulin sensitivity, increases in the concentration of the lipid transport protein 
HDL, and a reduction in the expression of inflammatory factors implicated in the disruption of 
endothelial and pancreatic β-cell functioning. Research investigating such pathways has tended 
to be limited, with most existing observational studies having been cross-sectional in nature, 
preventing causal inference. Where studies were interventional, these were commonly 
constrained by small sample sizes, acute durations and single levels of exposure, undermining a 
determination of dose-response within each sample. 
Where results from interventional studies have been reported, acute improvements in insulin 
sensitivity and fasting insulin have been observed,112 as well as linear increases in HDL 
cholesterol concentrations.117,119 However, a beneficial relationship between alcohol 
consumption and HDL concentration has not been supported by Mendelian randomisation 
studies,85 with such studies also reporting a null relationship between SNPs of HDL variance and 
T2DM risk.121 In a reversal of this apparent disparity in the findings of interventional and 
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Mendelian randomisation research, acute interventional trials currently report no association 
between alcohol consumption and inflammatory markers (though the number of such studies is 
small),118 while results from Mendelian randomisation studies indicate a J-shaped association 
between alcohol and CRP consistent with the dose-response between alcohol consumption and 
T2DM risk.131 And although a longitudinal cohort study has found associations between the 
concentration of CRP and T2DK risk, such an association was not identified when T2DM risk was 
stratified according to SNPs of variance in CRP concentration.132 Elsewhere, Mendelian 
randomisation studies have reported conflicting evidence concerning the relationship between 
inflammatory markers and vascular conditions.133,134,135 Thus, although conceivable that alcohol 
may indeed act upon T2DM risk through such pathways, results from existing studies are 
inconsistent and limited by small sample sizes. 
Studies included within the updated and revised meta-analyses were subject to their own 
shortcomings, undermining the inference that moderate volumes of alcohol consumption may 
confer a reduction in T2DM risk. In all but two of the cohorts analysed by Baliunas et al, risk 
estimates among drinkers had been calculated relative to a group of pooled non-drinkers.10 
Although conventional in epidemiological studies to measure the effect of an exposure relative 
to those who were not exposed, the use of a pooled non-drinking category has drawn criticism 
through the manner in which it captures a number of former drinkers whose health and lifestyle 
may predispose them to the development of T2DM.136,137 As such, apparent reductions in T2DM 
risk at moderate levels of consumption may have been overestimated, particularly among 
studies with poor adjustment for determinants of T2DM risk, such as physical activity and diet.  
To explore this further, the updated and revised meta-analysis included sensitivity analyses that 
explicitly documented the effect of reference group and confounder adjustment upon 
reductions in risk observed in aggregate data. These analyses supported a significant, sex-
adjusted interaction according to the choice of reference group, with reductions in risk particular 
to studies that calculated risks relative to pooled non-drinkers (Figure 3.5). Furthermore, after 
accounting for the effect of sex and reference category upon the dose-response relationship, a 
weak interaction was observed according to the degree of confounder adjustment, with 
multivariable-adjusted reductions in risk at moderate volumes of alcohol consumption 
appearing less pronounced than those derived from crude or age-adjusted estimates, though 
present across a broader range of consumption (Figure 3.8). Alongside these two factors, 
population region also appeared to have a sizeable effect upon dose-response, with smaller 
reductions in risk reported by studies that sampled participants from Asian regions (Figure 3.10). 
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Aside from the issue of reference group selection and confounder adjustment, a further 
limitation of the current literature concerned the tendency of longitudinal studies to define 
alcohol consumption according to a single baseline measure. Despite growing evidence that 
drinking may vary markedly across the life course,259 only one selected study was found to have 
explored the effect of changes in alcohol consumption upon the risk of T2DM.153 Of studies not 
captured by the revised and updated meta-analysis, only one additional publication was found 
to give any consideration to the variability of alcohol intake over time.267  
Results from the two available studies hint at a dose-response relationship more complex than 
captured by conventional analytical approaches. The first reported attenuated and non-
significant reductions in T2DM risk after accounting for longitudinal changes to the volume of 
alcohol consumption among sampled participanst,153 while the second reported significant 
differences in T2DM according to the longitudinal trajectory of alcohol consumption.267 For 
instance, of moderate drinkers (5.0-29.9 g/day) that reduced their consumption to none or light 
drinking (0-4.9 g/day), a 9% increase in hazards was observed (HR 1.09, 95% CI 0.92-1.30) on 
average over each four-year period of follow-up, indicating a possible sick quitter effect. 
Although limited, such analyses suggest that the categorisation of participants according to their 
consumption at baseline risked introducing some degree of misclassification error.150 
Accordingly, future research should apply analytical approaches capable of describing and 
modelling longitudinal changes to alcohol consumption and their association with T2DM risk. 
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5 Research aims 
Although results from the updated and revised meta-analysis suggest the presence of reductions 
in T2DM risk among women at moderate volumes of alcohol intake, with T2DM risk elevated 
even at low volumes among men, effect estimates abstracted from constituent studies were 
calculated according to a single baseline measure. Despite apparent changes in alcohol 
consumption behaviour across the adult life course,259 very few studies appear to have 
investigated the impact of such variation upon a person’s risk of T2DM. In the few instances 
where T2DM risk has been modelled as a function of longitudinal changes to alcohol 
consumption, results indicate a relationship more complex than captured by conventional 
analytical approaches,153,267 supporting recent calls for alcohol studies to give a better account 
of variations in alcohol consumption across the life course.266,285,286,287 With this in mind, a series 
of analyses will be undertaken to help better understand the longitudinal dynamics of the dose-
response relationship, beginning with a preliminary survival analysis designed to confirm the 
suitability of the chosen dataset for the analysis of dose-response relationships between alcohol 
consumption and T2DM. 
Aim 1: Establish whether baseline alcohol consumption is associated with T2DM 
risk (Chapter 7) 
 Undertake a conventional multivariable-adjusted survival analysis, reporting the dose-
response relationship between baseline categories of average weekly volume of alcohol 
consumption and T2DM risk. 
 Investigate whether the volume of alcohol consumption alone was sufficient for 
modelling T2DM risk by testing an interaction between the volume and frequency of 
alcohol consumption.  
 Compare results from the conventional survival analyses against those summarised as 
part of the revised meta-analysis in Chapter 3. 
Aim 2: Determine the degree to which baseline categories of alcohol 
consumption risked being subject to misclassification error as a result of 
longitudinal changes in alcohol consumption (Chapter 8) 
 Establish whether sex-specific trajectories of the mean weekly volume of alcohol 
consumption were constant over the captured life course. 
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 Establish the longitudinal stability of alcohol intake within categories defined by baseline 
consumption. 
Aim 3: Describe differences in the mean volume of alcohol consumption over 
the life course according to T2DM diagnosis (Chapter 8) 
 Determine whether trajectories of alcohol consumption differed according to whether 
or not participants developed T2DM. 
 Describe the nature of any differences in the mean weekly volume of alcohol 
consumption over the period leading up to the time of censoring or T2DM diagnosis. 
Aim 4: Formally explore the utility of more advanced survival models in 
developing a better understanding of the relationship between alcohol 
consumption and T2DM (Chapter 9) 
 Conduct a series of increasingly advanced survival models to estimate the sex-specific 
risk of T2DM as a function of age-varying alcohol consumption. 
 Compare dose-response relationships reported according to different 
parameterisations of the longitudinal trajectory. 
 Investigate the effect of adjustment for heterogeneous non-drinking groups upon the 
sex-specific dose-response relationship. 
 Establish whether declining trajectories represent a group of drinkers at elevated risk of 
T2DM. 
With these aims established, Chapter 6 details the selection and structure of a dataset 
considered suitable for exploring longitudinal trajectories of alcohol consumption and their 
relationship with T2DM. 
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6 Data selection and structure 
6.1 Introduction 
To investigate the sensitivity of conventional survival analyses to longitudinal changes in average 
volume of alcohol consumption and drinking patterns, it was necessary to identify a dataset with 
a number of fundamental characteristics. 
Given that alcohol consumption behaviours appeared to change across all periods of 
adulthood,264,265 it was important first of all to analyse a dataset that spanned as broad a period 
of the adult life course as possible, with repeated measures of alcohol consumption that were 
both comparable between waves and of sufficient frequency as to capture acute fluctuations in 
drinking over time. However, while many longitudinal datasets were found to include repeated 
measures of alcohol consumption, none detailed the full adult life course, each having 
documented a restricted life period, such as early adulthood288 or older age.289  
Of the numerous longitudinal cohorts available, Whitehall II provided the best compromise 
between the period of adulthood captured, frequency of repeated alcohol measures, sample 
size and availability of variables, including objectively defined measures of T2DM. For instance, 
while the English Longitudinal Study of Ageing benefits from regular repeated measures and a 
sample of similar size to Whitehall II, its coverage of the adult lifecourse is skewed toward later 
life and comprises just 14 years of follow-up relative to the three decades of data afforded by 
Whitehall II.290 Elsewhere, in terms of coverage, the MRC National Survey of Health and 
Development 1946 is perhaps one of the closest to Whitehall II, with measures of alcohol 
consumption available between the ages of 36 and 64 years. However, it is limited by self-
reported T2DM data, fewer repeated measures and a sample one third the size of that available 
in Whitehall II.291 Other cohorts, such as the Twenty-07 Study292 and the Caerphilly Prospective 
Study,293 benefit from a similar number of repeated measures to Whitehall II but with very small 
sample sizes. 
6.2 Whitehall II cohort profile 
The Whitehall II cohort was established in 1985 as a longitudinal occupational study and 
comprised 10,308 (6,895 male and 3,413 female) civil servants aged 35-55 years who worked in 
the offices of 20 Whitehall departments.294 All eligible employees were invited to participate via 
letter, of whom 73% consented.295 Baseline measurements were obtained between 1985 and 
1988 by way of a self-administered questionnaire and a clinical examination. Participants were 
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followed up at regular intervals of between a median 1.6 and 5.5 years, with self-administered 
questionnaires completed at each wave and a clinical examination undertaken once every two 
waves (Table 6.1).  
Although Whitehall II represents a geographically-concentrated and occupationally-narrow 
cohort, a recent paper confirmed that aetiological associations identified within the cohort are 
consistent with those reported from studies of general population samples, implying that 
aetiological analyses based on Whitehall II data are likely to offer sound external validity.296 
Table 6.1 Variable availability in Whitehall II by study wave 
 
Age range 34-56 37-60 40-64 42-66 45-69 48-71 50-74 54-77 55-80 60-84
Wave number 1 2 3 4 5 6 7 8 9 11
Alcohol consumption
Frequency
Volume
'Always non-drinker?'
T2DM
FPGa
HbA1cb
OGTTc
Self-reported
Covariates
Age
BMId
Diete
Education
Ethnicity
Employment status
Family history of T2DM
Government office region
Household income
Index of Multiple Deprivation
Occupational grade
Physical activity
Sex
Smoking status
aFasting plasma glucose; bGlycated hemoglobin A1c; cOral glucose tolerance test; dBody mass 
index; eDietary variables, including fibre and saturated fat. 
The main aim of wave 10 was to validate self-completed measures of psychiatric morbidity in older 
people. As only 337 participants were sampled for the validation exercise, data for wave 10 are not 
l isted.
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6.3 Defining alcohol consumption  
As shown in Table 6.1, estimates of average weekly alcohol consumption were available in waves 
one, two, three, five, seven, nine and 11. Participants were asked to report the number of 
alcoholic drinks they had consumed in the preceding week according to “measures” of spirits, 
“glasses” of wine, or “pints” of beer or cider. A standard measure of spirits and a glass of wine 
were each assumed to contain one unit of alcohol, and a pint of beer or cider two units of 
alcohol. Based on data provided by Drinkaware,11 these volumes were roughly equivalent to a 
small (125 ml) glass of 10% ABV white wine (1.2 units) and a 4% ABV pint of lager (2.3 units).  
Given recent increases to both the size of wine glasses (175 ml and 250 ml) and the average 
strength of wines (11.5-13.5% ABV),297 it was likely that alcohol consumption from wine is 
conservatively estimated in Whitehall II.298 This was supported by a number of small 
convenience studies that asked drinkers to pour self-defined usual glasses of various drink types. 
Among these, volumes of alcohol contained within a usual glass of wine were consistently 
greater than those assumed by Whitehall II, with mean alcohol content measuring 15 g of 
alcohol among 283 drinkers from six locations across South-East England,299 or around double 
the volume assumed in Whitehall II. Elsewhere, almost half of participants from a Scottish 
convenience study poured in excess of 16 g alcohol.300  
While wine consumption data could have been inflated retrospectively, any such alteration 
risked being arbitrary and simplistic given variations in underestimation between convenience 
studies according to factors such as age, sex and setting.299 In a recent study that investigated 
the impact of increasing the assumed alcohol content of wine from 8 g/glass to 16 g/glass, 
doubling the value of wine consumption had the effect of reducing the risk of all-cause, CVD and 
cancer mortality among very heavy drinkers (men: ≥408 g/week, women: ≥288 g/week), relative 
to moderate drinkers (men: 1-168 g/week; women: 1-112 g/week).300 Risks among former and 
pooled non-drinkers were attenuated, though not to a degree as to be statistically significant. 
Accordingly, any underestimation of wine consumption would not have influenced the direction 
of the dose-response association under study, but may lead to an overestimation of risk at 
higher volumes. With this in mind, the volume of alcohol consumption was left unchanged with 
the caveat that risks among very heavy, former and non-drinkers were likely to have been biased 
upward among participants who predominantly consumed wine. 
The total volume of alcohol consumption was reported within the Whitehall II dataset as average 
units/week. These data were transformed into grams/week assuming a UK unit equal to 7.9 g 
ethanol, consistent with conversions undertaken as part of the revised meta-analysis. At wave 
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one, median reported alcohol consumption was 63.2 g/week (IQR 23.7-134.3 g/week, n=6,840) 
and 23.7 g/week (IQR 0.0-55.3 g/week, n=3,374) among men and women respectively (Table 
6.2). Median weekly alcohol consumption varied over the course of the study, peaking among 
men and women at wave five (ages 45-69). 
Whitehall II also included data concerning the pattern of alcohol consumption, operationalised 
as the frequency of alcohol consumption over the last 12 months. In wave 11, frequencies were 
defined as: ‘never’, ‘≤1 occasion/month’, ‘2-4 occasions/month’, ‘2-3 occasions/week’ and ‘>3 
occasions/week’. In all other waves, frequencies were recorded as: ‘none’, ‘special occasions’, 
‘>1/month’, ‘>1/week’, ‘daily’ and ‘almost daily’. To maintain consistency across waves in the 
classification of consumption frequency, new variables were derived for each wave of data and 
categories defined as: ‘none’, ‘<1 occasion/week’, ‘1-3 occasions/week’, ‘daily or almost daily’. 
These derivations were in keeping with a prior publication that used alcohol consumption 
frequency data from Whitehall II.266  
6.4 Defining T2DM 
Self-reported T2DM was documented at all waves, defined as any self-reported doctor-diagnosis 
or self-reported prescription of anti-diabetic medication (Table 6.1). Given that close to one-
third of T2DM cases may be missed by subjective measures of T2DM,301 self-reports were 
supplemented by objective data. These were obtained using measures of blood glucose drawn 
during clinical examinations at waves three (1991-93, ages 39-64), five (1997-99, ages 45-69), 
seven (2003-04, ages 50-74), nine (2008-09, ages 55-79) and 11 (2012-2013, ages 61-85) 
following a minimum five-hour fast. At each clinical examination, cases of T2DM were defined 
according to the 1998 WHO criteria: a fasting plasma glucose (FPG) reading ≥7.0mmol/L.302 Data 
following an oral glucose tolerance test (OGTT) were also available, for which participants 
consumed 389 ml of Lucozade (75 g anhydrous glucose) over a five-minute period, with a blood 
sample taken two hours later. However, as shown in Table 6.1, this measure was unavailable in 
wave 11. Similarly, while HbA1c concentrations were also documented as an alternative 
objective diagnostic indicator, such data were only available from wave seven onwards. To 
maintain a consistent definition of T2DM over time, FPG was thus selected as the objective 
measure of choice alongside self-reported data.  
To ensure a baseline free of T2DM, known cases between waves one through three were 
excluded from any analyses involving T2DM. After wave three, a total 916 new cases were 
observed (men: 620; women: 296), with a median follow-up 20.1 years (IQR 14.8-20.6 years) 
among men and 19.8 years (IQR 12.8-20.4 years) among women (Table 6.2). 
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6.5 Confounding factors 
All confounding factors identified during the literature review were available in Whitehall II, 
including adiposity, dietary variables (fats, carbohydrates and fibre), ethnicity, physical activity, 
smoking status and family history of T2DM (Table 6.1).  
6.5.1 Adiposity  
Despite its strong association with T2DM risk,39 there was a possibility that adiposity may have 
operated as a mediator of the relationship between volume of alcohol consumption and T2DM 
risk, with evidence indicating that calories consumed via alcoholic drinks tended to be additional 
to those derived from other dietary sources such as evening meals, leading to an acute over-
consumption of calories relative to non-drinkers.303 However, research linking average volume 
of alcohol consumption to increases in adiposity itself is conflicting, with longitudinal studies 
having reported a variety of null, inverse and positive associations.303,304 Notably, where positive 
associations have been identified, absolute differences in adiposity across alcohol consumption 
categories were modest. For example, over a period of three-years, each 14 g increase in alcohol 
consumption per drinking occasion was associated with an increase in BMI of 0.03 kg/m2 (0.02, 
0.04 kg/m2) among men, or a rise of 0.03 kg/m2 (95% CI -0.01, 0.07 kg/m2) for each additional 
day of weekly consumption.305 Coefficients among women were even smaller and non-
significant. Elsewhere, in an analysis of three large occupational cohorts, each 14 g increase in 
the volume of consumption per drinking occasion was associated with an increase in weight of 
0.19 kg (95% CI 0.10, 0.27 kg) over a period of four years, or just 0.05 kg/annum.306 Similarly 
small increases in weight have been identified elsewhere.307  
On balance, given the body of available evidence, it was decided that while calories derived from 
alcoholic drinks may have some direct effect upon adiposity, the magnitude of such an 
association appears diminutive relative to other risk factors for adiposity, such as physical 
inactivity and poor diet. Accordingly, adiposity was included as a confounding factor in all 
multivariable-adjusted models, with negligible risk of overadjustment.  
Multiple measures of adiposity are available in Whitehall II, including BMI and waist 
circumference. Each has been strongly associated with an increased risk of T2DM, with risk 
estimates of comparable magnitudes and the predictive utility of each measure differing 
according to a range of participant characteristics.39 BMI was selected as a well-known indicator 
of adiposity. Data on participants’ height and weight were captured at each clinical examination. 
Mean BMI measured 24.6 kg/m2 (95% CI 23.3, 25.8 kg/m2, n=6,883) among men and 24.8 kg/m2 
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(95% CI 23.1, 26.5 kg/m2, n=3,441) among women at wave one, with mean BMI appearing to 
increase gradually at each successive wave (Table 6.2).  
6.5.2 Diet 
A number of dietary factors were considered in accordance with the literature review, including 
carbohydrates, fibre and dietary fats (e.g. polyunsaturated and trans fats). The consumption of 
such factors was estimated based on responses to an anglicised food frequency questionnaire 
(FFQ) based on that used in the US Nurses’ Health study.308 Foods commonly eaten in the UK 
were added to the FFQ as per the UK arm of the EPIC cohort study.309 A common portion size 
was assigned to each food, and participants then asked how often, on average, they consumed 
such a portion during the previous year. Frequencies ranged from ‘never or less than once per 
month’ to ‘six or more times per day’. The reported frequency for each food item was then 
converted to an estimated daily intake, with the consumption of constituent nutrients 
computed by multiplying the daily frequency of consumption by the estimated nutrient content 
of each portion.310 
Unfortunately, dietary variables were only available in waves three, five and seven of the 
Whitehall II cohort. In order to explore the merit of truncating the number of repeated measures 
of alcohol consumption in favour of greater covariate adjustment, the contribution of dietary 
factors upon the alcohol-T2DM relationship was explored alongside other covariates of interest 
by way of multiple sex-stratified Cox survival models. The method adopted was consistent with 
studies selected as part of the revised meta-analysis, with all covariates modelled only according 
to their values at baseline. The sample was restricted to T2DM-free participants at wave three, 
with T2DM defined according to a positive FPG, self-reported doctor diagnosis or use of 
hypoglycaemic medication. Dietary variables were treated as continuous variables that denoted 
their proportion of total energy intake (g/100g). With the exception of fibre, all dietary variables 
were subjected to a logarithmic transformation owing to skewness. In keeping with conventional 
survival models, categorical average weekly volume of alcohol consumption was selected as the 
exposure of interest.  
The reference model was adjusted for all a priori covariates (age, BMI, ethnicity, family history 
of T2DM, physical activity, sex, smoking and socio-economic status), excluding any dietary 
variables. Dietary variables were then added in a mutually exclusive manner, with a final model 
adjusted for all covariates and dietary variables. Results from these analyses identified a 
statistically significant inverse association between fibre consumption and T2DM risk among 
men, independent of adiposity (p=0.018), while all other dietary variables were far from 
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significant in both sexes (Appendix 6.1). In all models, dietary variables appeared to have little 
impact upon the relationship between alcohol consumption and T2DM risk. The relationship was 
similarly unchanged when alcohol consumption was modelled as a continuous variable, or when 
dietary variables were coded as tertiles.  
Such a series of results indicated that other covariates, particularly BMI, may have captured 
much of the effect of diet upon T2DM risk. Dietary factors were thus omitted as covariates from 
any subsequent multivariable-adjusted model. 
6.5.3 Ethnicity 
The ethnic group of participants was self-reported during screening at waves one and five. The 
ethnicity of participants was coded as ‘white’, ‘South Asian’ or ‘other’, which isolated into a 
separate category any Asian participants who were likely to have a heightened genetic 
sensitivity to alcohol203 and susceptibility to the development of T2DM.204 At baseline, 92.0% 
(95% CI 91.3-92.6) of participants were of a white ethnic background (Table 6.2). 
6.5.4 Family history of T2DM 
Family history of diabetes was self-reported by participants in waves one and two. Data were 
coded as a dichotomous variable according to whether a participant reported a parent or sibling 
as having developed T2DM. The variable was thus limited by failing to capture familial cases that 
developed after the first two waves of study. Among those who participated at baseline, 10.4% 
(95% CI 9.7-11.2%, n=709) of men and 14.1% (95% CI 12.9-15.3%, n=470) of women reported a 
family history of T2DM (Table 6.2). 
6.5.5 Physical activity 
Information regarding physical activity was ascertained via a 20-item questionnaire that 
included questions on the frequency and duration of participation in activities including walking, 
cycling, housework, gardening and sports in the preceding four weeks. These responses were 
used to derive the average number of hours spent doing each activity per week. Activities were 
classified as either mildly (e.g. gardening and housework), moderately (e.g. walking), or 
vigorously (e.g. running and swimming) energetic, relative to laying at rest.311 Time spent in 
mildly energetic physical activity was discounted as it predominantly captured women, 
potentially leading to a small sub-group in any adjusted analyses stratified by sex. This was 
consistent with a previous analysis using Whitehall II physical activity data.312 
A categorical physical activity variable was created, with participants classified according to 
WHO physical activity recommendations:313 meeting guidelines (≥150 minutes of moderate-
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intensity exercise per week, or ≥75 minutes of vigorous-intensity activity); inactive (<60 minutes 
of moderate physical activity and <60 minutes of vigorous physical activity; below guidelines 
(anyone not inactive or meeting the WHO guidelines). 
The proportion of participants who reported meeting WHO physical activity guidelines was 
greatest among men and women at wave five (ages 45-69), at 91.0% (95% CI 90.1-91.8%, 
n=4,234) and 79.6% (95% CI 77.8-81.4%, n=1,576) respectively (Table 6.2). This proportion then 
fell with increasing age up to the final wave of data, at 54.3% (95% CI 52.8-55.8%, n=2,389) 
among men and 36.6% (95% CI 34.4-38.8%, n=661) among women by wave 11. 
6.5.6 Smoking status 
Smoking data were collected at each wave and participants categorised according to whether 
they reported being a current, former or never smoker. The proportion of current smokers was 
greatest at wave one, at 15.9% (95% CI 15.1-16.8%, n=1,091) of men and 23.4% (95% CI 22.0-
24.9%, n=795) of women (Table 6.2). The proportion of current smokers declined as the cohort 
grew older, falling to 3.4% (95% CI 2.9-3.9%, n=141) of men and 4.8% (95% CI 3.8-5.9%, n=80) of 
women by wave 11. 
6.5.7 Socio-economic status 
Given the long history of research highlighting a social gradient in health inequalities, socio-
economic variables were considered as a means of capturing some degree of confounding not 
captured by other a priori selected variables. Such a decision was supported by research that 
indicated a social gradient in abstention and heavy drinking,314,315 which were disproportionally 
concentrated among those of low education or in unskilled occupations. Elsewhere, heavy 
drinking has also been associated with being unemployed or materially deprived,316,317 or living 
in deprived neighbourhoods.318 Similarly, the risk of T2DM also appears greatest among study 
participants of low income,319,320 education,320 socio-economic status,321 or area deprivation.322 
Although income, education, government office region (GOR) and Index of Multiple Deprivation 
(IMD) score were all available as potential socio-economic variables, data were present on each 
for only a sub-set of the baseline sample: GOR and IMD data were only available for 33.0% 
(n=3,398) of participants at wave one, income for 69.5% (n=7,161), and education for 74.5% 
(n=7,681). In complete-case analyses, such a high proportion of missing data would have led to 
a substantial reduction in sample size. 
Two alternative surrogate indicators of socio-economic status were thus selected: last known 
hierarchical occupational grade, based on salary and work role (administrative, 
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professional/executive, clerical/support), and employment status (employed, retired, 
redundant/sacked/sick/other). Where individuals lacked an occupational grade in waves after 
baseline measurement, such as due to having left the civil service through retirement, 
redundancy or long-term sickness, the last known occupational grade was used. Over 90.7% of 
male participants at wave one were among the top two tertiles of occupational grade, compared 
with 50.3% of female participants. The proportion of retired individuals rose at each successive 
wave to 77.7% (95% CI 76.5-78%, n=5,018) of men and 84.2% (95% CI 82.4-85.8%, n=1,554) of 
women by wave 11 (Table 6.2). To assess whether the inclusion of education, income, GOR and 
IMD would have helped capture additional confounding by socio-economic status, correlations 
were calculated between these factors and both employment status and occupational grade at 
wave three. The correlation between occupational grade and employment status was low (r=-
0.02), indicating that each was likely to describe different dimensions of socio-economic status. 
Weak to moderate correlations were found between occupational grade and income, IMD and 
education, with Pearson’s r ranging from 0.29-0.53, suggesting that such factors may have had 
some moderate additional predictive value in adjusted analyses. The weakest correlation was 
present between occupational grade and GOR (r=-0.08), indicating that area of residence may 
be an important socio-economic covariate despite the geographically concentrated nature of 
the cohort. Some degree of residual confounding within adjusted analyses was thus plausible. 
6.5.8 Variables not included 
6.5.8.1 Direct mediators 
Some selected studies reported models that also adjusted for factors such as serum insulin, 
glucose or triglyceride concentration. However, these factors were likely to exist on the causal 
pathway (see Section 2.2.2). By adjusting for a factor on the causal pathway between alcohol 
consumption and T2DM risk, the primary dose-response relationship under investigation will be 
biased toward the null.47 This is illustrated in Figure 6.1, where E indicates the exposure of 
interest (weekly volume of alcohol consumed), M the mediating mechanisms (insulin sensitivity, 
cholesterol, inflammation), and D the dependent event of interest (T2DM).  
 
Figure 6.1 Directed acyclic graph illustrating direct overadjustment bias 
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6.5.8.2 Indirect mediators 
Although self-rated general health was considered as a variable that may have helped adjust for 
confounding through an uneven distribution of poor health across alcohol consumption 
categories, and thereby potential differences in susceptibility to the development of T2DM, its 
inclusion was ruled out due to the possibility that it may also have served as a surrogate for 
mediating factors through which alcohol was hypothesised to modify T2DM risk. For instance, 
were moderate drinkers more likely to report good self-rated general health relative to non-
drinkers, this may have been attributable in part to (a) advantageous differences in alcohol-
induced insulin sensitivity, HDL cholesterol concentration and inflammation, and (b) a 
correspondingly lower burden of negative health conditions as a consequence of such a 
favourable metabolic profile, such as lower rates of stroke323,324,325 and CHD.326,327,328 The 
hypothesised role of self-rated general health as a surrogate mediator is illustrated in Figure 6.2, 
where U represents omitted mediators (inflammation, cholesterol and insulin sensitivity) and M 
the observed surrogate mediator (self-rated general health).  
 
Figure 6.2 Directed acyclic graph illustrating indirect overadjustment bias 
The exclusion of self-reported health as a covariate was supported by its absence as a 
confounding variable in models reported by selected studies, with preference given to lifestyle 
and demographic variables. Unfortunately, the degree to which a general health variable would 
have served as either a confounder or mediator could not be investigated statistically, each 
distinguishable only on a conceptual basis.329 
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Table 6.2 Descriptive summary of Whitehall II data, stratified by wave and sex 
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6.6 Missing data 
Evident in Table 6.2 were three sources of missing data: unit non-response, representing 
attrition by individuals who opted not to participate at all in a given wave; item non-response, 
characterised as individuals who participated but opted not to answer one or more questions in 
a given wave; and mortality. 
Were data missing completely at random (MCAR), no systematic differences would exist 
between participants with and without missing values.330 Under such a circumstance, missing 
data would be ignorable, with the only resultant limitation being a reduction in statistical power. 
In practice, however, data are rarely MCAR.331  
The following sections explored whether individuals with missing data differed markedly from 
those that provided valid responses. If differences were present on characteristics associated 
with T2DM, missing data would be considered informative and non-ignorable due to its potential 
to introduce attrition or survivorship biases to any complete-case analyses of the alcohol-T2DM 
relationship.332,333 For example, were individuals who opted not to answer certain questions 
found to have exhibited characteristics that placed them at greater risk of T2DM than those with 
complete covariate data, such as current smoking and physical inactivity, then complete-case 
analyses would have risked selecting a disproportionately healthy sub-sample and T2DM risk 
potentially underestimated as a consequence.  
6.6.1 Mortality 
Information concerning the mortality of study participants is available via linkage to the NHS 
Central Registry.294 By wave 11, a total 13.3% (n=915) of men and 14.6% (n=499) of women were 
documented as having died (Table 6.2).  
As with any other form of attrition, the death of participants risked producing results that were 
more optimistic than would otherwise be the case, with many of the risk factors for T2DM also 
being risk factors for mortality. If participants at high risk of T2DM had died prior to the 
development of the condition, the resulting dataset would have been biased, with the remaining 
cohort representing disproportionately healthy, low-risk participants relative to the original 
sample. To investigate the degree to participant characteristics differed according to mortality 
status, Table 6.3 summarises participant characteristics at wave one, stratified according to 
whether or not participants died during the course of the study. 
Men and women who died were found to exhibit a higher proportion of negative risk factors for 
T2DM than those that survived, including older age and higher BMI, as well as lower levels of 
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physical activity and a higher prevalence of current smoking. Men who died were also more 
likely to be lighter, occasional drinkers than those that survived, though lower volumes of 
alcohol consumption and less frequent drinking may have been attributable to their poor health 
status at baseline. That participants lost to mortality appeared of poorer health and at greater 
risk of T2DM at baseline, it was possible that mortality produced a healthier analytical sub-
sample in which T2DM risk was underestimated. In such an instance, mortality would be 
informative and represent a competing risk event, with death altering a participant’s probability 
of experiencing T2DM.334 
Unfortunately, no agreement was found concerning how best to deal with the informative effect 
of a competing risk such as mortality.332 Approaches have included deriving an outcome 
measure that included both mortality and the primary outcome of interest,335 or assigning those 
who died with the worst outcome value (e.g. coding all deceased individuals as having developed 
T2DM).336 In each case, the modification of an outcome variable in such a manner rendered 
difficult the interpretation of results within the context of the primary relationship of interest.337 
With a lack of agreement over the most appropriate method, and existing methods potentially 
complicating any inferences concerning the alcohol-T2DM relationship, no attempt was made 
to account for the effect of mortality except to note that analyses potentially underestimated 
the risk of event. 
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Table 6.3 Descriptive summary of Whitehall II data at baseline, stratified by sex and survival 
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6.6.2 Unit non-response 
Some participant data were also missing due to unit non-response. Of participants who survived 
the course of the study, only 65.5% of male and 53.4% female baseline participants were found 
to have taken part at all waves (Table 6.4). Such a loss of data was likely to have a substantial 
impact upon statistical power and thereby inflate the risk of type 2 error in any complete-case 
analyses. To elucidate whether unit non-response may have introduced some degree of attrition 
bias, baseline characteristics of surviving participants were stratified according to the number 
of waves for which unit non-response was observed (Table 6.5). 
Table 6.4 Proportion of surviving baseline participants with unit non-response  
 
Differences in baseline characteristics are evident according to participants’ degree of unit non-
response. As shown in Table 6.5, those with greater levels of unit non-response were more likely 
to be from minority ethnic backgrounds, lower occupational grades, less physically active and 
have the greatest proportion of current smokers. Those with unit non-response across ≥4 waves 
were also found to have a lower volume and frequency of alcohol consumption, potentially due 
to poor health. In addition to a worse metabolic risk profile, participants with unit non-response 
had a lower incidence of T2DM, suggesting T2DM may have been underreported due to non-
participation at clinical examinations. In summary, complete-case analyses may be subject to 
some degree of attrition bias, with any analytical sample skewed toward those with a more 
favourable risk profile.338
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Table 6.5 Descriptive summary of Whitehall II data at baseline, stratified by sex and degree of unit non-
response 
  
 
0 waves 1-3 waves ≥4 waves Differencea
Variables (wave 1)
% (95% CI)
n
% (95% CI)
n
% (95% CI)
n
Men
Age
Mean years 44.2 (44.0, 44.4)b
3,919
43.5 (43.2, 43.8)b
1,251
43.5 (43.1, 43.9)b
810
<0.001
Alcohol consumption frequency
None in past year 2.2 (1.8, 2.7)
87
4.1 (3.1, 5.3)
51
4.3 (3.1, 6.0)
35
<0.001
<1/week 18.8 (17.6, 20.1)
736
19.1 (17.0, 21.4)
239
25.6 (22.7, 28.7)
206
1-3 times/week 44.7 (43.1, 46.2)
1,747
42.5 (39.8, 45.3)
531
39.5 (36.1, 42.9)
318
Daily or almost daily 34.3 (32.8, 35.8)
1,341
34.3 (31.7, 36.9)
428
30.6 (27.6, 33.9)
247
Alcohol consumption volume
Median g/week 63.2 (31.6, 134.3)c
3,891
71.1 (31.6, 150.1)c
1,239
47.4 (15.8, 126.4)c
801
<0.001
BMI
Mean kg/m2 24.3 (24.2, 24.4)b
3,912
24.8 (24.6, 24.9)b
1,250
24.6 (24.4, 24.8)b
809
<0.001
Ethnicity
White 94.9 (94.1, 95.5)
3,716
89.1 (87.3, 90.8)
 1,108
84.3 (81.5, 86.6)
669
<0.001
South Asian 3.7 (3.1, 4.3)
143
6.8 (5.6, 8.4)
85
9.7 (7.8, 12.0)
77
Otherd 1.5 (1.1, 1.9)
58
4.0 (3.1, 5.3)
50
6.0 (4.6, 7.9)
48
Family history of T2DM
No 9.9 (9.0, 10.9)
384
10.0 (8.4, 11.8)
123
11.2 (9.2, 13.6)
89
0.536
Yes 90.1 (89.1, 91.0)
3,485
90.0 (88.2, 91.6)
 1,109 
88.8 (86.4, 90.8)
704
Occupational grade
Administrative (top) 43.1 (41.6, 44.7)
1,689
31.7 (29.1, 34.3)
396
28.3 (25.3, 31.5)
229
<0.001
Professional (middle) 52.4 (50.8, 53.9)
2,052
55.3 (52.5, 58.1)
692
52.8 (49.4, 56.3)
428
Clerical (bottom) 4.5 (3.9, 5.2)
178
13.0 (11.3, 15.0)
163
18.9 (16.3, 21.7)
153
Physical activitye
Inactive 7.6 (6.8, 8.5)
297
10.3 (8.7, 12.1)
126
14.1 (11.8, 16.7)
113
<0.001
Below guidelines 37.9 (36.4, 39.5)
 1,476
33.9 (31.3, 36.6)
417
36.5 (33.3, 39.9)
293
Met guidelines 54.4 (52.9, 56.0)
 2,119
55.8 (53.0, 58.6)
686
49.4 (45.9, 52.8)
396
Unit non-response
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Smoking
Never 51.0 (49.4, 52.5)
 1,983
45.9 (43.2, 48.7)
570
46.3 (42.9, 49.8)
371
<0.001
Former 37.0 (35.5, 38.5)
1,440 
37.0 (34.3, 39.7)
459
33.8 (30.6, 37.2)
271
Current 12.0 (11.0, 13.1)
467
17.1 (15.1, 19.3)
212
19.9 (17.2, 22.8)
159
Women
Age
Mean years 44.6 (44.3, 44.9)b
1,555
45.9 (45.4, 46.3)b
710
46.2 (45.7, 46.6)b
649
<0.001
Alcohol consumption frequency
None in past year 5.2 (4.2, 6.4)
80
7.6 (5.9, 9.8)
54
7.4 (5.6, 9.7)
48
<0.001
<1/week 35.2 (32.9, 37.7)
547
41.0 (37.4, 44.7)
290
45.4 (41.6, 49.2)
294
1-3 times/week 36.9 (34.6, 39.4)
573
33.8 (30.4, 37.4)
239
30.6 (27.1, 34.2)
198
Daily or almost daily 22.7 (20.7, 24.8)
352
17.5 (14.9, 20.5)
124
16.7 (14.0, 19.7)
108
Alcohol consumption volume
Median g/week 31.6 (7.9, 63.2)c
1,534
23.7 (0.0, 55.3)c
707
15.8 (0.0, 47.4)c
641
<0.001
BMI
Mean kg/m2 24.3 (24.1, 24.5)b
1,555
24.9 (24.6, 25.3)b
710
24.9 (24.6, 25.2)b
649
<0.001
Ethnicity
White 88.8 (87.1, 90.3)
1,379
81.6 (78.6, 84.3)
573
80.7 (77.4, 83.7)
503
<0.001
South Asian 5.4 (4.4, 6.7)
84
8.3 (6.4, 10.5)
58
9.1 (7.1, 11.7)
57
Otherd 5.8 (4.7, 7.1)
90
10.1 (8.1, 12.6)
71
10.1 (8.0, 12.7)
63
Family history of T2DM
No 13.3 (11.7, 15.1)
203
13.3 (11.0, 16.0)
93
15.0 (12.4, 18.0)
95
0.539
Yes 86.7 (84.9, 88.3)
 1,322
86.7 (84.0, 89.0)
606
85.0 (82.0, 87.6)
537
Occupational grade
Administrative (top) 16.7 (14.9, 18.6)
259
7.3 (5.6, 9.5)
52
5.4 (3.9, 7.4)
35
<0.001
Professional (middle) 46.9 (44.5, 49.4)
730
32.3 (28.9, 35.8)
229
31.7 (28.3, 35.4)
206
Clerical (bottom) 36.4 (34.0, 38.8)
566
60.4 (56.8, 64.0)
429
62.9 (59.1, 66.5)
408
Physical activitye
Inactive 20.3 (18.3, 22.4)
310
28.5 (25.2, 32.0)
194
29.9 (26.5, 33.6)
188
<0.001
Below guidelines 42.5 (40.1, 45.0)
650
36.1 (32.6, 39.8)
246
36.0 (32.3, 39.8)
226
Met guidelines 37.2 (34.8, 39.6)
568
35.4 (31.9, 39.1)
241
34.1 (30.5, 37.9)
214
Chapter 6: Data selection and structure  
144 
 
 
6.6.3 Item non-response 
The third source of missing data within the Whitehall II cohort was among individuals who 
participated in a given wave but provided no answer to a specific question or provided no 
anthropometric measure or blood draw at clinical examination. Most a priori selected covariates 
were subject to some degree of item non-response, as summarised below in Table 6.6. Item 
non-response was greatest for the BMI variable at wave five, with measurements absent among 
27.0% of male and 29.7% of female participants. This was understood to have been due to 
administrative problems at centres where clinical examinations were held. As a consequence, 
excess item non-response on BMI at this wave could be treated as MCAR. 
In addition to a cumulative loss of 34.5% of male and 46.5% of female baseline participants 
through unit non-response in complete-case analyses (Table 6.4), analytic samples risked being 
attenuated even further by item non-response. To isolate differences in baseline characteristics 
according to item non-response, the dataset was restricted to the 5,474 individuals who 
participated at all waves, with descriptive statistics then reported for each variable as stratified 
according to whether complete-case data were provided at all waves (Table 6.7). Close to half 
of participants free of unit non-response provided complete-case data (n=2,673). Among both 
sexes, those with item non-response had a higher BMI and proportion of minority ethnic 
participants at baseline (wave one), as well as lower occupational grade, physical activity and 
average volume and frequency of alcohol consumption. As with unit non-response, the loss of 
data through item non-response appeared to represent a further source of attrition bias, with 
complete-case analyses inevitably sampling a subset of participants with a more favourable 
T2DM risk profile. 
Smoking
Never 59.4 (57.0, 61.9)
919
50.8 (47.1, 54.5)
358
53.1 (49.2, 56.9)
343
<0.001
Former 25.4 (23.2, 27.6)
392
24.5 (21.5, 27.9)
173
20.0 (17.1, 23.2)
129
Current 15.2 (13.5, 17.1)
235
24.7 (21.6, 28.0)
174
26.9 (23.6, 30.5)
174
Figures excluded participants who died over the course of the study. Figures included participants who 
had T2DM at waves 1-3. Number of participants l isted under each variable differed according to the 
level of item non-response at baseline (wave one).
aTo explore differences between non-response groups, one-way ANOVA was used on continuous data, 
and the chi2 test on categorical data (where continuous data exhibited a non-normal distribution, data 
were log-transformed prior to testing; bMean and 95% confidence interval; cMedian and 25th and 75th 
percentiles; de.g. black Caribbean, African and Arabic; eMeeting guidelines (≥150 minutes of moderate-
intensity or ≥75 minutes of vigorous-intensity activity per week); inactive (<60 minutes of moderate 
and <60 minutes of vigorous activity; below guidelines (not inactive or meeting guidelines).
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In order to reduce the impact of attrition bias upon any analyses, values missing due to unit or 
item non-response were estimated using multiple imputation. This process and its underlying 
assumptions are outlined in the following section. 
Table 6.6 Degree of item non-response by wave, stratified by sex 
 
Wave 1 Wave 3 Wave 5 Wave 7 Wave 9 Wave 11
Variables with item non-response
%
n
%
n
%
n
%
n
%
n
%
n
Men
Alcohol consumption frequency 0.3
20
5.2
317
9.1
498
2.3
113
2.7
127
6.2
278
Alcohol consumption volume 0.8
55
5.3
323
8.9
489
2.6
123
2.9
135
1.3
58
BMI 0.2
12
7.7
466
27.0
1,477
6.6
324
7.0
335
9.4
420
Employment status - 0.0
0
0.6
34
0.4
19
0.2
7
0.0
1
Ethnicity 0.6
40
0.3
18
0.0
2
0.1
7
0.2
10
0.1
6
Family history of T2DM 1.6
108
1.4
85
1.5
80
1.5
71
1.3
63
1.2
55
Incident diabetes from wave 3a - - 2.5
134
2.4
115
3.2
148
3.1
135
Physical activity 1.0
70
5.2
318
15.0
819
2.7
131
1.7
80
1.4
60
Smoking status 0.8
54
10.6
642
7.6
416
1.1
53
5.9
279
5.9
261
Women
Alcohol consumption frequency 0.3
10
6.5
179
13.2
317
3.7
77
4.8
96
11.7
217
Alcohol consumption volume 1.1
39
6.2
168
12.3
288
4.1
83
4.8
94
1.2
21
BMI 0.1
2
10.0
275
29.7
712
9.3
1.3
11.6
233
14.8
273
Employment status - 0.0
0
0.6
14
0.4
9
0.2
4
0.2
3
Ethnicity 1.5
52
0.8
22
0.3
7
0.3
6
0.3
6
0.2
4
Family history of T2DM 2.0
69
2.0
54
1.8
43
1.8
38
1.9
37
1.9
35
Incident diabetes from wave 3a - - 3.1
73
2.8
56
3.9
77
3.8
69
Physical activity 2.6
88
6.5
178
17.4
418
4.4
91
3.5
70
2.2
41
Smoking status 0.5
18
12.9
356
10.7
256
1.7
35
7.1
143
9.0
167
aRestricted to diabetes-free participants at wave 3
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Table 6.7 Descriptive summary of Whitehall II data at baseline (wave one), stratified by sex and item 
non-response 
 
Complete Incomplete Differencea
Variables (wave 1)
% (95% CI)
n
% (95% CI)
n
Men
Age
Mean years 44.1 (43.8, 44.3)b
1,976
44.3 (44.1, 44.6)b
1,943
0.163
Alcohol consumption frequency
None in past year 0.8 (0.5, 1.3)
15
3.7 (3.0, 4.7)
72
<0.001
<1/week 19.0 (17.4, 20.8)
376
18.6 (16.9, 20.4)
360
1-3 times/week 45.7 (43.6, 48.0)
904
43.6 (41.4, 45.8)
843
Daily or almost daily 34.5 (32.4, 36.6)
681
34.1 (32.0, 36.3)
660
Alcohol consumption
Median g/week 71.1 (31.6, 142.2)c
1,976
63.2 (23.7, 126.4)c
1,915
<0.001
BMI
Mean kg/m2 24.2 (24.1,24.3)b
1,976
24.4 (24.2, 24.5)b
1,936
0.051
Ethnicity
White 96.5 (95.6, 97.2)
1,907
93.2 (92.0, 94.2)
1,809
<0.001
South Asian 2.3 (1.7, 3.1)
46
5.0 (4.1, 6.1)
97
Othere 1.2 (0.8, 1.7)
23
1.8 (1.3, 2.5)
35
Family history of T2DMd
No 91.1 (89.8, 92.3)
1,801
89.0 (87.5, 90.3)
1,684
0.023
Yes 8.9 (7.7, 10.2)
175
11.0 (9.7, 12.5)
209
Incident diabetes from wave 3
No 89.4 (87.9, 90.7)
1,766
88.2 (86.7, 89.6)
1,649
0.261
Yes 10.6 (9.3, 12.1)
210
11.8 (10.4, 13.3)
220
Occupational grade
Administrative (top) 43.3 (41.1, 45.5)
856
42.9 (40.7, 45.1)
833
0.006
Professional (middle) 53.2 (51.0, 55.4)
1,051
51.5 (49.3, 53.7)
1,001
Clerical (bottom) 3.5 (2.8, 4.4)
69
5.6 (4.7, 6.7)
109
Item response
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Physical activitye
Inactive 5.9 (4.9, 7.0)
116
9.4 (8.2, 10.8)
181
<0.001
Below guidelines 40.5 (38.4, 42.7)
801
35.2 (33.1, 37.4)
675
Met guidelines 53.6 (51.4, 55.8)
1,059
55.3 (53.1, 57.5)
1,060
Smoking
Never 50.1 (47.8, 52.3)
989
51.9 (49.7, 54.2)
994
0.085
Former 38.6 (36.5, 40.8)
763
35.4 (33.3, 37.5)
677
Current 11.3 (10.0, 12.8)
224
12.7 (11.3, 14.3)
243
Women
Age
Mean years 43.7 (43.3, 44.1)b
697
45.3 (44.9, 45.7)b
858
<0.001
Alcohol consumption frequency
None in past year 2.6 (1.6, 4.1)
18
7.3 (5.7, 9.2)
62
<0.001
<1/week 32.1 (28.8, 35.7)
224
37.8 (34.6, 41.1)
323
1-3 times/week 38.5 (34.9, 42.1)
305
35.7 (32.5, 39.0)
305
Daily or almost daily 26.8 (23.7, 30.3)
165
19.3 (16.8, 22.1)
165
Alcohol consumption
Median g/week 31.6 (7.9, 71.1)c
697
23.7 (0.0, 55.3)c
837
<0.001
BMI
Mean kg/m2 23.9 (23.6, 24.2)b
697
24.7 (24.4, 25.0)b
858
<0.001
Ethnicity
White 92.8 (90.7, 94.5)
647
85.5 (83.0, 87.7)
732
<0.001
South Asian 2.4 (1.5, 3.9)
17
7.8 (6.2, 9.8)
67
Othere 4.7 (3.4, 6.6)
33
6.7 (5.2, 8.5)
57
Family history of T2DMd
No 87.9 (85.3, 90.2)
613
85.6 (83.1, 87.9)
709
0.184
Yes 12.1 (9.8, 14.7)
84
14.4 (12.1, 16.9)
119
Incident diabetes from wave 3
No 90.4 (88.0, 92.4)
630
85.3 (82.8, 87.6)
710
0.003
Yes 9.6 (7.6, 12.0)
67
14.7 (12.4, 17.2)
122
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6.6.4 Multiple imputation 
Given the concomitant issues of reduced sample size and a potential introduction of attrition 
bias through unit and item non-response, the decision was made to try and populate any values 
deemed missing due to non-response. 
A number of different imputation methods were available for handling missing data. One of the 
most basic was mean substitution, which would have replaced missing values with the observed 
variable mean. However, such an approach would have assumed that missing data were MCAR, 
such that the mean of the observed data provided a sound approximation of the missing values 
of a given variable, as in the case of excess item non-response on the BMI at wave five due to 
an administrative error, or a blood sample having been dropped at random in a laboratory. This 
assumption was not supported by the analyses undertaken in preceding sections. Additionally, 
Occupational grade
Administrative (top) 20.5 (17.7, 23.7)
143
13.5 (11.4, 16.0)
116
<0.001
Professional (middle) 51.4 (47.6, 55.1)
358
43.4 (40.1, 46.7)
372
Clerical (bottom) 28.1 (24.9, 31.6)
196
43.1 (39.8, 46.5)
370
Physical activitye
Inactive 17.8 (15.1, 20.8)
124
22.4 (19.7, 25.3)
186
0.007
Below guidelines 46.6 (42.9, 50.4)
325
39.1 (35.8, 42.5)
325
Met guidelines 35.6 (32.1, 39.2)
248
38.5 (35.3, 41.9)
320
Smoking
Never 58.2 (54.5, 61.9)
406
60.4 (57.1, 63.7)
513
0.222
Former 27.4 (24.2, 30.8)
191
23.7 (20.9, 26.7)
201
Current 14.3 (11.9, 17.2)
100
15.9 (13.6, 18.5)
135
Data were restricted to individuals who participated at all  waves. Sample sizes differed 
according to item non-response at baseline (wave one).
aTo explore differences between non-response groups, one-way ANOVA was used on 
continuous data, and the chi 2 test on categorical data (where continuous data exhibited a 
non-normal distribution, data were log-transformed prior to testing; bMean and 95% 
confidence interval; cMedian and 25th and 75th percentiles; de.g. black Caribbean, African 
and Arabic; eMeeting guidelines (≥150 minutes of moderate-intensity or ≥75 minutes of 
vigorous-intensity activity per week); inactive (<60 minutes of moderate and <60 minutes of 
vigorous activity; below guidelines (not inactive or meeting guidelines).
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adding no new information to the dataset beyond what was already observed, mean 
substitution would have resulted in an underestimation of variance.339 Alternative simple 
imputation methods, such as hot deck imputation and its replacement of missing data with an 
observed value selected at random from participants with similar characteristics, were each 
subject to the same two limitations.339 
Among more complex methods, multiple imputation represented a popular and 
methodologically superior approach to those described above.340 Unlike simple imputation 
methods, the most likely value of each missing data point was predicted multiple times via a 
series of iterative regression models, with each series of predictions forming its own dataset 
alongside the observed data.341 Values from each prediction were then averaged, and associated 
variances calculated according to two components: the standard variance present within each 
dataset, and the variance present between datasets. As a consequence, as well as adding new 
data as opposed to merely duplicating what has already been observed, variances following 
multiple imputation are larger and better reflect the uncertainty surrounding true values of the 
missing data. Given these benefits, multiple imputation was selected as the imputation method 
of choice. 
6.6.4.1 Statistical analysis 
Given the non-monotone nature of item non-response across waves (Table 6.2), as well as the 
presence of multiple variable types (e.g. categorical and continuous data), multiple imputation 
was undertaken using chained equations (MICE), which represented a method suited to 
handling such data characteristics.342,343 
MICE offered a sequential approach to multiple imputation, whereby variables with missing data 
were imputed iteratively via a sequence of regression models that predicted missing data as 
conditional on all other observed variables.342 For each variable missing data, the most 
appropriate regression model was utilised, including logistic regression models for binary data 
and multinomial logistic regression for non-ordered categorical variables. Given the difficulty 
with which linear regression models predict missing data on skewed continuous variables,343 
skewed data were log transformed prior to imputation, then converted back to their original 
scale post-imputation. 
The imputation procedure began by populating all missing data with random values so as to 
permit the inclusion of missing data points within regression models. Then, starting with the 
variable for which the proportion of missing data was lowest (x1), observed data on that variable 
Chapter 6: Data selection and structure  
150 
 
were regressed against all other covariates in the model (x2,...,xp). Missing values on x1 were 
then replaced by data drawn from the predicted distribution of values missing on x1, given 
x2,...,xp.344 Once complete, the imputation procedure moved to the variable with the next lowest 
proportion of missing data (x2). Observed values of x2 were then regressed on all other covariates 
(x1,x3,…,xp), with x1 including all data predicted at the preceding stage.344 This process continued 
iteratively until missing values had been imputed for all variables with missing data, representing 
one complete iteration of the imputation procedure. 
At the start of a second iteration, missing data were populated with predictions from the 
previous iteration as opposed to random noise. The calculation of new iterations continued until 
the predicted values were consistent between iterations. In such a circumstance, any variation 
in predicted values between iterations appeared random and the data were said to have 
converged. At the point of convergence, predicted data were stored in a dataset as one 
complete imputation.344  
In order to reliably capture the degree of uncertainty surrounding the predicted values, 50 
imputations were run. This was in keeping with guidance which advises that the total number 
of imputed datasets should be equal to at least the total proportion of participants without 
complete-case data (see Tables 6.4 and 6.6).344 
The imputation procedure was undertaken while data were stored in their wide format. This 
modelled each wave of a given variable as a separate covariate in each regression model, 
allowing for the modelling of missing data as a function of observations at all times that 
preceded and followed the wave of unit or item non-response. Data were imputed using Stata 
13 and the -mi- package. The augment option was also applied to overcome any circumstances 
in which perfect prediction between variables may have occurred, adding random observations 
with very low weights to the included variables. 
6.6.4.2 Diagnostics 
Imputed estimates was examined to identify any incongruous values, such as negative alcohol 
consumption. Where any invalid values were identified, the imputation model was modified 
accordingly and re-run. In the case of average weekly volume of alcohol consumption, for 
example, this involved the use of a truncated regression model, which restricted the lower limit 
of predicted alcohol consumption to a value of zero. 
Trace plots were then undertaken to check that predicted values of missing data had 
converged.345 These plotted the mean predicted value of a variable at each iteration, indicating 
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visually whether any variation in values between iterations had become random such that 
additional iterations provided no further improvement to the predictions made. The optimal 
number of iterations recommended to reach convergence ranged from 10344 to 20346 depending 
upon the degree of correlation between variables. A total 20 iterations were initially run for each 
imputation, though convergence was not achieved on a minority of variables. The number of 
iterations was thus doubled to 40, which was found to be a sufficient number of iterations to 
reach convergence across all covariates. Examples of the resulting trace plots are reported in 
Appendix 6.2.  
Once predictions had successfully converged and were deemed congruous, descriptive statistics 
were reported according to whether data were observed or imputed. Due to marked differences 
in participant characteristics according to the presence of missing data (Tables 6.5 and 6.7), the 
missingness process was considered informative and results thus documented according to both 
the imputed and observed datasets where possible within the limitations of Stata. 
6.6.4.3 Variable selection 
All variables identified a priori for use in any subsequent statistical analysis were included in the 
imputation model. These substantive variables thus comprised the frequency and total weekly 
volume of alcohol consumption plus an interaction term between these two dimensions, all 
confounding factors, and T2DM. Specifically, T2DM was represented by three variables: binary 
variable that denoted the number of new cases of T2DM captured at each wave of 
measurement, a continuous variable that represented the time to event, and the cumulative 
baseline hazard function. The inclusion of these outcome variables in the imputation model 
ensured that missing values on any independent variables each reflected the covariance that 
existed between observed covariate data and the risk of T2DM. Failure to include such variables 
risked biasing toward the null any associations subsequently calculated between covariates and 
T2DM risk when using imputed data.347,348  
With missing values predicted conditional upon observed data, the multiple imputation model 
operated under the assumption that data were missing at random (MAR), i.e. that any 
systematic differences between participants with and without missing data could be entirely 
according to observed data included in the imputation model.349 Accordingly, the plausibility of 
the MAR assumption and the performance of any imputation model was strengthened by an 
inclusive covariate selection strategy, including a broad range of auxiliary variables likely to 
covary with the variables upon which missing data were to be predicted.342,350 A number of 
suitable auxiliary variables were theorised and are described in the section below.  
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Unfortunately, despite the inclusion of numerous auxiliary variables, it was possible that the 
MAR assumption may have been invalid; that some proportion of the systematic difference in 
participant characteristics evident between those with and without missing data (Tables 6.5 and 
6.7) may have been a consequence of unobserved factors not included in the imputation model. 
340,341 Nevertheless, in the case of both unit and item non-response, the MAR assumption was 
considered reasonable given the range of auxiliary variables considered.  
6.6.4.3.1 Predictors of unit non-response 
Although the reason for unit non-response was unknown, potential explanations were 
hypothesised to include instances were individuals were not solicited at all (e.g. due to 
inaccurate contact records) or participants who were solicited but unable to participate (e.g. 
due to physical or mental incapacity, or scheduling problems).  
The first group was believed to represent a very small proportion of total unit non-response, 
given efforts by cohort administrators to maintain accurate contact information and actively 
trace those lost to postal contact.294 Such individuals were assumed to be MCAR. Of those with 
unit non-response across just a couple of waves, attrition was most logically explained by 
scheduling problems such as work commitments or holidays, or the development of acute 
physical or mental incapacity sufficient to preclude participations. By contrast, of those with unit 
non-response across the majority of waves, attrition was most likely attributable to the 
development of chronic physical or mental incapacity that prevented participation over the long 
term.  
In either case, it was thought possible to capture information concerning the probability of unit 
non-response through the inclusion of variables concerning mental and physical health prior to 
unit non-response, as well as factors likely to influence time available to participate. In the first 
instance, mental incapacity was included as an auxiliary variable via two variables. The first was 
the General Health Questionnaire (GHQ), a 30-item screening instrument administered at all 
waves and designed to capture self-reported symptoms of anxiety, depression and associated 
psychosocial dysfunction, with scores that ranged from 0 to 30.351 Defined as any score greater 
than four,352 the tool has been validated on Whitehall II data for the detection of mild psychiatric 
disorder.352 Mild psychiatric disorder was thus included as a predictor of unit non-response by 
way of a binary GHQ variable. In addition to psychiatric morbidity, any unit non-response due to 
impaired mental cognition was captured via results from the Mini Mental State Examination 
(MMSE), a 30-point screening instrument for the quantitative assessment of global cognitive 
function.353 The MMSE comprised a series of 11 questions concerning seven distinct cognitive 
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domains, including orientation to time, attention and recall, and has been validated as sensitive 
to the detection of moderate-to-severe cognitive impairment.354 The MMSE was first introduced 
in wave 5 and applied only to persons aged ≥60 years. MMSE data were then available at all 
subsequent waves and delivered to all participants. In an effort to capture participants’ physical 
health, participants' self-rated general health was also included, available at all waves and coded 
according to three categories: 'very good or excellent', 'good' and 'fair or poor'. 
With regard to any unit non-response attributable to scheduling problems, the imputation 
model included data concerning the average number of hours worked in a week, as captured at 
wave three, as well as the amount of time participants reported being ‘worn out’ in the four 
weeks prior to each wave, defined as 'all of the time', 'most of the time', 'a good bit of the time', 
'some of the time', 'a little of the time' or 'none of the time'. Regression models also included a 
variable that denoted whether family obligations reduced a participant’s time available for 
relaxation. These data were documented at waves three, five and seven, with categories defined 
as 'not at all', 'to some extent', ' a great deal', or 'not applicable', e.g. no family obligations.  
6.6.4.3.2 Predictors of item non-response 
Alcohol consumption 
Although alcohol consumption appeared lower at baseline (wave one) among those with item 
non-response at later waves (Table 6.7), it was possible that participants who opted not to 
disclose their consumption at later waves had experienced an alcohol use disorder.355 Such 
individuals may not have disclosed their consumption behaviour out of shame or an inability to 
reliably recall volumes accurately due to inebriation. In case missing alcohol consumption data 
were associated with problematic levels of drinking, data from the CAGE questionnaire were 
included as a screening instrument for the detection of problem drinking,356 which was found to 
correlate well with clinical diagnoses of alcoholism.357 The CAGE questionnaire was first 
introduced in the Whitehall II study at wave 3 and comprises four questions concerning alcohol 
consumption behaviour and participants' perceptions thereof, such as whether they ever felt 
guilty about their drinking behaviour. Alcohol dependence was defined according to a score 
≥2.356 
With studies also having identified lower levels of alcohol intake among those in poor 
health,144,145,146,141,358 self-rated general health was posited to provide a useful correlate of 
alcohol consumption. Alongside this, substantive ethnicity and socio-economic variables were 
thought to help explain any religious or genetic factors that might have influenced alcohol 
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consumption or the willingness of participants to report it,359 as well as differences in alcohol 
consumption by socio-economic strata.360 
BMI 
Beyond substantive variables such as physical activity,361 socio-economic factors,362,363 and 
smoking,361 potential correlates of BMI were thought to include: mild psychiatric disorder, as 
captured via the GHQ;364 blood pressure;365 plasma triglycerides and HDL;366,367 and dietary 
factors identified during the literature review, including carbohydrate, polyunsaturated fat, 
trans fat and fibre.  
Blood pressure readings were obtained at each clinical examination, averaged across two 
readings with continuous systolic and diastolic blood pressure variables documented in 
millimetres of mercury (mmHg).368 Blood samples were also taken at each clinical examination, 
with triglyceride and HDL concentrations recorded in mmol/L.369 Data concerning dietary factors 
were obtained via the FFQ, available at waves three, five and seven only.  
It was possible that information on BMI was absent for some individuals due to hairstyles or 
clothing that would have rendered invalid any attempt to measure height or weight. Missing 
data in such cases were assumed to be MCAR, or else partially correlated with ethnicity, such as 
being unable to accurately measure height owing to religious headdresses. 
Employment status 
It was hypothesised that the probability of retirement would have been correlated with age, 
while the probability of exiting the labour market for reasons other than retirement was posited 
to be associated with indicators of mental health and self-reported general health.370 
Ethnicity 
Item non-response on the ethnicity variable was low (Table 6.6). However, given notable ethnic 
inequalities in labour participation in the UK,371,372 it was hypothesised that any missing ethnicity 
data could be predicted through a partial correlation with variables that denoted employment 
status and occupational grade. 
Family history of T2DM 
Item non-response on this variable was also low, absent for just 1.6% of male and 2.0% of female 
baseline participants (Table 6.6). It was hypothesised that these data may have been missing 
because participants simply did not know whether there was a history of T2DM in the family. 
Such data were thus assumed to be MCAR. 
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Incidence of T2DM 
Possible randomly distributed reasons for not having an objective indicator of T2DM diagnosis 
were posited to include refusal to have bloods taken, inability by the clinic nurse to obtain a 
suitable blood sample or poor adherence to the necessary protocol (e.g. had not fasted). 
Conversely, the lack of a subjective self-reported measure might have been attributable to the 
inability of a participant to recall whether or not T2DM had been reported by a doctor, or a lack 
of time with which to attend the clinic or complete all necessary measurements upon 
attendance. Missing values of T2DM were thus predicted according to indicators of availability 
and cognition, as described previously, as well as key risk factors for the disease, including age, 
BMI, ethnicity and both serum triglyceride and HDL concentration.  
Physical activity 
BMI was considered a key correlate of physical activity level, along with other clinical markers 
such as serum HDL and triglycerides.373 Aside from such factors, studies indicate that, among 
employed individuals, time spent in leisure-time physical activity may be determined by factors 
that influence the amount of free time available to undertake such activity.374 These factors were 
included as auxiliary predictors of physical activity, as described for unit non-response. Further 
correlates were thought to include socio-economic factors and self-rated general health, with 
different types and amounts of leisure-time physical activity undertaken across social 
strata.375,376,377 
Smoking 
As was likely with both BMI and physical activity, it was posited that item non-response may 
been greater among those participants who perceived their smoking behaviour to be less 
socially desirable. Given the clustering of negative health behaviours,78,378 it was postulated that 
alcohol consumption, physical activity and BMI would all correlate with smoking, as well as 
clinical measures such as blood pressure379 and serum HDL concentration.380 
6.6.4.4 Results 
6.6.4.4.1 Convergence 
Trace plots indicated good convergence across all variables of interest, with between-iteration 
variation in predicted values appearing stable at the point of draw following 40 iterations. These 
data are reported in Appendix 6.2 and indicated that further iterations would have provided no 
improvement to the predicted values, with any variation between imputations having been a 
consequence of random error. 
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6.6.4.4.2 Summary of imputed data 
Wave-specific characteristics of participants within the imputed dataset are reported below in 
Table 6.8, with observed cohort data reported in Table 6.2. After accounting for unit and item 
non-response, participants within the imputed dataset reported higher levels of average weekly 
volume consumption, particularly among women, suggesting that many may not have reported 
their consumption due to perceived social undesirability. The imputed data also predicted 
higher levels of BMI among women, relative to the observed dataset, suggesting that women 
may have systematically declined such a measurement for similar reasons. A higher proportion 
of imputed individuals were employed, relative to those that were observed, suggesting that 
many who did not participate may have done so due to scheduling problems and time 
constraints. Both sexes with missing data were also more likely to have been of minority ethnic 
origin, lower occupational grade and current smokers. Additionally, while not shown in Tables 
6.2 and 6.8, the proportion of participants who reported being of very good or good general 
health was highest among those who were observed, with any discrepancies between the two 
datasets largest in later waves. For instance, of those who participated in wave 11, 48.0% of men 
and 44.2% of women reported being in good or very good general health. By contrast, within 
the imputed dataset, equivalent figures were just 40.4% and 34.8% respectively. Systematic 
differences between the observed (Table 6.2) and imputed data (Table 6.8) confirm that missing 
data were unlikely to have been MCAR, with complete-case analyses subject to attrition bias 
and the selection of a healthier sub-sample of participants. 
6.7 Statistical power 
Of the 3,413 women who participated at baseline, just 2,094 (61.4%) were free of prevalent 
T2DM at wave three and provided complete-case data concerning alcohol consumption, the 
confounding factors outlined in Section 6.5, and incident T2DM. Among these, only 247 incident 
cases were documented. There is therefore a possibility that statistical power may be 
insufficient to detect relatively small dose-response or interaction effects among women.381  
To establish the power of any subsequent survival model to detect a difference in survivor 
functions for a one-unit change in consumption among women, the -stpower- package was 
used.381 This assumed a conventional alpha level of 0.05, a sample of 2,094 participants, and 
survival in the reference group equal to the average observed among all female participants 
(88.2%). The power to detect a 20% reduction in hazards per unit increase in consumption was 
estimated at just 0.39, indicating a 61% probability of type II error. Based upon the graph in 
Figure 6.3, a sample of ~5,900 women would be required to reach a conventional power 
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threshold of 0.80. These calculations thus indicate that low statistical power may present a 
particular limitation for dose-response analyses of female Whitehall II participants. 
 
Figure 6.3 Power versus sample size for a log-rank test of differences in survivor functions 
6.8 Summary of the dataset 
Although numerous longitudinal cohorts are available, Whitehall II offers a number of benefits 
relevant to the study of longitudinal consumption trajectories and associations with T2DM. 
Perhaps of foremost importance, the cohort includes multiple waves of follow-up data for 
alcohol consumption and a wide range of potential confounders. The regular frequency of these 
follow-up data is such that acute fluctuations in health behaviours are more likely to be 
captured, increasing the accuracy of plotted trajectories and attempts to model risk with 
consideration to changes in participant characteristics across 50 years of the adult life course. 
Finally, the availability of an objective measure of T2DM reduces the potential for under-
estimating the incidence of T2DM relative to the use of self-reported data.  
However, with a predominantly male sample, statistical power is likely to be low for analyses of 
women. Additionally, as with any cohort, a number of participants were lost to follow-up or 
failed to answer all questions included in self-completion questionnaires, with complete-case 
data available for just 65.5% of men and 53.4% of women (Table 6.4). Systematic differences in 
baseline characteristics are apparent according to the presence of unit or item non-response, 
with observed participants having reported a lower metabolic risk profile at the beginning of the 
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study than those with missing data. Complete-case analyses thus risked being subject to 
selection bias, sampling a healthier sub-set of the source population in a manner that may 
impact the validity of any dose-response relationship estimated. Although missing data have 
been imputed using chained equations and a broad range of ancillary variables, the use of 
imputed data within analytical models is currently limited. As noted in forthcoming chapters, 
these limitations included variability in the predicted values of stratification variables between 
imputations and an inability to use imputed event data within survival models. These restrictions 
were such that little difference is reported between results based on the observed and imputed 
datasets. In addition to restrictions concerning the range of statistical tests that can be applied 
to imputation models, including goodness-of-fit statistics, it was decided to report results based 
upon the observed data as the primary analyses, with results obtained from the imputed dataset 
reported in the appendices. 
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Table 6.8 Descriptive summary of imputed Whitehall II data, stratified by wave and sex 
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7 A preliminary conventional survival analysis 
7.1 Introduction 
Given changes to drinking behaviour across the life course as evidenced by multiple cohort 
studies,266 it is possible that conventional survival models that define intake according to a single 
baseline measure may have been simplistic in their approach and subject to misclassification 
error through a failure to consider the effect of variations in alcohol consumption over time. 
Prior to exploring such shortcomings in more detail, this chapter reports preliminary analyses 
undertaken to confirm the suitability of the Whitehall II dataset for such an analysis. Specifically, 
results are reported from a series of conventional survival models in order to establish whether 
observed dose-response relationships within the Whitehall II cohort were consistent with those 
identified in the revised meta-analysis. Although a conventional survival analysis of T2DM risk 
has previously been published using Whitehall II data, pooled heterogeneous non-drinking 
categories were used with adjustment only for age and ethnicity.241 
Unlike the majority of existing studies, the conventional survival model reported in this chapter 
will also jointly examine two dimensions of alcohol consumption to ascertain whether drinking 
frequency represent an additional independent determinant of T2DM risk alongside the volume 
of consumption. The chapter will also explore the dose-response relationship between different 
drink types, given evidence discussed in Chapter 3 indicating the possibility of effect 
modification.  
7.2 Objective 
The objectives of the chapter were thus to: 
 Undertake a conventional survival analysis, reporting the dose-response relationship 
between baseline categories of average weekly volume of alcohol consumption and 
T2DM risk. 
 Investigate whether any interaction existed between the average volume of alcohol 
intake and the frequency of consumption. 
 Establish whether independent dose-response relationships exist between drink type 
and T2DM risk. 
 Compare results against those summarised as part of the revised meta-analysis in 
Chapter 3. 
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7.3 Hypotheses 
Given that aetiological associations identified within Whitehall II are accordant with those found 
in general population cohorts,296 it was hypothesised that results from conventional survival 
analyses applied to Whitehall II data would be broadly similar to those reported in Chapter 3. 
Specifically, that: 
 Reductions in T2DM risk will be greatest among women who consumed alcohol 
at moderate volumes; 
 Any elevated risks will be most pronounced among former drinkers and those 
that reported a low frequency of alcohol intake. 
 After accounting for consumption of other drink types, reductions in risk will be 
most pronounced among wine drinkers. 
7.4 Methods 
7.4.1 Sample 
The sample was restricted to T2DM-free individuals who participated at baseline plus at least 
one other wave from which longitudinal time-to-event data could be determined. The baseline 
was defined as wave three, the first wave at which cases of T2DM were identified via both 
subjective and objective measures. 
7.4.2 Variables 
7.4.2.1 Alcohol consumption 
With wave three representing the first period at which data were sufficient for the demarcation 
of never and former drinkers, participants were defined according to categories of alcohol 
consumption reported at wave three. 
Using the volume and frequency variables described in Section 6.3, abstainers were categorised 
as either never drinkers or non-current drinkers. Never drinkers were defined as those who 
reported never having consumed alcohol over the year preceding participation at wave three 
and as being ‘always a non-drinker’. To provide a stricter definition of never drinkers, this 
category excluded any participant who reported ‘always being a non-drinker’ at wave three yet 
also reported non-zero consumption at wave one (n=47), leaving a total 106 men and 111 
women categorised as never drinkers. Non-current drinkers were thus defined as those who 
reported no alcohol consumption in the year preceding participation at wave three, and who 
reported not having always been a non-drinker. This category also included the 47 participants 
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who described themselves as never drinkers at wave three but reported non-zero consumption 
at wave one. The non-current drinkers were considered roughly analogous to a former drinking 
category and totalled 103 men and 78 women. 
Current drinkers were defined according to their reported total volume of alcohol intake in the 
week preceding baseline. Male current drinkers were categorised as having consumed 0.1-50.0 
g/week (n=1,692), 50.1-100.0 g/week (n=1,163), 100.0-150.0 g/week (n=725) or >150.0 g/week 
(n=1,316). For women, among whom the volume of alcohol consumption was lower, current 
drinkers were defined as having drunk 0.1-50.0 g/week (n=1,081), 50.1-100.0 g/week (n=387) 
or >100.0 g/week (n=323). Intervals of 50 g/week were chosen to strike a balance between being 
narrow enough to detect differences in T2DM risk across relatively small changes in the volume 
of alcohol consumption, and being broad enough to each capture an ample number of cases. 
Additionally, the use of regular intervals permitted a direct comparison of dose-response 
between men and women.  
Alongside current drinkers, a separate group of ‘infrequent drinkers’ was defined, which 
represented participants who reported having consumed alcohol in the year preceding 
interview, but that did not drink alcohol in the week prior to measurement. The category of 
infrequent drinkers thus excluded participants who reported consuming alcohol at some point 
in the year prior to interview, but did not provide an answer to the questions concerning 
consumption in the last week; such individuals may have consumed alcohol in the last week, but 
missing data were such that this could not be determined. In total, 628 men and 597 women 
were classified as infrequent drinkers, among whom close to 85% reported drinking alcohol less 
than once a week, monthly or only on special occasions. 
To test for an interaction between average weekly volume and the frequency with which alcohol 
was consumed over the week, a consumption pattern variable was defined according to whether 
or not participants reported ‘daily or almost daily’ alcohol consumption at wave three. This 
binary variable was chosen for consistency with previous studies that reported reductions in risk 
as greatest among participants that regularly consumed moderate volumes of alcohol 
throughout the week.95,97,240,244 
Finally, continuous variables denoting the weekly volume of consumption of different drink 
types were derived based on responses to questions concerning the number of “measures” of 
spirits, “glasses” of wine, or “pints” of beer or cider consumed. A glass of wine and a measure of 
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spirits were each assumed to contain one unit of alcohol (7.9 g), with two units of alcohol (15.8 
g) in and a pint of beer or cider. 
7.4.2.2 T2DM 
As documented in Section 6.4, cases of T2DM were defined according to any self-reported 
doctor diagnosis or use of hypoglycaemic medication, or a positive FPG result following clinical 
examination. Analyses focussed upon incident cases of T2DM and so therefore excluded any 
cases prevalent at baseline. 
As the number of participants predicted to have developed T2DM over the course of the study 
varied between imputations, analyses applied to the imputed dataset were restricted to 
participants with observed T2DM diagnosis data such that the number of participants remained 
static between imputations.342 
7.4.2.3 Covariates 
All covariates selected a priori were included in multivariable-adjusted models, operationalised 
as described in Section 6.5. Included covariates were age, BMI, ethnicity, employment status, 
family history of T2DM, occupational grade, physical activity, and smoking status. As with alcohol 
consumption, all covariates were defined at baseline, with the exception of ethnicity for which 
data were obtained from waves one and five. 
7.4.3 Statistical analyses 
7.4.3.1 Data synthesis 
7.4.3.1.1 Cumulative hazard functions 
Where cumulative hazard functions were reported, these were calculated using the Nelson-
Aalen estimator, which plotted the cumulative hazard as a function of the number of 
participants at risk and the number of events observed at each point in time. Differences in 
cumulative hazard functions were tested using the log-rank test of equality. 
7.4.3.1.2 Categorical dose-response 
In keeping with methods applied by conventional analyses, Cox proportional hazards models 
were used to investigate the relationship between categories of alcohol consumption and T2DM 
risk. At its most simple, the Cox survival model is expressed according to Formula 7.1.382 
hi(t)=h0(t)exp{βxi} 
Formula 7.1 Calculation of a Cox proportional hazard model 
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Here, the hazard of T2DM was calculated as a function of the baseline hazard of the sample at a 
given point in time (h0(t)), which represented the hazard for a participant when all covariates 
were equal to zero, plus the effect of substantive covariate values (xi) and their corresponding 
coefficients (β). 
Results were reported separately for men and women based on apparent sex-specific 
differences in dose-response reported by the revised meta-analysis (Chapter 3). For each sex, 
age-adjusted and multivariable-adjusted dose-response relationships were described. Although 
few in number, never drinkers were selected as the reference group of choice for consistency 
with analyses undertaken as part of the revised and updated meta-analysis reported in Chapter 
3, permitting a direct comparison of dose-response. 
7.4.3.1.3 Frequency interaction 
To investigate whether the effect of weekly volume of alcohol consumption differed according 
to the frequency of intake, a multiplicative interaction between the weekly volume of alcohol 
consumption and drinking frequency was included in the model. A categorical drinking variable 
denoting graduated volumes of intake was not used as part of the interaction analyses due to 
the small number of participants and cases when categories were divided according to values of 
the frequency variable. Instead, the weekly volume of alcohol consumption was modelled as a 
continuous variable, with a binary frequency variable denoting whether or not participants 
consumed alcohol on a daily or almost daily basis.  
Non-current and infrequent drinkers were excluded from the interaction analysis so that 
relationships were calculated relative to never drinkers, consistent with preceding models. 
However, a sensitivity analysis was also run to examine the effect of their inclusion in a 
multivariable-adjusted interaction model.  
Hazards were reported per 10 g/week increase in consumption and robust Huber-White 
standard errors were utilised for the calculation of confidence intervals due to the positive 
skewness of the continuous alcohol consumption variable.383,384,385 These standard errors are 
robust to the heteroscedasticity of residuals when modelling skewed variables, and thereby 
account for the underestimation of variance that can occur in its presence.  
Models that incorporated a continuous measure of alcohol intake assumed a linear dose-
response relationship with T2DM incidence in conflict with the J-shaped associations previously 
observed. Accordingly, the possibility of a non-linear relationship was explored by raising the 
continuous measure of average volume of alcohol consumption according to a range of 
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fractional powers, as per the method described in Section 3.2.4.1. The fit of the non-linear dose-
response models was then compared against the original linear model. 
7.4.3.1.4 Drink type 
To establish the association between different drink types and the risk of T2DM, the weekly 
volume of alcohol consumption from wine, spirits and beer or cider were each included 
concurrently within a multivariable-adjusted model as separate continuous variables. 
Consumption of each drink type was not categorised in an effort to avoid small sub-group 
sample size and low precision – a limitation inherent to a number of existing studies to have 
explored the effect of drink type upon T2DM risk.97,219,245 No adjustment was made for total 
consumption to avoid overadjustment in instances where participants only consumed a single 
type of drink at baseline. 
As described above, these models assumed a linear relationship between drink type and T2DM 
risk. Accordingly, the volume of each drink type was raised to a series of fractional powers as 
described in Section 3.2.4.1. Results from the best-fitting models were reported.  
7.4.3.2 Goodness of fit 
To determine which models best fit the underlying data, the Bayesian information criterion (BIC) 
was calculated in each instance. Developed as a tool to aid model selection, the BIC was 
calculated as follows:386 
BIC=(-2*ln(ℓ))+(ln(nT))(np) 
Formula 7.2 Calculation of the Bayesian information criterion 
Here, ℓ refers to the likelihood function, or the probability of having reached the calculated 
effect estimates given the included parameters. As per the deviance statistic described in 
Section 3.2.4.1, a perfectly specified model would report a value of zero. The log of the total 
number of observations (or in the case of nested data, the effective sample size) was expressed 
as nT, while np denoted the total number of included parameters. Unlike the likelihood function, 
which always improves when new parameters are introduced, the BIC includes a penalty to 
models of greater complexity due to their reduced parsimony and increased risk of overfitting, 
risking coefficients having modelled random error specific to the Whitehall II dataset and 
thereby reducing the generalisability of findings to other samples.  
Likelihood and thereby BIC statistics could not be reported for analyses of imputed data, as the 
final estimates were not drawn from a single model but from identical models applied to 
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multiple different datasets.342 At the time of writing, there was no clear solution to the 
derivation of summary fit statistics for analyses of imputed data.387 Though one group of 
researchers proposed a method by which likelihood statistics could be averaged across 
imputations,388 the package was not compatible with the latest -mi- commands and applicable 
only to a restricted range of regression models (i.e. linear, logistic and ordered logistic).389 
Simpler alternative recommendations included documenting the individual fit statistics for one, 
a sub-sample or all constituent imputation models.387 Due to the time costs involved in 
calculating and storing 50 fit statistics for each statistical model, the mean and range of log-
likelihood and BIC statistics are reported in each case according to just the first three 
imputations.  
7.4.3.3 Proportionality assumption 
Standard survival models operate under an assumption of proportional hazards: that relative 
differences in hazards between categories of volume of alcohol consumption are proportionate 
over time compared to the hazard of the reference group, such that the relative hazard of T2DM 
for a given category is approximately equal at all time points and thus suitable for reporting 
according to a single hazard ratio. This assumption was tested in each sex-specific multivariable-
adjusted model through the inclusion of an interaction between categories of weekly alcohol 
consumption and a linear expression of time. Any violations of proportionality are reported. 
7.4.3.4 Statistical package 
Analyses of observed data were undertaken using the -st- package of commands available in 
Stata 13,390 while results from analyses of imputed data were reported using the -mi- suite.342 
As Stata 13 did not permit the use of imputed diagnosis data due to differences in the predicted 
number of cases and duration of follow-up between imputations, analyses of both observed and 
imputed datasets were both restricted to participants with observed T2DM diagnosis data only. 
Similarly, due to the small number of never and non-current drinkers, it was not possible to 
derive imputed alcohol consumption categories at wave three; no imputation model would 
converge even when the number covariates against which never drinking was predicted were 
drastically reduced. Accordingly, imputed analyses reported in this chapter accounted only for 
attrition due to missing covariate data.  
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7.5 Results 
7.5.1 Descriptive statistics 
A total 5,456 men and 2,434 women provided valid alcohol consumption and T2DM data, with 
a median 20.2 and 20.0 years of follow-up respectively. Of those with valid alcohol consumption 
and T2DM diagnosis data, a total 589 incident cases of T2DM were documented among men 
and 279 cases among women, or 10.8% and 11.5% of the sample. In multivariable-adjusted 
analyses, complete-case data were available for 4,869 men and 2,094 women, among whom 
527 and 247 cases of T2DM were documented. Women appeared to develop T2DM at a slightly 
faster rate over time (p=0.078, Appendix 7.1).  
Notable differences in metabolic risk profile were evident at baseline between those that did 
and did not develop T2DM (Table 7.1). Consistent with findings from the literature review 
reported in Section 2.1.3, those who developed T2DM over the course of the study tended to 
be older, had higher values of BMI, were more likely to have been of Asian ethnicity, have a 
family history of T2DM, poorer self-reported general health, lower physical activity or be of 
lower occupational grade. The same differences were evident within the imputed dataset 
(Appendix 7.2). 
Differences in crude cumulative hazards were present across categories of weekly volume of 
alcohol consumption, particularly among women (men: p=0.090; women: p=<0.001). Male non-
current and never drinkers exhibited the greatest incidence of T2DM over the course of the 
study, with cumulative hazards roughly equivalent among current and infrequent drinkers 
(Appendix 7.3). By contrast, while female current drinkers also had a lower overall incidence of 
T2DM than non-current and never drinkers, cumulative hazards were greatest among those 
defined as infrequent drinkers (Appendix 7.3). For both men and women, the cumulative 
hazards were greatest among those who reported no consumption or a frequency of less than 
one occasion a week over the year preceding baseline interview (Appendix 7.4).  
As might be expected given their higher incidence of T2DM, non-current and never drinkers 
exhibited a worse metabolic risk profile at baseline than current drinkers, with male and female 
abstainers having poorer self-reported general health, lower physical activity, a lower 
occupational grade, a greater proportion of South Asian participants and a higher prevalence of 
family history of T2DM than current drinking categories (Table 7.2). Similarly, differences in the 
baseline characteristics of current drinkers and infrequent drinkers were most pronounced 
among women. Specifically, female infrequent drinkers tended to be older, have a higher BMI, 
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lower occupational grade, lower physical activity, poorer self-reported general health, and a 
greater proportion of South Asian participants and individuals who were out of work for reasons 
such as long-term illness. In all cases, imputed descriptive data were comparable (Appendix 7.5). 
Table 7.1 Baseline characteristics of participants free of T2DM at wave three and with valid follow-up 
data, stratified by sex. Observed data. 
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Table 7.2 Baseline characteristics of participants free of T2DM at wave three and with valid follow-up 
data, stratified by sex and categories of average weekly volume of alcohol consumption. Observed data. 
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7.5.2 Age-adjusted models 
Although sex-specific differences in dose-response were evident from the meta-analysis 
reported in Chapter 3, the presence of such a disparity within Whitehall II was formally tested 
via an interaction was between sex and categories of baseline alcohol consumption. Following 
a likelihood ratio test of age-adjusted models with and without a sex interaction, the interaction 
term was found to provide a statistically significant improvement in fit (p=<0.001). This was 
consistent with results from the earlier meta-analysis and supported the case for the 
stratification of results by sex. 
In age-adjusted analyses, male and female current drinkers showed significantly reduced risks 
of T2DM, relative to never drinkers (Table 7.3). Among men, risks were of a generally consistent 
magnitude across categories of current drinkers, at around a 41-50% reduction. Conversely, 
among women, an inverse dose-response relationship was apparent. Here, risks appeared to 
decline with each categorical increase in consumption, with a hazard ratio lowest among women 
who consumed >150.0 g/week (HR 0.28, 95% CI 0.14-0.58). 
7.5.3 Multivariable-adjusted models 
Adjustment for confounders improved the fit of both models and resulted in substantial 
attenuations to reductions in risk among current drinkers, with all estimates rendered 
statistically non-significant (Table 7.3). Among men, the largest reductions in risk were visible 
among those who reported consuming 0.1-50.0 g/week (HR 0.92, 95% CI 0.53-1.61). Above 
these volumes, risks were higher than the null except for among the heaviest drinkers (>150.0 
g/week), for whom an insubstantial and likely artefactual 1% reduction in risk was observed (HR 
0.99, 95% CI 0.56-1.79). For women, the risk of T2DM remained lowest in the highest drinking 
category, though attenuated from a 73% to a 45% reduction in risk relative to never drinkers 
(HR 0.55, 95% CI 0.24-1.24).  
While not statistically significant, non-current drinkers showed a greater risk than never drinkers 
among both sexes (men: HR 1.38, 95% CI 0.65-2.94; women: HR 1.07, 95% CI 0.48-2.40). Further, 
while the risk of T2DM was marginally lower among male infrequent drinkers (HR 0.95, 95% CI 
0.52-1.73), female infrequent drinkers showed an elevated risk (HR 1.44, 95% CI 0.79-2.62). 
Results from analyses that utilised imputed covariate data showed similar findings, though 
smaller reductions in risk were evident among female current drinkers (Appendix 7.6). 
A sizeable change in dose-response was evident according to whether risks were adjusted only 
for age or all a priori risk factors concurrently. To identify the covariates most responsible for 
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the changes observed, a post-hoc analysis was undertaken for which groups of covariates were 
added in a mutually exclusive fashion: age only; age plus ethnic and genetic factors (ethnicity 
and family history of T2DM); age plus adiposity (BMI); age plus other lifestyle factors (physical 
activity and smoking status); and age plus socio-economic factors (employment status and 
occupational grade). For consistency between models, the post-hoc analysis was restricted to 
the multivariable-adjusted sample in Table 7.3. Among both sexes, the greatest improvement in 
fit is evident following adjustment for BMI and age, relative to age only, while coefficients vary 
markedly between models (Table 7.4).
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Table 7.3 Age and multivariable-adjusted dose-response relationship between categories of average 
weekly volume of alcohol consumption and T2DM, stratified by sex. Observed data. 
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Table 7.4 Iteratively-adjusted dose-response relationship between categories of average weekly 
volume of alcohol consumption and T2DM, stratified by sex. Observed data. 
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7.5.4 Frequency interaction 
When multivariable-adjusted survival models included an interaction between the frequency 
and volume of consumption (Table 7.5), no relationship was observed among men for every 10 
g/week increase in the weekly volume of alcohol intake (HR 1.00, 95% CI 0.99-1.01), while 
women showed a statistically significant 5% reduction in risk for each increment (HR 0.95, 95% 
CI 0.92-0.99). Among both sexes, the dose-response relationship between the volume of 
consumption and T2DM risk did not differ according to drinking frequency (men: p=0.361; 
women: p=0.450), with an interaction term having provided no improvement to the fit of any 
model. Results from analyses of imputed data are reported in Appendix 7.7, and also show no 
significant interaction among men (p=0.653) or women (p=0.324).  
When non-current and infrequent drinkers were included (Appendix 6.8), the dose-response 
relationship was unchanged and interaction terms remained statistically insignificant (men: 
p=0.621; women: p=0.536). Results from analyses that utilised imputed data are reported in 
Appendix 7.9 and were comparable to those obtained from models applied to the observed 
data.  
Given that models of continuous data assumed a linear dose-response relationship between the 
volume of alcohol consumption and T2DM, a range of non-linear transformations were tested 
to explore whether a non-linear association provided a better fit of the underlying data. The 
dose-response relationship was best described by a linear association. 
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Table 7.5 Multivariable-adjusted interaction between a continuous measure of average weekly volume 
of alcohol consumption and drinking frequency, stratified by sex and excluding non-current and 
infrequent drinkers. Observed data. 
 
7.5.5 Proportionality assumption 
In multivariable-adjusted models, the association between categories of average weekly volume 
of alcohol consumption and the risk of T2DM did not vary overall as a function of time among 
men (p=0.820). However, among women, non-proportional hazards were present among very 
light and never drinkers at baseline (p=0.032). As shown in Appendix 7.10, while the risk of T2DM 
was higher among infrequent and very light drinkers than never drinkers at baseline, the 
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Men (n=4,266)
Dose-response by volume
Per 10 g/week increase 1.00 (0.99-1.01) 0.522 0.99 (0.98-1.00) 0.164
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 0.80 (0.58-1.09) 0.151
Difference in dose-response 
by frequency
Daily - - (reference)
Non-daily - - 1.01 (0.99-1.04) 0.361
Log likelihood -3601 -3600
BIC a 7320 7334
Women (n=1,566)
Dose-response by volume
Per 10 g/week increase 0.95 (0.92-0.99) 0.025 0.96 (0.90-1.02) 0.160
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 1.01 (0.47-2.18) 0.980
Difference in dose-response 
by frequency
Daily - - (reference)
Non-daily - - 0.96 (0.87-1.06) 0.450
Log likelihood -988 -1698
BIC a 2078 3519
Model 1 Model 2
Model 1 reported the linear dose-response relationship between volume alcohol consumption 
and T2DM. Model 2 included an interaction term between a continuous measure of volume 
alcohol consumption and whether participants reported drinking alcohol daily or less than 
daily over the year preceding interview. All models adjusted for baseline covariates: age, BMI, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity, 
smoking status. Ethnicity was derived from responses at waves one and five. All  models 
excluded non-current drinkers from the reference level of exposure (0g/week).
aBayesian information criterion.
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magnitude of this difference decreased by around 16-17% with every additional year of follow-
up.  
7.5.6 Drink type 
As shown in Table 7.6, when consumption from each drink type was included concurrently 
within a single multivariable-adjusted model, no difference in linear dose-response was evident 
among male drinkers, as supported by a Wald test of equality between coefficients (p=0.300). 
Among women, reductions in risk were close to statistical significance across all drink types, but 
with the magnitude of reduction per 10 g/week increase in consumption being greatest for beer 
drinkers (HR 0.86, 95% CI 0.74-1.01). Nevertheless, a Wald test indicated no difference in dose-
response by drink type (p=0.460). Results from the imputed dataset were comparable (Appendix 
7.11). Non-linear dose-response associations were explored, but none provided an 
improvement in fit over the linear models. 
Table 7.6 Multivariable-adjusted dose-response relationship between categories of average weekly 
volume of alcohol consumption, drink type and T2DM, stratified by sex. Observed data. 
 
7.6 Summary of results 
Differences in metabolic risk were evident at baseline according to T2DM diagnosis, with those 
that developed the condition being older and more likely to have higher values of BMI, lower 
physical activity, poorer self-reported health, be of a South Asian ethnic background have a 
family history of T2DM than those who were not diagnosed (Table 7.1). Risk factors for T2DM 
were also found to be more common among never and non-current drinkers at baseline, who 
exhibited worse self-reported health, lower physical activity and a greater proportion of South 
Asian participants and family history of T2DM than current drinking categories (Table 7.2). 
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Drink type
Beer (per 10 g/week) 0.99 (0.98-1.00) 0.206 0.86 (0.74-1.01) 0.060
Spirits (per 10 g/week) 1.01 (0.99-1.03) 0.252 0.93 (0.86-1.01) 0.080
Wine (per 10 g/week) 1.00 (0.97-1.02) 0.642 0.96 (0.91-1.01) 0.095
Log likelihood -4166 -1699
BIC a 8468 3521
Men (n=4,869) Women (n=2,094)
Models reported results adjusted for all  a priori covariates: age, BMI, employment status, ethnicity, 
family history of T2DM, occupational grade, physical activity, smoking status. Ethnicity was derived 
from responses at waves one and five. Models also included variables representing the volume of 
each drink type consumed during the week prior to interview. aBayesian information criterion.
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In age-adjusted survival analyses, both male and female current drinkers showed statistically 
significant reductions in the risk of T2DM, relative to never drinkers (Table 7.3). Reductions were 
of greatest magnitude among women, for whom a positive dose-response relationship was 
apparent. Following adjustment for confounding factors, reductions in risk were substantially 
attenuated, with all estimates rendered statistically non-significant (Table 7.3). While point 
estimates among men were all very close to the null, sizeable if non-significant reductions in risk 
were still reported among women at volumes in excess of 50 g/week. Among men, sizeable but 
statistically non-significant elevations in risk were present among non-current drinkers, while 
female infrequent drinkers exhibited the highest risk relative to never drinkers. 
The dose-response relationship between the volume of alcohol consumption and T2DM risk did 
not appear to differ according to the frequency of consumption, with an interaction term 
according to daily or non-daily consumption providing no improvement to the fit of any survival 
model (Table 7.5). Additionally, no evidence was found in support of differences in dose-
response according to the type of alcoholic drink consumed, with no drink type exhibiting a 
statistically significant association with T2DM risk after accounting for the consumption of other 
types of drink (Table 7.11). 
7.7 Limitations 
Analyses based on both the observed and imputed datasets were restricted to T2DM-free 
participants at wave three who had valid T2DM diagnosis data. This necessarily omitted 
individuals who participated at wave three but were absent at all subsequent waves of follow-
up such that their T2DM status could not be ascertained. As indicated in Table 6.5, those who 
did not participate for ≥4 waves had a worse metabolic risk profile than those that participated 
across all waves, indicating that the incidence of T2DM was likely to have been underestimated, 
with analyses applied to a healthier sub-sample of the original cohort.  
Additionally, given that participants with unit non-response across ≥4 waves also reported 
significantly lower volumes of alcohol consumption at wave one than those with complete-case 
data (men: p=<0.001; women: p=<0.001), models were likely to have under-sampled lighter and 
potentially less healthy drinkers. Although attempts were made to impute missing alcohol 
consumption data, the small number of observed never drinkers was such that an imputation 
model would not successfully converge. Analyses of both the observed and imputed datasets 
therefore excluded participants with missing alcohol consumption data. Taken together, there 
was a possibility that the risk of T2DM associated with lower volumes of alcohol may be 
underestimated. 
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By using a small, strictly-defined reference category, it was possible that statistical power was 
low, impairing the ability to detect differences in risk between exposed and unexposed 
categories. To explore this further, post-hoc power calculations were undertaken for the 
detection of differences in hazards between never drinkers and participants in the lowest 
current drinking category (0.1-50 g/week). Sex-specific survival probabilities and sample sizes 
across the two categories were used to calculate the power to detect a 20% reduction in hazards 
at a 0.05 level of significance if such a difference were present. Statistical power measured 0.59 
among men and 0.39 among women, or a 41% and 61% probability of failing to detect a 20% 
difference in the hazard ratio. Contrary to expectation, however, the inclusion of non-current 
drinkers within the abstention reference category was likely to have done little to remedy the 
issue. Specifically, statistical power fell to 0.56 among male participants and rose to 0.44 among 
female participants when non-current drinkers were combined with never drinkers. These 
oppositional changes in power were attributed to sex-specific differences in the survival 
probabilities of never and non-current drinkers such that, when combined, the male pooled non-
drinking survival probability was drawn closer to that of the current drinking comparison group, 
while the female abstention survival probability was drawn further away. Despite the limited 
statistical power of categorical comparisons, dose-response relationships could nonetheless be 
visually examined by referred to point estimates reported across categories of alcohol 
consumption. 
The breadth of consumption categories was limited by the positive skewness of the volume at 
which alcohol was consumed within the Whitehall II cohort, with the top categories necessarily 
defined as any consumption >150.0 g/week among men and >100.0 g/week among women. As 
such, any increased risk of T2DM as commonly seen among heavier drinkers was likely diluted 
within the top category by a large number of relatively moderate drinkers. This was especially 
likely among women, where the median consumption within the highest category was just 134.3 
g/week (IQR 110.6, 165.9), or a little over one pint of 4% ABV lager per day.11 Among men, 
median intake within the top consumption category was 221.2 g/week (IQR 173.8, 292.3). By 
capturing relatively few heavier drinkers, alcohol consumption data within Whitehall II was likely 
to have been inadequate for the detection of increases in risk at higher volumes of consumption, 
as otherwise reported by previous publications. This was further indicated by the lack of 
improvement to model specification when non-linear associations were tested (Section 7.5.3).  
Adding to this issue was the possibility that the volume of alcohol consumption may have been 
subject to some degree of inaccuracy, with self-reported data limited by various reporting and 
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recall biases as well as measurement error.391,392 The issue of recall bias was posited to have 
been small, with the reliability of recall over seven-day periods found to be better than over 
longer retrospective episodes.393 Reporting biases were expected to have been a larger problem, 
though the magnitude, direction and determinants of any such bias appeared variable and 
multifaceted,391 negating any real conclusion as to the degree to which reported results may 
have been under- or overestimated on average. Nevertheless, in one study that investigated the 
accuracy of participant self-reports, measures were increasingly reliable within older age 
categories, with no apparent difference between the sexes.394 Accordingly, the accuracy of self-
reported alcohol consumption data was posited to have improved over time as the constituent 
sample grew older.  
A further issue concerned the reliability of quantity-frequency questionnaires for the estimation 
of alcohol consumption. Adopted within Whitehall II, such questionnaires have tended to 
produce lower drinking estimates than alternative graduated frequency questionnaires, which 
ask participants to estimate the frequency with which they consumed alcohol at pre-specified 
volumes.391 In this regard, reported volumes of alcohol consumption may have been 
underestimated.  
7.8 Discussion 
Age-adjusted analyses reported in Table 7.3 indicate a statistically significant reduction in the 
risk of T2DM across nearly all categories of current drinking, relative to never drinkers. Among 
men, the magnitude of such reductions were roughly equivalent at all levels of consumption, at 
around 50%, while risks among women declined with each categorical increase in consumption. 
Consistent with results from the updated meta-analysis (Figure 3.8) and other studies,395 less 
pronounced dose-response associations were evident following adjustment for confounding 
factors (Table 7.3). Although all coefficients were rendered non-significant, it was possible that 
attenuated risk estimates were of magnitudes no longer sufficient to be detected as significant 
owing to low statistical power.  
Looking instead to the point estimates reported by the multivariable-adjusted models, male and 
female non-current drinkers showed a greater risk of T2DM than never drinkers (Table 7.3), 
potentially supporting the case for having excluded former drinkers from any categorical 
abstention category. These elevated risks were greatest among men, suggesting that male 
former drinkers may be less healthy and more likely to have previously been heavy drinkers than 
their female equivalents. Infrequent drinkers exhibited the highest risk of T2DM among women 
(Table 7.3), calling into question claims that infrequent drinkers may represent a more 
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appropriate reference group than never drinkers. In keeping with previous research,96,97,239 such 
an elevated risk might be expected were such women predominantly episodic heavy drinkers. 
By contrast, male infrequent drinkers showed little difference in risk, relative to never drinkers.  
Among male current drinkers, multivariable-adjusted estimates were close or equal to the null. 
By contrast, female point estimates indicated an inverse relationship between the volume of 
alcohol consumption and T2DM risk. That reductions in risk may have been specific to women 
was in accordance with results from the updated meta-analysis (Figures 3.4 and 3.6), with sex-
specific effects and a heightened risk among non-current drinkers both supporting hypotheses 
laid out at the beginning of the chapter. 
As reported in Table 7.5, no difference in dose-response was detected according to whether 
participants consumed alcohol on a daily or non-daily basis, with effect sizes of negligible 
magnitude. It was possible that the choice of interaction variable represented a poor 
parameterisation of consumption pattern, failing to truly reflect episodic heavy drinking 
occasions. However, even if sufficient data were available as to permit the identification of 
episodic heavy drinkers, it was possible that the number of such individuals may be insufficient 
to detect an interaction. While the prevalence and odds of excessive episodic heavy drinking 
appear greatest within younger men and adults of lower socio-economic status or 
neighbourhood deprivation,396,397 Whitehall II predominantly samples middle-aged adults of 
higher socio-economic status. With an interaction between the volume and frequency of 
consumption either not present, undetectable or incorrectly specified, analyses in subsequent 
chapters would forgo any secondary analysis of differences in dose-response according to 
reported consumption frequency. 
The body of current evidence seems to suggest that reductions in risk may be specific to or at 
least most pronounced among wine drinkers398 – an effect hypothesised to be conferred through 
the effect of anti-inflammatory compounds common to fruit-based drinks.280,281 However, when 
the average weekly volume of alcohol consumption from each drink type was modelled 
concurrently, no statistically significant difference in the dose-response relationship was found 
between drink types for either sex. Of the effect estimates reported, there was a weak indication 
that beer may be the most strongly associated with a reduction in T2DM risk among women, 
contrary to other observational studies. While recent publications suggest the beer-specific 
compound xanthohumol may have an anti-inflammatory effect, preliminary results are currently 
only available from in vitro399 or in vivo animal studies.400 It was possible that the absence of any 
significant difference in dose-response by drink type may have been a consequence of having 
Chapter 7: A preliminary conventional survival analysis  
191 
 
constrained the models to report linear dose-response associations with T2DM, masking 
reductions in risk at very low or moderate volumes as a consequence of increases in risk at higher 
levels of intake. However, as with total volume in Section 7.5.4, transforming consumption from 
each drink type according to a range of fractional powers provided no improvement in fit relative 
to a standard linear survival model.  
Concordance between the conventional survival analysis and findings from the updated meta-
analysis suggest that Whitehall II represents a cohort suitable for further investigating the 
relationship between alcohol consumption and T2DM. Before constructing survival models 
capable of accounting for changes to consumption over time, the following chapter first explores 
the stability of alcohol intake across the life course and whether longitudinal trajectories differ 
by T2DM diagnosis. 
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8 Trajectories of alcohol consumption 
8.1 Introduction 
Having established the suitability of Whitehall II for exploring the relationship between the 
alcohol consumption and T2DM within a conventional survival framework, this chapter begins 
by describing whether drinking among men and women within the cohort was constant over 
time. With survival analyses having almost exclusively modelled T2DM risk according to a single 
cross-sectional measure of consumption, this chapter goes on to report the longitudinal drinking 
trajectory as stratified according to categories of baseline alcohol consumption. Such analyses 
will help to highlight the degree of any potential misclassification error that may be inherent to 
a conventional survival approach, and thereby the validity of results reported by such analyses. 
In conflict with findings from Mendelian randomisation studies,85 results from the revised meta-
analysis of current observational studies (Chapter 3) and a preliminary survival analysis of 
Whitehall II data (Chapter 7) show a significant and sex-specific dose-response relationship 
between alcohol consumption and T2DM. Despite observational research indicating reductions 
in risk among female moderate drinkers and increases in risk at high volumes of consumption 
among both sexes, little is currently known about how drinking changes over time among those 
that do and do not develop T2DM. Accordingly, this chapter also reports the longitudinal 
trajectory of alcohol consumption as stratified by sex and T2DM diagnosis. These results will 
help shed light upon whether any increases or reductions in risk as reported by current survival 
analyses were likely to have accrued gradually over the life course as a result of prolonged heavy 
or moderate consumption, or occurred as a consequence of differences in intake specific to 
periods of heightened biological sensitivity.401 For instance, given apparent deteriorations to the 
alcohol metabolism with increased age,196,197,198,199 older age may represent a period of the life 
course in which alcohol consumption may have particularly manifest effects upon T2DM risk. 
8.2 Objectives 
The objectives of this chapter are thus to: 
 Determine whether sex-specific trajectories of the mean weekly volume of alcohol 
consumption were constant over the captured adult life course. 
 Report the longitudinal stability of alcohol consumption within categories defined 
according to baseline intake. 
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 Describe the nature of any differences in the longitudinal trajectory alcohol 
consumption according to whether or not participants develop T2DM. 
8.3 Hypotheses 
Based on existing research that combined longitudinal measures of alcohol consumption from 
multiple cohorts,266 it was expected that the mean volume of alcohol consumption would peak 
around middle-age before gradually declining thereafter. When stratified according to baseline 
drinking categories, it was further hypothesised that any decreases in consumption would be 
most pronounced among heavier baseline drinkers, with non-drinkers representing the most 
stable baseline category. This supposition was based on results from the Health Professionals 
Follow-up Study, which reported changes in alcohol consumption over a four-year period.267 
Here, study participants were split into three categories according to their alcohol consumption 
at baseline, representing non-drinkers (0 g/week), moderate drinkers (<105.0 g/week) and 
heavier drinkers (>105.0 g/week). Stability was greatest among non-drinkers, among whom 
93.4% maintained their abstention over the period. By contrast, stability was lowest among 
heavier drinkers, with 55.8% having reduced their consumption over time.  
Regarding differences in the trajectory of alcohol consumption according to the diagnosis of 
T2DM, a number of plausible differences were hypothesised: 
 Firstly, if the risk of T2DM accumulates over time as a result of chronic heavy drinking, 
the trajectory of alcohol consumption among those who developed T2DM would have 
been consistently or else predominantly higher on average than among those that did 
not develop the condition, as illustrated in Figure 8.1a. Similarly, with reductions in risk 
apparent at more moderate volumes among women (Chapter 3), it was posited that 
women without T2DM would exhibit a markedly lower volume of consumption over 
time. 
 Secondly, given evidence indicating deteriorations to the alcohol metabolism with 
increased age,196,197,198,199 older age may represent a period during which any deleterious 
effect of alcohol consumption upon T2DM risk may be particularly pronounced. Under 
this alternative assumption, and with the incidence of T2DM greatest in older age,402 
there was a possibility that any disparity in drinking between those that do and do not 
develop the condition may be greatest during a period immediately preceding diagnosis, 
such as per the example illustrated in Figure 8.1b. Specifically that, regardless of 
differences in alcohol consumption earlier in the trajectory, the average volume of 
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alcohol intake would be greatest among those who developed the condition in the few 
years prior to diagnosis. 
 Finally, with a growing number of studies linking the onset of ill-health to a subsequent 
cessation or attenuation of alcohol consumption,144,145,146,141 participants who 
developed T2DM may exhibit a marked decline in their consumption in line with a 
gradual deterioration in health status prior to diagnosis (Figure 8.1c). Such a downward 
trajectory may represent either a proactive attempt by participants to improve their 
health, or else a response to medical advice or pharmaceutical contraindication 
following a diagnosis of impaired glucose tolerance or other T2DM risk factors such as 
obesity and high blood pressure.  
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Figure 8.1 Hypothesised differences in average alcohol consumption trajectory according to T2DM 
diagnosis 
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8.4 Methods 
8.4.1 Sample 
8.4.1.1 Prospective trajectories of mean weekly volume of alcohol consumption 
To model the mean trajectory of alcohol consumption, the sample was defined as any 
participant who reported their volume of alcohol consumption in the week prior to interview at 
any point over the course of study since its inception (wave one). Concerned solely with 
describing changes to the volume of alcohol consumption with increased age, participants were 
included irrespective of T2DM diagnosis.  
8.4.1.2 Trajectories of mean weekly volume of alcohol consumption by T2DM diagnosis 
Exploring differences in the trajectory of alcohol consumption according to the development of 
T2DM, the sample was defined as any participant free of prevalent T2DM at wave three and 
who reported their volume of alcohol consumption in the week prior to interview at any point 
over the course of the study since its inception and also participated in at least one clinical 
examination after wave three such that their diagnosis status could be established.  
8.4.2 Variables 
8.4.2.1 Alcohol consumption 
Alcohol consumption was captured as described in Section 6.3 and treated as a continuous 
variable. Participants who consumed 0 g/week in the week prior to interview thus comprised an 
assortment of never, non-current (former) and infrequent drinkers. No distinction between 
these groups was made in primary analyses that plotted the mean drinking trajectory. If a sick 
quitter effect were present within the data, evidenced by a decline in consumption over time, 
then the exclusion of non-current or infrequent drinkers would risk an underestimation of any 
downward trajectory. 
In secondary analyses that stratified the alcohol consumption trajectory according to drinking 
categories defined at wave one, the stratification variable was coded as per section 7.4.2.1. 
Never drinkers and non-current drinkers were combined into a single category owing to the 
absence of questions sufficient for disaggregating the two non-drinking groups at wave one.  
Due to the inherent variation of imputed data, between-imputation differences were present 
when allocating participants to baseline consumption categories when alcohol consumption 
data were missing. Accordingly, it was inappropriate to stratify longitudinal alcohol consumption 
trajectories by baseline consumption category when imputed alcohol data were used. Analyses 
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of the imputed dataset were thus restricted to participants with observed measures of baseline 
consumption, with models then capitalising upon imputed repeated measures of volume of 
alcohol consumption across waves. 
8.4.2.2 T2DM 
As documented in Section 6.4, cases of T2DM were defined according to any self-reported 
doctor diagnosis or self-reported use of hypoglycaemic medication, or a positive FPG result 
following clinical examination. Wave three was the first period of observation for which both 
subjective and objective measures were available, and thus represented the wave at which 
prevalent cases were identified and excluded. 
8.4.3 Statistical analysis 
8.4.3.1 Prospective trajectories of mean weekly volume of alcohol consumption 
Seeking to explore how alcohol consumption changed over the life course, age in years was 
selected as the timescale of interest for this subset of analyses. Age was defined according to 
the date on which the self-administered questionnaire was completed. In instances where no 
such date was documented, the date of clinical examination was used. Where both dates were 
undocumented, the mean wave-specific date of self-administered questionnaire completion 
was assumed.  
8.4.3.1.1 Linear mixed effects models 
Although trajectories of alcohol consumption could have been calculated using a standard 
regression model, this approach treats repeated measures as a series of unique and 
independent data points, leading to an overestimation of precision.403 Accordingly, consumption 
trajectories were calculated using mixed effects models, which nest repeated measures within 
participants. This inflates standard errors proportionate to the magnitude of correlation 
between repeated measures, with degrees of freedom calculated according to the number of 
participants as opposed to the number of data points. The resulting random intercept model is 
expressed in general terms per Formula 8.1, with the subscript i denoting the participant and 
the subscript j denoting the repeated measure: 
yi(tij)=(β0+b0i)+(β1)tij+εij 
Formula 8.1 Calculation of a linear random intercept model 
The true predicted value of weekly alcohol consumption at the age of the jth measurement for 
the ith participant is therefore calculated as the estimated mean intercept (β0) plus a random 
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effect denoting the participant’s predicted deviation from the mean intercept value (b0i), with a 
fixed slope (β1(tij)) that equates to the estimated mean rate of change in alcohol consumption 
per unit of age. Random error was denoted by εij, representing any remaining variation in alcohol 
consumption not explained by the model. The resulting random intercept model is illustrated in 
Figure 8.2a. 
As shown in Figure 8.2a, although the nesting of repeated measures allows each participant their 
own intercept value, slopes are constrained and therefore parallel to the mean trajectory. With 
existing research indicating a variety of slopes,259 the assumption that any change in alcohol 
consumption was equal between participants was unlikely to reflect reality. 
To capture any underlying differences in slopes between participants, a random slopes model 
was also constructed, which allowed each participant to exhibit their own rate of change in 
alcohol consumption per year increase in age. This was achieved by adding a random effects 
term to the fixed mean slope coefficient, which denotes the predicted deviation of each 
participant-specific slope from the mean slope (b1i(tij)). The resulting random slopes model is 
expressed per Formula 8.2, and illustrated in Figure 8.2b. 
yi(tij)=(β0+b0i)+(β1+b1i)tij+εij 
Formula 8.2 Calculation of a linear random slopes model 
An unstructured covariance matrix was specified for the random slopes models, which allowed 
the within-participant covariance between the intercept and repeated measures to take any 
form.  
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Figure 8.2 An illustration of random intercept and random slopes models 
8.4.3.1.2 Non-linear mixed effects models 
Although the random slopes model permitted individual-level variation in the rate of change, 
shifts in alcohol consumption with increased age were assumed to be linear. Owing to the 
possibility that changes over the life course may have been non-linear, age was subjected to a 
series of polynomial transformations as per the methods outlined in Section 3.2.4.1. The fit of 
each non-linear model was then compared against that of the linear model. Where trajectories 
were better explained by a non-linear slope, the output of any such models were reported.  
8.4.3.1.3 Stability of baseline categories 
To explore the longitudinal stability of drinking within baseline categories of alcohol 
consumption, an interaction term was included between the rate of change and the baseline 
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category of alcohol consumption. Where a significant interaction was identified, trajectories of 
were stratified according to categories of baseline intake. These analyses were undertaken using 
fixed slope models due to a lack of variation between repeated measures when nested within 
baseline categories. This may have been attributable to a real lack of individual-level variation 
in the rate of change among participants within the same baseline category, or a consequence 
of stratified sample sizes being too small to achieve numerical integration.  
8.4.3.2 Trajectories of mean weekly volume of alcohol consumption by T2DM diagnosis 
Participants were separated into two groups according to whether or not they developed T2DM 
over the course of the study. The period of observation began at the date of diagnosis for those 
who developed T2DM, or the final date of participation for those who did not, and in each cases 
coded as year zero. For each participant the volume of alcohol consumption was then traced 
backwards to the very first reported measure. A time of -15 years thus represented a measure 
of alcohol consumption that was taken 15 years prior to diagnosis or censoring from the study. 
As the number of participants predicted to have developed T2DM over the course of the study 
varied between imputations, analyses applied to the imputed dataset were restricted to 
participants with observed T2DM diagnosis data such that the number of participants remained 
static between imputations.342  
8.4.3.2.1 Linear mixed effects models 
Using methods described in Section 8.4.3.1.1, sex-specific trajectories were first calculated using 
linear mixed effects models with an interaction between T2DM diagnosis and time. Both fixed 
and random slopes were estimated, with results reported from the best-fitting model.  
8.4.3.2.2 Non-linear mixed effects models 
As per section 8.5.1.3, a number of non-linear trajectories were also explored. In this series of 
comparisons, transformations were restricted to quadratic and cubic exponents due to 
limitations concerning the range of transformations that can be applied to negative values of 
time. This was consistent with previous research.404,405 When calculating fit statistics for each 
non-linear mixed effects model, fixed slopes were assumed owing to issues of convergence 
when random slopes were expressed for some transformations. Results from the best-fitting 
models were reported allowing for random slopes. 
8.4.3.2.3 Sick-quitter effects 
Secondary analyses were undertaken to calculate the trajectory of alcohol consumption 
following diagnosis. These models were constructed in a piecewise manner, with models 
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constructed separately for consumption data prior to and after the date of diagnosis. Non-linear 
trajectories were explored in each instance as per the methods in section 8.5.1.3. 
8.4.3.2.4 Stability of baseline categories 
Finally, the longitudinal stability of alcohol consumption within baseline categories was explored 
per the methods outlined in Section 8.4.3.1.4.  
8.4.3.3 Goodness of fit 
Goodness of fit was reported according to the log-likelihood and BIC statistics, as described in 
Section 7.4.3.2. An improvement in fit was defined as any reduction in the BIC greater than or 
equal to a value of 10.406 
8.4.3.4 Statistical package 
Mixed models were calculated in Stata 13 using the -mixed- package.407 As per the conventional 
survival analysis reported in Chapter 7, robust Huber-White standard errors were utilised for the 
calculation of confidence intervals due to the positive skewness of the alcohol consumption 
variable in its natural form. Although the volume of intake could have been transformed, this 
would have complicated interpretation and the communication of results to general audiences.  
8.5 Results 
8.5.1 Prospective trajectories of mean weekly volume of alcohol consumption 
8.5.1.1 Descriptive statistics 
The weekly volume of alcohol consumption was measured across 31,342 person-observations 
among men and 13,765 person-observations among women, as reported by 6,882 and 3,402 
participants respectively across a mean 4.6 and 4.0 waves. Within the imputed dataset, alcohol 
consumption was captured across 39,160 person-observations among men and 19,305 person-
observations among women, representing 6,895 and 3,413 women across a mean 5.7 waves. 
The age of participants ranged from 34.1-83.6 years, capturing almost 50 years of the adult life 
course over the period of study. 
8.5.1.2 Linear trajectories 
Random slopes models best described the observed (Table 8.1) and imputed (Appendix 8.1) 
linear trajectory of alcohol consumption across the captured life course for both men and 
women. Covariance between the random intercepts and random slopes was negative, indicating 
a convergence of trajectories with increased age. 
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Table 8.1 Crude sex-specific linear trajectory of mean weekly volume of alcohol consumption between 
the ages of 34-84 years: goodness of fit statistics. Observed data. 
 
To confirm the suitability of stratifying drinking trajectories by sex, linear models were run with 
and without a sex interaction with age. The interaction term provided a statistically significant 
improvement in model specification (p=<0.001), supporting the case for sex stratification. As 
reported in Table 8.2, consumption at baseline was estimated as 110.5 g/week (95% CI 107.2-
113.8) among men and 48.5 g/week (95% CI 46.0-51.0) among women, falling by an average 2.8 
(95% CI 1.8-3.9) g/week and 2.2 (95% CI 1.5-3.0) g/week respectively per 10-year increase in 
age.  
Intercept values were slightly higher within the imputed dataset among both sexes, with a 
steeper rate of decline reported among men than evident within the observed dataset 
(Appendix 8.2). Among women, the rate of change was so small as to be rendered statistically 
insignificant (p=0.352). Plotted linear trajectories from analyses of the observed dataset are 
shown in Figure 8.3, with trajectories based upon the imputed dataset reported in Appendix 8.3. 
  
Linear mixed models Log-likelihood BIC
a
Men
Intercept only -184343 368717
Linear mixed model, fixed slopes -184318 368678
Linear mixed model, random slopes -184042 368146
Women
Intercept only -72552 145133
Linear mixed model, fixed slopes -72531 145100
Linear mixed model, random slopes -72500 145057
Fit statistics
aBayesian information criterion.
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Table 8.2 Crude sex-specific linear and non-linear trajectories of mean weekly volume of alcohol 
consumption between the ages of 34-84 years. Observed data. 
 
 
  
Mixed models g/week (95% CI) p-value
Men (n=6,882)
Linear model
Intercept 110.5 (107.2, 113.8) <0.001
Age -2.8 (-3.9, -1.8) <0.001
Non-linear model
Intercept 91.8 (90.0, 95.7) <0.001
Age1 12.2 (10.1, 14.4) <0.001
Age3 -0.9 (-1.0, -0.8) <0.001
Women (n=3,402)
Linear model
Intercept 48.5 (46.0, 51.0) <0.001
Age -2.2 (-3.0, -1.5) <0.001
Non-linear model
Intercept 45.4 (43.4, 47.4) <0.001
lnAge 3.5 (1.7, 5.3) <0.001
Age3 -0.2 (-0.3, -0.2) <0.001
Age coefficients refer to the change in the average volume of weekly alcohol 
consumption per 10-year increase in age.
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Figure 8.3 Crude sex-specific linear trajectories of mean weekly volume of alcohol consumption 
between the ages of 34-84 years. Observed data. 
8.5.1.3 Non-linear trajectories 
A range of non-linear slopes were explored, with fit statistics for each non-linear transformation 
reported in Appendices 8.4 and 8.5. When applied to both the observed and imputed datasets, 
non-linear slopes were found to provide a substantial improvement in fit over the linear models. 
Coefficients from the best-fitting non-linear models are documented in Table 8.2 for the 
observed dataset and Appendix 8.2 for the imputed dataset, with trajectories plotted in Figure 
8.4 and Appendix 8.6 respectively. 
Within the observed dataset, the volume of alcohol consumption was consistently highest 
among men. The mean weekly volume of alcohol consumption increased up to around 56 years 
of age among men and 51 years of age among women, peaking at 110 g/week (95% CI 107-112) 
and 46 g/week (95% CI 44-48) respectively (Figure 8.4). Beyond 56 and 51 years of age, the mean 
volume of alcohol consumption steadily declined, falling to 49 g/week (95% CI 43-55) among 
men and 23 g/week (95% CI 19-26) among women by the age of 83.5 years (Figure 8.4). Analyses 
based upon the imputed dataset reported higher volumes of alcohol consumption, measuring a 
peak of 114 g/week (95% CI 111-117) among men aged 55 years and 52 g/week (95% CI 50-55) 
among women aged 59 years, before falling to 63 g/week (95% CI 57-68) among men and 28 
g/week (95% CI 24-33) among women by the age of 83.5 years (Appendix 8.6). 
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Figure 8.4 Crude sex-specific non-linear trajectories of mean weekly volume of alcohol consumption 
between the ages of 34-84 years. Observed data. 
8.5.1.4 Stability of baseline categories 
As reported in Table 8.3 and shown in Figure 8.5, significant differences in the longitudinal slope 
were identified according to the category of intake at baseline, with similar trends apparent in 
both sexes. Specifically, slopes between baseline categories tended to converge with increased 
age, whereby participants in higher categories exhibited downward longitudinal trajectories and 
those in lower baseline categories exhibited upward or stable slopes over the period, on 
average.  
Among both men and women, changes over the captured life course were most pronounced 
within the highest baseline category. Relative to the rate of change among non-drinkers, 
consumption within the highest baseline category fell by an average 29.7 g/week among men 
and 20.1 g/week among women for every 10 year increase in age. Increases were greatest 
among infrequent drinkers, whose drinking rose by 8.7 g/week and 3.1 g/week respectively per 
10 year increase in age, relative to non-drinkers. However, this rise may have been a 
consequence of such participants having consumed alcohol more frequently with advancing age 
such that their drinking was more likely to have been captured by the quantity-frequency 
questionnaire at each successive wave (Table 6.2). The only stable baseline category was female 
light drinkers (0.1-50.0 g/week), who showed no statistically significant change in alcohol 
consumption with increased age, relative to pooled non-drinkers. Although drinking declined 
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among women defined as more moderate drinkers at baseline (50.1-100.0 g/week), this 
equated to a mere 2.6 g/week change per decade, relative to non-drinkers. As such, light and 
moderate baseline consumption categories appeared largely stable over the period of the life 
course captured by the Whitehall II study. 
Results based upon the imputed dataset were similar, with decreasing consumption evident 
within higher baseline categories and increasing consumption within lower baseline categories 
(Appendices 8.7 and 8.8). Interestingly, analyses applied to the imputed dataset indicate an 
increase in alcohol consumption among pooled non-drinkers equal to an average 5.9 g/week 
(95% CI 4.2-7.6) among men and 5.2 g/week (95% CI 3.8-6.6) among women, suggesting that 
some former or never drinkers with missing data were predicted to resume or take up drinking 
alcohol as they aged. 
Given that participants varied between 35 and 55 years of age at the time that baseline 
categories were defined, and with marked differences in alcohol consumption reported by age 
group in Sections 2.2.1 and 8.5.1.5, there was a possibility that some of the difference in 
longitudinal trajectories may have been attributable to disparities in the age of participants 
within each baseline category. A post-hoc sensitivity analyses was thus undertaken which re-ran 
the mixed effects models with adjustment for differences in age at baseline, parameterised as 
dates of birth. Adjustment for birth date provided no improvement in the fit of either sex-
specific model, and altered intercept and slope coefficients only by fractions of a g/week. The 
effect of any difference in age at baseline within each category was thus considered negligible.  
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Figure 8.5 Crude sex-specific linear trajectories of mean weekly volume of alcohol consumption 
between the ages of 34-84 years, stratified by baseline alcohol consumption category. Observed data. 
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Table 8.3 Crude sex-specific interaction between the trajectory of mean weekly volume of alcohol 
consumption and baseline alcohol consumption category. Observed data. 
 
8.5.2 Trajectories of mean weekly volume of alcohol consumption by T2DM diagnosis 
8.5.2.1 Descriptive statistics 
Of the 10,308 individuals originally enlisted at baseline, 8,815 participated at wave three. Among 
these, 250 prevalent cases were documented and thus excluded. A total 5,723 T2DM-free men 
and 2,570 T2DM-free women survived to and participated in at least one subsequent wave such 
that incident diagnosis status could be determined. After excluding repeated measures of 
alcohol consumption recorded after the date of diagnosis, plus one female participants who did 
not provide a measure of alcohol consumption for at least one wave prior to their date of 
Linear mixed models Sample n g/week (95% CI) p-value
Men
Difference in baseline consumption by drinking category
Non-drinker 220 Reference
Infrequent drinker 669 0.7 (-2.4, 3.9) 0.651
0.1-50.0 g/week 2,073 30.3 (27.8, 33.0) <0.001
50.1-100.0 g/week 1,432 76.5 (72.5, 80.4) <0.001
100.1-150.0 g/week 881 131.6 (127.3, 125.9) <0.001
>150.0 g/week 1,563 286.6 (278.5, 294.7) <0.001
Difference in the rate of change by drinking category
Non-drinker Reference
Infrequent drinker 8.7 (6.8, 10.5) <0.001
0.1-50.0 g/week 6.2 (4.9, 7.5) <0.001
50.1-100.0 g/week 4.5 (2.2, 6.8) <0.001
100.1-150.0 g/week -2.7 (-5.0, -0.4) 0.020
>150.0 g/week -29.7 (-32.8, -26.6) <0.001
Women
Difference in baseline consumption by drinking category
Non-drinker 216 Reference
Infrequent drinker 764 1.0 (-0.7, 2.6) 0.256
0.1-50.0 g/week 1,428 29.3 (27.5, 31.2) <0.001
50.1-100.0 g/week 542 76.2 (72.7, 79.6) <0.001
>100.0 g/week 422 176.5 (167.3, 185.7) <0.001
Difference in the rate of change by drinking category
Non-drinker Reference
Infrequent drinker 3.1 (1.9, 4.2) <0.001
0.1-50.0 g/week -0.0 (-1.2, 1.1) 0.936
50.1-100.0 g/week -2.6 (-4.8, -0.4) 0.019
>100.0 g/week -20.1 (23.6, 16.6) <0.001
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censoring or diagnosis, this left an analytic sample of 5,723 men and 2,569 women with 27,711 
male person-observations and 11,734 female person-observations over a mean 4.8 waves. 
Participants were observed over a median 9.5 years for both sexes, up to a maximum of 28.0 
years among men and 27.9 years among women. In total, 620 men and 296 women developed 
T2DM over the period. 
Participants who developed T2DM exhibited a worse metabolic profile at wave one than those 
who did not develop the condition (Table 8.4), with a greater proportion of such participants 
being physically inactive, of South Asian ethnicity, a lower occupational grade and having a 
family history of T2DM as well as a higher BMI and more advanced age. In terms of alcohol 
consumption behaviour, women who developed T2DM reported a lower volume of weekly 
alcohol consumption at baseline. Imputed descriptive statistics were comparable (Appendix 
8.9).  
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Table 8.4 Baseline characteristics of T2DM-free participants, stratified by T2DM diagnosis. Observed 
data. 
  
 
T2DM Censored
Variables (wave one)
% (95% CI)
n
% (95% CI)
n Difference
a
Men
Age
Mean years 45.0 (44.6, 45.5)b
620
44.4 (44.2, 44.6)b
5,103
0.013
Alcohol consumption frequency
None in past year 4.4 (3.0, 6.3)
27
2.6 (2.2, 3.1)
132
0.028
<1/week 21.8 (18.8, 25.3)
135
19.7 (18.6, 20.8)
1,001
1-3 times/week 40.3 (36.5, 44.2)
249
43.7 (42.3, 45.0)
2,223
Daily or almost daily 33.5 (29.9, 37.3)
207
34.1 (32.8, 35.4)
1,734
Alcohol consumption volume
Median g/week 98.8 (89.8, 107.8)c
617
101.5 (98.5, 104.6)c
5,067
0.570
BMI
Mean kg/m2 26.1 (25.8, 26.3)b
619
24.3 (24.2, 24.4)b
5,094
<0.001
Ethnicty
White 84.8 (81.8, 87.5)
526
94.6 (93.9, 95.2)
4,815
<0.001
South Asian 11.8 (9.5, 14.6)
73
3.4 (3.0, 4.0)
175
Otherd 3.4 (2.2, 5.1)
21
2.0 (1.6, 2.4)
101
Family history of T2DM
Yes 81.1 (77.8, 84.1)
495
91.2 (90.4, 91.9)
4,589
<0.001
No 18.9 (15.9, 22.2)
115
8.8 (8.1, 9.6)
444
Occupational grade
Administrative (top) 35.0 (31.3, 38.9)
217
41.3 (39.9, 42.6)
2,106
<0.001
Professional (middle) 54.0 (50.1, 57.9)
335
52.1 (50.7, 53.4)
2,657
Clerical (bottom) 11.0 (8.7, 13.7)
68
6.7 (6.0, 7.4)
340
Physical activitye
Inactive 12.4 (10.0, 15.2)
76
8.1 (7.4, 8.9)
410
<0.001
Below guidelines 40.1 (36.2, 44.0)
246
37.4 (36.1, 38.8)
1,892
Met guidelines 47.6 (43.6, 51.5)
292
54.5 (53.1, 55.8)
2,753
Smoking
Never 42.0 (38.1, 45.9)
258
49.8 (48.5, 51.2)
2,525
<0.001
Former 39.3 (35.6, 43.3)
242
36.4 (35.1, 37.7)
1,845
Current 18.7 (15.8, 22.0)
115
13.8 (12.8, 14.7)
697
Women
Age
Years 46.7 (46.0, 47.4)b
296
45.3 (45.1, 45.6)b
2,274
<0.001
Alcohol consumption frequency
None in past year 9.5 (6.6, 13.4)
28
5.7 (4.8, 6.7)
128
<0.001
<1/week 51.4 (45.6, 57.0)
152
35.4 (33.4, 37.4)
801
1-3 times/week 28.7 (23.8, 34.2)
85
36.6 (34.6, 38.6)
829
Daily or almost daily 10.5 (7.4, 14.5)
31
22.4 (20.7, 24.1)
507
Alcohol consumption volume
g/week 29.4 (23.3, 35.5)c
296
46.9 (44.4, 49.4)c
2,247
<0.001
BMI
kg/m2 28.0 (27.4, 28.6)b
296
24.2 (24.0, 24.3)b
2,273
<0.001
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Smoking
Never 42.0 (38.1, 45.9)
258
49.8 (48.5, 51.2)
2,525
<0.001
Former 39.3 (35.6, 43.3)
242
36.4 (35.1, 37.7)
1,845
Current 18.7 (15.8, 22.0)
115
13.8 (12.8, 14.7)
697
Women
Age
Mean years 46.7 (46.0, 47.4)b
296
45.3 (45.1, 45.6)b
2,274
<0.001
Alcohol consumption frequency
None in past year 9.5 (6.6, 13.4)
28
5.7 (4.8, 6.7)
128
<0.001
<1/week 51.4 (45.6, 57.0)
152
35.4 (33.4, 37.4)
801
1-3 times/week 28.7 (23.8, 34.2)
85
36.6 (34.6, 38.6)
829
Daily or almost daily 10.5 (7.4, 14.5)
31
22.4 (20.7, 24.1)
507
Alcohol consumption volume
Median g/week 29.4 (23.3, 35.5)c
296
46.9 (44.4, 49.4)c
2,247
<0.001
BMI
Mean kg/m2 28.0 (27.4, 28.6)b
296
24.2 (24.0, 24.3)b
2,273
<0.001
Ethnicty
White 71.2 (65.7, 76.1)
210
89.1 (87.7, 90.3)
2,012
<0.001
South Asian 14.6 (11.0, 19.1)
43
4.6 (3.8, 5.5)
103
Otherd 14.2 (10.7, 18.7)
42
6.4 (5.4, 7.5)
144
Family history of T2DM
Yes 68.8 (63.1, 73.9)
198
89.2 (87.8, 90.4)
1,989
<0.001
No 31.3 (26.1, 36.9)
90
10.8 (9.6, 12.2)
242
Occupational grade
Administrative (top) 4.1 (2.3, 7.0)
12
14.0 (12.7, 15.5)
319
<0.001
Professional (middle) 36.8 (31.5, 42.5)
109
43.0 (41.0, 45.1)
978
Clerical (bottom) 59.1 (53.4, 64.6)
175
43.0 (40.9, 45.0)
977
Physical activitye
Inactive 31.9 (26.7, 37.6)
91
22.6 (20.9, 24.4)
504
0.002
Below guidelines 34.4 (29.1, 40.1)
98
40.7 (38.7, 42.8)
907
Met guidelines 33.7 (28.4, 39.4)
96
36.6 (34.6, 38.6)
815
Smoking
Never 59.0 (53.3, 64.6)
173
54.2 (52.2, 56.3)
1,227
0.299
Former 22.2 (17.8, 27.3)
65
24.9 (23.2, 26.8)
564
Current 18.8 (14.7, 23.7)
55
20.8 (19.2, 22.5)
471
Sample sizes differed according to item non-response at baseline (wave one). Employment 
status not l isted as all  participants were employed at wave one.
aTo explore differences between non-response groups, one-way ANOVA was used on 
continuous data, and the chi 2 test on categorical data; bMean and 95% confidence interval; 
cMedian and 25th and 75th percentiles; de.g. black Caribbean, African and Arabic; eMeeting 
guidelines (≥150 minutes of moderate-intensity or ≥75 minutes of vigorous-intensity activity 
per week); inactive (<60 minutes of moderate and <60 minutes of vigorous activity; below 
guidelines (not inactive or meeting guidelines).
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8.5.2.2 Linear trajectories 
For both sexes, random slopes models best described the observed (Table 8.5) and imputed 
(Appendix 8.10) linear trajectories of alcohol consumption over the period leading up to the 
development of T2DM or censoring, suggesting marked variability in drinking between repeated 
measures.  
Table 8.5 Sex-specific interaction between the linear trajectory of mean weekly volume of alcohol 
consumption and T2DM diagnosis: goodness of fit statistics. Observed data 
 
Likelihood ratio tests were undertaken to formally establish the suitability of stratifying linear 
mixed models by sex. The inclusion of sex interactions between time and diagnosis status each 
improved the goodness of fit (p=<0.001), supporting the case for sex stratification. Sex stratified 
results are reported in Table 8.6, with corresponding plots shown in Figure 8.6. Men who did 
not develop T2DM over the course of study showed a gradual decline in their volume of alcohol 
consumption up to their time of censoring, while men who did develop the condition exhibited 
a marked increase in consumption up to their time of diagnosis. Based upon the coefficients 
Ethnicty
White 71.2 (65.7, 76.1)
210
89.1 (87.7, 90.3)
2,012
<0.001
South Asian 14.6 (11.0, 19.1)
43
4.6 (3.8, 5.5)
103
Otherd 14.2 (10.7, 18.7)
42
6.4 (5.4, 7.5)
144
Family history of T2DM
Yes 68.8 (63.1, 73.9)
198
89.2 (87.8, 90.4)
1,989
<0.001
No 31.3 (26.1, 36.9)
90
10.8 (9.6, 12.2)
242
Occupational grade
Administrative (top) 4.1 (2.3, 7.0)
12
14.0 (12.7, 15.5)
319
<0.001
Professional (middle) 36.8 (31.5, 42.5)
109
43.0 (41.0, 45.1)
978
Clerical (bottom) 59.1 (53.4, 64.6)
175
43.0 (40.9, 45.0)
977
Physical activitye
Inactive 31.9 (26.7, 37.6)
91
22.6 (20.9, 24.4)
504
0.002
Below guidelines 34.4 (29.1, 40.1)
98
40.7 (38.7, 42.8)
907
Met guidelines 33.7 (28.4, 39.4)
96
36.6 (34.6, 38.6)
815
Smoking
Never 59.0 (53.3, 64.6)
173
54.2 (52.2, 56.3)
1,227
0.299
Former 22.2 (17.8, 27.3)
65
24.9 (23.2, 26.8)
564
Current 18.8 (14.7, 23.7)
55
20.8 (19.2, 22.5)
471
Sample sizes differed according to item non-response at baseline (wave one). Employment 
status not l isted as all  participants were employed at wave one.
aTo explore differences between non-response groups, one-way ANOVA was used on 
continuous data, and the chi 2 test on categorical data; bMean and 95% confidence interval; 
cMedian and 25th and 75th percentiles; de.g. black Caribbean, African and Arabic; eMeeting 
guidelines (≥150 minutes of moderate-intensity or ≥75 minutes of vigorous-intensity activity 
per week); inactive (<60 minutes of moderate and <60 minutes of vigorous activity; below 
guidelines (not inactive or meeting guidelines).
Mixed model Log-likelihood BICa Log-likelihood BICa
Crude linear mixed model, fixed slope -162536 325134 -61948 123953
Crude linear mixed model, random slopes -162287 324655 -61907 123889
Men Women
aBayesian information criterion. 
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reported in Table 8.6, the mean volume of alcohol consumption thirty years prior to diagnosis 
or censoring was estimated to have been 108.1 g/week (103.6+[1.5*3]) among male non-cases 
and 75.6 g/week ([103.6+22.4]+[-16.8*3]) among male cases. By the time of diagnosis or 
censoring, the weekly volume of alcohol consumption was estimated to be an average 103.6 
g/week and 126.0 g/week respectively. 
By contrast, women who developed T2DM exhibited consistently lower volumes of alcohol 
consumption throughout the period of observation than those who were censored. By the end 
of observation, female consumption measured a mean 46.1 g/week among non-cases and 27.7 
g/week (46.1-18.4) among cases, or a difference of 18.4 g/week. Results from analyses based 
upon the imputed dataset were comparable for both sexes, and reported in Appendices 8.11 
and 8.12. 
Table 8.6 Crude sex-specific interaction between the linear trajectory of mean weekly volume of alcohol 
consumption and T2DM diagnosis. Observed data. 
 
Crude linear mixed models g/week (95% CI) p-value
Men (n=5,723)
Consumption volume
Intercept 103.6 (100.5, 106.6) <0.001
Change per 10 years prior to diagnosis or censoring -1.5 (-2.7, -0.3) 0.011
Difference in consumption at the time of diagnosis or censoring
Censored Reference
T2DM 22.4 (11.2, 33.7) <0.001
Difference in the rate of change by diagnosis or censoring
Censored Reference
T2DM 16.8 (10.9, 22.7) <0.001
Women (n=2,569)
Consumption volume
Intercept 46.1 (43.5, 48.6) <0.001
Change per 10 years prior to diagnosis or censoring -1.5 (-2.5, -0.6) 0.002
Difference in consumption at the time of diagnosis or censoring
Censored Reference
T2DM -18.4 (-24.5, -12.3) <0.001
Difference in the rate of change by diagnosis or censoring
Censored Reference
T2DM 1.3 (-2.7, 5.2) 0.529
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Figure 8.6 Crude sex-specific linear trajectory of mean weekly volume of alcohol consumption, stratified 
by T2DM diagnosis. Observed data. 
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8.5.2.3 Non-linear trajectories 
A range of non-linear slopes were explored, with fit statistics reported in Appendices 8.13 and 
8.14. Consumption trajectories among men and women who developed T2DM were best 
described as a linear function of time, with a non-linear trajectories provided the best fit of the 
underlying data among censored participants (Table 8.7 and Figure 8.7). Results from models 
applied to the imputed dataset were comparable and reported in Appendices 8.15 and 8.16. 
At 30 years prior to date of diagnosis or censoring, alcohol consumption was roughly equivalent 
among men at around 80.0 g/week regardless of whether they later developed T2DM or were 
censored. However, by the time of diagnosis or censoring, mean alcohol intake among men who 
didn’t develop T2DM was lower than among men who developed the condition, at 92.6 g/week 
and 126.0 g/week respectively. This equated to a difference of 33.4 g/week, or around 1.8 pints 
of 4.0% ABV lager.11 Among women, consumption remained consistently higher among those 
that did not develop T2DM. In contrast to men, disparities were most acute at both the 
beginning and end of the observation period, at just 13.3 g/week at the time of event or 
censoring, or around 0.7 pints of 4.0% ABV lager.11 
Table 8.7 Crude, sex-specific and best-fitting trajectory of mean weekly volume of alcohol consumption, 
stratified by T2DM diagnosis. Observed data. 
 
Crude best-fitting mixed models g/week (95% CI) p-value
Men
T2DM (n=620)
Intercept 126.0 (115.2, 136.9) <0.001
Time1 15.2 (9.4, 21.0) <0.001
Censored (n=5,103)
Intercept 92.6 (89.6, 95.6) <0.001
Time1 -33.2 (-36.6, -29.8) <0.001
Time2 -1.3 (-1.4, -1.1) <0.001
Women
T2DM (n=296)
Intercept 27.8 (22.2, 33.4) <0.001
Time1 -0.2 (-4.1, 3.7) 0.919
Censored (n=2,273)
Intercept 41.1 (38.6, 43.6) <0.001
Time1 -15.9 (-19.0, -12.7) <0.001
Time2 -0.6 (-0.7, -0.4) <0.001
Time coefficients refer to the change in the average volume of weekly alcohol consumption 
per 10 years prior to diagnosis or censoring. 
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Figure 8.7 Crude sex-specific linear trajectory of mean weekly volume of alcohol consumption, stratified 
by T2DM diagnosis. Observed data. 
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8.5.2.4 Sick-quitter effects 
Looking specifically at participants who developed T2DM, trajectories were estimated for 
alcohol consumption beyond the date of diagnosis, with goodness-of-fit statistics for all 
corresponding models reported in Appendices 8.17 and 8.18. Of the 620 men and 296 women 
who developed T2DM over the course of the study, alcohol consumption data were observed 
after the date of diagnosis among 552 and 267 participants respectively. Trajectories of alcohol 
consumption were estimated based upon a 3,262 person-observations among men and 1,513 
person-observations among women. 
Table 8.8 Crude trajectories of mean weekly volume of alcohol consumption up to and beyond the date 
of diagnosis, stratified by sex 
 
As shown in Table 8.8 and Figure 8.8, both sexes showed significant reductions in their 
consumption following diagnosis, equal to 21.2 g/week per decade among men and 4.5 g/week 
per decade among women. Trajectories from analyses of the imputed dataset differed little, and 
are shown in Appendix 8.19. 
Piecewise models g/week (95% CI) p-value g/week (95% CI) p-value
Up to diagnosis
Intercept 126.0 (115.2, 136.9) <0.001 27.8 (22.2, 33.4) <0.001
Time1 15.2 (9.4, 21.0) <0.001 -0.2 (-4.1, 3.7) 0.919
After diagnosis
Intercept 103.1 (91.4, 114.8) <0.001 21.2 (16.4, 25.9) <0.001
Time1 -21.2 (-32.2, -10.3) <0.001 -4.5 (-7.9, -1.2) 0.008
Time coefficients refer to the change in the average volume of weekly alcohol 
consumption per 10 years of follow-up.
Men Women
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Figure 8.8 Crude trajectories of mean weekly volume of alcohol consumption up to and beyond the date 
of T2DM diagnosis, stratified by sex 
8.5.2.5 Stability of baseline categories 
Significant differences in the longitudinal trajectory of alcohol consumption were identified 
according to categories of intake at baseline, as reported in Table 8.9 and shown for men and 
women in Figures 8.9 and 8.10 respectively. The length of each plotted trajectory was 
dependent upon the time between baseline and diagnosis or censoring. No incident cases were 
observed in the final wave of observation among participants defined as baseline non-drinkers.  
Regardless of diagnosis status, male drinking increased on average within all but the highest 
baseline consumption categories. Within the highest category, alcohol intake was estimated to 
fall by an average 20.8 g/week per decade among men that developed T2DM, relative to non-
drinkers, or 27.2 g/week per decade among those that were censored. Of the upward 
trajectories apparent within more moderate categories of baseline consumption, increases were 
shallower among participants that did not develop T2DM.  
Present within both the highest (>100.0 g/week) and second-highest (50.1-100.0 g/week) 
categories of baseline consumption, downward trajectories were more apparent among 
women. These slopes were steepest among those that developed T2DM. For instance, of women 
who drank 50.1-100.0 g/week at baseline, the mean volume of alcohol consumption fell by 17.0 
g/week among those who were diagnosed with T2DM and by just 1.9 g/week among those who 
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were censored, relative to non-drinkers. Although longitudinal increases in consumption were 
evident among both censored and diagnosed baseline moderate drinkers, elevations appeared 
too small to be clinically significant. For example, of women who drank just 0.1-50.0 g/week at 
baseline, consumption rose by an average 3.0 g/week each decade among those that went on 
to develop T2DM, and by a statistically insignificant 0.4 g/week among women that were 
censored, relative to non-drinkers. These same longitudinal trends were observed within the 
imputed dataset, as reported in Appendices 8.20-8.22. 
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Table 8.9 Crude sex-specific interaction between the trajectory of mean weekly volume of alcohol 
consumption and baseline category, stratified by T2DM diagnosis. Observed data. 
 
 
 
Crude linear mixed models g/week (95% CI) p-value g/week (95% CI) p-value
Men
Difference in consumption at the time 
of diagnosis or censoring by baseline 
consumption category
Non-drinker Reference Reference
Infrequent drinker 26.2 (6.9, 45.4) 0.008 29.7 (23.5, 36.0) <0.001
0.1-50.0 g/week 59.1 (40.2, 78.1) <0.001 51.9 (47.4, 56.4) <0.001
50.1-100.0 g/week 123.7 (99.5, 148.0) <0.001 92.4 (85.4, 99.3) <0.001
100.1-150.0 g/week 162.3 (130.1, 194.5) <0.001 122.7 (115.3, 130.2) <0.001
>150.0 g/week 216.1 (182.6, 249.7) <0.001 188.3 (179.3, 197.2) <0.001
Difference in the rate of change by 
baseline consumption categorya
Non-drinker Reference Reference
Infrequent drinker 11.7 (3.4, 20.0) 0.006 8.3 (6.2, 10.4) <0.001
0.1-50.0 g/week 14.7 (6.2, 23.2) 0.001 6.1 (4.5, 7.7) <0.001
50.1-100.0 g/week 25.9 (14.6, 37.3) <0.001 4.9 (2.1, 7.8) 0.001
100.1-150.0 g/week 26.0 (11.0, 41.1) 0.001 -1.9 (-4.7, 0.8) 0.173
>150.0 g/week -20.8 (-39.1, -2.5) 0.026 -27.2 (-30.8, -23.7) <0.001
Women
Difference in consumption at the time 
of diagnosis or censoring by baseline 
consumption category
Non-drinker Reference Reference
Infrequent drinker 11.6 (4.8, 18.5) 0.001 14.4 (10.8, 18.0) <0.001
0.1-50.0 g/week 27.0 (19.7, 34.2) <0.001 30.9 (27.4, 34.4) <0.001
50.1-100.0 g/week 39.5 (24.5, 54.6) <0.001 70.4 (64.3, 76.4) <0.001
>100.0 g/week 100.7 (68.8, 132.7) <0.001 109.4 (98.8, 119.9) <0.001
Difference in the rate of change by 
baseline consumption categorya
Non-drinker Reference Reference
Infrequent drinker 6.8 (2.7, 10.9) 0.001 3.6 (2.1, 5.2) <0.001
0.1-50.0 g/week 3.0 (-1.1, 7.1) 0.155 0.4 (-1.1, 1.9) 0.609
50.1-100.0 g/week -17.0 (-24.5, -9.4) <0.001 -1.9 (-4.4, 0.6) 0.139
>100.0 g/week -25.0 (-52.2, 2.3) 0.072 -18.3 (-22.6, -14.0) <0.001
aRate of change per 10 years prior to diagnosis or censoring.
CensoredT2DM
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Figure 8.9 Crude male trajectories of mean weekly volume of alcohol consumption, stratified by baseline alcohol 
consumption category and T2DM diagnosis. Observed data. 
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Figure 8.10 Crude female trajectories of mean weekly volume of alcohol consumption, stratified by baseline alcohol 
consumption category and T2DM diagnosis. Observed data. 
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8.6 Summary of results 
Between the ages of 34 and 84 years, the mean weekly volume of alcohol consumption was 
markedly higher among men than women. Despite this, the relationship with age was broadly 
comparable, with volumes increasing up to around 56 years of age among men and 51 years of 
age among women before decreasing thereafter (Figure 8.4). 
When trajectories were stratified by categories of baseline consumption, moderate drinkers 
were found to remain relatively stable across the adult life course, while heavy drinkers 
decreased their volume of alcohol consumption and infrequent drinkers increased their intake 
over the period (Figure 8.5). These changes indicated that, depending upon when in the adult 
life course a study categorises the alcohol intake of a participant, cross-sectionally defined 
moderate drinkers may be subject to differential degrees of misclassification error through 
contamination with heavy and infrequent drinkers.  
Stratifying the longitudinal trajectory by T2DM diagnosis revealed that consumption among men 
and women who did not develop T2DM gradually increased up to around 15 years prior to the 
time of censoring, before decreasing steadily toward the end of the observation period (Figure 
8.7). By contrast, linear increases were evident among men that developed the condition. Thus, 
by the time of diagnosis or censoring, the mean weekly volume of alcohol consumption among 
men who didn’t develop T2DM was 33.4 g/week lower than among men who developed the 
condition. A different picture was apparent among women. Here, rather than a similar linear 
increase among those who developed T2DM, the mean weekly volume of alcohol consumption 
remained consistently lower than among women who were censored. These differences were 
most acute at both the beginning and end of the observation period. 
Regardless of sex-specific differences in the consumption trajectory prior to developing T2DM, 
drinking fell among both sexes after the date of diagnosis, at 21.2 g/week among men and 4.5 
g/week among women per decade of follow-up (Figure 8.8). 
8.7 Limitations 
Although Whitehall II captured around 50 years of the adult life course, the dataset was not 
comprehensive, lacking measures of consumption through early adulthood (18-33 years of age) 
and advanced old age (≥83 years). Although data concerning these periods were missing, it was 
expected based on existing research that the unobserved period of early adulthood was likely 
to have been marked by a trend of increasing consumption, with a decrease in drinking during 
the unobserved period of advanced old age.259,266  
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As noted in Section 7.6, all analyses of Whitehall II data were dependent upon self-reported 
measures of alcohol consumption. Consequentially, plotted trajectories were potentially subject 
to some degree of inaccuracy owing to factors including reporting and recall biases391 as well as 
measurement error.392 In addition, no consideration was given to changes in reported 
consumption frequency across the life course. This decision was taken after having previously 
identified no difference in the dose-response relationship according to the frequency of 
consumption (Table 7.5). 
The results reported in this chapter focus on the mean trajectory of sampled participants by age 
and time. Although some analyses stratified alcohol consumption trajectories according to 
categories of baseline consumption, providing an indication as to how different drinking groups 
altered their intake over the life course, all results nonetheless dealt with averages that mask 
longitudinal changes to the constitution of the mean trajectory. For instance, the declining 
slopes seen among censored men and women in Figure 8.7 may have been a consequence of 
either a general decrease in the weekly volume of alcohol consumption to more moderate 
intakes or the transition of a minority of participants from heavy consumption to non-drinking. 
To get a rough idea as to the effect of transitions to non-drinking upon plotted trajectories, a 
post-hoc analysis was undertaken that calculated the best-fitting models in Figure 8.8 when 
participants with zero consumption (0 g/week) were excluded from each wave. Estimated 
trajectories are shown in Appendix 8.23. Although little difference was evident among male 
trajectories beyond an expected elevation in intercept values, both female slopes were shifted 
upward relative to those reported in Figure 8.7. The degree of change was largest among women 
who developed T2DM. While results in Table 8.7 indicated a flat trajectory among such 
participants (-0.2 g/week per decade, p=0.919), the exclusion of non-drinkers resulted in a near-
significant upward trajectory equal to an average increase of 5.5 g/week per decade (p=0.103). 
By contrast, among censored women, the difference in slopes between the two models was 
closer to just 1.5 g/week per decade. Such differences suggest that both female slopes may have 
been skewed downward by transitions from drinking to non-drinking up to the time of diagnosis 
or censoring, with transitions to zero consumption being most pronounced among women who 
developed T2DM.  
A further limitation of the longitudinal mean trajectories was the testing of just two polynomial 
terms within the non-linear mixed effects models. Although two polynomial terms 
accommodate a broad family of non-monotonic trajectories,176 the range and complexity of any 
resulting slopes is limited to a maximum of one turning point. Plotted non-linear trajectories 
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may therefore be simplistic and fail to reflect multimodal trajectories present within the 
underlying data. However, while multiple turning points can be accommodated through the 
introduction of additional polynomial terms,176 the added flexibility of such an approach comes 
at the risk of overfitting the data, producing trajectories that provide a better statistical fit of the 
observed dataset at the cost of poor generalisability to other cohorts.175 
As outlined in Section 6.6.1, mortality was likely to have represented a competing risk, with 
some study participants potentially censored due to mortality before they would otherwise have 
developed T2DM. Assuming that participants predominantly died due to chronic non-
communicable conditions, those who were censored due to death may have exhibited a 
pronounced downward trajectory in the period leading up to their final wave of participation. In 
order to investigate the effect of mortality upon the longitudinal trajectories, the best-fitting 
models were calculated for each sex excluding data from any participant censored due to death. 
This involved the exclusion of observations from 594 men and 290 women. As shown in 
Appendix 8.24, the omission of data from participants censored through death had little impact 
upon plotted trajectories.  
8.8 Discussion 
8.8.1 Prospective trajectories of mean weekly volume of alcohol consumption 
Analyses confirm that drinking varies with advancing age, increasing up to 56 years of age among 
men and 51 years of age among women before declining thereafter. This finding is consistent 
with previous research 266 and calls into question the validity of results from analyses that define 
consumption according to a single baseline measurement.  
When consumption trajectories were stratified according to baseline categories of alcohol 
consumption, mean alcohol intake was found to vary differentially as a function of age (Table 
8.3) and in a manner concordant with findings elsewhere.267 Drinking among both sexes was 
least stable within the highest baseline categories, where volumes of consumption fell markedly 
with increasing age. Reasons for such a decline are likely to be complex, as indicated by a study 
of Whitehall II participants aged 61-85 years at wave 11.408 Of the 40% of participants who 
reduced their consumption during the decade preceding wave 11, one of the main reasons given 
was a decline in opportunities for social drinking (men: 46%; women: 41%), with attenuations 
also commonly described as a proactive health precaution (men: 45%; women: 34%) or a 
response to ill-health or pharmaceutical contraindication (men: 20.7%; women: 21.9%). If 
heavier drinkers were more likely to have reduced their intake owing to ill-health, this may go 
Chapter 8: Trajectories of alcohol consumption 
228 
 
some way toward explaining the elevated risks of T2DM evident among non-current drinkers 
(Chapter 7). 
Trajectories stratified according to baseline consumption were found to converge toward 
moderate volumes with advancing age. There was therefore an indication that the risk of 
misclassification error may be greatest in studies of older cohorts where cross-sectionally 
defined moderate drinkers are likely to be contaminated by a greater proportion of infrequent 
and former heavy drinkers than in younger samples. If infrequent and former heavy drinkers are 
at greater risk of T2DM than stable moderate drinkers, this longitudinal contamination may help 
explain why less pronounced reductions in the risk of CHD409 and all-cause mortality395 are 
apparent among older moderate drinkers in conventional survival analyses. 
While results from analyses of the imputed dataset showed similar disparities in the longitudinal 
trajectory by categories baseline consumption, non-drinkers exhibited a more pronounced 
increase in consumption with advancing age. This suggests either that many former or never 
drinkers with missing data may have resumed or taken up drinking as they got older, or that the 
imputation model was poorly specified and did not predict zero values of alcohol consumption 
effectively. 
Whatever the reasons for changes in drinking across the life course, longitudinal variation in the 
volume of alcohol consumption indicate that the categorisation of study participants according 
to consumption reported at a single point in time risks introducing misclassification error, with 
the magnitude of error operating at least in part as a function of participant age.  
8.8.2 Trajectories of mean weekly volume of alcohol consumption by T2DM diagnosis 
Results from the revised and updated meta-analysis indicate increases in T2DM risk among men 
from very low volumes of consumption, with reductions in risk specific to moderate female 
drinkers (Figure 3.4). By examining differences in the trajectory of alcohol consumption by T2DM 
diagnosis, this chapter aimed to develop a better understanding of whether dose-response 
relationships reported by conventional survival analyses were the result of harms or benefits 
having accumulated over time following prolonged exposure to particular volumes of alcohol, 
or a consequence of acute differences in consumption during periods of the life course in which 
sensitivity to the effects of alcohol may be especially pronounced. 
Among men, alcohol intake was approximately equivalent between groups until just a few years 
prior to diagnosis, at which point the volume of consumption was greatest among men who 
developed the condition (Figure 8.7). This finding was most consistent with the second 
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hypothesis, which contended that sensitivity to the deleterious effects of higher alcohol intakes 
may be most pronounced later in the life course, with the mean age at diagnosis measuring 61.9 
(95% CI 61.4, 62.3) years among men.  
While male consumption increased linearly over the period, those who did not develop the 
condition exhibited a marked decline in their consumption prior to censoring. As noted in the 
preceding section, the reasons for such a decline were likely to be a combination of factors, 
including as a response to deteriorating health or as a proactive health precaution.408 Whatever 
the predominant motivation, the lack of a similar downward trajectory among men who 
developed T2DM appeared to be in conflict the third hypothesis outlined in Section 8.3, which 
posited that declining health prior to diagnosis would elicit a sick quitter effect marked by a 
reduction in consumption. When trajectories of alcohol consumption were calculated beyond 
the date of diagnosis, reductions were found to be evident among both sexes after the date of 
diagnosis (Figure 8.8), suggesting that any deterioration in health prior to the diagnosis of T2DM 
may have been of insufficient magnitude as to elicit a change in drinking behaviour, with 
consumption only falling following medical advice. 
Neither the first or second hypotheses were supported in women. Here, participants who 
developed T2DM exhibited an average weekly intake consistently below that of women who did 
not develop T2DM, with disparities by diagnosis status most pronounced during a period 15 
years prior to the date of diagnosis or censoring. Regardless of such a disparity, volumes of 
alcohol consumption within both female groups were well within the range of intake associated 
with reductions in the risk of T2DM among women in the updated meta-analysis (Figure 3.4). At 
least two reasons for this conflict with a priori hypotheses were possible. First, the lower 
volumes consumed by women who developed T2DM may have produced an effect insufficient 
to offset any increased risk conferred by other factors, with women who developed T2DM 
having a worse metabolic health profile at wave three than those who were censored (Table 
7.1). Secondly, given their worse metabolic health profile, the mean trajectory for women who 
developed T2DM may have been comprised not primarily of persistent low volume and 
therefore lower risk drinkers, but of sick quitters who had already attenuated their drinking 
owing to poor health. Thirdly, it was possible that the absence of distinct female trajectories by 
diagnosis status may have been attributable to a relatively limited range of alcohol consumption 
among women within the Whitehall II cohort, with heavier drinkers being few in number. For 
instance, while estimates from the meta-analysis in Chapter 3 indicate that the risk of T2DM 
becomes elevated among women at volumes >140 g/week, relative to pooled non-drinkers, just 
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239 women within the Whitehall II cohort reported consumption anywhere above that level at 
wave one, falling to just 105 participants by wave 11. A general population cohort with a greater 
breadth of female consumption similar to that available for men may be better suited to 
identifying disparities in the mean volume of alcohol consumption among women according to 
their diagnosis of T2DM.  
That the disparity in alcohol intake by diagnosis category was greatest among men in the few 
years preceding the end of observation suggests that any increased risk conferred by heavy 
alcohol consumption may occur later in the adult life course and over a relatively acute period 
of time. Given this indication, survival analyses in Chapter 9 will explore whether the dose-
response relationship is better parameterised according to different dimensions of the 
longitudinal trajectory, providing a clearer picture of differences in dose-response across the life 
course. Furthermore, while censored participants appeared to reduce their intake during the 
period leading up to the end of observation, it is unclear whether these downward trajectories 
represent a proactive attempt to modify negative health behaviours (a ‘worried well’) or a 
reaction to deteriorating health (‘sick quitters’). Accordingly, survival models reported in 
Chapter 9 will also be constructed to explore the association between the longitudinal slope and 
the risk of T2DM independent of the actual volume consumed. 
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9 Longitudinal alcohol consumption and the risk of T2DM 
9.1 Introduction 
Having established in Chapter 8 that drinking varies over the life course and differentially within 
baseline consumption categories, it was possible that estimates derived from conventional 
survival analyses may fail to adequately capture the complexity of the dose-response 
relationship between alcohol consumption upon T2DM risk. The primary aim of this chapter was 
thus to explore the utility of modelling the dose-response relationship according to 
parameterisations of the longitudinal trajectory other than just the baseline value of 
consumption. To achieve this, three increasingly complex survival models are considered: an 
age-varying covariate model, a two-stage model and a shared random effects model.410,411 Each 
approach is subject to its own advantages and limitations, and makes differing assumptions 
concerning the form of the longitudinal process.412,413,414,415  
Notably, the shared random effects approach offers greater flexibility than the other methods, 
permitting the calculation of differences in dose-response according to whether drinking is 
defined according to the intercept value of the longitudinal trajectory or consumption at the 
time of diagnosis. In modelling these two parameters within a single model, the shared random 
effects approach will help establish whether these different dimensions of the longitudinal 
process are each independently associated with T2DM risk. Additionally, with alcohol 
consumption varying as a function of each, the use of an age timescale within such models will 
permit an exploration of whether the dose-response relationship changes when alcohol is 
consumed at different points in the adult life course. 
With analyses in Chapter 8 having also identified longitudinal decreases in consumption among 
heavier drinkers and participants who were not diagnosed with T2DM, the shared random 
effects approach will also be used to estimate the relationship between the rate of change and 
T2DM risk after adjustment for the volume of past and current consumption. This final analysis 
will thus explore the sick quitter hypothesis, establishing whether participants who decreased 
their consumption tended to be at a higher risk of T2DM than those who did not.  
9.2 Objectives 
To formally explore the utility of using alternative parameterisations of the longitudinal 
trajectory, and establish whether downward trajectories are consistent with a sick quitter effect, 
the objectives of this chapter are thus to: 
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 Compare dose-response relationships reported according to different 
parameterisations of the longitudinal trajectory. 
 Investigate the effect of adjustment for heterogeneous non-drinking groups upon the 
sex-specific dose-response relationship. 
 Establish whether declining trajectories represent a group of drinkers at elevated risk of 
T2DM. 
9.3 Hypotheses 
9.3.1 The primary dose-response relationship 
Based on results from the preliminary conventional survival model reported in Chapter 7, it is 
hypothesised that the dose-response relationship estimated according to the intercept of the 
longitudinal trajectory would indicate a null or increased risk of T2DM among men and a 
decreased risk among women at higher volumes of consumption (Table 7.5). By contrast, when 
parameterised according to intake at the time of diagnosis, it is posited that the so-called 
‘current value’ of consumption would be associated with a heightened risk of T2DM, particularly 
among men. As indicated in Chapter 8, differences in male drinking were most pronounced in 
the few years prior to diagnosis or censoring, with volumes markedly higher on average among 
those who developed T2DM (Figure 8.8). With a mean age of diagnosis around 62 years, there 
was thus some suggestion that an increased risk of T2DM may be most pronounced when 
alcohol is consumed in higher volumes at older ages, representing a period in the life course 
during which the metabolism of alcohol is impaired and sensitivity to its deleterious effects 
potentially intensified.196,197,198,199,416,417 Given the possibility that dose-response effects may 
differ according to a deterioration in the alcohol metabolism with increased age, it was 
hypothesised that both the intercept and current value parameterisations would have 
contrasting and independent associations with T2DM risk. 
9.3.2 Sick quitter effects 
At least as far back as 1988, study participants who reduce their intake over time have been 
referred to as ‘sick quitters’ – a group of individuals speculated to attenuate their consumption 
owing to ill-health.138 This is a view maintained within the alcohol literature136 and supported by 
the heightened risk of T2DM among former drinkers (Table 7.3). Elsewhere, T2DM risk 
factors139,140 and poor self-reported health141,142,143 have been identified as more prevalent 
among former drinkers than current drinkers, with the onset of ill-health associated with a 
cessation from alcohol consumption.144,145,146 
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Based on such findings, it is possible that downward trajectories of alcohol consumption may be 
indicative of an increased risk of T2DM owing to a worse metabolic health. For instance, an 
analysis of participants from the English Longitudinal Study of Ageing showed that declines in 
the frequency of alcohol consumption were most rapid among participants who reported a 
deterioration in self-rated health or otherwise exhibited poor self-rated health across the entire 
period of follow-up.418 Similarly, although sub-group sample sizes were small, results from the 
Health Professionals Follow-Up Study indicate that those who decreased their intake over a four-
year period tended to show an elevated if non-significant risk of T2DM regardless of baseline 
consumption category.267  
However, a longitudinal decrease in alcohol consumption may not solely occur due to a ‘sick 
quitter’ effect. As reported following an analysis of Whitehall II participants aged 61-85 years at 
wave 11, reasons for a reduction in drinking range from illness, medicinal contraindication, 
proactive health precaution, a decline in opportunities for social drinking and a history of alcohol 
misuse.408 It was therefore likely that individuals with decreasing consumption may not simply 
represent a homogenous group of ‘sick quitters’, but a cohort of ‘worried well’ or socially 
isolated adults. It was perhaps because of these disparate motivations that analyses stratified 
by categories of baseline consumption showed decreasing slopes among heavier baseline 
drinkers irrespective of T2DM diagnosis (Figures 8.10 and 8.11). 
If reductions in alcohol consumption were primarily a response to poor metabolic health, a 
downward trajectory was expected to be associated with an increased risk of T2DM 
independent of the volume consumed. Alternatively, if reductions in the volume of alcohol 
consumption were instead a consequence of proactive attempts to improve health or were a 
result of fewer opportunities for social drinking due to factors unrelated to health status,408 then 
a downward slopes is expected to be associated with a decreased or null association with T2DM 
risk respectively. The precise constitution of any downward trajectory will thus determine the 
direction of any relationship between the rate of change and T2DM. 
9.4 Methods 
9.4.1 Sample 
The survival models chosen to calculate dose-response according to different parametrisations 
of the drinking trajectory all handle data in a different manner. For instance, while conventional 
survival models exclude any participant for whom covariate data are missing at baseline, 
longitudinal methods are able to include such participants by utilising measures obtained at later 
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waves. By contrast, while a conventional survival model can estimate dose-response 
associations for baseline participants based on all observed cases, longitudinal models drop any 
case diagnosed at a wave on which covariate data are missing. In order that results from each 
set of analyses were directly comparable, it was necessary to restrict the sample such that the 
number of participants and incident cases of T2DM were internally consistent.  
Given notable if non-significant differences in the risk of T2DM as reported by infrequent and 
heterogeneous non-drinkers (Table 7.3), the baseline was set as wave three, the first wave at 
which drinking data were sufficient for disaggregating and thereby adjusting for differences in 
risk between such groups. The restriction of the sample thus began by including only those 
individuals who participated at wave three (men: 6,057; women: 2,758) and who were free of 
prevalent T2DM at wave three (men: 5,898; women: 2,691). Participants were then excluded if 
they did not provide valid responses to questions concerning the volume and frequency of 
alcohol consumption (men: 306; women: 169), and did not participate in at least one other wave 
such that their diagnosis status could not be determined (men: 136; women: 88). Finally, 
participants were excluded if incident T2DM was documented on a wave for which covariate 
data were missing (men: 29; women: 0). 
In the case of crude models adjusted only for consumption category, this left an analytical 
sample of 5,427 men and 2,434 women, or 89.2% of wave three participants. A total incident 
560 and 268 cases were identified respectively. Longitudinal alcohol consumption data were 
available across 21,337 and 8,842 person-observations among men and women, with a median 
follow-up of 20.2 years and 20.0 years. In multivariable-adjusted models, sample sizes were 
reduced to 4,793 men and 2,053 women, with 451 and 206 incident cases respectively. 
9.4.2 Variables 
9.4.2.1 Alcohol consumption 
The weekly volume of alcohol consumption was captured and defined as described in Section 
6.3 and treated as a continuous variable. As robust standard errors could not be calculated 
within the shared random effects model, the continuous g/week variable was transformed 
according to the base 2 logarithm owing to positive skewness. Here, any risk estimate is thus 
interpreted as the change in risk per two-fold increase in the volume consumed. 
All models include adjustment for heterogeneous consumption category, defining participants 
at each wave according to whether they were never drinkers, non-current drinkers, infrequent 
drinkers or current drinkers. Using the volume and frequency variables described in Section 6.3, 
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never drinkers were strictly defined at each wave as those who reported never having consumed 
alcohol at the current and all prior waves. This definition thus excludes any participant who 
reported ‘always being a non-drinker’ at given wave yet also reported non-zero consumption at 
a prior wave. Such individuals were categorised as non-current drinkers, defined as any 
individual who reported no alcohol consumption in the year prior to interview but who 
otherwise reported non-zero consumption at a prior wave. Current drinkers were defined at 
each wave as anyone who reported non-zero consumption in the week prior to interview, while 
infrequent drinkers were participants who reported consuming alcohol during the year but did 
not drink alcohol in the week prior to interview.  
As a consequence of seeking to explicitly identify different groups of non-drinkers, continuous 
alcohol consumption data reported prior to wave three were excluded, as questions concerning 
never drinking were only available from wave three onwards. Additionally, as never drinking 
could not be imputed among individuals with missing data due to the small number of such 
participants, alcohol consumption was restricted to observed data only in all models. 
Representing the largest category at all waves, current drinkers were selected as the reference 
group. 
9.4.2.2 T2DM 
As documented in Section 6.4, cases of T2DM were defined according to any self-reported 
doctor diagnosis or use of hypoglycaemic medication, or a positive FPG result following clinical 
examination. Analyses focussed upon incident cases of T2DM and so therefore excluded any 
prevalent diagnoses at baseline. 
As the number of participants predicted to have developed T2DM over the course of the study 
varied between imputations, analyses applied to the imputed dataset were restricted to 
participants with observed T2DM diagnosis data such that the number of diagnosed participants 
remained static between imputations.342 
9.4.2.3 Covariates 
Covariates were defined in Section 6.5 and include BMI, ethnicity, employment status, family 
history of T2DM, occupational grade, physical activity, and smoking status. As described in the 
statistical analysis section below, age in years was selected as the timescale. As such, it was 
inappropriate to also adjust for the age of participants at each wave. Instead, adjustment was 
made for date of birth. Where repeated measures were available, covariates were treated as 
age-varying within all but the conventional survival analysis where only the baseline values were 
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used. Given the lack of any indication as to an interaction between the volume and frequency 
of consumption (Table 7.5), or differences in dose-response according to drink type (Table 7.6), 
these two factors were not included.  
9.4.3 Statistical analysis 
9.4.3.1 Time scale 
With an interest in testing differences in dose-response according to consumption reported at 
disparate periods of the adult life course, age in years was selected as the most meaningful 
timescale. This was contrary to the approach commonly adopted within existing studies, but 
serves as a conceptual distinction recommended elsewhere over the use of a time-to-event 
metric due to the incidence of T2DM operating as a function of advancing age as opposed to 
time since study entry.419,420,421  
For the conventional survival analyses, which only considered covariate values at baseline, start 
times were defined as the age of each participant at baseline, with stop times defined according 
to the age at diagnosis or censoring. For all other analyses, which utilised repeated measures, 
start times were equal to the age at participation in each wave, and stop times equal to the age 
at participation in the next wave of study. In circumstances where the date of participation in a 
wave was identical to their date of diagnosis or censoring, a value of 0.001 was arbitrarily added 
to their stop variable such that covariate data for that final wave could be included. The start 
and stop variables were scaled according to the minimum age at baseline so that intercept 
values were equal to consumption at 39.6 years of age. 
As Stata does not permit the use of imputed survival data, start and stop data were not imputed 
for waves of unit non-response. Accordingly, results from analyses applied to the imputed 
dataset only gave account of item non-response present on included covariates during observed 
waves of participation.  
9.4.3.2 Conventional survival model 
A proportional hazards model was constructed as per the method described in Chapter 7, with 
all covariates fixed according to their values at wave three. This approach is consistent with the 
method conventionally applied for survival analyses of the alcohol-T2DM relationship. Given the 
highly significant sex interaction reported in Chapter 7, all survival analyses were stratified by 
sex. 
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As the maximisation procedure of the shared random effects model requires that the functional 
form of the underlying baseline hazard be explicitly defined,415,422 proportional hazards models 
were run using parametric Weibull, Gompertz and exponential distributions. The parametric 
distribution that provided the best fit of the unobserved baseline hazard function was then 
selected for all subsequent models, defined as the model with the smallest BIC. 
9.4.3.3 Age-varying covariates survival model 
The age-varying covariates model serves as an extension of the conventional survival model and 
represents the simplest method for estimating the association between a longitudinally varying 
exposure and a survival process. As per Formula 9.1, alcohol consumption for the ith participant 
at the jth measurement is represented at each diagnosis by the last observed value (dij). The 
association parameter (α) linking alcohol consumption and T2DM thus reports the change in risk 
for a one-unit increase in the last observed or ‘current’ volume of alcohol consumption. 
Additional explanatory variables included in the survival model are represented by xi(t), with the 
effect of such covariates captured by their associated regression coefficients (β). Notably, 
although covariate values are allowed to change as a function of age, the regression effect of 
each covariate value is treated as proportional and thereby independent of age. 
hi(t)=h0(t)exp{βxi(t)+αdi(tij)} 
Formula 9.1 Calculation of a Cox proportional hazard model with time-varying covariates 
When obtaining the most probable risk estimates given the observed data, the survival model 
in Formula 9.1 requires that a complete covariate history is known for all participants.423 
However, in Whitehall II as in other cohorts, longitudinal measures are only captured 
periodically. The age-varying covariate model thus operates under the assumption that 
observed values of a covariate remain constant between examinations when drawing on the last 
known covariate value, as illustrated in Figure 9.1. Although this approach may work well if 
repeated measures are sufficient in number and frequency as to capture acute changes in 
consumption, the treatment of the longitudinal trajectory as a step-function is simplistic and can 
produce a hazard rate unlikely to reflect biological reality.424  
A further limitation of the age-varying covariates model is that the longitudinal trajectory is 
assumed to be measured without error. By giving no account of the inherent variability of the 
observed values and the degree to which they may differ from the true covariate values, noise-
attributable regression dilution can lead to an underestimation of the true longitudinal 
trajectory and thereby the real effect of alcohol consumption upon T2DM risk.412,413,424  
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Figure 9.1 Illustration of the longitudinal trajectory and hazard function within age-varying covariate 
and two-stage survival models 
9.4.3.4 Two-stage survival model 
The two-stage method provides a better reflection of the inherent uncertainty surrounding the 
observed values of weekly alcohol consumption. Instead of a survival model that estimates 
hazards according to the last observed value of alcohol intake, the two-stage approach utilises 
participant-specific predictions of the true volume of alcohol consumption as first estimated via 
a mixed effects model.412 By accounting for sampling variability through the inclusion of a 
random error term, predicted values are closer to the true values of weekly alcohol consumption 
than the crudely observed data. As such, any underestimation of the association between the 
weekly volume of alcohol consumption and T2DM tends to be reduced relative to an age-varying 
covariate model (Figure 9.2).412 
hi(t)=h0(t)exp{βxi(tij)+αŷi(tij)} 
ŷi(tij)=(β0+b0i)+(β1+b1i)tij+εij 
Formula 9.2 Calculation of a two-stage survival model 
As shown in Formula 9.2, predicted values of weekly volume of alcohol consumption for the ith 
individual at the jth observation (ŷi(tij)) are calculated within the mixed effects model as the 
estimated mean intercept (β0) and the predicted deviation of each participant from the mean 
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intercept (b0), plus the estimated mean change in alcohol consumption per unit increase in age 
(β1(tij)) and the predicted participant-specific deviation from the mean slope per year increase 
in age (b1(tij)), with εij representing random error.  
Given that the accuracy of a survival model is dependent upon an appropriately specified 
function of alcohol consumption, linear and non-linear mixed effects models were run on the 
log2-transformed volume of alcohol intake according to the restricted range of fractional powers 
defined in Section 3.2.4.1. Random slopes were assumed in all cases and individual-level 
predictions from the best-fitting sex-specific models then extracted and added to the parametric 
survival model.  
However, while measurement error is factored in during the calculation of the individual-level 
predictions, this uncertainty is not carried across into the survival model, which only utilises the 
fitted values estimated by the mixed model. As a consequence, while a two-stage approach 
generally provides an improvement in accuracy over age-varying covariate models, producing 
parameter estimates that are less biased toward the null by random error, resulting coefficients 
tend to exhibit too great a degree of precision.412 Additionally, in only using fitted values as 
predicted for each jth observation, the survival component of the two-stage model still assumes 
that covariate values are constant between observations (Figure 9.1). 
9.4.3.5 Shared random effects survival model 
In an attempt to circumvent some of the limitations that carry over into the two-stage method, 
the dose-response relationship between the volume of alcohol consumption and T2DM risk was 
also estimated using a shared random effects model. Unlike the two-stage approach, the shared 
random effects model estimates the longitudinal and survival processes simultaneously within 
a single model.415 In doing so, rather than the risk of T2DM being calculated according to the last 
fitted value available, predictions are instead calculated for all points across the life course (yi(t)), 
as illustrated in Figure 9.3.425  
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Figure 9.2 Illustration of the longitudinal trajectory and hazard function within a shared random effects 
survival model 
Though computationally intensive, the result is a longitudinal sub-model that better 
operationalises the unobserved trajectory of alcohol consumption for each participant and 
allows for the risk of T2DM among surviving participants at each diagnosis to be calculated 
according to the predicted participant-specific volume of alcohol consumption at the precise age 
recorded at diagnosis (Formula 9.3).415,422 
hi(t)=h0(t)exp{βxi(tij)+αyi(t)} 
yi(t)=(β0+b0i)+(β1+b1ij)tij+εij 
Formula 9.3 Calculation of a shared random effects survival model 
In simulation studies, these shared random effects models have been found to produce the least 
biased estimates of any of the three methods considered,411,412 with hazards closest to the true 
association under study and the most robust to any misspecification within the mixed effects 
model.422,426 Furthermore, by directly accounting for measurement error through the inclusion 
of random effects within the survival sub-model, parameters estimated by a shared random 
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effects approach also exhibit a larger and more appropriate degree of precision relative to the 
two-stage method.412,425 
9.4.3.5.1 Intercepts versus current values 
To explore how the dose-response relationship differs according to consumption at different 
points in the adult life course, separate models were run that calculated risk according to 
consumption as predicted at the intercept ((β0+b0i)) or the age at diagnosis 
((β0+b0i)+(β1+b1ij)tij). Then, to ascertain the independent contribution of the two parameters, 
each was then adjusted for the other via concurrent inclusion within a single model. 
9.4.3.5.2 Sick quitter effects 
To test whether participants with downward trajectories represented a group of ‘sick quitters’ 
at increased risk of T2DM, shared random effects models were constructed that also included a 
parameter equal to the association between the rate of change and the risk of T2DM (α3). By 
holding constant any differences in consumption at the intercept (α1) and at the age of diagnosis 
(α2), these fully adjusted models report the relationship between the slope of the longitudinal 
trajectory independent of past and current consumption (Formula 9.4). 
hi(t)=h0(t)exp{βxi(tij)+α1yai(t)+α2ybi+α3yci} 
yai(t)=(β0+b0ij)tij+εij 
ybi(t)=(β0+b0ij)+(β1+b1ij)tij+εij 
yci(t)=(β1+b1ij)tij+εij 
Formula 9.4 Calculation of a shared random effects survival model with an age-dependent slope 
parameterisation 
The resulting slope coefficient is interpreted as the difference in risk per unit increase in the rate 
of change per year of age (i.e. a slope coefficient equal to one). In order to make this coefficient 
more meaningful, it was transformed as shown in Formula 9.5 to reflect a 5% increase (HRinc) or 
decrease (HRdec) in the rate of change per decade increase in age, versus the mean percentage 
change in weekly alcohol consumption over the period (v).427 The p-values reported for the each 
HR are equal, referring to the p-value for the untransformed slope coefficient. To simplify the 
calculation of the mean rate of change per decade, these shared random effects models were 
calculated with linear slopes. 
 
HRinc=exp(α2*((log(1+5/100))-log(1+v/100))) 
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HRdec=exp(α2*((log(1-5/100))-log(1+v/100))) 
Formula 9.5 Calculating the risk of T2DM for a 5% increase or decrease in the rate of change versus 
the mean percentage change over the period 
9.4.3.5.3 Reference category 
Finally, to formally explore the effect of providing no adjustment for differences in risk between 
heterogeneous infrequent, non-current and never drinkers, a sensitivity analyses was run that 
calculated the intercept and current value dose-response associations without the inclusion of 
the alcohol consumption indicator variable. Doing so was considered equivalent to running a 
survival analysis relative to pooled non-drinkers. 
9.4.3.6 Goodness of fit 
As in Chapter 8, goodness of fit was measured according to the log-likelihood and BIC statistics, 
with an improvement in fit defined as any reduction in the BIC greater than or equal to a value 
of 10.406  
9.4.3.7 Statistical packages 
Proportional hazard models were calculated using the -st- package.390 Where fitted values of 
weekly alcohol consumption were predicted for inclusion within the two-stage survival model, 
linear and non-linear predictions were created using the -mixed- package.407 Shared random 
effects models were calculated using the -stjm- package.415 Results from analyses that utilised 
imputed covariate data were calculated using the -mi- suite of commands.342 The use of imputed 
data was not supported by the -stjm- package. 
9.5 Results 
9.5.1 Conventional survival model 
Construction of the conventional survival model began with identifying the best-fitting 
parametric baseline hazard. Fit statistics from the resulting crude models are reported in Table 
9.1. For both men and women, the baseline hazard function was best represented by a Weibull 
distribution, which was thus selected for all subsequent models in this chapter. The observed 
and predicted baseline hazard functions are shown in Appendix 9.1. 
 
Table 9.1 Relationship between the average weekly volume of alcohol consumption and the risk of 
T2DM, stratified by sex. Shared random effects model, goodness of fit statistics, observed data. 
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After adjustment for drinking category, a two-fold increase in the weekly volume of alcohol 
consumption at the intercept was associated with a 4% (HR 1.04, 95% CI 0.98-1.12) increase in 
the risk of T2DM among men and a statistically significant 26% (HR 0.74, 95% CI 0.65-0.84) 
decrease in risk among women (Table 9.2).  
Multivariable adjustment improved the fit of both male and female conventional survival 
models. Increases in risk among men were attenuated to the null (HR 0.99, 95% CI 0.92-1.06), 
and reductions in risk among women reduced to 20% (HR 0.80, 95% CI 0.69-0.93) per two-fold 
increase in consumption. Results from the imputed dataset, which accounted for missing 
covariate data, showed comparable results (Appendix 9.2). 
 
 
 
 
 
 
 
 
Table 9.2 Relationship between the average weekly volume of alcohol consumption and the risk of 
T2DM, stratified by sex. Conventional survival analysis, observed data. 
Baseline hazard function Log-likelihood BICa
Men
Cox (unspecified) -4461 8957
Exponential -1728 3500
Gompertz -1698 3448
Weibull -1693 3437
Women
Cox (unspecified) -1879 3790
Exponential -759 1557
Gompertz -749 1546
Weibull -747 1542
a
Bayes ian information cri terion.
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9.5.2 Age-varying covariates survival model 
Hazard ratios reported according to the current value of alcohol consumption were elevated 
relative to those associated with consumption at the intercept in Table 9.2. As reported in Table 
9.3, doubling of alcohol consumption was associated with an 11% (HR 1.11, 95% CI 1.03-1.19) 
increase in the risk of T2DM among men and a 16% (HR 0.84, 95% CI 0.74-0.95) reduction in risk 
among women in crude models. Following multivariable adjustment, risks among men were 
reduced slightly to a 7% increase in hazards (HR 1.07, 95% CI 0.99-1.15), with an 8% reduction 
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.04 (0.98, 1.12) 0.211 0.74 (0.65, 0.84) <0.001
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.25 (0.75, 2.08) 0.385 0.48 (0.24, 0.95) 0.036
Non-current drinker 1.74 (0.83, 3.67) 0.142 0.46 (0.19, 1.11) 0.084
Never drinker 2.39 (1.24, 4.60) 0.009 0.42 (0.18, 0.96) 0.040
Log likelihood -1693 -747
BIC a 3437 1542
Model 2
Cases/non-cases 451/4,342 206/1,847
Consumption volume
g/week (log2) 0.99 (0.92, 1.06) 0.679 0.80 (0.69, 0.93) 0.004
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 0.84 (0.48, 1.44) 0.519 0.51 (0.23, 1.12) 0.092
Non-current drinker 1.19 (0.56, 2.55) 0.652 0.44 (0.16, 1.20) 0.109
Never drinker 0.81 (0.38, 1.75) 0.597 0.36 (0.14, 0.95) 0.040
Log likelihood -1253 -521
BIC a 2666 1188
WomenMen
Model 1 reported the dose-response relationship between the volume alcohol consumption and 
T2DM following adjustment for consumption category. Model 2 included additional adjustment 
for BMI, date of birth, employment status, ethnicity, family history of T2DM, occupational grade, 
physical activity and smoking status, as defined at baseline. Ethnicity was derived from responses 
at waves one and five. aBayesian information criterion.
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in hazards reported among women (HR 0.92, 95% CI 0.80-1.06). Hazard ratios estimated using 
the imputed dataset were comparable (Appendix 9.3). 
Table 9.3 Relationship between the average weekly volume of alcohol consumption and the risk of 
T2DM, stratified by sex. Age-varying covariate survival analysis, observed data. 
 
Alcohol consumption HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.11 (1.03, 1.19) 0.004 0.84 (0.74, 0.95) 0.005
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 2.35 (1.37, 4.05) 0.002 0.96 (0.48, 1.91) 0.906
Non-current drinker 2.07 (0.98, 4.37) 0.057 1.15 (0.53, 2.48) 0.722
Never drinker 3.91 (1.95, 7.84) <0.001 0.67 (0.26, 1.67) 0.387
Log likelihood -1673 -734
BIC a 3406 1523
Model 2
Cases/non-cases 451/4,342 206/1,847
Consumption volume
g/week (log2) 1.07 (0.99, 1.15) 0.098 0.92 (0.80, 1.06) 0.241
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.61 (0.90, 2.89) 0.110 1.14 (0.53, 2.45) 0.732
Non-current drinker 1.29 (0.57, 2.95) 0.539 1.26 (0.54, 2.96) 0.594
Never drinker 1.30 (0.58, 2.93) 0.528 0.62 (0.23, 1.71) 0.358
Log likelihood -1157 -478
BIC a 2500 1124
WomenMen
Model 1 reported the dose-response relationship between the volume alcohol consumption and 
T2DM following adjustment for consumption category. Model 2 included additional adjustment 
for BMI, date of birth, employment status, ethnicity, family history of T2DM, occupational grade, 
physical activity and smoking status. Ethnicity was derived from responses at waves one and five. 
aBayesian information criterion.
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9.5.3 Two-stage survival model 
The best-fitting mixed effects model was determined separately for men and women and 
plotted in Figure 9.3. These trajectories were consistent with those reported in Chapter 8 (Figure 
8.3), with the average volume of consumption increasing up to around 55 years of age before 
declining thereafter.  
 
Figure 9.3 Crude, sex-specific and best-fitting trajectories of the mean weekly volume of alcohol 
consumption (log2) between the ages of 40-84 years. Observed data. 
Multivariable-adjusted risk estimates were closer to the null and no longer statistically 
significant when calculated based upon predicted values of alcohol consumption. A 4% (HR 1.04, 
95% CI 0.97-1.11) increase in T2DM risk was observed per two-fold increase in alcohol intake 
among men, and an 8% (HR 0.93, 95% CI 0.85-1.02) reduction in risk among women (Table 9.4). 
Analyses based on the imputed dataset were comparable and are reported in Appendix 9.4.  
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Table 9.4 Relationship between the average weekly volume of alcohol consumption and the risk of 
T2DM, stratified by sex. Two-stage survival analysis, observed data. 
 
  
Alcohol consumption HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.05 (0.98, 1.11) 0.151 0.82 (0.76, 0.89) <0.001
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.41 (1.01, 1.97) 0.045 1.29 (0.91, 1.84) 0.155
Non-current drinker 1.31 (0.66, 2.58) 0.440 1.35 (0.81, 2.25) 0.253
Never drinker 2.52 (1.36, 4.67) 0.003 0.75 (0.36, 1.56) 0.445
Log likelihood -1677 -730
BIC a 3413 1514
Model 2
Cases/non-cases 451/4,342 206/1,847
Consumption volume
g/week (log2) 1.04 (0.97, 1.11) 0.262 0.93 (0.85, 1.02) 0.145
Consumption category
Current drinker (reference)
Infrequent drinker 1.23 (0.85, 1.78) 0.279 1.43 (0.95, 2.13) 0.083
Non-current drinker 1.04 (0.49, 2.20) 0.923 1.51 (0.85, 2.67) 0.160
Never drinker 1.06 (0.50, 2.22) 0.880 0.73 (0.33, 1.65) 0.456
Log likelihood -1158 -478
BIC a 2502 1123
Men Women
Model 1 reported the dose-response relationship between the volume alcohol consumption and 
T2DM following adjustment for consumption category. Model 2 included additional adjustment 
for BMI, date of birth, employment status, ethnicity, family history of T2DM, occupational grade, 
physical activity and smoking status. Ethnicity was derived from responses at waves one and five. 
aBayesian information criterion.
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9.5.4 Shared random effects model 
9.5.4.1 Intercept versus the current value 
Using the same best-fitting trajectories as shown in Figure 9.3, the multivariable-adjusted risk of 
T2DM per two-fold increase in the intercept and current values of alcohol consumption were 
estimated in separate models for each sex (Table 9.5). Intake predicted at the age of 39.6 years 
was associated with little change in the risk of T2DM among men (HR 0.98, 95% CI 0.92-1.05), 
while a two-fold increase in the current value of alcohol consumption was associated with a non-
significant 5% increase in risk (HR 1.05, 95% CI 0.97-1.14). Among women, both the intercept 
and current values of alcohol consumption were associated with non-significant reductions in 
risk, though with an effect strongest according to the intercept parameterisation.  
Table 9.5 Multivariable-adjusted relationship between intercept and current value parameterisations 
of average weekly volume of alcohol consumption and the risk of T2DM, stratified by sex. Shared 
random effects survival analysis, observed data. 
 
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 0.98 (0.92, 1.05) 0.628 0.89 (0.79, 1.00) 0.054
Consumption category
Current drinker (reference)
Infrequent drinker 1.03 (0.71, 1.50) 0.868 1.29 (0.83, 1.99) 0.259
Non-current drinker 0.84 (0.43, 1.66) 0.619 1.33 (0.71, 2.50) 0.368
Never drinker 0.82 (0.40, 1.68) 0.588 0.63 (0.26, 1.55) 0.315
Log likelihood -38234 -15907
BIC a 76703 32026
Current value
Consumption volume
g/week (log2) 1.05 (0.97, 1.14) 0.189 0.92 (0.81, 1.06) 0.244
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.32 (0.86, 2.02) 0.209 1.37 (0.83, 2.28) 0.217
Non-current drinker 1.14 (0.55, 2.39) 0.725 1.45 (0.73, 2.90) 0.289
Never drinker 1.14 (0.53, 2.44) 0.741 0.69 (0.27, 1.77) 0.443
Log likelihood -38233 -15908
BIC a 76701 32029
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion.
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Table 9.6 reports the same two parameterisations but included concurrently within single sex-
specific models. After adjusting for the current value of alcohol consumption, a two-fold 
increase in the intercept was associated with a statistically significant 20% (HR 0.80, 95% CI 0.69-
0.92) reduction in risk among men and a 36% (HR 0.64, 95% CI 0.43-0.97) reduction among 
women. By contrast, when holding intercept values constant, a two-fold increase in the current 
value of alcohol intake was associated with a statistically significant 35% increase in risk (HR 
1.35, 95% CI 1.12-1.62) among men and a 47% increase in risk among women (HR 1.47, 95% CI 
0.94-2.31). No differences in goodness of fit were observed between parameterisations. 
After adjustment for the intercept and current values of alcohol consumption, risks were 
elevated at any age among all heterogeneous non-drinking categories except for female never 
drinkers, for whom a non-significant reduction in risk was apparent relative to pooled current 
drinkers (HR 0.82, 95% CI 0.31-2.18). 
Table 9.6 Multivariable-adjusted associations between conditional intercept and current value 
parameterisations of average weekly volume of alcohol consumption and the risk of T2DM, stratified 
by sex. Shared random effects survival analysis, observed data. 
 
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 0.80 (0.69, 0.92) 0.002 0.64 (0.43, 0.97) 0.034
Current value
g/week (log2) 1.35 (1.12, 1.62) 0.001 1.47 (0.94, 2.31) 0.091
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.56 (1.00, 2.45) 0.052 1.74 (0.99, 3.06) 0.053
Non-current drinker 1.61 (0.73, 3.55) 0.242 1.87 (0.88, 3.99) 0.104
Never drinker 1.43 (0.63, 3.24) 0.397 0.82 (0.31, 2.18) 0.692
Log likelihood -38228 -15905
BIC a 76700 32032
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion.
Chapter 9: Longitudinal alcohol consumption and the risk of T2DM  
251 
 
9.5.4.2 Reference category 
When the separate survival models reported in Table 9.5 were re-run without adjustment for 
the differences in risk among heterogeneous non-drinking groups, little change in risk estimates 
was observed among men, while reductions in risk among women were increased. For instance, 
compared to a non-significant 8% (HR 0.92, 95% CI 0.81-1.06) reduction in risk per two-fold 
increase in the current value of alcohol intake after adjustment for consumption category, 
results in Table 9.7 show a significant 13% (HR 0.87, 95% CI 0.81-0.89) reduction in risk. 
Table 9.7 Multivariable-adjusted relationship between intercept and current value parameterisations 
of average weekly volume of alcohol consumption and the risk of T2DM, stratified by sex and without 
adjustment for alcohol consumption category. Shared random effects survival analysis, observed data. 
 
9.5.4.3 Sick quitter effects 
The linear trajectory on the log2 scale was flat over time among men, falling by 0.2% (p=0.894) 
per decade. By contrast, female consumption fell by an average 3.1% (p=<0.001) per decade. 
Table 9.8 reports the multivariable-adjusted association between differences in these rates of 
change and the risk of T2DM, after adjustment for past and current alcohol consumption.  
Among both sexes, a 5% increase in the decennial rate of change was associated with a slight 
increase in the risk of T2DM (men: HR 1.12, 95% CI 0.59-2.10; women: HR 1.11, 95% CI 1.01-
1.62). By contrast, a 5% reduction in the rate of change was associated with a small decrease in 
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 0.99 (0.94, 1.04) 0.569 0.86 (0.79, 0.93) <0.001
Log likelihood -38551 -16088
BIC a 77308 32361
Current value
Consumption volume
g/week (log2) 1.02 (0.97, 1.08) 0.358 0.87 (0.81, 0.95) 0.001
Log likelihood -38551 -16089
BIC a 77307 32364
Men (n=4,793) Women (n=2,053)
All models included adjustment for BMI, date of birth, employment status, ethnicity, family history 
of T2DM, occupational grade, physical activity and smoking status. Ethnicity was derived from 
responses at waves one and five. aBayesian information criterion.
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the risk of T2DM among both sexes (men: HR 0.89, 95% CI 0.46-1.73; women: HR 0.97, 95% CI 
0.60-0.99).  
Table 9.8 Multivariable-adjusted relationship between the rate of change in the average weekly volume 
of alcohol consumption and the risk of T2DM, stratified by sex. Shared random effects survival analysis, 
observed data. 
 
9.6 Summary of findings 
This chapter aimed to investigate the merit of utilising parameterisations of the longitudinal 
trajectory conventionally overlooked by existing survival analyses, and establish whether 
participants with downward trajectories of alcohol consumption represent a distinct group of 
sick quitters at elevated risk of T2DM. 
Despite adopting a different timescale, results from the conventional survival models reported 
in Table 9.2 are consistent with the meta-analysis reported in Chapter 3, whereby consumption 
predicted at 39.6 years of age was associated with reductions in risk only among women. When 
the dose-response relationship was instead modelled according to the current value of 
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 0.48 (0.24, 0.93) 0.030 0.54 (0.22, 1.33) 0.179
Current value
Consumption volume
g/week (log2) 2.45 (1.23, 4.88) 0.010 1.80 (0.73, 4.45) 0.202
Slope
5% increase in the rate of change
g/week (log2) 1.12 (0.59, 2.10) 0.733 1.11 (1.01, 1.62) 0.897
5% decrease in rate of change
g/week (log2) 0.89 (0.46, 1.73) 0.733 0.97 (0.60, 0.99) 0.897
Log likelihood -38282 -15917
BIC a 76808 32056
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian information 
criterion.
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consumption, female reductions in risk remained present but were of a smaller magnitude 
regardless of the method used (Tables 9.3 to 9.5).  
In order to establish which of these two different dimensions of the longitudinal trajectory might 
be the most important for estimating T2DM risk, a shared random effects model was 
constructed that modelled both parameters concurrently (Table 9.6). After adjusting for 
differences in the current volume of intake, a two-fold increase in alcohol consumption at the 
intercept was associated with sizeable reductions in T2DM risk. Conversely, when adjusting for 
differences in intercept values, higher current values of consumption were associated with a 
greater risk of T2DM. A sensitivity analysis that excluded adjustment for consumption category 
indicated more pronounced reductions in risk among women for both parameterisations of 
alcohol consumption (Table 9.7). 
Finally, to determine whether participants who decreased their consumption over time 
represented a group of ‘sick quitters’ who may have attenuated their intake owing to having 
manifested symptoms associated with an elevated risk of T2DM, a shared random effects model 
was constructed that modelled the effect of differences in rate of change independent of past 
and current consumption (Table 9.8). Although men and women who decreased their 
consumption at a faster rate appeared to show slightly lower risks of T2DM, associations were 
not statistically significant.  
9.7 Limitations 
The dose-response relationship between the weekly volume of alcohol consumption and the 
risk of T2DM was estimated by linking longitudinal and survival processes via a range of 
increasingly complex methods. An alternative approach considered was to jointly model both 
processes with trajectories of alcohol consumption captured via latent classes.428,429 Rather than 
treating participants as a homogenous group by estimating participant-specific slopes 
constrained according to the same longitudinal function, the joint latent class approach instead 
treats the population as heterogeneous and thus constituted of multiple disparate trajectory 
profiles, such as those illustrated in Figure 3.17. Using this approach, participants are divided 
into a finite number of latent sub-groups, with their membership defined according to a 
categorical latent variable that can then be included within a survival sub-model.428 As each 
latent class represents a specific average trajectory, corresponding risk estimates can be used 
to ascertain the effect of a particular drinking typologies upon the risk of T2DM, such as a pattern 
of stable moderate consumption. In this sense, a joint latent class model can offer an 
interpretive benefit over a shared random effects model.  
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However, the joint latent class approach is subject to its own limitations.428 As described 
elsewhere, the composition of distinct latent classes is in part dependent upon population 
heterogeneity or, more specifically, the degree of longitudinal variability in a given variable.259 
Thus, if most participants within a cohort exhibit similar consumption trajectories over time, the 
majority will be categorised into a single latent class with no resulting capacity for exploring 
differences in risk according to heterogeneous trajectories of clinical interest. This particular 
shortcoming has been found to apply to the Whitehall II dataset, with heterogeneous non-
drinking groups pooled with light drinkers, and heavier drinkers combined with more moderate 
users of alcohol.430,431 Such groupings highlight the arbitrary and potentially non-informative 
nature of statistically-derived latent classes, and indicate that joint latent class models applied 
to Whitehall II data for the exploration of T2DM risk were likely to insufficiently disaggregate 
heterogeneous consumption categories, thereby falling foul of the same misclassification errors 
present in analytic methods conventionally applied in epidemiologic research. In addition, by 
modelling heterogeneity in longitudinal consumption solely through the derivation of latent 
categories, it is not possible to explore the relationship between different dimensions of such 
heterogeneity and T2DM risk, such as the rate of change or deviation from the mean 
trajectory.422 It was for these reasons that a shared random effects approach was chosen. 
In contrast to the majority of previous studies, which report age-adjusted risk estimates with a 
time-to-event metric, the analyses reported in this chapter used age as the timescale of interest 
due to both the incidence of T2DM and volume of alcohol consumption operating as a function 
of age as opposed to the time and length of participation.419,420 Results derived from models in 
this chapter and those reported elsewhere thus may not be directly comparable. To explore how 
results may have differed according to the choice of timescale, post-hoc sensitivity analyses 
were run that reproduced the shared random effects models reported in Tables 9.5 and 9.6 but 
using a conventional time-to-event timescale. With the intercept and current value 
parameterisations modelled separately, estimates remain of the same direction and 
approximate magnitude, with reductions in risk continuing to be most pronounced among 
women (Appendix 9.5). When both parameters were estimated concurrently, as per Table 9.6, 
both parameterisations remained statistically significant, with the same differential dose-
response relationships still reported (Appendix 9.6). These sensitivity analyses affirm that similar 
conclusions are drawn irrespective of the choice of timescale. Specifically, that conventional 
approaches may oversimplify the relationship between alcohol and T2DM risk through a failure 
to consider changes in alcohol consumption across the life course.  
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Utilising an age-based timescale within a shared random effects framework should permits the 
calculation of dose-response relationships according to intakes at specific ages that may be of 
utility to policymakers or clinicians. This is achieved by applying a lag effect to the current value 
parameter, whereby the risk of T2DM at age t is calculated according to the value of the 
longitudinal trajectory at t-c, where c is the lag of interest.422 Unfortunately, the -stjm- package 
still in the process of being developed, with such functionality is not yet available. As a result, 
risks reported Chapter 9 were limited to alcohol consumption at the intercept (40 years of age) 
and the current value (a mean 62 years of age). Although possible to rescale the age variable 
such that the intercept intersects age at a point in the life course that may be of greater 
interested to policymakers, such as the minimum legal drinking age, such a model would be 
required to extrapolate the longitudinal trajectory far beyond the period observed. The validity 
of any resulting estimates would thus be questionable given that the functional form of the 
longitudinal trajectory between middle age and later life was unlikely to hold when extended to 
a period such as young adulthood, which is marked by pronounced elevations in consumption 
from very low volumes.259,266  
All reported models assumed a linear dose-response relationship between the volume of alcohol 
consumption and the risk of T2DM. Such an assumption was not consistent with the non-linear 
dose-response curve reported in Chapter 3. However, as indicated in Chapter 7, the positive 
skewness and low average volume of alcohol consumption within the Whitehall II cohort were 
such that it may not have been possible to detect non-linear dose-response relationships, such 
as increases in risk at higher intakes. To explore the possibility that a non-linear dose-response 
relationship may be present between an alternative parameterisation of alcohol consumption 
and T2DM risk, fitted values from the two-stage models reported in Table 9.4 were transformed 
according to a restricted range of fractional powers, as detailed in Section 3.2.4.1. No 
improvements in BIC were identified for any non-linear dose-response association, relative to 
the linear model. As a result of such a limitation, caution should be applied when interpreting 
the linear dose-response coefficients and seeking to extrapolate them to higher volumes of 
drinking. Moreover, from a public health perspective, while higher volumes of alcohol 
consumption at the intercept appear associated with reductions in T2DM risk among both sexes 
after adjustment for consumption later in the life course (Table 9.6), it should be borne in mind 
that drinking may still be associated with a heightened risk of other health conditions even at 
relatively low volumes.432 
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Although little difference was evident between coefficients reported for models applied to the 
observed data and those that accounted for item non-response on covariates, all models were 
restricted to individuals free of missing alcohol consumption and diagnosis data at wave three. 
As reported in Chapter 6, participants with unit non-response across ≥4 waves of follow-up 
(Table 6.5) or item non-response at any point during the study (Table 6.7) exhibited a lower 
volume of alcohol consumption and worse metabolic risk profile at the beginning of the study 
than those with observed data. There was thus the possibility that risks associated with lower 
volumes of alcohol may have been underestimated. 
9.8 Discussion 
Analyses reported in Chapter 3 and Chapter 7 both indicate a disparity in the dose-response 
relationship between men and women, with reductions in risk specific to female participants. 
When the dose-response relationship was parameterised according to drinking at the intercept, 
two-fold increases in the weekly volume of alcohol consumption were associated with a null 
effect among men and a borderline significant 11% reduction in risk among women (Table 9.5), 
consistent with earlier findings.  
Capitalising upon the flexibility afforded by shared random effects models, the relationship 
between intake at the intercept and T2DM risk was recalculated with adjustment for the current 
value of consumption (Table 9.6). Here, two-fold increases in the intercept were associated with 
significant reductions in risk in both sexes, but with the magnitude of reduction remaining 
greatest among women (men: 20%; women: 36%). By contrast, when holding the intercept 
constant, increases in the current volume of consumption were marked by sizeable increases in 
risk (men: 35%; women: 45%). With this same disparity in effect found to be apparent when 
shared random effects models were recalculated based on a time-to-event as opposed to an 
age-based timescale (Appendix 9.6), there was thus an indication that both parameterisations 
of the longitudinal trajectory exhibit statistically independent and divergent relationships with 
T2DM risk. Additionally, that conventional survival analyses which adjust for age and rely upon 
a single measurement of alcohol consumption fail to report important differences in the dose-
response relationship across the adult life course.  
Given a mean age of 62 years at the time of diagnosis, and a median follow-up of 20 years from 
the intercept, the results suggest that increases in risk associated with higher volumes of 
consumption may be specific to intake at older age. Such an effect would be in accordance with 
studies that report age-related impairments to the alcohol metabolism196,197,198,199 and 
consequent increases in length of exposure to higher concentrations of pro-inflammatory 
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metabolites such as acetaldehyde and acetate.200,201 Unfortunately, although interventional 
studies have investigated the relationship between alcohol consumption and a range of 
inflammatory biomarkers, the number of studies is small, methods are heterogeneous and 
pooled effects statistically insignificant.118 While a J-shaped association was estimated between 
alcohol consumption and CRP in an analysis based on data from 22 Mendelian randomisation 
studies,131 estimates were not disaggregated by age group. As such, it was not possible to state 
conclusively whether alcohol may differentially affect the concentration of inflammatory 
biomarkers according to the age of participants. Although evidence concerning the 
inflammatory pathway is currently tenuous, results in Table 9.6 nonetheless allude to the 
possibility that any advantageous biological effects of alcohol consumption, such as the linear 
increases in HDL concentration reported by interventional studies,117,118,119 may be outweighed 
in later life by heightened inflammatory responses following age-related impairments to the 
alcohol metabolism. 
This hypothesis was further substantiated by a post-hoc analysis, which estimated the effect of 
differences in the longitudinal trajectory after adjusting solely for drinking at the intercept 
(Appendix 9.7). Relative to the mean slope, a 5% decrease in the rate of change was associated 
with significant reductions in the risk of T2DM among both sexes (men: HR 0.42, 95% CI 0.29-
0.61; women: HR 0.77, 95% CI 0.63-0.94). These reductions in risk may have been a consequence 
of participants with faster longitudinal declines in alcohol consumption having consumed 
alcohol in lower volumes during the sensitive period of old age, relative to those who decreased 
their intake at the average rate.  
Adults who reduce their intake over time are typically posited to represent a group of individuals 
who attenuate their drinking owing to ill-health,136,138 with a number of studies linking the onset 
of poor health to a cessation of drinking144,145,146 or a reduction in the frequency of 
consumption.418 In an effort to isolate the relationship between differences in the rate of change 
and T2DM risk, analyses were undertaken that reported a slope coefficient following adjustment 
for past and current intake (Table 9.8). Among both sexes, participants who reduced their 
alcohol consumption at a faster rate than the mean experienced a lower risk of T2DM, though 
risk estimates were non-significant. Accordingly, the fully-adjusted model failed to corroborate 
the presence of a sick quitter effect, whereby participants with a faster rate of decline would 
instead be expected to report a higher risk of T2DM, independent of the volume consumed. 
It was possible that a sick quitter effect was lost as a consequence of the diverse reasons for 
which study participants appear to attenuate their alcohol consumption. For instance, while 
Chapter 9: Longitudinal alcohol consumption and the risk of T2DM 
258 
 
previously published analyses of Whitehall II data indicate that around 21% of men and 22% of 
women who reduced their intake did so as a direct consequence of illness or pharmaceutical 
contraindication, a far higher proportion reduced their drinking as a health precaution (men: 
45%; women: 34%), with others doing so for reasons as broad as a reduction in opportunities 
for social drinking, an effort to save money, pressure from family and friends and a history of 
alcohol misuse.408 Elsewhere, an analysis of longitudinal data from the Health and Retirement 
Study reported differences in longitudinal trajectories according to a range of socio-economic 
factors, with greater affluence and a higher frequency of socialising all associated with increased 
probabilities of an upward drinking trajectory.289 Other studies report similar findings, with low 
incomes433,434,435 and low education435 associated with reductions or steeper declines in the 
volume or frequency of alcohol consumption, suggesting that disposable incomes and social 
networks may affect drinking behaviours other than just the onset of poor health. Although 
associations have also been found between drinking trajectories and retirement, effects appear 
to vary according to differences in occupational drinking cultures.435 While differences in 
consumption by these socio-economic factors could feasible be a consequence of correlations 
between socio-economic status and health,436 effects were robust to adjustment for illness and 
self-reported health.289,433,434,435 Thus, despite evidence linking decreases in alcohol consumption 
to a decline in health, the determinants of downward trajectories are complex, with health 
protection, family pressures and socio-economic factors all playing a role in determining 
longitudinal drinking patterns.  
As an alternative explanation for the absence of an increased risk among participants with faster 
rates of decline, it was possible that selection bias may have been a factor. Specifically, 
participants who were experiencing a decline in health status owing to issues associated with a 
heightened risk of T2DM, such as such as obesity or hypertension, may have chosen to withdraw 
themselves from the study. In doing so, sampled participants with downward trajectories would 
disproportionately represent those who decreased their consumption due to factors not 
associated with an increased T2DM risk. 
In summary, the results reported in this chapter appear to indicate that conventional survival 
analyses may provide too simplistic a picture of the relationship between alcohol consumption 
and the risk of T2DM. When intercept and current values of alcohol intake were estimated 
concurrently, disparate dose-response associations were identified. With age used as the 
timescale, there was an indication that reductions in risk associated with alcohol consumption 
in midlife may be countered by a greater sensitivity to alcohol in older age. In the absence of 
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more robust evidence concerning the validity of putative pathways by which alcohol may reduce 
the risk of T2DM, it would be unwise to recommend that non-drinking adults begin consuming 
alcohol, especially if such individuals abstained owing to ill-health, pharmaceutical 
contraindication or a history of alcohol misuse. Furthermore, with higher volumes of alcohol 
consumption associated with an increased risk of T2DM with advancing age, and relatively 
moderate volumes in midlife associated with reductions in risk, it would be a reasonable 
precaution to recommend a general attenuation to the volume of consumption among drinkers.  
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10 Discussion  
10.1 Research questions 
Previous meta-analyses suggest that moderate alcohol consumption may reduce the risk of 
T2DM, with the latest publication at the time of commencing this project having reported a J-
shaped association and a peak reduction in risk at around 22-24 g/day among both sexes, 
relative to quasi-never drinkers.10 When this meta-analysis was updated through the inclusion 
of 21 studies that were either newly published or provided updated data with longer periods of 
follow-up or improved confounder adjustment, significant differences in dose-response were 
found between men and women. As reported in Chapter 3, the most up-to-date observational 
data suggest that any reduction in risk may actually be specific to women, peaking among those 
that consume an average 35 g/day (HR 0.66, 95% CI 0.55-0.78).  
However, when constituent studies were investigated in more detail, a series of methodological 
flaws were identified that may undermine the validity of any inference drawn from this result, 
including a failure to account for differences in risk among heterogeneous non-drinkers and 
limited consideration as to the effect of longitudinal changes in alcohol consumption upon the 
dose-response relationship reported. 
As a result of such observations, a number of primary aims were formulated: 
1. Determine the degree to which categories of alcohol consumption risked being subject 
to misclassification error as a result of longitudinal changes in alcohol consumption. 
2. Describe differences in the mean volume of alcohol consumption over the life course 
according to T2DM diagnosis. 
3. Formally explore the utility of more advanced survival models in developing a better 
understanding of the relationship between alcohol consumption and T2DM. 
Findings from each resulting analysis are summarised in the following section. 
10.2 Summary of findings 
10.2.1 Misclassification error 
Although analyses of the relationship between alcohol consumption and T2DM have 
conventionally defined intake according to a single measure as reported at baseline, longitudinal 
data from multiple cohort studies have shown that alcohol consumption varies across the life 
course.259 As a consequence of such changes, there was a risk that categories of alcohol 
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consumption defined in the existing literature may have been subject to misclassification error, 
complicating interpretations of associated risk estimates. To provide an indication as to how any 
misclassification error might be distributed across baseline categories, mixed effects models 
were constructed to plot the mean longitudinal trajectory of alcohol consumption within a series 
of distinct baseline categories. 
When the sex-specific trajectory was stratified in such a manner, marked differences in rates of 
change were apparent over the adult life course captured by Whitehall II (Figure 8.5). While 
consumption among moderate baseline drinkers remained little changed over time, male and 
female participants in the highest categories exhibited a marked decline in drinking with 
advancing age, with gradual increases in consumption among infrequent drinkers. Accordingly, 
depending upon the point in the life course at which baseline categories are defined, moderate 
drinkers may be subject to differential degrees of misclassification error through contamination 
with heavy and infrequent drinkers. Given the longitudinal convergence of baseline 
consumption categories toward moderate volumes, misclassification error may be most 
pronounced in cohorts of older ages. This may go some way toward explaining the less 
pronounced reductions in the risk of CHD409 and all-cause mortality395 reported elsewhere 
among moderate drinkers in older age groups. 
Further stratifying longitudinal trajectories according to the diagnosis of T2DM revealed that the 
risk of misclassification error appeared greatest among men and women who developed the 
condition, with greater rates of change as a function of age than those who were censored 
(Figures 8.10 and 8.11). In particular, consumption among male moderate baseline drinkers 
increased to such a degree as to be markedly higher than originally classified come the time of 
diagnosis. As a consequence, conventional survival analyses may risk overestimating the 
hazardous effects of moderate drinking among men by failing to consider increases to their 
consumption over time. By contrast, while moderate female drinkers who developed T2DM 
instead showed little change in consumption over time, they instead risked being increasingly 
contaminated by infrequent and former heavy drinkers depending upon the point of baseline 
measurement. As such, studies of women with a shorter time to event may underestimate any 
advantageous effects of moderate drinking by giving no consideration to the disparate drinking 
histories of cross-sectionally defined moderate drinkers. 
Longitudinal changes to the volume of alcohol consumption as reported in Chapter 8 help draw 
attention to the risk of misclassification error inherent to conventional survival analyses 
according to the age of participants at baseline and the time to diagnosis. In so doing, Chapter 
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8 highlights the possibility that studies may be improved by analyses that give consideration to 
changes in alcohol consumption across the life course. 
10.2.2 Differences in alcohol consumption according to the diagnosis of T2DM  
Based on the current literature, a number of hypotheses were proposed concerning how the 
mean trajectory of alcohol consumption might differ by T2DM status. These included the 
possibility that the increased risk of T2DM associated with higher volumes of consumption may 
accumulate over time and therefore be indicated by prolonged or permanently elevated intakes 
among participants who developed the condition – particularly among men, for whom 
reductions in risk were not apparent at any level according to the revised and updated meta-
analysis reported in Chapter 3. Alternatively, it was possible that increases or decreases in the 
risk of T2DM might instead be specific to a period of the life course during which sensitivity to 
the effects of alcohol may be elevated. 
While male intake was equivalent around 30 years prior to diagnosis, differences by diagnosis 
category gradually increased over time. At the point of diagnosis or censoring, consumption 
among men that developed T2DM was higher than among those who were censored, with a 
difference equal to around 1.8 pints of 4.0% ABV lager per week on average. With an average 
age at the time of diagnosis of 62 years, male consumption trajectories were most in keeping 
with the second hypothesis: that male sensitivity to the deleterious effects of alcohol 
consumption may be most pronounced later in the life course.  
By contrast, neither hypothesis was supported by results from models applied to women. Rather 
than consumption among those who developed the condition being consistently higher than 
among censored female participants, or highest specifically during the few years preceding 
diagnosis, mean consumption was instead consistently below that of women who did not 
develop T2DM. Such a finding was in conflict with results from the revised meta-analysis in 
Chapter 3, particularly with mean consumption among both groups of women being 
permanently within the threshold at which reductions in risk were reported (Chapter 3).  
At least two reasons for this incongruity were possible. First, the plotting of mean consumption 
trajectories may have masked important differences in the constitution of each female 
trajectory. For instance, the mean trajectory for women who developed T2DM may have been 
comprised not primarily of persistent low volume and therefore lower risk drinkers, but of both 
infrequent and former heavy drinkers who may have attenuated their drinking due to poor 
health prior to study participation. Loosely supporting this, sensitivity analyses that plotted the 
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same trajectories but excluded zero consumption data indicated that transitions to non-drinking 
prior to diagnosis or censoring appeared most common among women who developed T2DM, 
attenuating the difference between the two trajectories (Appendix 8.25). It was therefore 
plausible that women at risk of T2DM tended to drink alcohol in lower volumes or were more 
likely to transition to abstention due to adverse health effects from pre-diabetes or its 
associated risk factors. In this sense, though their volume of drinking was within the range 
associated with a lower risk of T2DM, this reduction in risk may have been offset by risk factors 
unaccounted for in the crude analyses. As an alternative explanation, it was also plausible that 
the absence of trajectories consistent with a priori hypotheses may have been attributable to a 
relatively limited range of alcohol consumption among women, with heavier drinkers being few 
in number. As such, higher-risk heavier drinkers may have been hidden by a vastly greater 
proportion of more moderate female drinkers who developed the condition. 
10.2.3 Importance of different dimensions of the longitudinal trajectory 
10.2.3.1 Intercept versus current consumption 
10.2.3.1.1 Primary findings 
Despite marked changes to the volume of drinking across the life course, and apparent 
differences in longitudinal alcohol consumption among men by diagnosis status, survival 
analyses have conventionally parameterised the dose-response relationship according to just a 
single cross-sectional measurement obtained at baseline. A final series of analyses was thus 
undertaken to formally explore the appropriateness of limiting the parameterisation of alcohol 
consumption in such a fashion. 
To achieve this, shared random effects models were constructed that calculated the dose-
response relationship according to whether drinking was defined at the intercept (40 years) or 
the time of diagnosis (mean 62 years of age), with a further analysis undertaken to model both 
parameters concurrently so as to establish the relationship of each parameter with T2DM after 
accounting for future or prior drinking. By using age as the timescale, such analyses also 
permitted some inference to be made as to differences in the dose-response relationship 
according to the age at which alcohol was consumed. Although the use of age as a timescale is 
currently rare within the alcohol literature, with only one study selected as part of the revised 
and updated meta-analysis having adopted such an approach,245 sensitivity analyses that used 
the more conventional time-to-event timescale corroborated findings from the primary analyses 
(Appendices 9.5 and 9.6). 
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In models that parameterised the longitudinal trajectory according to consumption at the 
intercept, results were in keeping with those from the revised and updated meta-analyses 
reported in Chapter 3, whereby reductions in risk were specific to female drinkers (Table 9.5). 
When the relationship between the weekly volume of alcohol consumption and T2DM risk was 
instead parameterised according to the current value of alcohol consumption, reductions in risk 
remained among women but were attenuated in magnitude (Table 9.5). However, when the 
dose-response relationship was calculated between the intercept and T2DM risk following 
adjustment for consumption later in the life course, significant reductions in risk were apparent 
among both sexes, with the magnitude of reduction still greatest among women, at 36% per 
two-fold increase in consumption versus 20% among men (Table 9.6). By contrast, when the 
current value of consumption was modelled after holding constant the volume of drinking at the 
intercept, increased risks of T2DM were evident among both sexes. Such a finding confirms that 
both parameterisations exhibit statistically independent and divergent relationships with T2DM 
risk, and thereby suggests that conventional survival analyses fail to capture differences in dose-
response across the life course due to their use of a single baseline measure. 
That risks associated with higher volumes of consumption appeared more pronounced with 
advancing age was an effect in accordance with findings from Chapter 8 and consistent with 
studies that report an age-related deterioration to the alcohol metabolism.196,197,198,199 While 
such deterioration may to individuals of a more advanced age experiencing longer periods of 
exposure to higher concentrations of pro-inflammatory metabolites such as acetaldehyde and 
acetate,200,201 insufficient evidence is currently available to substantiate a dose-response effect 
of alcohol consumption upon inflammatory biomarkers, or how any such effect might operate 
differentially across the life course.  
10.2.3.1.2 Possible explanations for sex-specific dose-response effects 
Differential biological pathways 
Analyses undertaken in Chapters 3, 7 and 9 all report reductions in the risk of T2DM as being 
either specific to or most pronounced among women when defined at baseline, even following 
adjustment for consumption at the time of diagnosis. The reproducibility of this difference lends 
credence to the possibility that putative biological pathways may operate differently between 
men and women. However, of the studies available, little evidence of a sex interaction is 
currently apparent. While there is some suggestion from interventional studies that acute 
alcohol exposure may elicit a greater increase in insulin sensitivity among women than men, 
such a disparity was no longer statistically significant following the exclusion of a study that 
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represented a primary source of between-study heterogeneity.112 Although studies investigating 
the effect of alcohol upon HDL concentration are far greater in number, no sex-specific effects 
have been identified across interventional118 or Mendelian randomisation studies.85 Similarly, 
there is no apparent difference in CRP concentration among men and women sampled across 
42 Mendelian randomisation studies,85 while a meta-analysis of the few interventional studies 
investigating alcohol and inflammatory markers reported no sex interaction.118 Though possible 
that putative biological mechanisms may indeed operate differentially between men and 
women, robust supporting evidence is lacking.  
Differential drink preference 
Alternative explanations considered included sex-specific differences in drink preference. While 
current evidence tends to indicate greater reductions in risk among study participants who 
consume wine,238,246,398 no such effect appeared evident within the Whitehall II cohort, with no 
difference in dose-response found by drink type within preliminary conventional analyses (Table 
7.6). Although the magnitude of reductions in risk appeared greatest for beer consumption, 
current evidence concerning pathways between beer-specific compounds any anti-
inflammatory response was only available from a small number of in vitro399 and in vivo animal 
studies.400 Given its potency, it seems more likely that the inflammatory effects of ethanol may 
far outweigh any anti-inflammatory effects of drink-specific compounds.282 
Differential consumption patterns 
An alternative hypothesis concerned the possibility that female drinkers within the cohort were 
more likely to spread their weekly volume of alcohol consumption over a greater number of 
days, with a larger proportion of men being episodic heavy drinkers. Such an assertion was 
mooted following research indicating that reductions in the risk of T2DM and other vascular 
events may be lowest among regular moderate drinkers,95,97,240,244 with elevated risks most 
apparent among binge and episodic heavy drinkers,96 244 even if binge drinkers otherwise 
consume alcohol at moderate volumes the majority of the time.268 When continuous weekly 
alcohol consumption data were modelled in Chapter 7 with an interaction according whether 
participants consumed alcohol on a daily or non-daily basis, interaction terms were statistically 
insignificant for both sexes (Table 7.5). It was likely that the absence of a statistically significant 
interaction was attributable to Whitehall II volume and frequency data being insufficient to 
explicitly identify episodic heavy drinking – the specific characteristic most strongly associated 
with heightened risks relative to regular moderate drinking. However, even were such variables 
available, it was possible that the number of episodic heavy drinkers may have been insufficient 
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to detect an interaction, with both excessive consumption and binge drinking most prevalent 
within lower socio-economic groups396,397 and the Whitehall II being skewed toward higher levels 
of socio-economic status. 
Interaction with sex hormones 
A final alternative hypothesis pertains to the possibility that sex hormones may play a role in 
modifying the effect of alcohol upon T2DM risk. To date, two hormonal biomarkers have been 
implicated as modifiers of T2DM risk: estradiol, a female sex hormone, and SHBG, a protein 
involved in the transport of sex hormones. Although results pooled from multiple case-control 
studies have indicated no difference between men and women in the concentration of estradiol 
by diagnosis status, women who develop T2DM showed lower concentrations of SHBG while 
men displayed no difference in concentration by diagnosis status.273 Unfortunately, in addition 
a lack of any clear pathway by which factors such as SHBG may modify T2DM risk,273 research 
concerning a sex-specific effect of alcohol consumption upon hormone transport activity is 
lacking and almost entirely cross-sectional.  
Summary 
Current research is insufficient to draw any firm conclusions as to why female drinkers appear 
to experience the greatest reduction in the risk of T2DM. In the absence of further and more 
robust analyses concerning sex differences in the effects of alcohol consumption upon putative 
biological pathways, disparities in consumption pattern are perhaps the most likely 
determinant, with data from UK-based studies indicating a greater prevalence101 and 
probability269 of episodic heavy drinking among men.  
Whatever the precise reason for differences in dose-response between men and women, it is 
clear from more advanced survival analyses that the association between alcohol consumption 
and T2DM risk is likely to be more complex than captured from conventional survival analyses, 
which fail to consider differences in dose-response across the adult life course.  
10.2.3.1.3 Effect of abstention category upon dose-response 
Criticism has been levelled at the use of pooled non-drinkers as a reference group, with 
reductions in risk among current drinkers purported to be artificially increased given its inclusion 
of former drinkers predisposed to an increased risk of negative health events.136,137 In response, 
the revised and updated meta-analysis reported in Chapter 3 included sex-adjusted dose-
response curves stratified according to whether selected studies utilised a pooled non-drinking 
or strictly-defined never drinking abstention category. The dose-response relationship differed 
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significantly according to the choice of abstention reference category, with reductions in risk 
most pronounced among studies that calculated risks relative to pooled non-drinkers (Figure 
3.5). Such a finding is in keeping with studies of alcohol consumption and all-cause mortality, 
which report attenuated reductions in risk among current drinkers when former drinkers are 
excluded from the abstention reference category.136,147,148 
In Chapter 7 (Appendices 7.7 and 7.8) and Chapter 9 (Tables 9.5 and 9.7), sensitivity analyses 
were undertaken which calculated the dose-response relationship with and without adjustment 
for or the inclusion of heterogeneous infrequent and non-drinkers. Results from these analyses 
are in line with the meta-analysis of conventional survival studies, confirming the importance of 
disaggregating heterogeneous non-drinkers and accounting for any effect they may have upon 
the perceived harms or benefits of current drinking. In both chapters, effects were most 
pronounced among women. This nuance may have been attributable in part to the 
multivariable-adjusted risks among male infrequent and non-drinkers drinkers being closer to 
the null than among women (e.g. Table 9.5).  
10.2.4 Sick quitter effects 
Participants who reduce their intake over course of a study have for a long time been referred 
to as ‘sick quitters’ who attenuate their consumption owing to ill-health. 136,138 Such an assertion 
is supported by studies that report a higher prevalence of T2DM risk factors139,140 and poor self-
reported health141,142,143 among former drinkers than current drinkers, with the onset of ill-
health associated with a subsequent cessation from alcohol consumption.144,145,146 However, 
following a piecewise analysis of consumption trajectories prior to and following diagnosis 
(Figure 8.9), downward trajectories were only apparent after the date of diagnosis, suggesting 
that the effect of pre-diabetic symptoms may have been insufficient to elicit a change to drinking 
behaviour. Furthermore, when trajectories were stratified by baseline consumption, downward 
slopes were specific to heavier drinkers and evident regardless of sex or diagnosis status (Figures 
8.10 and 8.11). Such results indicate that any downward trajectories prior to diagnosis may not 
have been a consequence of declines to health status of a kind associated with a heightened 
T2DM risk. 
To explore this formally, shared random effects models were constructed that reported the 
effect of differences in the longitudinal rate of change upon the risk of T2DM after adjustment 
for past and current volume of consumption. As reported in Table 9.8, men and women who 
reduced their alcohol consumption at a faster rate than the sample average experienced a lower 
risk of T2DM, though risk estimates were non-significant. Such a finding appeared contrary to 
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the sick quitter hypothesis. However, it was possible that the presence of a sick quitter effect 
was lost as a consequence of the diverse reasons for which study participants attenuate their 
alcohol consumption, including financial constraints and a decline in opportunities for social 
drinking408 – factors not necessarily associated with T2DM risk. Thus, while some adults who 
reduce their consumption may indeed do so as a result of a deteriorating health status, a 
downward trajectory is not necessarily indicative of a heightened risk of T2DM but may instead 
be part of normal ageing processes. 
10.3 Limitations 
Despite a systematic attempt to describe and mitigate the impact of methodological 
shortcomings within the existing literature, a number of weaknesses remain that may potentially 
have biased or undermined the validity of reported associations.  
Perhaps the primary limitation concerns the variable used to denote the average weekly volume 
of alcohol consumed. Rather than strictly representing each participant’s average weekly intake, 
the variable was derived from questions that referred to the volume consumed during the week 
prior to each interview. It was possible that the volume of alcohol intake as documented during 
the week prior to an interview provided a poor surrogate for true average weekly consumption. 
For instance, heavy drinking during the week prior to interview may not have been indicative of 
a participant’s average weekly consumption throughout a given year, but instead an 
uncharacteristic period marked by a special occasion such as a family member’s birthday or 
wedding. Such a situation would thus have reflected an episodic heavy drinking occasion as 
opposed to a high average weekly volume of alcohol consumption. Unfortunately, episodic 
heavy drinking occasions, as associated elsewhere with a heightened risk of T2DM,96,240,245 could 
not be captured using the volume and frequency variables available within the Whitehall II 
cohort. It was perhaps because of this that interactions between these two drinking dimensions 
were not statistically significant, providing a poor parameterisation of the type of consumption 
pattern most associated with elevated risks of T2DM. The true effect of unobserved episodic 
heavy consumption upon the relationship between the weekly volume of alcohol consumption 
and T2DM risk was thus unknown and dependent upon the distribution of such episodes across 
the volume distribution.  
More useful alcohol consumption data may have been obtained from a graduated frequency 
questionnaire, which ask participants about the frequency with which they typically consume 
alcohol according to a series of pre-defined volumes. Such methods have been found to yield 
higher average volumes of estimated alcohol consumption than quantity-frequency 
Chapter 10: Discussion  
271 
 
questionnaires,391 and would help with the identification of episodic heavy consumption. The 
identification of such episodes is likely to be critical to providing a more accurate assessment of 
the benefits and risks associated with alcohol consumption.  
Although associations identified within the Whitehall II cohort appear consistent with those 
reported from studies of general population samples, 296 it should nonetheless be noted that the 
relatively low volume of alcohol consumption was such that power to detect increases in the 
risk of T2DM at higher levels of the volume distribution was likely to have been impaired. Thus, 
although the presence of a non-linear dose-response relationship was tested in Chapter 7 as 
part of a conventional survival analysis, the null result was unlikely to have been a consequence 
of a true linear reduction in risk at ever-increasing volumes of alcohol consumption but rather 
an insufficient number of heavier drinkers with which to detect a turning point in the dose-
response relationship. For instance, while point estimates from the meta-analysis in Chapter 3 
indicate that the risk of T2DM becomes elevated among women at volumes >140 g/week, 
relative to pooled non-drinkers, just 152 women within the Whitehall II cohort reported 
consumption anywhere above that level at wave three, with the figure falling to just 105 by wave 
11. 
Another notable limitation concerned the application of imputed data. Firstly, regarding 
imputed values of alcohol consumption, it was not possible to predict never drinking among 
participants with missing alcohol consumption data due to the small number of strictly defined 
never drinkers within the Whitehall II cohort. As such, analyses inclusive of a categorical alcohol 
consumption variable were restricted to participants with observed alcohol consumption data 
only. Given that the median volume of alcohol consumption was lower and the prevalence of 
metabolic risk factors greater at the commencement of the study among participants with unit 
(Table 6.5) or item non-response (Table 6.7) than those with complete-case data, restriction of 
the dataset may have resulted in an underrepresentation of higher-risk light or non-drinkers in 
survival analyses undertaken for Chapters 7 and 9.  
Aside from limitations concerning the use of imputed categories of alcohol consumption, 
constraints of the statistical software are such that it was not possible to utilise imputed T2DM 
and time to event data. As noted above, participants with unit non-response tended to have a 
worse metabolic risk profile at baseline than those with complete-case data. It was therefore 
likely that the incidence of T2DM among the original cohort was underestimated, with analyses 
applied to a healthier sub-sample than originally participated. The precise impact of such 
attrition upon reported dose-response relationships would be dependent upon how unobserved 
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cases were dispersed across the alcohol consumption distribution. For instance, were attrition 
more common among heavier drinkers, then any increased risk associated with higher volumes 
of alcohol intake would have been underestimated. Perhaps as a consequence of the limits 
concerning the imputed data that could be applied, differences in the primary dose-response 
relationship between models applied to the observed and imputed datasets were negligible.  
10.4 Strengths 
A deliberate attempt was made to systematically overcome the limitations inherent to the 
existing body of epidemiological research in the field, with a view to providing a more accurate 
and detailed understanding of the dose-response relationship between alcohol consumption 
and the risk of T2DM.  
Firstly, contrary to the vast majority of current studies, participants with zero consumption were 
disaggregated into heterogeneous infrequent and non-drinking categories, each posited and 
later confirmed to exhibit disparate and usually elevated risks of T2DM, relative to current 
drinkers (Table 9.6). Rather than combining these heterogeneous groups into a single reference 
category, as per convention, risk estimates were instead adjusted for differences in risk between 
heterogeneous non-drinkers. Such an approach is expected to have helped reduce the extent to 
which any reductions in risk reported among current drinkers occurred as an artefactual 
consequence of having compared drinkers against a number of less healthy non-drinkers (Table 
7.2). Such an approach is supported by research elsewhere,136,137,148,437 as well as by results from 
the meta-analysis in Chapter 3, which showed a greater reduction in risk at moderate volumes 
of consumption when former drinkers were included within the abstention reference category. 
In addition, contrary to the minority of current studies to have also distinguished between 
different non-drinking groups,96,219,230,244 never drinkers were not defined according to a single 
self-report of life-long abstention. With longitudinal research elsewhere having reported that 
between 52%,150 67%315 and 87%438 of study participants cross-sectionally defined as never 
drinkers had previously reported drinking at an earlier wave, never drinkers were instead coded 
as those who consistently reported being never drinkers and who declared zero consumption at 
all previous waves, thereby reducing the misclassification of never drinkers. 
This project is the first to report differences in the longitudinal trajectory by T2DM diagnosis, 
highlighting discrepancies in the volume of alcohol consumption and thereby the periods in 
which increases or decreases in risk may most likely be conferred (Chapter 8). The results 
reported in Chapter 9 also represent one of the very few instances in which consideration has 
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ever been given to longitudinal changes in alcohol consumption, with just two previous studies 
known to have documented the risk of T2DM according to temporal variations in 
consumption.153,267 Contrary to the approaches adopted by these two studies, the analyses in 
reported in Chapter 9 estimated the independent dose-response relationship between different 
dimensions of the longitudinal trajectory and T2DM, utilising advanced joint modelling 
techniques that provide more accurate estimates than simpler analytic alternatives.411,412  
10.5 Further research 
Results reported in Chapter 9 indicate that the risks associated with drinking may be especially 
pronounced in older age, potentially countering any reductions in risk conferred earlier in the 
life course. Important now are replication studies designed to establish whether the same dose-
response associations are present in different cohorts. Such research should focus upon the 
analysis of longitudinal datasets with repeated measures of sufficient regularity and covering as 
broad a duration of the adult life course as to model acute fluctuations in dose-response with 
advancing age. In selecting studies for testing reproducibility, a number of other important 
characteristics should be considered given the limitations present within Whitehall II.  
Firstly, because of the narrow range of weekly alcohol consumption reported by Whitehall II 
participants, cohorts should be selected with a greater number of heavier drinkers, providing a 
better capacity for modelling the non-linear associations indicated in Chapter 3. Secondly, with 
apparent differences in dose-response according to whether or not individuals participate in 
binge drinking,94,240,245 and an underestimation of average consumption based on quantity-
frequency questionnaires,391 chosen cohorts should provide more accurate alcohol consumption 
estimates and sufficient detail for identifying episodic heavy drinking occasions. To achieve this, 
studies may benefit from the addition of objective transdermal ethanol sensing as a means of 
monitoring blood alcohol concentrations over extended periods. Such data may prove useful as 
a means of validating the accuracy of survey-based self-reports, adjusting subjectively reported 
consumption data as required.439 Thirdly, to reliably test interactions between the volume of 
alcohol consumption and factors such as episodic heavy drinking, cohorts should be of a size 
sufficient to permit tests of sound statistical power. One future possibility is the UK Biobank, 
which sampled close to 500,000 adults aged 40-69 years by 2010 and is estimated to have 
statistical power sufficient to detect an odds ratio ≥1.3 after just six years of follow-up for 
T2DM.440 
Although reductions in risk appear either specific to or most prominent among female drinkers, 
research concerning sex-specific differences in the action of putative biological pathways is weak 
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and inconclusive. Heterogeneous in design and often conflicting in their conclusions, findings 
are commonly reported by cross-sectional or small-scale interventional studies. Further 
research is required to better understand the dose-response effects of alcohol consumption 
upon hypothesised causal intermediates, including insulin sensitivity, HDL concentration and 
inflammatory response. Such research may benefit from structural equation models designed 
to quantify both the effect of alcohol upon intermediate factors and the effect of changes to 
those intermediate factors upon T2DM risk. At present, no analysis has been published that 
considers the causal pathway in full.  
10.6 Policy implications 
Since at least 2004,441 reviews of the evidence base have reported reductions in the risk of T2DM 
at moderate volumes of regular consumption, with similar findings reported elsewhere for 
vascular conditions ranging from ischaemic heart disease and stroke.442 Although recent meta-
analyses10,84 suggest that that peak reductions in the risk of T2DM may be conferred at volumes 
close to the current recommended limits of 21 units/week among men and 14 units/week 
among women,98 T2DM prevention strategies in the UK give no consideration to the role of 
alcohol, with public health interventions focussing instead upon the impact of other lifestyle 
factors such as diet and physical activity.9 
This omission sits contrary to recommendations by some academics that at-risk patients be 
encouraged to incorporate moderate drinking into their diet,443,444 and the general public 
advised that moderate drinking may afford an overall health benefit,443 even among 
abstainers.445 That such recommendations have yet to be adopted by the UK government 
appears attributable to a lack of consensus amongst epidemiologists regarding the health 
benefits of drinking.170 This lack of consensus stems from series of methodological shortcomings, 
including poor confounder adjustment,139,446 a lack of established biological mechanisms446 and 
the misclassification of drinking categories.446,136,148 
With the benefits of moderate alcohol consumption reported by existing studies likely to have 
been overestimated, and insufficient evidence available to substantiate a clear biological 
mechanism by which alcohol may reduce the risk of T2DM, the appropriateness of using the 
current literature as grounds for recommending a specific volume of moderate drinking either 
at the population level or among at-risk sub-groups is questionable. This is especially so when 
considering the net impact of alcohol consumption, with drinking even at low volumes having 
been associated with increases in the risk of various cancers.432 Indeed there are calls from some 
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quarters that alcohol guidelines should explicitly discourage the drinking of alcohol for perceived 
health benefits.447  
Health policy may need to be more nuanced than these two starkly opposed positions, instead 
advising a general attenuation to the volume of alcohol consumed. Such a position affords two 
benefits. First, regardless of whether alcohol consumption exhibits J-shaped or linear 
associations with assorted non-communicable diseases, the net burden of harms associated 
with alcohol consumption would be lowered through a general reduction in the volume of 
consumption. Second, by avoiding any suggestion that moderate alcohol consumption may 
provide a benefit to health, the danger of inadvertently encouraging abstainers to resume 
consumption would be mitigated. This second point is important given that adults who abstain 
appear to do so owing to previous alcohol abuse problems, existing ill-health, pregnancy or 
contraindication with medication.145,146,408 
Evidence from analyses reported in Chapter 9 suggest that initiatives or policies designed to 
reduce alcohol consumption may need to pay particular attention to older drinkers. Such a focus 
is supported by the Royal College of Psychiatrists, which argues that alcoholism and alcohol-
related harms within older populations are an under-recognised problem within the UK, with 
public health policy giving scant consideration to the risks facing drinkers in older age.448 In 
response to a perceived oversight by policymakers, the Royal College of Psychiatrists has advised 
the introduction of age-specific consumption guidelines as a means of communicating at the 
population level the heightened risks to health experienced by older drinkers, recommending 
no more than 10.5 units/week for persons aged ≥65.448 However, although the implementation 
of an age-specific drinking guidelines for older populations may appear appropriate, such an 
approach should be balanced against the risk of creating a more complex and less unified health 
message.449 With the body of current yet methodologically limited evidence indicating that any 
cardiovascular benefit from drinking may be limited solely to women aged >55 years who 
consume volumes below just 5 units/week, and with the risk of non-vascular conditions 
apparently elevated among both sexes even at low volumes,99 health messages for older adults 
should be no different from those for the general population: that current drinkers should aim 
to reduce the amount they drink, and that non-drinkers should be encouraged to maintain their 
abstinence. 
One notable recommendation from the 2016 Alcohol Guidelines Review was that the alcohol 
consumption guideline for men should be reduced from 21 units/week to 14 units/week.99 Such 
a decision was based on new evidence concerning an increased risk of cancer at low volumes of 
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consumption and the burden of acute alcohol-related harms that appears to disproportionately 
befall men, such as drink-related road traffic collisions. Nevertheless, such a recommendation is 
circumstantially in keeping with results reported throughout this project, which indicate that the 
risk of T2DM may also be greatest among male drinkers, regardless of the age at which alcohol 
is consumed. To date, precise reasons underlying this difference are unclear. Of the various 
possibilities considered, perhaps the most likely factor concerns disparities in drinking pattern 
by sex, with episodic heavy drinking associated with heightened risks for both 
T2DM95,96,97,239,240,244,245 and ischaemic heart disease,268 and such drinking patterns being most 
prevalent among men.101,269 It is therefore reassuring that the 2016 Alcohol Guidelines Review 
explicitly advises against heavy drinking occasions, with the caveat that adults who continue to 
binge drink should at the very least aim to reduce the frequency of such behaviour.99  
While some academics call for the promotion of moderate alcohol consumption among both 
sexes, observational studies indicative of protective effects at moderate volumes of intake are 
methodologically weak, with clear causal mechanisms yet to be clearly established. Pending 
more reliable information concerning the effect of alcohol upon T2DM and a broad range of 
health conditions, it is inappropriate to recommend that adults take up moderate drinking for a 
perceived benefit to health, especially given that individuals who abstain from drinking may do 
so for reasons including a history of addiction, chronic ill-health, pregnancy or pharmaceutical 
contraindication. Instead, current drinkers should be advised to attenuate both their average 
weekly consumption and frequency of episodic heavy drinking as a precaution against risks 
associated with heavy drinking. 
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Appendix 3.2 The Newcastle-Ottawa quality assessment checklist 
NEWCASTLE-OTTAWA QUALITY ASSESSMENT SCALE FOR COHORT STUDIES 
Note: A study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability. 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average current drinker in the community *  
b) somewhat representative of the average current drinker in the community * 
c) selected group of users, e.g. nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non-exposed cohort 
a) drawn from the same community as the exposed cohort * 
b) drawn from a different source 
c) no description of the derivation of the non-exposed cohort  
3) Ascertainment of exposure 
a) secure record, e.g. surgical records * 
b) structured interview * 
c) written self-report, e.g. postal questionnaire 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes * 
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis 
a) study controls for a measure of adiposity * 
b) study controls for any additional factor *  
Outcome 
1) Assessment of outcome  
a) independent blind assessment or objective ascertainment * 
b) record linkage * 
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur 
a) yes, at least six years duration * 
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b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up: all subjects accounted for *  
b) subjects lost to follow up unlikely to introduce bias: >5% lost, or description of those lost 
c) follow up rate <95% and no description of those lost 
d) no statement 
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11.2 Appendices for Chapter 6 
Appendix 6.1 Effect of dietary factors upon the alcohol-T2DM relationship 
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Appendix 6.2 Trace plots illustrating convergence on key variables 
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11.3 Appendices for Chapter 7 
Appendix 7.1 Crude Nelson-Aalen cumulative hazard estimate, stratified by sex. Observed 
data. 
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Appendix 7.2 Baseline characteristics of participants free of T2DM at wave three and with 
valid follow-up data, stratified by sex. Imputed data. 
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Appendix 7.3 Crude Nelson-Aalen cumulative hazard estimate, stratified by sex and category 
of average weekly volume of alcohol consumption. Observed data. 
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Appendix 7.4 Crude Nelson-Aalen cumulative hazard estimate, stratified by sex and frequency 
of alcohol consumption. Observed data. 
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Appendix 7.5 Baseline characteristics of participants free of T2DM at wave three and with 
valid follow-up data, stratified by sex and categories of average weekly volume of alcohol 
consumption. Imputed data. 
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Appendix 7.6 Multivariable-adjusted dose response relationship between categories of 
average weekly volume of alcohol consumption and T2DM, stratified by sex. Imputed data. 
 
 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Never drinkersa (reference) (reference)
Non-current drinkers b 1.26 (0.61-2.64) 0.531 1.12 (0.53-2.39) 0.769
Infrequent drinkers c 0.99 (0.57-1.74) 0.981 1.62 (0.92-2.88) 0.098
0.1-50.0g/week 0.97 (0.57-1.64) 0.905 1.06 (0.59-1.91) 0.845
50.1-100.0g/week 1.03 (0.60-1.76) 0.925 0.86 (0.42-1.73) 0.666
100.1-150.0g/week 1.05 (0.60-1.84) 0.866 0.58 (0.27-1.25) 0.163
>150.0g/weekd 1.01 (0.59-1.73) 0.972 - -
Log likelihood -4733 (-4735, -4731) -1963 (-1964, -1962)
BIC e 9630 (9625, 9634) 4066 (4064, 4068)
Men (n=5,456) Women (n=2,434)
Models adjusted for all  a priori covariates at baseline: age, BMI, employment status, ethnicity, 
family history of T2DM, occupational grade, physical activity, smoking status. Ethnicity was 
derived from responses at waves one and five.
aParticipants who reported no consumption in the past week in waves 1 and 3, no consumption 
in the past year in waves 1 and 3, and stated they had 'always been a non-drinker' in wave 3, the 
first year the always non-drinker variable was available;   bParticipants who reported no 
consumption in the last year but had not 'aways been a non-drinker'; cConsumed alcohol in the 
past year but not in the past week; dAmong women, this category was merged with those who 
reported consuming 100.1-150.0g/week; eBayesian information criterion. Fit statistics refer to 
the mean and range of values reported by the first three imputations.
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Appendix 7.7 Multivariable-adjusted interaction between a continuous measure of average weekly 
alcohol volume and consumption frequency, stratified by sex and excluding non-current and 
infrequent drinkers. Imputed data. 
 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Men (n=4,770)
Dose-response by volume
Per 10 g/week increase 1.00 (0.99-1.01) 0.761 1.00 (0.99-1.01) 0.480
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 0.89 (0.67-1.20) 0.449
Difference in dose-response by 
frequency
Daily - - (reference)
Non-daily - - 1.01 (0.98-1.03) 0.653
Log likelihood -4074 (-4076, -4072) -4074 (-4075, -4071)
BIC a 8267 (8262, 8270) 8283 (8278, 8286)
Women (n=1,814)
Dose-response by volume
Per 10 g/week increase 0.95 (0.92-0.99) 0.021 0.96 (0.91-1.02) 0.156
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 1.06 (0.52-2.17) 0.867
Difference in dose-response by 
frequency
Daily - - (reference)
Non-daily - - 0.95 (0.87-1.05) 0.324
Log likelihood -1095 (-1095, -1095) -1094 (-1094, -1094)
BIC a 2295 (2295, 2295) 2308 (2308, 2309)
Model 1 reported the linear dose-response relationship between volume alcohol consumption 
and T2DM. Model 2 included an interaction term between a continuous measure of volume 
alcohol consumption and whether participants reported drinking alcohol daily or less than 
daily over the year preceding interview. All models adjusted for baseline covariates: age, BMI, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity, 
smoking status. Ethnicity was derived from responses at waves one and five. All  models 
excluded non-current drinkers from the reference level of exposure (0g/week). aBayesian 
information criterion. Fit statistics refer to the mean and range of values reported by the first 
three imputations.
Model 1 Model 2
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Appendix 7.8 Multivariable-adjusted interaction between a continuous measure of average 
weekly volume of alcohol consumption and drinking frequency, stratified by sex and including 
non-current and infrequent drinkers. Observed data. 
 
 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Men (n=4,874)
Dose-response by volume
Per 10 g/week increase 1.00 (0.99-1.00) 0.504 0.99 (0.98-1.00) 0.240
Difference in risk by frequency
Dai ly - - (reference)
Non-dai ly - - 0.86 (0.65-1.14) 0.301
Difference in dose-response 
by frequency
Daily - - (reference)
Non-daily - - 1.00 (0.98-1.03) 0.621
Log likelihood -4177 -4177
BIC a 8473 8489
Women (n=2,094)
Dose-response by volume
Per 10 g/week increase 0.94 (0.90-0.97) 0.001 0.93 (0.86-1.00) 0.055
Difference in risk by frequency
Dai ly - - (reference)
Non-dai ly - - 0.78 (0.35-1.72) 0.536
Difference in dose-response 
by frequency
Daily - - (reference)
Non-daily - - 0.97 (0.88-1.08) 0.536
Log likelihood -1700 -1700
BIC a 3507 3519
Model 1 Model 2
Model 1 reported the linear dose-response relationship between volume alcohol consumption 
and T2DM. Model 2 included an interaction term between a continuous measure of volume 
alcohol consumption and whether participants reported drinking alcohol daily or less than 
daily over the year preceding interview. All models adjusted for baseline covariates: age, BMI, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity, 
smoking status. Ethnicity was derived from responses at waves one and five. All  models 
included non-current drinkers in the reference level of exposure (0g/week).
aBayesian information criterion.
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Appendix 7.9 Multivariable-adjusted interaction between a continuous measure of average 
weekly volume of alcohol consumption and drinking frequency, stratified by sex and including 
non-current and infrequent drinkers. Imputed data. 
 
 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Men (n=5,464)
Dose-response by volume
Per 10 g/week increase 1.00 (0.99-1.01) 0.695 1.00 (0.99-1.01) 0.565
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 0.94 (0.72-1.23) 0.661
Difference in dose-response by 
frequency
Daily - - (reference)
Non-daily - - 1.00 (0.98-1.02) 0.910
Log likelihood -4734 (-4736, -4731) -4734 (-4735, -4731)
BIC a 9588 (9583, 9592) 9605 (9600, 9609)
Women (n=2,437)
Dose-response by volume
Per 10 g/week increase 0.93 (0.90-0.97) <0.001 0.93 (0.86-1.00) 0.039
Difference in risk by frequency
Daily - - (reference)
Non-daily - - 0.81 (0.39-1.67) 0.562
Difference in dose-response by 
frequency
Daily - - (reference)
Non-daily - - 0.95 (0.87-1.05) 0.347
Log likelihood -1964 (-1965, -1962) -1962 (-1963, -1961)
BIC a 4037 (4035, 4039) 4048 (4046, 4051)
Model 1 reported the linear dose-response relationship between volume alcohol consumption 
and T2DM. Model 2 included an interaction term between a continuous measure of volume 
alcohol consumption and whether participants reported drinking alcohol daily or less than 
daily over the year preceding interview. All models adjusted for baseline covariates: age, BMI, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity, 
smoking status. Ethnicity was derived from responses at waves one and five. All  models included 
non-current drinkers in the reference level of exposure (0g/week). aBayesian information 
criterion. Fit statistics refer to the mean and range of values reported by the first three 
imputations.
Model 1 Model 2
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Appendix 7.10 Multivariable-adjusted dose response relationship between categories of 
average weekly volume of alcohol consumption and T2DM, stratified by sex. Hazards were 
permitted to vary as a function of linear time. Observed data. 
 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Risk at baseline
Never drinkersa (reference) (reference)
Non-current drinkers b 1.83 (0.30-11.24) 0.515 8.41 (0.79-89.64) 0.078
Infrequent drinkers c 0.87 (0.20-3.85) 0.856 11.99 (1.59-90.47) 0.016
0.1-50.0g/week 1.13 (0.29-4.40) 0.864 9.48 (1.23-73.25) 0.031
50.1-100.0g/week 1.44 (0.35-5.86) 0.610 4.28 (0.42-43.71) 0.220
100.1-150.0g/week 0.69 (0.15-3.14) 0.631 2.51 (0.20-30.96) 0.472
>150.0g/weekd 1.34 (0.33-5.50) 0.686 - -
Risk per year increase in follow-up
Never drinkers (reference)
Non-current drinkers 0.98 (0.83-1.14) 0.772 0.84 (0.69-1.01) 0.064
Infrequent drinkers 1.01 (0.89-1.14) 0.906 0.83 (0.71-0.97) 0.017
0.1-50.0g/week 0.98 (0.88-1.10) 0.776 0.83 (0.71-0.96) 0.016
50.1-100.0g/week 0.97 (0.86-1.09) 0.636 0.87 (0.73-1.03) 0.113
100.1-150.0g/week 1.03 (0.91-1.17) 0.592 0.88 (0.72-1.06) 0.185
>150.0g/week 0.97 (0.87-1.10) 0.674 - -
Log likelihood -4162 -1690
BIC e 8647 3657
Men (n=4,874) Women (n=2,094)
Models adjusted for all  a priori covariates at baseline: age, BMI, employment status, ethnicity, 
family history of T2DM, occupational grade, physical activity, smoking status. Ethnicity was 
derived from responses at waves one and five.
aParticipants who reported no consumption in the past week in waves 1 and 3, no consumption 
in the past year in waves 1 and 3, and stated they had 'always been a non-drinker' in wave 3, the 
first year the always non-drinker variable was available;   bParticipants who reported no 
consumption in the last year but had not 'aways been a non-drinker'; cConsumed alcohol in the 
past year but not in the past week; dAmong women, this category was merged with those who 
reported consuming 100.1-150.0g/week; eBayesian information criterion.
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Appendix 7.11 Multivariable-adjusted dose-response relationship between categories of 
average weekly volume of alcohol consumption, drink type and T2DM, stratified by sex. 
Imputed data. 
  
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Drink type
Beer (per 10 g/week) 0.99 (0.98-1.00) 0.236 0.85 (0.72-0.99) 0.042
Spirits (per 10 g/week) 1.01 (0.99-1.03) 0.343 0.94 (0.87-1.01) 0.113
Wine (per 10 g/week) 1.00 (0.98-1.02) 0.773 0.95 (0.90-1.01) 0.081
Log likelihood -4509 (-4574, -4378) -1758 (-1759, -1758)
BIC a 8895 (8893, 8897) 3640 (3640, 3641)
Men (n=5,083) Women (n=2,224)
Models reported results adjusted for all  a priori covariates: age, BMI, employment status, ethnicity, 
family history of T2DM, occupational grade, physical activity, smoking status. Ethnicity was derived 
from responses at waves one and five. Models also included variables representing the volume of each 
drink type consumed during the week prior to interview.
aBayesian information criterion. Fit statistics refer to the mean and range of values reported by the 
first three imputations.
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11.4 Appendices for Chapter 8 
Appendix 8.1 Crude sex-specific linear trajectory of mean weekly volume of alcohol 
consumption between the ages of 34-84 years: goodness of fit statistics. Imputed data. 
 
  
Linear mixed models Log-likelihood BIC
a
Men
Intercept only -232502 (-232763,-232191) 465035 (464414-465557)
Linear mixed model, fixed slopes -232476 (-232731,-232165) 464994 (464371-465504)
Linear mixed model, random slopes -232361 (-232622,-232023) 464786 (464109-465306)
Women
Intercept only -103392 (-103679,-103192) 206814 (206414-207387)
Linear mixed model, fixed slopes -103390 (-103677,-103191) 206820 (206422-207393)
Linear mixed model, random slopes -103355 (-103650,-103150) 206756 (206360-207320)
Fit statistics
aBayesian information criterion. Values refer to the mean and range of fit statistics as reported 
from the first three imputations.
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Appendix 8.2 Crude sex-specific linear and non-linear trajectories of mean weekly volume of 
alcohol consumption between the ages of 34-84 years: results. Imputed data. 
 
Mixed models g/week (95% CI) p-value
Men (n=6,895)
Linear model
Intercept 114.8 (111.3, 118.3) <0.001
Age -3.0 (-4.2, -1.9) <0.001
Non-linear model
Intercept 88.6 (84.2, 93.0) <0.001
Age1 2.5 (2.1, 2.8) <0.001
Age2 -6.1 (-6.8, -6.3) <0.001
Women (n=3,413)
Linear model
Intercept 50.5 (47.6, 53.4) <0.001
Age -0.5 (-1.4, 0.5) 0.352
Non-linear model
Intercept 39.4 (36.1, 42.8) <0.001
Age1 0.8 (0.6, 1.0) <0.001
Age3 -0.4 (-0.5, -0.3) <0.001
Age coefficients refer to the change in the average volume of weekly 
alcohol consumption per 10-year increase in age.
Chapter 11: Appendices 
316 
 
Appendix 8.3 Crude sex specific trajectories of mean weekly volume of alcohol consumption 
between the ages of 34-84 years: figure. Imputed data. 
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Appendix 8.4 Crude sex-specific linear and non-linear trajectories of mean weekly volume of 
alcohol consumption between the ages of 34-84 years: goodness of fit statistics. Observed 
data. 
  
First-order polynomial models Log-likelihood BIC
a
Log-likelihood BIC
a
age-2 -184343 368748 -72549 145156
age-1 -184320 368702 -72538 145133
age-0.5 -184254 368571 -72520 145098
ln(age) -184130 368322 -72496 145049
age0.5 -184072 368206 -72494 145045
age -184042 368146 -72500 145057
age2 -184056 368174 -72493 145043
age3 -184098 368259 -72465 144987
Second-order polynomial models Log-likelihood BIC
a
Log-likelihood BIC
a
age-2+age-1 -184343 368717 -72549 145164
age-2+age-0.5 -184342 368757 -72547 145161
age-2+ln(age) -184337 368747 -72543 145152
age-2+age0.5 -184329 368730 -72537 145140
age-2+age -184315 368702 -72529 145125
age-2+age2 -184284 368641 -72514 145095
age-2+age3 -184261 368552 -72503 145073
age-1+age-2 -184320 368712 -72538 145142
age-1+age-0.5 -184313 368699 -72533 145133
age-1+ln(age) -184304 368680 -72528 145123
age-1+age0.5 -184291 368655 -72522 145110
age-1+age -184276 368624 -72514 145096
age-1+age2 -184246 368564 -72501 145068
age-1+age3 -184225 368523 -72491 145050
age-0.5+age2 -184253 368579 -72520 145106
age-0.5+age-1 -184247 368565 -72517 145101
age-0.5+ln(age) -184225 368523 -72508 145083
age-0.5+age0.5 -184207 368487 -72500 145067
age-0.5+age -184190 368452 -72493 145052
age-0.5+age2 -184160 368392 -72480 145027
age-0.5+age3 -184143 368358 -72472 145011
Men Women
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ln(age)+age-2 -184127 368327 -72495 145058
ln(age)+age-1 -184117 368306 -72492 145051
ln(age)+age-0.5 -184106 368284 -72489 145044
ln(age)+age0.5 -184051 368174 -72469 145005
ln(age)+age -184035 368143 -72463 144993
ln(age)+age2 -184009 368090 -72452 144971
ln(age)+age3 -183997 368067 -72447 144960
age0.5+age-2 -184068 368208 -72494 145054
age0.5+age-1 -184054 368180 -72490 145047
age0.5+age-0.5 -184037 368147 -72485 145037
age0.5+ln(age) -184000 368072 -72473 145013
age0.5+age -183968 368009 -72462 144991
age0.5+age2 -183941 367954 -72452 144970
age0.5+age3 -183933 367938 -72447 144961
age+age-2 -184037 368147 -72500 145066
age+age-1 -184022 368116 -72497 145060
age+age-0.5 -184003 368079 -72492 145050
age+ln(age) -183968 368009 -72481 145029
age+age0.5 -183953 367978 -72476 145019
age+age2 -183909 367890 -72461 144988
age+age3 -183905 367883 -72458 144983
age2+age-2 -184052 368177 -72493 145052
age2+age-1 -184037 368147 -72491 145048
age2+age-0.5 -184019 368110 -72486 145040
age2+ln(age) -183990 368052 -72479 145024
age2+age0.5 -183975 368023 -72475 145016
age2+age -183961 367994 -72470 145008
age2+age3 -183953 367978 -72467 145000
age3+age-2 -184096 368264 -72465 144996
age3+age-1 -184084 368241 -72464 144995
age3+age-0.5 -184070 368213 -72461 144989
age3+ln(age) -184050 368172 -72456 144980
age3+age0.5 -184041 368155 -72454 144975
age3+age -184034 368141 -72452 144971
age3+age2 -184033 368138 -72452 144970
aBayesian information criterion.
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Appendix 8.5 Crude sex-specific linear and non-linear trajectories of mean weekly volume of 
alcohol consumption between the ages of 34-84 years: goodness of fit statistics. Imputed data. 
 
First-order polynomial models Log-likelihood BIC
a
Men
age-2 -232501 (-232762, -232191) 465034 (464414, 465556)
age-1 -232501 (-232762, -232191) 465045 (464424, 465567)
age-0.5 -232501 (-232762, -232191) 465044 (464423, 465567)
ln(age) -232501 (-232761, -232191) 465044 (464423, 465564)
age0.5 -232492 (-232750, -232181) 465027 (464405, 465542)
age -232476 (-232731, -232165) 464994 (464371, 465504)
age2 -232436 (-232686, -232126) 464915 (464295, 465415)
age3 -232407 (-232655, -232099) 464857 (464241, 465352)
Women
age-2 -103392 (-103677, -103192) 206823 (206424, 207394)
age-1 -103389 (-103673, -103190) 206817 (206419, 207385)
age-0.5 -103389 (-103673, -103189) 206817 (206418, 207386)
ln(age) -103391 (-103677, -103191) 206822 (206421, 207393)
age0.5 -103392 (-103679, -103192) 206824 (206424, 207397)
age -103390 (-103677, -103191) 206820 (206422, 207393)
age2 -103380 (-103666, -103184) 206800 (206408, 207372)
age3 -103369 (-103655, -103176) 206778 (206391, 207349)
Second-order polynomial models Log-likelihood BIC
a
Men
age-2+age-1 -232501 (-232762, -232191) 465034 (464414, 465556)
age-2+age-0.5 -232500 (-232762, -232190) 465032 (464412, 465555)
age-2+ln(age) -232500 (-232761, -232190) 465043 (464423, 465563)
age-2+age0.5 -232492 (-232750, -232181) 465026 (464405, 465542)
age-2+age -232475 (-232730, -232164) 464993 (464371, 465503)
age-2+age2 -232436 (-232686, -232126) 464914 (464294, 465414)
age-2+age3 -232407 (-232655, -232099) 464856 (464240, 465351)
age-1+age-2 -232501 (-232762, -232191) 465045 (464424, 465567)
age-1+age-0.5 -232500 (-232762, -232190) 465054 (464433, 465576)
age-1+ln(age) -232500 (-232761, -232190) 465054 (464433, 465574)
age-1+age0.5 -232492 (-232750, -232181) 465037 (464415, 465552)
age-1+age -232475 (-232730, -232164) 465004 (464381, 465513)
age-1+age2 -232436 (-232686, -232126) 464925 (464304, 465425)
age-1+age3 -232407 (-232655, -232099) 464867 (464251, 465362)
Men (m=3/50)a
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age-0.5+age2 -232500 (-232762, -232190) 465032 (464412, 465555)
age-0.5+age-1 -232500 (-232762, -232190) 465054 (464433, 465576)
age-0.5+ln(age) -232466 (-232722, -232152) 464985 (464357, 465498)
age-0.5+age0.5 -232444 (-232699, -232131) 464942 (464314, 465450)
age-0.5+age -232422 (-232674, -232109) 464897 (464271, 465401)
age-0.5+age2 -232387 (-232635, -232077) 464827 (464206, 465324)
age-0.5+age3 -232369 (-232617, -232062) 464791 (464176, 465286)
ln(age)+age-2 -232500 (-232761, -232190) 465043 (464423, 465563)
ln(age)+age-1 -232500 (-232761, -232190) 465054 (464433, 465574)
ln(age)+age-0.5 -232466 (-232722, -232152) 464985 (464357, 465498)
ln(age)+age0.5 -232419 (-232671, -232105) 464890 (464264, 465394)
ln(age)+age -232396 (-232646, -232084) 464845 (464222, 465345)
ln(age)+age2 -232367 (-232614, -232058) 464786 (464169, 465281)
ln(age)+age3 -232357 (-232604, -232051) 464766 (464156, 465261)
age0.5+age-2 -232492 (-232750, -232181) 465026 (464405, 465542)
age0.5+age-1 -232492 (-232750, -232181) 465037 (464415, 465552)
age0.5+age-0.5 -232444 (-232699, -232131) 464942 (464314, 465450)
age0.5+ln(age) -232419 (-232671, -232105) 464890 (464264, 465394)
age0.5+age -232374 (-232622, -232064) 464800 (464180, 465296)
age0.5+age2 -232353 (-232600, -232047) 464759 (464147, 465252)
age0.5+age3 -232352 (-232599, -232048) 464756 (464149, 465250)
age+age-2 -232475 (-232730, -232164) 464993 (464371, 465503)
age+age-1 -232475 (-232730, -232164) 465004 (464381, 465513)
age+age-0.5 -232422 (-232674, -232109) 464897 (464271, 465401)
age+ln(age) -232396 (-232646, -232084) 464845 (464222, 465345)
age+age0.5 -232374 (-232622, -232064) 464800 (464180, 465296)
age+age2 -232348 (-232594, -232044) 464748 (464140, 465240)
age+age3 -232353 (-232600, -232051) 464758 (464155, 465253)
age2+age-2 -232436 (-232686, -232126) 464914 (464294, 465414)
age2+age-1 -232436 (-232686, -232126) 464925 (464304, 465425)
age2+age-0.5 -232387 (-232635, -232077) 464827 (464206, 465324)
age2+ln(age) -232367 (-232614, -232058) 464786 (464169, 465281)
age2+age0.5 -232353 (-232600, -232047) 464759 (464147, 465252)
age2+age -232348 (-232594, -232044) 464748 (464140, 465240)
age2+age3 -232362 (-232611, -232062) 464778 (464176, 465275)
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age3+age-2 -232407 (-232655, -232099) 464856 (464240, 465351)
age3+age-1 -232407 (-232655, -232099) 464867 (464251, 465362)
age3+age-0.5 -232369 (-232617, -232062) 464791 (464176, 465286)
age3+ln(age) -232357 (-232604, -232051) 464766 (464156, 465261)
age3+age0.5 -232352 (-232599, -232048) 464756 (464149, 465250)
age3+age -232353 (-232600, -232051) 464758 (464155, 465253)
age3+age2 -232362 (-232611, -232062) 464778 (464176, 465275)
Women
age-2+age-1 -103386 (-103670, -103186) 206821 (206421, 207389)
age-2+age-0.5 -103388 (-103673, -103188) 206826 (206425, 207395)
age-2+ln(age) -103391 (-103676, -103191) 206831 (206431, 207402)
age-2+age0.5 -103391 (-103677, -103192) 206832 (206434, 207404)
age-2+age -103389 (-103675, -103191) 206827 (206431, 207398)
age-2+age2 -103378 (-103664, -103184) 206806 (206417, 207376)
age-2+age3 -103368 (-103652, -103176) 206785 (206401, 207353)
age-1+age-2 -103386 (-103670, -103186) 206821 (206421, 207389)
age-1+age-0.5 -103388 (-103673, -103189) 206826 (206428, 207395)
age-1+ln(age) -103388 (-103672, -103190) 206825 (206429, 207394)
age-1+age0.5 -103385 (-103669, -103189) 206819 (206427, 207387)
age-1+age -103380 (-103663, -103186) 206809 (206420, 207376)
age-1+age2 -103368 (-103650, -103177) 206785 (206403, 207350)
age-1+age3 -103358 (-103639, -103168) 206765 (206386, 207328)
age-0.5+age2 -103388 (-103673, -103188) 206826 (206425, 207395)
age-0.5+age-1 -103388 (-103673, -103189) 206826 (206428, 207395)
age-0.5+ln(age) -103383 (-103666, -103187) 206815 (206423, 207382)
age-0.5+age0.5 -103377 (-103660, -103183) 206804 (206416, 207368)
age-0.5+age -103370 (-103652, -103178) 206790 (206405, 207353)
age-0.5+age2 -103357 (-103637, -103168) 206763 (206384, 207324)
age-0.5+age3 -103348 (-103627, -103160) 206745 (206368, 207304)
ln(age)+age-2 -103391 (-103676, -103191) 206831 (206431, 207402)
ln(age)+age-1 -103388 (-103672, -103190) 206825 (206429, 207394)
ln(age)+age-0.5 -103383 (-103666, -103187) 206815 (206423, 207382)
ln(age)+age0.5 -103367 (-103648, -103175) 206784 (206400, 207345)
ln(age)+age -103359 (-103639, -103169) 206767 (206386, 207327)
ln(age)+age2 -103346 (-103624, -103157) 206741 (206364, 207298)
ln(age)+age3 -103338 (-103617, -103151) 206726 (206351, 207283)
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age0.5+age-2 -103391 (-103677, -103192) 206832 (206434, 207404)
age0.5+age-1 -103385 (-103669, -103189) 206819 (206427, 207387)
age0.5+age-0.5 -103377 (-103660, -103183) 206804 (206416, 207368)
age0.5+ln(age) -103367 (-103648, -103175) 206784 (206400, 207345)
age0.5+age -103348 (-103627, -103159) 206746 (206368, 207303)
age0.5+age2 -103337 (-103615, -103149) 206724 (206348, 207280)
age0.5+age3 -103333 (-103611, -103145) 206715 (206339, 207272)
age+age-2 -103389 (-103675, -103191) 206827 (206431, 207398)
age+age-1 -103380 (-103663, -103186) 206809 (206420, 207376)
age+age-0.5 -103370 (-103652, -103178) 206790 (206405, 207353)
age+ln(age) -103359 (-103639, -103169) 206767 (206386, 207327)
age+age0.5 -103348 (-103627, -103159) 206746 (206368, 207303)
age+age2 -103333 (-103611, -103145) 206715 (206338, 207271)
age+age3 -103331 (-103610, -103143) 206712 (206335, 207269)
age2+age-2 -103378 (-103664, -103184) 206806 (206417, 207376)
age2+age-1 -103368 (-103650, -103177) 206785 (206403, 207350)
age2+age-0.5 -103357 (-103637, -103168) 206763 (206384, 207324)
age2+ln(age) -103346 (-103624, -103157) 206741 (206364, 207298)
age2+age0.5 -103337 (-103615, -103149) 206724 (206348, 207280)
age2+age -103333 (-103611, -103145) 206715 (206338, 207271)
age2+age3 -103333 (-103613, -103144) 206716 (206337, 207276)
age3+age-2 -103368 (-103652, -103176) 206785 (206401, 207353)
age3+age-1 -103358 (-103639, -103168) 206765 (206386, 207328)
age3+age-0.5 -103348 (-103627, -103160) 206745 (206368, 207304)
age3+ln(age) -103338 (-103617, -103151) 206726 (206351, 207283)
age3+age0.5 -103333 (-103611, -103145) 206715 (206339, 207272)
age3+age -103331 (-103610, -103143) 206712 (206335, 207269)
age3+age2 -103333 (-103613, -103144) 206716 (206337, 207276)
Fit statistics calculated on fixed effect models due to issues of convergence when some 
transformations were included as random effects. Values represent the mean and range of 
fit statistics as reported from the first three imputations. aBayesian information criterion.
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Appendix 8.6 Crude sex-specific non-linear trajectories of mean weekly volume of alcohol 
consumption between the ages of 34-84 years: figure. Imputed data. 
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Appendix 8.7 Crude sex-specific interaction between the trajectory of mean weekly volume of alcohol 
consumption and baseline alcohol consumption category: results. Imputed data. 
 
Linear mixed models Sample n g/week (95% CI) p-value
Men
Difference in baseline consumption by drinking category
Non-drinker 220 Reference
Infrequent drinker 669 7.8 (3.6, 12.0) <0.001
0.1-50.0 g/week 2,073 37.6 (33.9, 41.3) <0.001
50.1-100.0 g/week 1,432 85.6 (81.1, 90.1) <0.001
100.1-150.0 g/week 881 140.8 (135.1, 146.3) <0.001
>150.0 g/week 1,563 291.9 (283.1, 301.0) <0.001
Difference in the rate of change by drinking category
Non-drinker Reference
Infrequent drinker 4.0 (1.9, 6.2) <0.001
0.1-50.0 g/week 1.7 (-0.3, 3.6) 0.092
50.1-100.0 g/week -1.3 (-3.8, 1.1) 0.276
100.1-150.0 g/week -8.9 (-11.6, -6.1) <0.001
>150.0 g/week -36.4 (-40.0, -32.8) <0.001
Women
Difference in baseline consumption by drinking category
Non-drinker 216 Reference
Infrequent drinker 764 4.9 (2.0, 7.8) 0.001
0.1-50.0 g/week 1,428 33.4 (30.4, 36.5) <0.001
50.1-100.0 g/week 542 82.0 (77.1, 86.8) <0.001
>100.0 g/week 422 184.1 (173.2, 195.0) <0.001
Difference in the rate of change by drinking category
Non-drinker Reference
Infrequent drinker 1.2 (-0.4, 2.8) 0.143
0.1-50.0 g/week -2.6 (-4.3, -1.0) 0.002
50.1-100.0 g/week -7.1 (-9.5, -4.6) <0.001
>100.0 g/week -27.1 (-31.2, -23.0) <0.001
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Appendix 8.8 Crude sex-specific linear trajectories of mean weekly volume of alcohol 
consumption between the ages of 34-84 years, stratified by baseline alcohol consumption 
category: figure. Imputed data. 
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Appendix 8.9 Baseline characteristics of T2DM-free participants, stratified by T2DM diagnosis. 
Imputed data. 
 
 
T2DM Censored
Variables (wave one)
% (95% CI)
n
% (95% CI)
n
Men
Age
Mean years 45.0 (44.6, 45.5)a
620
44.4 (44.2, 44.6)a
5,103
Alcohol consumption frequency
None in past year 4.4 (2.8, 6.1)
28
2.6 (2.2, 3.0)
132
<1/week 21.9 (18.6, 25.1)
136
19.6 (18.5, 20.7)
1,002
1-3 times/week 40.2 (36.4, 44.1)
249
43.6 (42.3, 45.0)
2,226
Daily or almost daily 33.5 (29.7, 37.2)
207
34.2 (32.8, 35.5)
1,743
Alcohol consumption volume
Median g/week 98.8 (89.9, 107.8)b
620
101.8 (98.7, 104.9)b
5,103
BMI
Mean kg/m2 26.1 (25.8, 26.3)a
620
24.3 (24.2, 24.4)a
5,103
Ethnicty
White 84.8 (82.0, 87.7)
526
94.6 (94.0, 95.2)
4,826
South Asian 11.8 (9.2, 14.3)
73
3.4 (2.9, 3.9)
175
Otherc 3.4 (2.0, 4.8)
21
2.0 (1.6, 2.4)
101
Family history of T2DM
Yes 81.1 (78.0, 84.2)
503
91.2 (90.4, 92.0)
4,652
No 18.9 (15.8, 22.0)
117
8.8 (8.0, 9.6)
451
Occupational grade
Administrative (top) 35.0 (31.2, 38.8)
217
41.3 (39.9, 42.6)
2.106
Professional (middle) 54.0 (50.1, 58.0)
335
52.1 (50.7, 53.4)
2,657
Clerical (bottom) 11.0 (8.5, 13.4)
68
6.7 (6.0, 7.3)
340
Physical activityd
Inactive 12.4 (9.8, 15.0)
77
8.3 (7.6, 9.1)
425
Below guidelines 40.0 (36.1, 43.9)
248
37.4 (36.1, 38.8)
1,911
Met guidelines 47.6 (43.6, 51.5)
295
54.2 (52.9, 55.6)
2,767
Smoking
Never 42.4 (38.5, 46.3)
263
49.9 (48.5, 51.2)
2,545
Former 39.1 (35.2, 42.9)
242
36.4 (35.0, 37.7)
1,855
Current 18.6 (15.5, 21.6)
115
13.8 (12.8, 14.7)
703
Women
Age
Years 46.7 (46.0, 47.4)a
296
45.3 (45.1, 45.6)a
2,274
Alcohol consumption frequency
None in past year 9.5 (6.1, 12.8)
28
5.7 (4.7, 6.6)
129
<1/week 51.4 (45.6, 57.1)
152
35.3 (33.4, 37.3)
803
1-3 times/week 28.7 (23.5, 33.9)
85
36.6 (34.6, 38.5)
831
Daily or almost daily 10.5 (7.0, 14.0)
31
22.5 (20.7, 24.2)
511
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Physical activityd
Inactive 12.4 (9.8, 15.0)
77
8.3 (7.6, 9.1)
425
Below guidelines 40.0 (36.1, 43.9)
248
37.4 (36.1, 38.8)
1,911
Met guidelines 47.6 (43.6, 51.5)
295
54.2 (52.9, 55.6)
2,767
Smoking
Never 42.4 (38.5, 46.3)
263
49.9 (48.5, 51.2)
2,545
Former 39.1 (35.2, 42.9)
242
36.4 (35.0, 37.7)
1,855
Current 18.6 (15.5, 21.6)
115
13.8 (12.8, 14.7)
703
Women
Age
Mean years 46.7 (46.0, 47.4)a
296
45.3 (45.1, 45.6)a
2,274
Alcohol consumption frequency
None in past year 9.5 (6.1, 12.8)
28
5.7 (4.7, 6.6)
129
<1/week 51.4 (45.6, 57.1)
152
35.3 (33.4, 37.3)
803
1-3 times/week 28.7 (23.5, 33.9)
85
36.6 (34.6, 38.5)
831
Daily or almost daily 10.5 (7.0, 14.0)
31
22.5 (20.7, 24.2)
511
Alcohol consumption volume
Median g/week 29.4 (23.3, 35.5)b
296
47.0 (44.5, 49.5)b
2,274
BMI
Mean kg/m2 28.0 (27.4, 28.6)a
296
24.2 (24.0, 24.3)a
2,274
Ethnicty
White 71.1 (65.9, 76.3)
211
89.1 (87.8, 90.3)
2,025
South Asian 14.5 (10.5, 18.6)
43
4.6 (3.7, 5.4)
103
Otherc 14.3 (10.3, 18.4)
42
6.4 (5.4, 7.4)
145
Family history of T2DM
Yes 68.9 (63.6, 74.3)
204
89.1 (87.8, 90.4)
2,026
No 31.1 (25.7, 36.4)
92
10.9 (9.6, 12.2)
248
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Alcohol consumption volume
g/week 29.4 (23.3, 35.5)b
296
47.0 (44.5, 49.5)b
2,274
BMI
kg/m2 28.0 (27.4, 28.6)a
296
24.2 (24.0, 24.3)a
2,274
Ethnicty
White 71.1 (65.9, 76.3)
211
89.1 (87.8, 90.3)
2,025
South Asian 14.5 (10.5, 18.6)
43
4.6 (3.7, 5.4)
103
Otherc 14.3 (10.3, 18.4)
42
6.4 (5.4, 7.4)
145
Family history of T2DM
Yes 68.9 (63.6, 74.3)
204
89.1 (87.8, 90.4)
2,026
No 31.1 (25.7, 36.4)
92
10.9 (9.6, 12.2)
248
Occupational grade
Administrative (top) 4.1 (1.8, 6.3)
12
14.0 (12.6, 15.5)
319
Professional (middle) 36.8 (31.3, 42.4)
109
43.0 (41.0, 45.0)
978
Clerical (bottom) 59.1 (53.5, 64.8)
175
43.0 (40.9, 45.0)
977
Physical activityd
Inactive 32.8 (27.4, 38.3)
97
23.0 (21.2, 24.7)
522
Below guidelines 34.2 (28.7, 39.7)
101
40.3 (38.3, 42.3)
917
Met guidelines 33.0 (27.6, 38.4)
98
36.7 (34.7, 38.7)
835
Smoking
Never 59.1 (53.5, 64.7)
175
54.3 (52.2, 56.3)
1,234
Former 22.2 (17.4, 27.0)
66
24.9 (23.1, 26.7)
567
Current 18.7 (14.2, 23.1)
55
20.8 (19.1, 22.5)
473
aMean and 95% confidence interval; bMedian and 25th and 75th percentiles; ce.g. black 
Caribbean, African and Arabic; dMeeting guidelines (≥150 minutes of moderate-intensity or 
≥75 minutes of vigorous-intensity activity per week); inactive (<60 minutes of moderate and 
<60 minutes of vigorous activity; below guidelines (not inactive or meeting guidelines).
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Appendix 8.10 Sex-specific interaction between the linear trajectory of mean weekly volume 
of alcohol consumption and T2DM diagnosis: goodness of fit statistics. Imputed data 
 
  
Mixed model Log-likelihood BICa
Men
Crude linear mixed model, fixed slope -173035 (-173255, -172857) 346132 (345776, 346571)
Crude linear mixed model, random slopes -172951 (-173171, -172765) 345984 (345613, 346424)
Women
Crude linear mixed model, fixed slope -67229 (-67566, -67016) 134514 (134089, 135188)
Crude linear mixed model, random slopes -67196 (-67546, -66969) 134467 (134014, 135167)
aBayesian information criterion. Values refer to the mean and range of fit statistics as reported by 
the first three imputations.
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Appendix 8.11 Crude sex-specific interaction between the linear trajectory of mean weekly 
volume of alcohol consumption and T2DM diagnosis: results. Imputed data. 
 
Crude linear mixed models g/week (95% CI) p-value
Men (n=5,723)
Consumption volume
Intercept 104.9 (101.9, 107.9) <0.001
Change per 10 years prior to diagnosis or censoring -1.5 (-2.7, -0.4) 0.009
Difference in consumption at the time of diagnosis or censoring
Censored Reference
T2DM 22.2 (10.8, 33.5) <0.001
Difference in the rate of change by diagnosis or censoring
Censored Reference
T2DM 17.0 (11.1, 23.0) <0.001
Women (n=2,570)
Consumption volume
Intercept 48.3 (45.7, 50.8) <0.001
Change per 10 years prior to diagnosis or censoring -1.0 (-2.0, -0.0) 0.045
Difference in consumption at the time of diagnosis or censoring
Censored Reference
T2DM -18.2 (-24.4, -12.0) <0.001
Difference in the rate of change by diagnosis or censoring
Censored Reference
T2DM 2.1 (-1.7, 6.0) 0.279
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Appendix 8.12 Crude sex-specific linear trajectory of mean weekly volume of alcohol 
consumption, stratified by T2DM diagnosis: figure. Imputed data. 
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Appendix 8.13 Crude sex-specific linear and non-linear trajectories of mean weekly alcohol 
consumption, stratified by T2DM diagnosis: goodness of fit statistics. Observed data. 
 
First-order models Log-likelihood
aBIC Log-likelihood
aBIC
Men
time-2 -12665 25361 -149882 299804
time-1 -12665 25361 -149866 299772
time1 -12648 25327 -149877 299794
time2 -12647 25324 -149882 299805
time3 -12649 25329 -149876 299792
Women
time-2 -4758 9543 -57154 114345
time-1 -4758 9543 -57153 114343
time1 -4759 9545 -57152 114342
time2 -4759 9545 -57159 114355
time3 -4759 9545 -57159 114355
Second-order models Log-likelihood
aBIC Log-likelihood
aBIC
Men
time-2+time-1 -12665 25368 -149813 299678
time-2+time -12648 25334 -149875 299801
time-2+time2 -12647 25332 -149880 299812
time-2+time3 -12649 25336 -149874 299799
time-1+time-2 -12665 25368 -149813 299678
time-1+time -12648 25334 -149862 299774
time-1+time2 -12647 25332 -149864 299778
time-1+time3 -12649 25336 -149857 299764
time+time-2 -12648 25334 -149875 299801
time+time-1 -12648 25334 -149862 299774
time+time2 -12647 25332 -149709 299468
time+time3 -12647 25333 -149730 299510
time2+time-2 -12647 25332 -149880 299812
time2+time-1 -12647 25332 -149864 299778
time2+time -12647 25332 -149709 299468
time2+time3 -12646 25331 -149779 299609
time3+time-2 -12649 25336 -149874 299799
time3+time-1 -12649 25336 -149857 299764
time3+time -12647 25333 -149730 299510
time3+time2 -12647 25331 -149779 299609
T2DM No T2DM
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Women
time-2+time-1 -4758 9549 -57152 114351
time-2+time -4758 9550 -57147 114340
time-2+time2 -4758 9550 -57154 114354
time-2+time3 -4758 9550 -57154 114354
time-1+time-2 -4758 9549 -57152 114351
time-1+time -4758 9549 -57146 114339
time-1+time2 -4758 9549 -57152 114351
time-1+time3 -4758 9549 -57153 114352
time+time-2 -4758 9550 -57147 114340
time+time-1 -4758 9549 -57146 114339
time+time2 -4759 9552 -57103 114252
time+time3 -4759 9552 -57111 114268
time2+time-2 -4758 9550 -57154 114354
time2+time-1 -4758 9549 -57153 114351
time2+time -4759 9552 -57103 114252
time2+time3 -4759 9552 -57129 114305
time3+time-2 -4758 9550 -57154 114354
time3+time-1 -4758 9549 -57153 114352
time3+time -4759 9552 -57111 114268
time3+time2 -4759 9552 -57129 114305
Fit statistics calculated on models with fixed slopes and without robust standard errors due 
to issues of convergence for some transformations when random slopes were expressed. 
aBayesian information criterion.
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Appendix 8.14 Crude sex-specific linear and non-linear trajectories of mean weekly alcohol 
consumption, stratified by T2DM diagnosis: goodness of fit statistics. Imputed data. 
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Appendix 8.15 Crude, sex-specific and best-fitting trajectories of mean weekly volume of 
alcohol consumption, stratified by T2DM diagnosis: results. Imputed data. 
 
  
Crude best-fitting mixed models g/week (95% CI) p-value
Men
T2DM (n=620)
Intercept 127.1 (116.0, 138.2) <0.001
Time1 15.4 (9.4, 21.3) <0.001
Censored (n=5,103)
Intercept 93.4 (90.4, 96.3) <0.001
Time1 -34.9 (-38.6, -31.1) <0.001
Time2 -1.3 (-1.5, -1.2) <0.001
Women
T2DM (n=296)
Intercept 30.1 (24.5, 35.7) <0.001
Time1 1.2 (-2.5, 5.0) 0.514
Censored (n=2,274)
Intercept 42.7 (40.1, 45.3) <0.001
Time1 -17.0 (-20.4, -13.6) <0.001
Time2 -0.6 (-0.8, -0.5) <0.001
Time coefficients refer to the change in the average volume of weekly alcohol consumption 
per 10 years prior to diagnosis or censoring.
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Appendix 8.16 Crude sex-specific best-fitting trajectories of mean weekly volume of alcohol 
consumption, stratified by T2DM diagnosis: figure. Imputed data. 
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Appendix 8.17 Crude linear and non-linear trajectories of alcohol consumption up to and 
beyond the date of diagnosis, stratified by sex: goodness of fit statistics. Observed data. 
 
  
Function Log-likelihood
aBIC Log-likelihood
aBIC
Up to diagnosis
time-2 -12665 25361 -4758 9543
time-1 -12665 25361 -4758 9543
time1 -12648 25327 -4759 9545
time2 -12647 25324 -4759 9545
time3 -12649 25329 -4759 9545
time-2+time-1 -12665 25368 -4758 9549
time-2+time -12648 25334 -4758 9550
time-2+time2 -12647 25332 -4758 9550
time-2+time3 -12649 25336 -4758 9550
time-1+time -12648 25334 -4758 9549
time-1+time2 -12647 25332 -4758 9549
time-1+time3 -12649 25336 -4758 9549
time+time2 -12647 25332 -4759 9552
time+time3 -12647 25333 -4759 9552
time2+time3 -12646 25331 -4759 9552
After diagnosis
time-2 -6777 13582 -2721 5468
time-1 -6775 13578 -2721 5467
time1 -6767 13562 -2719 5463
time2 -6766 13561 -2718 5461
time3 -6768 13565 -2718 5462
time-2+time-1 -6769 13573 -2720 5472
time-2+time -6766 13566 -2718 5469
time-2+time2 -6766 13568 -2718 5468
time-2+time3 -6768 13571 -2718 5467
time-1+time -6766 13566 -2718 5469
time-1+time2 -6766 13568 -2718 5468
time-1+time3 -6768 13571 -2718 5468
time+time2 -6766 13567 -2718 5468
time+time3 -6766 13568 -2718 5468
time2+time3 -6766 13567 -2718 5468
Men Women
Fit statistics calculated on models with fixed slopes and without robust standard errors due to 
issues of convergence for some transformations when random slopes were expressed. aBayesian 
information criterion.
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Appendix 8.18 Crude linear and non-linear trajectories of alcohol consumption up to and 
beyond the date of diagnosis, stratified by sex: goodness of fit statistics. Imputed data. 
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Appendix 8.19 Crude trajectories of mean weekly volume of alcohol consumption up to and 
beyond the date of diagnosis, stratified by sex. Imputed data. 
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Appendix 8.20 Crude sex-specific interaction between the trajectory of mean weekly volume 
of alcohol consumption and baseline alcohol consumption category, stratified by T2DM 
diagnosis: results. Imputed data. 
 
Crude linear mixed models Sample n g/week (95% CI) p-value g/week (95% CI) p-value
Men
Difference in consumption at the time 
of diagnosis or censoring by baseline 
consumption category
Non-drinker Reference Reference
Infrequent drinker 24.9 (5.3, 44.5) 0.013 27.7 (21.1, 34.3) <0.001
0.1-50.0 g/week 59.4 (40.8, 78.1) <0.001 50.0 (44.9, 55.0) <0.001
50.1-100.0 g/week 122.3 (97.9, 146.7) <0.001 89.6 (83.1, 96.2) <0.001
100.1-150.0 g/week 160.6 (126.2, 195.1) <0.001 120.9 (112.9, 129.0 <0.001
>150.0 g/week 209.1 (176.0, 242.2) <0.001 184.2 (175.0, 193.5) <0.001
Difference in the rate of change by 
baseline consumption categorya
Non-drinker Reference Reference
Infrequent drinker 10.8 (1.4, 20.1) 0.024 7.4 (5.0, 9.8) <0.001
0.1-50.0 g/week 14.4 (5.1, 23.7) 0.002 5.1 (3.1, 7.0) <0.001
50.1-100.0 g/week 25.1 (12.9, 37.3) <0.001 3.3 (0.7, 6.0) 0.012
100.1-150.0 g/week 24.1 (6.0, 42.2) 0.009 -3.3 (-6.4, -0.3) 0.034
>150.0 g/week -27.5 (-45.8, -9.3) 0.003 -30.0 (-33.9, -26.4) <0.001
Women
Difference in consumption at the time 
of diagnosis or censoring by baseline 
consumption category
Non-drinker Reference Reference
Infrequent drinker 14.4 (7.4, 21.4) <0.001 14.0 (10.0, 18.0) <0.001
0.1-50.0 g/week 28.5 (21.1, 35.9) <0.001 29.5 (25.6, 33.4) <0.001
50.1-100.0 g/week 39.6 (24.4, 54.6) <0.001 68.8 (62.3, 75.4) <0.001
>100.0 g/week 102.0 (65.6, 138.5) <0.001 106.2 (95.5, 116.9) <0.001
Difference in the rate of change by 
baseline consumption categorya
Non-drinker Reference Reference
Infrequent drinker 8.3 (4.0, 12.7) <0.001 3.6 (1.8, 5.4) <0.001
0.1-50.0 g/week 4.1 (-0.2, 8.4) 0.064 -0.2 (-1.9, 1.5) 0.849
50.1-100.0 g/week -17.4 (-25.0, -9.7) <0.001 -2.5 (-5.3, 0.2) 0.071
>100.0 g/week -25.0 (-52.4, 2.4) 0.074 -20.4 (-24.7, 16.1) <0.001
aRate of change per 10 years prior to diagnosis or censoring.
T2DM Censored
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Appendix 8.21 Crude male trajectories of mean weekly volume of alcohol consumption, 
stratified by baseline alcohol consumption category and T2DM diagnosis: figure. Imputed 
data. 
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Appendix 8.22 Crude female trajectories of mean weekly volume of alcohol, stratified by 
baseline alcohol consumption category and T2DM diagnosis: figure. Imputed data. 
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Appendix 8.23 Crude sex-specific best-fitting trajectory of mean weekly volume of alcohol 
consumption, stratified by T2DM diagnosis and excluding non-drinkers. Observed data. 
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Appendix 8.24 Crude sex-specific and best-fitting trajectory of mean weekly volume of alcohol 
consumption, stratified by T2DM diagnosis: a competing risk sensitivity analysis. Observed 
data. 
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11.5 Appendices for Chapter 9 
Appendix 9.1 Alternative distributional functions of the cumulative baseline hazard 
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Appendix 9.2 Relationship between the average weekly volume of alcohol consumption and 
the risk of T2DM, stratified by sex. Conventional survival analysis, imputed data. 
Alcohol consumption (wave 3) HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.04 (0.98, 1.12) 0.211 0.74 (0.65, 0.84) <0.001
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.25 (0.75, 2.08) 0.385 0.48 (0.24, 0.95) 0.036
Non-current drinker 1.74 (0.83, 3.67) 0.142 0.46 (0.19, 1.11) 0.084
Never drinker 2.39 (1.24, 4.60) 0.009 0.42 (0.18, 0.96) 0.040
Log likelihood -1693 (-1693, -1693) -747, (-747, -747)
BIC a 3437 (3437, 3437) 1542 (1542, 1532)
Model 2
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.00 (0.93, 1.06) 0.888 0.81 (0.71, 0.93) 0.003
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 0.94 (0.57, 1.54) 0.805 0.61 (0.30, 1.22) 0.160
Non-current drinker 1.16 (0.57, 2.37) 0.686 0.42 (0.18, 1.00) 0.050
Never drinker 0.96 (0.49, 1.88) 0.911 0.38 (0.16, 0.90) 0.028
Log likelihood -1507 (-1508, -1505) -639 (-640, -638)
BIC a 3177 (3173, 3180) 1427 (1425, 1428)
Model 1 reported the dose-response relationship between the volume alcohol consumption and T2DM 
following adjustment for consumption category. Model 2 included additional adjustment for BMI, 
date of birth, employment status, ethnicity, family history of T2DM, occupational grade, physical 
activity and smoking status, as defined at baseline. Ethnicity was derived from responses at waves 
one and five. aBayesian information criterion. Fit statistics refer to the mean and range of values 
reported from the first three imputations.
Men Women
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Appendix 9.3 Relationship between the average weekly volume of alcohol consumption and 
the risk of T2DM, stratified by sex. Age-varying covariate survival analysis, imputed data. 
 
 
Alcohol consumption HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.11 (1.03, 1.19) 0.004 0.84 (0.74, 0.95) 0.005
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 2.35 (1.37, 4.05) 0.002 0.96 (0.48, 1.91) 0.906
Non-current drinker 2.07 (0.98, 4.37) 0.057 1.15 (0.53, 2.48) 0.722
Never drinker 3.91 (1.95, 7.84) <0.001 0.67 (0.26, 1.67) 0.387
Log likelihood -1673 (-1673, -1673) -734 (-734, -734)
BIC a 3406 (3406, 3406) 1523 (1523, 1523)
Model 2
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.07 (1.00, 1.15) 0.053 0.93 (0.82, 1.05) 0.227
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.68 (0.99, 2.86) 0.054 1.19 (0.60, 2.34) 0.623
Non-current drinker 1.19 (0.56, 2.54) 0.654 1.27 (0.59, 2.72) 0.536
Never drinker 1.67 (0.84, 3.33) 0.146 0.67 (0.28, 1.64) 0.386
Log likelihood -1456 (-1456, -1455) -620 (-621, -620)
BIC a 3101 (3099, 3102) 1414 (1412, 1415)
Men Women
Model 1 reported the dose-response relationship between the volume alcohol consumption and T2DM 
following adjustment for consumption category. Model 2 included additional adjustment for BMI, 
date of birth, employment status, ethnicity, family history of T2DM, occupational grade, physical 
activity and smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion. Fit statistics refer to the mean and range of values reported from the first three 
imputations.
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Appendix 9.4 Relationship between the average weekly volume of alcohol consumption and 
the risk of T2DM, stratified by sex. Two-stage survival analysis, imputed data. 
 
  
Alcohol consumption HR (95% CI) p-value HR (95% CI) p-value
Model 1
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.05 (0.98, 1.11) 0.151 0.82 (0.76, 0.89) <0.001
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.41 (1.01, 1.97) 0.045 1.29 (0.91, 1.84) 0.155
Non-current drinker 1.31 (0.66, 2.58) 0.440 1.35 (0.81, 2.25) 0.253
Never drinker 2.52 (1.36, 4.67) 0.003 0.75 (0.36, 1.56) 0.445
Log likelihood -1677 (-1677, -1677) -730 (-730, -730)
BIC a 3413 (3413, 3413) 1514 (1514, 1514)
Model 2
Cases/non-cases 560/4,867 268/2,155
Consumption volume
g/week (log2) 1.04 (0.98, 1.10) 0.209 0.92 (0.85, 1.00) 0.056
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.25 (0.90, 1.74) 0.189 1.38 (0.97, 1.96) 0.073
Non-current drinker 0.93 (0.46, 1.85) 0.831 1.41 (0.84, 2.35) 0.190
Never drinker 1.33 (0.72, 2.45) 0.370 0.74 (0.37, 1.50) 0.404
Log likelihood -1457 (-1458, -1456) -620 (-620, -619)
BIC a 3103 (3101, 3104) 1412 (1411, 1413)
Men Women
Model 1 reported the dose-response relationship between the volume alcohol consumption and T2DM 
following adjustment for consumption category. Model 2 included additional adjustment for BMI, 
date of birth, employment status, ethnicity, family history of T2DM, occupational grade, physical 
activity and smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion. Fit statistics refer to the mean and range of values reported from the first three 
imputations.
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Appendix 9.5 Multivariable-adjusted relationship between intercept and current value 
parameterisations of average weekly volume of alcohol consumption and the risk of T2DM, 
stratified by sex. Shared random effects survival analysis, time-to-event timescale, observed 
data. 
 
 
 
  
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 1.02 (0.95, 1.09) 0.90 (0.80, 1.02) 0.111
Consumption category
Current drinker (reference)
Infrequent drinker 1.14 (0.77, 1.69) 1.31 (0.80, 1.02) 0.250
Non-current drinker 0.96 (0.47, 1.93) 1.35 (0.70, 2.59) 0.369
Never drinker 1.03 (0.49, 2.16) 0.67 (0.27, 1.66) 0.385
Log likelihood -38075 -15914
BIC a 76384 32039
Current value
Consumption volume
g/week (log2) 1.05 (0.97, 1.13) 0.258 0.95 (0.83, 1.08) 0.411
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.28 (0.83, 1.97) 0.268 1.47 (0.89, 2.43) 0.135
Non-current drinker 1.10 (0.53, 2.30) 0.796 1.54 (0.77, 3.10) 0.221
Never drinker 1.19 (0.55, 2.55) 0.664 0.77 (0.30, 1.97) 0.584
Log likelihood -38074 -15915
BIC a 76383 32041
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion.
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Appendix 9.6 Multivariable-adjusted associations between conditional intercept and current 
value parameterisations of average weekly volume of alcohol consumption and the risk of 
T2DM, stratified by sex. Shared random effects survival analysis, time-to-event timescale, 
observed data. 
 
  
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 0.83 (0.67, 1.02) 0.075 0.32 (0.15, 0.72) 0.005
Current value
g/week (log2) 1.28 (1.01, 1.63) 0.042 3.05 (1.33, 6.96) 0.008
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.41 (0.90, 2.20) 0.134 2.06 (1.16, 3.64) 0.013
Non-current drinker 1.26 (0.59, 2.68) 0.553 2.28 (1.06, 4.89) 0.035
Never drinker 3.52 (1.80, 14.64) 0.547 0.97 (0.36, 2.62) 0.957
Log likelihood -38073 -15909
BIC a 76389 32038
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion.
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Appendix 9.7 Multivariable-adjusted relationship between the rate of change in the average 
weekly volume of alcohol consumption and the risk of T2DM, stratified by sex and adjusted 
for intake at the intercept. Shared random effects survival analysis, observed data. 
 
  
  
Parameterisation HR (95% CI) p-value HR (95% CI) p-value
Intercept value
Consumption volume
g/week (log2) 1.14 (1.03, 1.26) 0.010 0.96 (0.83, 1.11) 0.581
Consumption category
Current drinker (reference) (reference)
Infrequent drinker 1.69 (1.08, 2.64) 0.023 1.80 (1.05, 3.10) 0.034
Non-current drinker 1.97 (0.88, 4.42) 0.100 2.00 (0.93, 4.29) 0.077
Never drinker 1.83 (0.76, 4.40) 0.175 0.84 (0.31, 2.29) 0.730
Slope
5% increase in the rate of change
g/week (log2) 2.42 (1.65, 3.56) <0.001 2.89 (1.28, 6.54) 0.011
5% decrease in rate of change
g/week (log2) 0.42 (0.29, 0.61) <0.001 0.77 (0.63, 0.94) 0.011
Log likelihood -38285 -15918
BIC a 76804 32048
Men (n=4,793) Women (n=2,053)
All models included adjustment for consumption category as well as BMI, date of birth, 
employment status, ethnicity, family history of T2DM, occupational grade, physical activity and 
smoking status. Ethnicity was derived from responses at waves one and five. aBayesian 
information criterion.
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